matchedPattern,context,lineNumber,columnNumber,publicationName
p.G193S,"mutation, p.G193S, causing fatal infantile cardioencephalomy...",289,11,Acta_Myol_2011_Jul_30(1)_9-15.txt
p.T378P,...harbored the same previously unreported mutation (p.T378P) that we had identified in our latest pati...,98,294,Acta_Myol_2011_Oct_30(2)_96-102.txt
p.V600E,"...quently found in cutaneous melanomas (c.1799 T>A, p.V600E), raising the question whether this is a m...",3,2201,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Pro,...able 3). All mutations were present in codon 209 (p.Gln209Pro and p.Gln209Leu) and were somatic muta...,81,162,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,...ations were present in codon 209 (p.Gln209Pro and p.Gln209Leu) and were somatic mutations (Fig. 2). ...,81,178,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.V600E,"...BRAF gene revealed one BRAF mutation (c.1799 T>A, p.V600E), in a melanoma. No HRAS or NRAS mutations...",81,801,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Pro,3	MC	c.626 A>C (p.Gln209Pro)	wt	wt	wt,86,17,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Pro,7	MC	c.626 A>C (p.Gln209Pro)	wt	wt	wt,90,17,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Pro,9	MC	c.626 A>C (p.Gln209Pro)	wt	na	wt,92,17,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,10	MM	c.626 A>T (p.Gln209Leu)	wt	wt	na,93,18,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,12	MC	c.626 A>T (p.Gln209Leu)	wt	na	na,95,18,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,13	MC	c.626 A>T (p.Gln209Leu)	wt	wt	na,96,18,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,14	MC	c.626 A>T (p.Gln209Leu)	wt	wt	wt,97,18,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.V600E,15	MM	wt	c.1799 T>A (p.V600E)	na	wt,98,22,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.V600E,"... with a BRAF point mutation (case 15; c.1799 T>A, p.V600E) might be a metastasis rather than a prima...",114,857,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Val600Glu,... Kular J Millward M Iacopetta B Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecu...,152,68,Acta_Neuropathol_Commun_2013_May_30_1_20.txt
p.Val600Lys,...d M Iacopetta B Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 1...,152,84,Acta_Neuropathol_Commun_2013_May_30_1_20.txt
p.V600E,...l S Cote JF Peschaud F Capper D Detection of BRAF p.V600E mutations in melanomas: comparison of four...,162,128,Acta_Neuropathol_Commun_2013_May_30_1_20.txt
p.Tyr1858Sto,...rphic features.	Yes From birth	ex45; c.5574C > G; p.Tyr1858Stop; int122; c.19101 + 5G > A; p.Leu6333...,36,326,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Tyr4356Thr,...rom birth	ex86 (triplicated region); c.13066delT; p.Tyr4356Thrfs*8 ex110; c.17535G > A; p.Glu5845Glu...,39,327,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Glu5845Glu,....13066delT; p.Tyr4356Thrfs*8 ex110; c.17535G > A; p.Glu5845Glu	exon 86: frameshift mutation leading ...,39,365,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Glu8229Glu,...ocephaly.	Yes From birth	ex177; c.24686_24687del; p.Glu8229Glufs*18	both mutations truncating/degrad...,40,352,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Arg7807Ser,ex163; c.23420_23421del; p.Arg7807Serfs*16,41,26,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Glu8229Glu,...ocephaly.	Yes From birth	ex177; c.24686_24687del; p.Glu8229Glufs*18	both mutations truncating/degrad...,42,360,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Arg7807Ser,ex163; c.23420_23421del; p.Arg7807Serfs*16,43,26,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Gly6976Gly,...acheostomy.	Yes From 1 month	ex139; c.20928G > T; p.Gly6976Gly	RTPCR and Sanger sequencing of cDNA s...,46,389,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Pro8148Ser,"... 5 months	homozygous ex174; c.24440_24441insGTCA, p.Pro8148Serfs*15	truncating/degrading	Present pap...",48,390,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Val7425Ser,...3 + 5G > A p.Arg1747_Thr1778del ex153; c.22273del p.Val7425Serfs49*	intron 43: a splice site mutatio...,49,380,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Ser8193Ser,"...non-invasive ventilation.	No	ex175; c.24579G > A, p.Ser8193Ser ex119; c.18676C > T, p.Gln6226*	ex175...",50,383,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Gln6226*,"...; c.24579G > A, p.Ser8193Ser ex119; c.18676C > T, p.Gln6226*	ex175: a splice site mutation ex119: a ...",50,417,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Val3348Ala,".... Diffuse muscle pain.	No	ex69; c.10043_10046del, p.Val3348Alafs *43 ex49; c.6388G > C p.Ala2130Pro	...",52,285,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Ala2130Pro,"...43_10046del, p.Val3348Alafs *43 ex49; c.6388G > C p.Ala2130Pro	ex69: truncating/degrading ex49: miss...",52,322,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.Ala8203Gln,ex176; c.24606del p.Ala8203Glnfs*13,55,19,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.V600E,"...rs, but in none of the group I tumors, and a BRAF:p.V600E mutation in 43% of group I tumors, but in ...",7,753,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,"... KIAA1549-BRAF fusions are found in PAs, and BRAF:p.V600E mutations are frequently detected in PXAs ...",17,414,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,... frequently detected in PXAs (~70%) [14-19]. BRAF:p.V600E mutations are also present in about one qu...,17,485,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,BRAF: p.V600E,27,7,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,BRAF:p.V600E mutations were detected in 7 of 16 (43%) g...,123,6,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,"...1, RNF130, CLCN6, MKRN1 and GNAI1[17,19,21]. BRAF:p.V600E mutations occur in PXAs (~70%), gangliogli...",133,512,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,...ere unable to show a KIAA1549-BRAF fusion or BRAF:p.V600E mutation. Low-grade neuroepithelial tumors...,133,925,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.R132H,...rs presenting in childhood rarely contain an IDH1:p.R132H mutation. This mutation is regarded as a h...,133,1023,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,...not characterized by KIAA1549-BRAF fusion or BRAF:p.V600E mutation [27],133,1448,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,"...tures of a classic ganglioglioma, harbored a BRAF:p.V600E mutation. This mutation is the most common...",135,239,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.Phe93Leu,"...sly reported missense mutation [1, 2], c.279C > G p.Phe93Leu in patient 3s. Patients 1 and 2s had no...",118,117,Acta_Neuropathol_Commun_2015_Jul_25_3_44.txt
p.Phe91Ile,"...atients 1 and 2s had novel mutations, c.271 T > A p.Phe91Ile, and c.273C > G p.Phe91Leu, respectivel...",118,194,Acta_Neuropathol_Commun_2015_Jul_25_3_44.txt
p.Phe91Leu,"...mutations, c.271 T > A p.Phe91Ile, and c.273C > G p.Phe91Leu, respectively, affecting the same amino...",118,221,Acta_Neuropathol_Commun_2015_Jul_25_3_44.txt
p.K510E,"...gically, including cases with the newly described p.K510E mutation and a case with both a known p.P5...",5,897,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...bed p.K510E mutation and a case with both a known p.P525L mutation in the FUS gene and a truncating ...,5,943,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...p.P525L mutation in the FUS gene and a truncating p.Y374X mutation in the TARDBP gene,5,993,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...ARDBP with one exception. Case 6 harboured both a p.P525L FUS mutation and also a TARDBP p.Y374X tru...,34,627,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,"...red both a p.P525L FUS mutation and also a TARDBP p.Y374X truncation mutation, the latter of which h...",34,666,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,"...r parent of case 6 to test for segregation of the p.P525L and p.Y374X mutations, however, clinical r...",34,906,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,"...case 6 to test for segregation of the p.P525L and p.Y374X mutations, however, clinical records descr...",34,918,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R495X,1	14	c.1483C>T	p.R495X	34	F	9	Yes	Yes	L	No,37,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,2	14	c.1528A>G	p.K510E	39	M	15	Yes	Yes	B	No,38,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,3	15	c.1561C>T	p.R521C	33	M	10	NA	Yes	NA	No,39,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,4†	15	c.1561C>T	p.R521C	35	F	7	Yes	Yes	B	No†,40,17,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,5	15	c.1562G>A	p.R521H	35	F	>36	NA	Yes	L	No,41,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,15	c.1574C>T	p.P525L,43,15,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R514G,7	15	c.1540A>G	p.R514G	60	M	>96	NA	Yes	B	No,45,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,aCase 6 also carried a previously described p.Y374X TARDBP mutation (cDNA position c.1119_1120...,49,45,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,...l surviving angulated neurons (arrows) in case 5 (p.R521H). H&E. b Well circumscribed basophilic inc...,121,136,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...ion (arrow) in an anterior horn neuron in case 6 (p.P525L and p.Y374X TARDBP mutation). This contras...,121,239,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...in an anterior horn neuron in case 6 (p.P525L and p.Y374X TARDBP mutation). This contrasts with an a...,121,251,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,...sophilic aggregate-like inclusions (inset-case 2 (p.K510E)) which resemble condensed Nissl substance...,121,389,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R495X,...in the anterior horns of the spinal cord. Case 1 (p.R495X). Anti p62. d-f. Reveal the differing shap...,121,582,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R495X,"...e anterior horns of the spinal cords in case 1 (d-p.R495X), case 2 (e-p.K510E), and case 4 (f-p.R521...",121,756,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,"...the spinal cords in case 1 (d-p.R495X), case 2 (e-p.K510E), and case 4 (f-p.R521C). Anti-FUS. Scale ...",121,776,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,"... 1 (d-p.R495X), case 2 (e-p.K510E), and case 4 (f-p.R521C). Anti-FUS. Scale Bar (a)-140 μm, (b) (c) ...",121,800,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,...n the anterior horn of the spinal cord in case 2 (p.K510E) with remnants of FUS immunopositivity. An...,124,89,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...ts of FUS immunopositivity. Anti-FUS. b-e Case 6 (p.P525L and p.Y374X TARDBP mutation) also does exh...,124,159,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...munopositivity. Anti-FUS. b-e Case 6 (p.P525L and p.Y374X TARDBP mutation) also does exhibit FUS-imm...,124,171,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R495X,... and anti-p62 in (e) inset. f The cord in case 1 (p.R495X) revealing very mild loss of myelin in the...,124,807,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,Fig. 3 Case 6 (p.P525L and p.Y374X TARDBP mutation) (a) and inset...,126,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,Fig. 3 Case 6 (p.P525L and p.Y374X TARDBP mutation) (a) and inset illustrates...,126,28,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,"...ilarly Baumer et al. illustrated 2 cases with the p.P525L mutation, one of whom had no UMN features ...",135,1549,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510M,...uffering from a locked-in state associated with a p.K510M mutation and abundant FUS pathology in the...,135,2417,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,...ed UMN pathology but this time in patients with a p.R521C mutation which is identical to our cases 3...,135,2612,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...ous basophilic inclusions (including 2 cases with p.P525L mutations) tended to have a more rapid dis...,135,3215,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,"...t, and slower progression (including 2 cases with p.R521C mutations). Our findings do not fit neatly...",135,3462,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,...nto this distinct grouping. Whereas case 5 with a p.R521H mutation would certainly appear to partial...,135,3564,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...neuronal loss present in the cord. Case 6 (with a p.P525L mutation) also had moderate-large numbers ...,135,4214,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,"...ed this, in that this patient as well as having a p.P525L mutation also had a truncating p.Y374X TAR...",135,4494,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...s having a p.P525L mutation also had a truncating p.Y374X TARDBP mutation on chromosome 1. The patho...,135,4533,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,.... Daoud et al. have described the genetics of the p.Y374X TARDBP mutation and have predicted this to...,135,5525,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510E,...ption of a patient with ALS-FUS associated with a p.K510E mutation. Syriani et al. described the cli...,137,107,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R514G,The p.R514G missense mutation again has been detected ...,139,5,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.K510M,...ra S   A Japanese patient with familial ALS and a p.K510M mutation in the gene for FUS (FUS) resulti...,184,150,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.N352S,...anese familial amyotrophic lateral sclerosis with p.N352S mutation in TARDBP Neuropathol Appl Neurob...,187,179,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.A31P,...iomyopathy in young Maine Coon cats caused by the p.A31P cMyBP-C mutation - the clinical significanc...,3,196,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...tution of an alanine for a proline at residue 31 (p.A31P) of cMyBP-C. The pattern of inheritance has...,4,263,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...cance of being homozygous or heterozygous for the p.A31P cMyBP-C mutation in young to middle-aged ca...,4,704,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...lood samples or buccal swabs and screened for the p.A31P cMyBP-C mutation in exon 3 of the gene, usi...",7,197,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...s that were homozygous for the mutation had fHCM. p.A31P heterozygosity was not associated with a si...,10,360,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ar that most MC cats that develop fHCM due to the p.A31P mutation prior to the age of approximately ...,13,255,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...tution of an alanine for a proline at residue 31 (p.A31P) of the cMyBP-C protein. Affected cats exhi...,22,217,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...M and MC cats heterozygous and homozygous for the p.A31P cMyBP-C mutation in a large cohort of MC ca...,24,126,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,The p.A31P cMyBP-C genotype of all cats was unknown to...,32,5,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ed significance. The clinical significance of the p.A31P cMyBP-C protein mutation was determined by ...,38,185,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...es. There was tendency to an increasing effect of p.A31P cMyBP-C homozygosity with age, though the t...",44,255,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...1, P = 0.09. There was only a low effect of being p.A31P cMyBP-C heterozygous, ρ = 0.09, P = 0.4. Bo...",44,391,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...e corresponding line of tendency. Green indicates p.A31P cMyBP-C heterozygous coordinates and the co...,44,708,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...he corresponding line of tendency. Blue indicates p.A31P cMyBP-C homozygous where and the correspond...,44,803,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...according to their fHCM clinical presentation and p.A31P cMyBP-C, respectively",48,417,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,cMyBP-C p.A31P genotype	P-value mutation negative vs,73,10,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...quivocal and the fHCM positive cats in respect to p.A31P genotype,97,99,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,cMyBP-C p.A31P genotype	P-value,107,10,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,p.A31P cMyBP-C genotypin,132,1,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...butions of fHCM and equivocal cases in respect to p.A31P cMyBP-C genotype status. A: Histogram of th...,135,66,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... distribution for the entire cohort. The group of p.A31P cMyBP-C homozygous cats had an increased pr...,135,167,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,The significance of the p.A31P cMyBP-C mutatio,139,25,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...lated for heterozygous and homozygous carriers of p.A31P cMyBP-C between fHCM affected and non-affec...,140,188,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...rozygous cats were classified as equivocal. Among p.A31P cMyBP-C homozygous MC cats, 50% had fHCM an...",142,145,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...f diastolic IVS and LVFW as a function of age and p.A31P cMyBP-C heterozygous or homozygous status. ...,157,116,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...examine the significance of being affected by the p.A31P cMyBP-C mutation in middle-aged cats. The s...,159,172,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...n of fHCM and equivocal cats as a function of the p.A31P cMyBP-C genotype is shown in Figure 4B. Tab...,159,911,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...cance of being heterozygous or homozygous for the p.A31P cMyBP-C mutation in a cohort of young MC ca...,162,87,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... thickness had a tendency to progress with age in p.A31P cMyBP-C homozygous cats compared to heteroz...,164,92,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...zygous. Again, no significant association between p.A31P cMyBP-C and fHCM was found in heterozygous ...",166,314,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...d in heterozygous cats. This again indicated that p.A31P cMyBP-C associated fHCM was a disease with ...,166,396,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... homozygous for the mutation. We propose that the p.A31P cMyBP-C mutation results in an inheritance ...,166,602,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,".... Very recently, Wess et al. [11] stated that the p.A31P mutation is less pathogenic than reported s...",168,480,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ociated HCM [22]. It can not be excluded that the p.A31P cMyBP-C mutation may exhibit a dominant pat...,170,188,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...at those pedigrees with cats heterozygous for the p.A31P mutation and affected with fHCM may represe...,170,467,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...her yet undiscovered mutation is present with the p.A31P cMyBP-C mutation. Digenic or compound heter...,170,627,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,The p.A31P cMyBP-C genotype distribution was not in Ha...,180,5,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...umber of homozygous cats, which supports that the p.A31P cMyBP-C mutation was disease-causing and re...",180,270,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...roduction. That the prevalence of fHCM and of the p.A31P cMyBP-C mutation found in our cohort is sim...,180,885,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"In conclusion, p.A31P cMyBP-C associated fHCM is a disease with v...",183,16,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... cats. Our results support the pathogenic role of p.A31P when two affected gene alleles are present ...,183,156,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...to the high probability of developing fHCM in the p.A31P cMyBP-C homozygous cats the 'production' of...,183,556,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...ould be avoided. Thus, although genotyping of the p.A31P cMyBP-C mutation can not stand alone in lim...",183,678,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... left ventricular inner diameter; MC: Maine Coon; p.A31P: alanine substituted for a proline at resid...,186,407,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.Thr328Lys,...ith affected women and men is associated with the p.Thr328Lys mutation in the F12 gene J Allergy Cli...,168,169,Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_15.txt
p.A53T,"...triplications [72] or the SNCA missense mutation, p.A53T [73]. A number of other early-onset familie...",59,313,Alzheimers_Res_Ther_2013_Jul_31_5(Suppl_1)_S7.txt
p.T185S,"... [13,14]. A nonsynonymous SNP numbered rs3173615 (p.T185S) located in exon 6 of the TMEM106B gene sh...",18,956,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,...fibrillary degeneration)	pTDP-43 immunoreactivity	p.T185S genotype,28,178,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"...n the frontal cortex and the hippocampus, and the p.T185S genotype of the rs3173615 single nucleotid...",55,454,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,p.T185S genotypin,65,1,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,The rs3173615 SNP composed of p.T185S (C760G) in exon 6 of the human TMEM106B ge...,66,31,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"...able 1. Before starting this, we investigated the p.T185S genotype of rs3173615 in the human TMEM106...",89,243,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"...e disequilibrium with the coding rs3173615 SNP of p.T185S, is closely associated with FTLD-TDP in th...",124,115,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"... showing the complete linkage disequilibrium with p.T185S on rs3173615 [3,13,15], is reduced in AD c...",130,152,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,Showing p.T185S genotyping analysis. The rs3173615 SNP com...,150,9,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,...enotyping analysis. The rs3173615 SNP composed of p.T185S (C760G) in exon 6 of the human TMEM106B ge...,150,68,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,...Graff-Radford NR Dickson DW Rademakers R TMEM106B p.T185S regulates TMEM106B protein levels: implica...,179,221,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.G130A,"...with a heterozygous mutation in SOX2 (c.389G > C, p.G130A) [Kelberman et al., 2006] makes this anoth...",22,103,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.A242T,"Exon 3	Chr9: 125,817,622	n/a	c.724G > A	1/97 (1)	p.A242T, conserveda",123,51,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.D255D,"...	Chr9: 125,823,236	rs61734362	c.765C > T	1/97 (1)	p.D255D",125,58,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.P261P,"...Chr9: 125,823,254	rs1042486	c.783G > C	46/97 (45)	p.P261P",126,59,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.A339A,"...Exon 5	Chr9: 125,834,603	n/a	c.1017C > G	1/97 (1)	p.A339A",127,52,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.Ala242Thr,"...ed a heterozygous c.724G > A change, resulting in p.Ala242Thr. Though this is a conserved alanine re...",135,96,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.Asn125Ser,"...erozygous missense mutation in HESX1, c.374A > G (p.Asn125Ser). However, since this polymorphism has...",140,161,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.Ala172Phe,...al ReportsThe Fibroblast Growth Factor Receptor 2 p.Ala172Phe Mutation in Pfeiffer Syndrome—History ...,3,204,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...drome caused by a heterozygous missense mutation, p.Ala172Phe, located in the IgII domain of FGFR2. ...",7,835,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Pro252Arg,"...011]. Occasionally, a specific mutation in FGFR1, p.Pro252Arg can cause Pfeiffer syndrome—phenotypic...",14,295,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...cutive nucleotides (c.514_515delGCinsTT, encoding p.Ala172Phe) and was previously known only from Pf...",16,795,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...ere present in cis: c.514_515delGCinsTT, encoding p.Ala172Phe. This sequence change is identical to ...",33,429,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...regated with a 142 bp allele, suggesting that the p.Ala172Phe mutation had arisen independently in t...",37,675,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...ted British family, has also been implicated. The p.Ala172Phe mutation, involving a double nucleotid...",40,462,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,...e Pfeiffer syndrome phenotype associated with the p.Ala172Phe mutation is atypical in both its combi...,42,76,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...anomalies, these are a more severe feature of the p.Ala172Phe mutation than most other FGFR2-associa...",42,1762,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...ype (mild skull/severe limb) correlation with the p.Ala172Phe mutation, both within and across famil...",42,2474,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...ons and direct receptor–receptor contacts. In the p.Ala172Phe mutation, substituting the small alani...",71,807,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"... conclusion, Pfeiffer syndrome resulting from the p.Ala172Phe mutation is infrequent—only two famili...",75,53,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.W299R,JC_0759	62	M	6/12	6/12	23.16	22.92	RGS9	p.W299R / p.R128X	MCW,93,41,Am_J_Ophthalmol_2015_Dec_160(6)_1269-1275_e1.txt
p.R128X,JC_0759	62	M	6/12	6/12	23.16	22.92	RGS9	p.W299R / p.R128X	MCW,93,51,Am_J_Ophthalmol_2015_Dec_160(6)_1269-1275_e1.txt
p.Arg110*,"...tion mutations, a premature stop codon (c.328C>T, p.Arg110*) and a donor splice‐site mutation (c.840...",42,228,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
p.Arg110*,...c.328C>T) causing a premature translational stop (p.Arg110*) at position chr22: 32 322 242 (NM_00100...,80,706,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
p.Arg110*,"... causing a premature translational stop c.328C>T, p.Arg110* at genomic position chr22: 32 322 242 wa...",82,275,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
p.Arg110*,"...requencies of the MITF nonsense variant c.328C>T, p.Arg110* (chr22: 32 322 242a) and the splice‐site...",88,69,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
p.Ile442Met,"...nsin I complex, subunit G (NCAPG) gene encoding a p.Ile442Met variant is associated with an increase...",1143,89,Anim_Sci_J_2016_Feb_11_87(2)_159-167.txt
p.Gln1124*,...uencing of genomic DNA revealing homozygosity for p.Gln1124*. The DST gene encodes multiple transcri...,18,219,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Arg1249*,...ical findings. The second mutation identified was p.Arg1249*. It was reported in an Iranian woman bo...,18,493,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Gln1124*,"...listering and were all shown to be homozygous for p.Gln1124*, the mutation that was originally ident...",18,855,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Pro1929Leu,"...was a homozygous frameshift mutation, c.5786delC (p.Pro1929Leufs*8). Then, two European cases were s...",33,188,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Phe466Leu,...the mutations in the German case were c.1395delC (p.Phe466Leufs*44) and c.2897delC (p.Pro966Leufs*11...,33,364,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Pro966Leu,"...ere c.1395delC (p.Phe466Leufs*44) and c.2897delC (p.Pro966Leufs*11), whereas in the British case the...",33,398,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Pro649Pro,... British case the mutations comprised c.1947dupC (p.Pro649Profs*11) and c.2249C>A (p.Ser750*). The m...,33,481,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Ser750*,"...ised c.1947dupC (p.Pro649Profs*11) and c.2249C>A (p.Ser750*). The most recently reported case, from ...",33,514,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Leu1217*,"...m Pakistan, involved homozygosity for c.3650T> A (p.Leu1217*). All pathogenic mutations were located...",33,612,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Pro392Val,"...a homozygous frameshift mutation, c.1173_1174del (p.Pro392Valfs*2). The second case, from Gaza, had ...",48,306,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Arg628Pro,"...n, had a homozygous missense mutation, c.1883G>C (p.Arg628Pro) that occurred within the extracellula...",48,491,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Arg463Trp,"...as was the mutation in the fifth case, c.1387C>T (p.Arg463Trp)17. Clues to the molecular pathology o...",48,781,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Ala349Ser,"...strated the deleterious effects of the mutations (p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 i...",51,1428,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Arg463Trp,"...s of the mutations (p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 integrin structure, processing ...",51,1458,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Y279N,"...m. We described a novel homozygous, c. 835 T > A (p.Y279N) mutation in exon 6 in two patients",3,1589,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
p.Y279N,...evealed a homozygous novel mutation c. 835 T > A (p.Y279N) in exon 6,37,129,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
p.Arg438Cys,"...performed and the pathogenic mutation, c.1312C>T (p.Arg438Cys), was identified. Interestingly, this ...",3,1972,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
p.Arg438Cys,...that resulted in a change in the protein level of p.Arg438Cys (Fig. 2). Mutation analysis and clinic...,17,547,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
p.Arg632Gln,"...7-10 as well as a frameshift mutation (c.1893dup; p.Arg632Glnfs*20). To our knowledge, this is the f...",3,1938,Ann_Lab_Med_2014_Sep_21_34(5)_395-398.txt
p.Arg632Gln,...M_000218.2) and a frameshift mutation (c.1893dup; p.Arg632Glnfs*20) in the proband and his brother. ...,21,204,Ann_Lab_Med_2014_Sep_21_34(5)_395-398.txt
p.Arg632Gln,...erozygous for the frameshift mutation (c.1893dup; p.Arg632Glnfs*20) but neither exon deletions nor d...,21,457,Ann_Lab_Med_2014_Sep_21_34(5)_395-398.txt
p.Arg632Gln,...mstances [2]. The frameshift mutation (c.1893dup; p.Arg632Glnfs*20) leads to a premature stop codon ...,26,819,Ann_Lab_Med_2014_Sep_21_34(5)_395-398.txt
p.Arg632Gln,"...alysis revealed a frameshift mutation (c.1893dup; p.Arg632Glnfs*20) in the proband, his mother, and ...",41,75,Ann_Lab_Med_2014_Sep_21_34(5)_395-398.txt
p.Glu255Lys,... a missense mutation [ABL1 NM_005157.4: c.763G>A (p.Glu255Lys)] was newly detected in the second eva...,15,772,Ann_Lab_Med_2015_Jan_8_35(1)_159-161.txt
p.Glu255Lys,...e was changed from G to A [NM_005157.4: c.763G>A (p.Glu255Lys)],25,501,Ann_Lab_Med_2015_Jan_8_35(1)_159-161.txt
p.G296S,...S    A novel mutation KCNQ4 pore-region mutation (p.G296S) causes deafness by impairing cell-surface...,150,98,Appl_Clin_Genet_2012_Oct_18_5_97-104.txt
p.Arg1256X,"...mutations, c.1153dupG (p.Val385fs) and c.3766C>T (p.Arg1256X), in EIF2AK4. Unaffected parents were h...",18,405,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
p.Arg1150X,"... (c.860-1G>A) and a nonsense mutation, c.3438C>T (p.Arg1150X). No mutations were identified in this ...",18,913,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
p.D630Y,"... GNA11, GNAQ, and SF3B1). The mutation (c.G1888T, p.D630Y) lies in the Y-domain of the highly conser...",41,346,Appl_Clin_Genet_2016_Sep_6_9_147-155.txt
p.D630Y,...tein is a downstream target of GNA11/GNAQ and the p.D630Y PLCB4 mutation was mutually exclusive with...,41,602,Appl_Clin_Genet_2016_Sep_6_9_147-155.txt
p.Asp411Val,premature STOP codon: c.1232_1234delinsTTTGAA (p.Asp411Valfs*2). No pathogeni,53,48,Arq_Bras_Cardiol_2015_Nov_105(5)_536-539.txt
p.Asp411Val,(p.Asp411Valfs*2) in the KCNH2 (HERG) gene. Althoug...,109,2,Arq_Bras_Cardiol_2015_Nov_105(5)_536-539.txt
p.Asp411Val,...genetic alterations. This analysis classified the p.Asp411Valfs*2 mutatio,114,64,Arq_Bras_Cardiol_2015_Nov_105(5)_536-539.txt
p.Asp411Cys,...n of this codon showed that in-vitro mutagenesis (p.Asp411Cys) resulting i,119,62,Arq_Bras_Cardiol_2015_Nov_105(5)_536-539.txt
p.Asp411Val,further supporting the pathogenicity of the novel p.Asp411Valfs*2 alteration,123,51,Arq_Bras_Cardiol_2015_Nov_105(5)_536-539.txt
p.His161Arg,...active Crohn's disease and analysis of the IL-17F p.His161Arg polymorphism in IBD Inflamm Bowel Dis ...,141,325,Arthritis_Res_Ther_2008_Apr_18_10(2)_206.txt
p.Gln4154Lys,"...ciation of the APOB gene polymorphism c.12669G>A, p.Gln4154Lys with the risk of CAD varies considera...",3,1299,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Gln4154Lys,"...ve studied the APOB gene polymorphism c.12669G>A, p.Gln4154Lys and its relationship with lipid, apoB...",3,1580,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Gln4154Lys,"...ion in linking APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) with CAD risk in different populatio...",8,1395,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Gln4154Lys,"...he role of the APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) was studied in native Indian Punjabi...",28,74,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Asp727Glu,"... MNG. We investigated the codon 727 polymorphism (p.Asp727Glu, p.D727E) of the human TSHR gene using...",3,1433,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...stigated the codon 727 polymorphism (p.Asp727Glu, p.D727E) of the human TSHR gene using the polymera...",3,1446,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...ers in exon 10 of the TSHR gene that contains the p.D727E polymorphism and digested by theNlaIII (Hi...,3,1835,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...e TSH (p = 0.047). These results suggest that the p.D727E polymorphism of the TSHR gene may not cont...,3,2354,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,Multi nodular goiter (MNG)Codon 727 polymorphismp.D727EThyroid-stimulating hormone receptor (TSHR)...,5,49,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.Asp727Glu,... substitution of glutamic acid for aspartic acid (p.Asp727Glu; p.D727E) in the intracellular portion...,8,1212,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,... of glutamic acid for aspartic acid (p.Asp727Glu; p.D727E) in the intracellular portion of the recep...,8,1225,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...ith toxic or non toxic MNG, the expression of the p.D727E variant in eukaryotic cells resulting in a...",8,1351,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...type TSHR gene increased cAMP accumulation. Thus, p.D727E could induce growth and function of thyroc...",8,1578,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...s [1]. We have investigated the frequency of this p.D727E polymorphism in Turkish patients with MNG ...,8,1681,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...ion in exon 10 of the TSHR gene that contains the p.D727E polymorphism (rs1991517), as previously de...",17,263,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...th the non toxic MNG and control group, while the p.D727E polymorphism is significantly correlated w...",26,551,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"We screened the p.D727E polymorphism of the TSHR gene, a predispos...",29,17,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...ta did not show a direct relationship between the p.D727E polymorphism and non toxic MNG in our grou...,29,177,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...c MNG in our groups. Clearly, the presence of the p.D727E polymorphism in the TSHR gene is not suffi...",29,260,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,Gabriel et al.[1] indicated that a p.D727E polymorphism of the human TSHR gene was si...,31,36,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...at the presence of the heterozygous state for the p.D727E polymorphism of the TSHR gene was not sole...,31,363,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...al.[13] studied the frequency of the polymorphism p.D727E in a large group of patients with non auto...,33,192,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...sion, taking into consideration the fact that the p.D727E TSHR variant is frequently detected in the...",35,60,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...in our population. This is the first study of the p.D727E polymorphism in Turkish patients with MNG....,35,466,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...ish patients with MNG. According to our data, the p.D727E variant is frequently detected in the gene...",35,544,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...igure 1 The PCR-based restriction analysis of the p.D727E polymorphisms of the TSHR gene shown on 2%...,37,52,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,Table 3 The distribution of the p.D727E genotypes and allelic frequencies of the T...,68,33,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.G130V,...anze A.   New evidence for the correlation of the p.G130V mutation in the GJB2 gene and syndromic he...,163,178,Biochem_J_2010_Aug_1_429(Pt_3)_473-483.txt
p.Trp400Val,"...X:47086041-47086043, delTG, Q00536-2 (isoform 2): p.Trp400ValfsVPAP]. This result led us to propose ...",91,589,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
p.Arg488Ter,"...cal case [chrX:47086497C>T, Q00536-2 (isoform 2): p.Arg488Ter] (http://genetics.emory.edu/egl/emvcla...",91,924,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
p.L849P,"...oint mutation Cav1.4 L860P [14,15] referred to as p.L849P in these publications and the truncation m...",33,78,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.R1816X,...tion mutation Cav1.4 R1827X ([15]; referred to as p.R1816X therein) were introduced into the Cav1.4 ...,33,172,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.R1816X,... mutation in C-terminus at position Arg1827 (also p.R1816X in [15]; Fig. 1a) was found in an 8-year ...,52,57,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.Leu849Pro,"...utation, where a proline residue replaced Leu860 (p.Leu849Pro in [14,15]). The L860P mutation is loc...",56,73,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.Val220Ile,"... mutations: the already described c.658_659delGT (p.Val220Ilefs) mutation on BRCA2 exon 8, and a pre...",84,628,Biomark_Res_2015_Jun_6_3_13.txt
p.Ile982Tyr,"...exon 8, and a previously unknown c.2944_2944delA (p.Ile982Tyrfs) mutation on BRCA2 exon 11 (Fig. 3)a...",84,711,Biomark_Res_2015_Jun_6_3_13.txt
p.Ile982Tyr,"...tion, the previously undescribed c.2944_2944delA (p.Ile982Tyrfs), occurs on BRCA2 exon 11. The segre...",114,607,Biomark_Res_2015_Jun_6_3_13.txt
p.Ile982Tyr,"...n 11, the previously undescribed c.2944_2944delA (p.Ile982Tyrfs) mutation. Overall, these data sugge...",116,661,Biomark_Res_2015_Jun_6_3_13.txt
p.S34N,"...ported that local deficiency in hCAP-18/LL-37 and p.S34N mutation in CAMP gene, which is the gene en...",28,875,Biomed_Res_Int_2014_May_19_2014_420830.txt
p.S34N,...koğlu O  Berdeli A  Emingil G  Atilla G   A novel p.S34N mutation of CAMP gene in patients with peri...,188,57,Biomed_Res_Int_2014_May_19_2014_420830.txt
p.V600E, c.1799T>A	p.V600E	56 (29.9),189,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.K601E, c.1801A>G	p.K601E	11 (5.9),192,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.G12S, c.34G>A	p.G12S	1 (0.5),194,10,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	34 (18.2),196,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.181C>A	p.Q61K	5 (2.7),197,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	7 (3.7),199,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.181C>A	p.Q61K	6 (3.2),200,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61H, c.183G>T	p.Q61H	1 (0.5),201,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	8 (4.3),203,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61H, c.181C>A	p.Q61H	1 (0.5),204,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.180_181TC>AA	p.Q61K	1 (0.5),205,17,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.V600E, c.1799T>A	p.V600E	51,244,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.K601E, c.1801A>G	p.K601E	6,246,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.G12S, c.34G>A	p.G12S	1,248,10,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	29,250,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.181C>A	p.Q61K	7,251,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	4,253,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.181C>A	p.Q61K	3,254,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	2,256,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.180_181TC>AA	p.Q61K,257,17,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.R1441C,... K.  Rademakers R.  Theuns J.    Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene ...,127,63,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
p.R196P,23	1	−	+ (76%)	Exon 6/p.R196P,58,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R273H,24	2	+ (86%)	−	Exon 8/p.R273H,59,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.H178D,25	2	+ (80%)	−	Exon 5/p.H178D,60,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R175H,26	2	+ (70%)	−	Exon 5/p.R175H,61,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R273H,27	2	+ (94%)	−	Exon 8/p.R273H,62,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R248E,28	2	+ (79%)	−	Exon 7/p.R248E,63,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R249S,29	2	+ (6%)	−	Exon 7/p.R249S,64,22,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.P142R,30	2	+ (53%)	−	Exon 5/p.P142R and exon 6/m.P222 L,66,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.V272M,31	2	+ (91%)	−	Exon 8/p.V272M,67,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.Del264L,37	3	+ (17%)	−	Exon 8/p.Del264L,73,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.Gly646Trp,...ility that the most frequent mutation (c.1934dupG;p.Gly646TrpfsX12) in virtually all the studies mig...,29,109,Blood_Cancer_J_2011_Mar_4_1(3)_e7.txt
p.Gly646Trp,...at were presented at ASH 2010 included c.1934dupG;p.Gly646TrpfsX12 as a true mutation and reported m...,29,929,Blood_Cancer_J_2011_Mar_4_1(3)_e7.txt
p.Gly646Trp,...st commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alteration Leuk...,189,112,Blood_Cancer_J_2011_Mar_4_1(3)_e7.txt
p.R771Pfs,...from Patients with McArdle's Disease Carrying the p.R771PfsX33 PYGM Mutation PLoS One 2010 5 10 e131...,157,233,BMC_Biochem_2011_Nov_4_12_57.txt
p.G12V,...hybridization. A KRAS codon 12 mutation (c.35G>T; p.G12V) was detected in the pyloric gland adenoma ...,7,900,BMC_Cancer_2012_Dec_4_12_570.txt
p.G12V,"...ed a point mutation at exon 1, codon 12 (c.35G>T; p.G12V) and wildtype sequence at exon 2 in the pyl...",55,100,BMC_Cancer_2012_Dec_4_12_570.txt
p.G12R,"...in, serotonin, somatostatin, gastrin	KRAS exon 1 (p.G12R; c.34G>C)",83,172,BMC_Cancer_2012_Dec_4_12_570.txt
p.G12V,"...C1, p16), negative: MUC2, CD10, CDX2	KRAS exon 1 (p.G12V; c.35G>T); CGH: gains at 1q, 6p11p22, 7p, 1...",96,152,BMC_Cancer_2012_Dec_4_12_570.txt
p.G13D,...  Frattini M  Piessevaux H    Association of KRAS p.G13D mutation with outcome in patients with chem...,417,146,BMC_Cancer_2016_Aug_2_16_585.txt
p.Ala567Thr,c.1699G>A	p.Ala567Thr	rs1803274,41,12,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Asp2213Asn,c.6637G>A	p.Asp2213Asn	rs529038,44,12,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Pro200Leu,c.599C>T	p.Pro200Leu	rs1050450,50,11,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Arg176Cys,c.526C>T	p.Arg176Cys	rs7412,56,11,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Cys130Arg,c.388 T>C	p.Cys130Arg	rs429358,59,12,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Asp432Glu,c.1296 T>G	p.Asp432Glu	rs7041,62,13,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Thr436Lys,c.1307C>A	p.Thr436Lys	rs4588,65,12,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Met1Thr,c.2 T>C	p.Met1Thr	rs2228570,68,10,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Ala567Thr,"...ly the rs1803274 polymorphism of BCHE (c.1699G>A, p.Ala567Thr) was associated with an increased risk...",250,189,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Ala567Thr,"Our results show that the rs1803274 (1699G>A, p.Ala567Thr) polymorphism of BCHE was also signifi...",265,47,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.T972M,"...n exon 7 of the CaSR gene was found, predicting a p.T972M amino acid substitution in cytoplasmic tai...",43,551,BMC_Endocr_Disord_2014_Oct_7_14_81.txt
p.T972M,"...ction was carried out with the following primers (p.T972M, For: 5’ -catctttggcagcggcaTggtcaccttctcac...",85,183,BMC_Endocr_Disord_2014_Oct_7_14_81.txt
p.T972M,"... novel variant of the exon 7, namely c.2915C > T, p.T972M (Figure 1) in heterozygosity. This variant...",100,512,BMC_Endocr_Disord_2014_Oct_7_14_81.txt
p.R605Q,"..., respectively. Two missense mutations (p.M1? and p.R605Q) of unknown functional significance were i...",7,259,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.L398L,Exon 12	c.1194A>G	NA	p.L398L	benign	AA 9/39; AG 12/39; GG 18/39 (AF:A 0...,36,22,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.R605Q,Exon 17	c.1814G>A	NA	p.R605Q	unknown	1/39 (het: Pt-7) (0.013)	0/100	pre...,37,22,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.R605Q,...f cDNA from an 851del4-homozygous patient and the p.R605Q-heterozygous individual revealed correct s...,47,63,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.R605Q,"... to have 851del4, IVS16ins3kb, 1638ins23, and the p.R605Q variant (creating a BsrDI restriction site...",47,242,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.R605Q,"...n AGC2 function, it remains to be elucidated. The p.R605Q mutation occurs at a conserved amino acid ...",112,450,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.D19H,Gallstone disease is associated with p.D19H of ABCG8 as well as alterations of choleste...,4,38,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,...ed from blood leukocytes. Genotype frequencies of p.D19H were established using MALDI-TOF mass spect...,7,494,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,...ption was about 24% lower in individuals carrying p.D19H compared to wild type (Psitosterol = 0.0080...,10,495,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"... Moreover, irrespective of phenotype, carriers of p.D19H displayed a significant lower absorption th...",10,620,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,... in gallstone carriers and controls regardless of p.D19H presence,10,1039,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,Both gallstone disease and p.D19H of ABCG8 are associated with diminished cho...,13,28,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"... with diminished cholesterol absorption. However, p.D19H is not responsible for the differences in s...",13,108,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"...verweight simultaneous carriers of gallstones and p.D19H displayed a higher OR (OR = 3.2, P = 0.0430...",142,881,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,...t. (GG) = wild type individual; (Gc) = carrier of p.D19H; (GG) = 93 and (Gc) = 25. * Psitosterol = 0...,158,546,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"..., P = 0.0347 and wild type controls to cases with p.D19H 37%, P = 0.0030). Regarding the cholesterol...",160,775,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"...vidual): C = 75, GS = 14; Gc genotype (carrier of p.D19H): C = 18, GS = 11",162,680,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,...s. (GG) = wild type individual; (Gc) = carrier of p.D19H. Controls: (GG) = 80 and (Gc) = 15; gallsto...,166,499,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"...ividuals and gallstone carriers, with and without p.D19H. Protein content was determined by densitom...",166,733,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"...erol gallstones [27,29]. In our study carriers of p.D19H were characterised by significantly reduced...",181,503,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.Trp82Arg,...of nine affected members of a new family with the p.Trp82Arg ALys variant were recorded. All affecte...,7,222,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...amyloid deposits in all cases and all carried the p.Trp82Arg ALys variant at a heterozygous state,7,633,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,Hereditary amyloidosis associated with the p.Trp82Arg lysozyme variant in this new family is ...,10,44,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...y. We report here a new large family in which the p.Trp82Arg variant (this nomenclature includes the...,16,1003,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,"...iety guidelines, http://www.hgvs.org/mutnom// and p.Trp82Arg corresponds to the previous Trp64Arg va...",16,1172,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,"...ge of the amino acid from tryptophan to arginine (p.Trp82Arg in the new nomenclature, corresponds to...",25,399,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,"... the mature protein from tryptophane to arginine. p.Trp82Arg in the new nomenclature, wich was previ...",40,429,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...new family of hereditary ALys associated with the p.Trp82Arg variant is of particular interest becau...,66,56,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,The families with the p.Trp82Arg variant already reported are either fro...,76,23,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.R163Q,"...etween Asia and all other populations, due to the p.R163Q (c.488 G>A) polymorphism. The least amount...",9,397,BMC_Genet_2008_Apr_10_9_31.txt
p.P18A,p.P18A	c.52 C>G	0	0	0	0	0.08	0	0	0,40,1,BMC_Genet_2008_Apr_10_9_31.txt
p.C35Y,p.C35Y	c.104 G>A	0	0	0	0	0	0.12	0	0,41,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V38M,p.V38M	c.112 G>A	0	0	0	0	0	0.06	0	0,42,1,BMC_Genet_2008_Apr_10_9_31.txt
p.L44V,p.L44V	c.130 C>G	0	0	0	0	0	0.06	0	0,43,1,BMC_Genet_2008_Apr_10_9_31.txt
p.F45L,p.F45L	c.133 T>C	0	0	0	0	0	0.24	0	0,44,1,BMC_Genet_2008_Apr_10_9_31.txt
p.S47I,p.S47I	c.140 G>T	0	0.43	0	0	0	0	0	0,45,1,BMC_Genet_2008_Apr_10_9_31.txt
p.L50L,p.L50L	c.150 G>A	0	1.28	0	0	0	0	0	0,46,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V60L,p.V60L	c.178 G>T	0.10	0	0	0	10.69	15.75	13.21	0,47,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R67Q,p.R67Q	c.200 G>A	0	0	1.17	0	0	0.06	0	0,48,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A81P,p.A81P	c.241 G>C	0	0	0	0	0.08	0	0	0,49,1,BMC_Genet_2008_Apr_10_9_31.txt
p.S83P,p.S83P	c.247 T>C	0	0	0	0	0.15	0.12	0.19	0,50,1,BMC_Genet_2008_Apr_10_9_31.txt
p.S83L,p.S83L	c.248 C>T	0	0	0	0	0	0.06	0	0,51,1,BMC_Genet_2008_Apr_10_9_31.txt
p.D84E,p.D84E	c.252 C>A	0	0	0	0	1.00	0.12	1.51	0,52,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V92M,p.V92M	c.274 G>A	0.07	0	13.41	0.94	8.00	3.70	9.06	...,53,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T95M,p.T95M	c.284 C>T	0	0	0	0	0.08	0.12	0	0,54,1,BMC_Genet_2008_Apr_10_9_31.txt
p.L99I,p.L99I	c.295 C>A	0	0.43	0	0	0	0	0	0,55,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A103A,p.A103A	c.309 C>T	0	0.43	0	0	0	0	0	0,56,1,BMC_Genet_2008_Apr_10_9_31.txt
p.L106Q,p.L106Q	c.317 T>A	0	0	0	0	0	0.06	0	0,57,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A111V,p.A111V	c.332 C>T	0	0	0	0	0	0.18	0	0,59,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I120T,p.I120T	c.359 T>C	0	0	1.75	0	0	0.06	0	0,60,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V122M,p.V122M	c.364 G>A	0	0	0	0	0	0.24	0	0,61,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V122V,p.V122V	c.366 G>C	0	0	0	0	0	0.12	0	0,62,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R142H,p.R142H	c.425 G>A	0.01	0	0	0	0.62	1.31	0.75	0,63,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R151C,p.R151C	c. 451 C>T	0.03	0	0	0	5.62	3.16	6.42	0,64,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Y152X,p.Y152X	c.456 C>A	0	0	0	0	0	0.06	0	0,65,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I155T,p.I155T	c.464 T>C	0	0	0	0	0.23	0.48	1.51	0,66,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R160W,p.R160W	c.478 C>T	0.04	0	0	0	8.31	1.85	7.17	0,67,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R160Q,p.R160Q	c.479 G>A	0	0	0	0	0	0.06	0	5,68,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R163Q,p.R163Q	c.488 G>A	0.14	0	75.51	4.72	4.62	1.61	4.15...,69,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A166A,p.A166A	c.498 G>A	0	0	0	0	0	0	0	11.25,70,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I168I,p.I168I	c.504 C>T	0	0.43	0	0	0	0	0	0,71,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A171D,p.A171D	c.512 C>A	0	0	0	0	0	0.06	0	0,72,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V174I,p.V174I	c.520 G>A	0	0	0	0	0.08	0	0	0,73,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Y182Y,p.Y182Y	c.546 C>T	0	0	0	0	0	0	0.19	0,74,1,BMC_Genet_2008_Apr_10_9_31.txt
p.F196L,p.F196L	c.586 T>C	0	2.14	0.15	0	0.08	0	0	0,75,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R213W,p.R213W	c.637 C>T	0	0	0	0	0	0.06	0	0,76,1,BMC_Genet_2008_Apr_10_9_31.txt
p.G220G,p.G220G	c.660 C>T	0	0	0	0	0	0.06	0	0,77,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Q228Q,p.Q228Q	c.684 G>A	0	0	0	0	0	0.12	0	0,78,1,BMC_Genet_2008_Apr_10_9_31.txt
p.P230L,p.P230L	c.689 C>T	0	0	0	0	0.31	0	0	0,79,1,BMC_Genet_2008_Apr_10_9_31.txt
p.P230P,p.P230P	c.690 G>A	0	0	0	0	0.08	0	0	0,80,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Q233Q,p.Q233Q	c.699 G>A	0	0	0	0	0	0.36	0.19	0,81,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A240A,p.A240A	c.720 T>C	0	0	0	0	0	0	0.19	0,82,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T242T,p.T242T	c.726 C>T	0	0	0	0	0	0.12	0	0,83,1,BMC_Genet_2008_Apr_10_9_31.txt
p.G248V,p.G248V	c.743 G>T	0	0	0	0	0	0.06	0	0,84,1,BMC_Genet_2008_Apr_10_9_31.txt
p.H260P,p.H260P	c.779 A>C	0	0	0	0	0.23	0	0	0,85,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I264I,p.I264I	c.792 C>T	0	0	0	0	0.15	0	0	0,86,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V265V,p.V265V	c.795 C>G	0	1.28	0	0	0	0	0	0,87,1,BMC_Genet_2008_Apr_10_9_31.txt
p.C273C,p.C273C	c.819 C>T	0	0.43	0	0	0	0	0	0,88,1,BMC_Genet_2008_Apr_10_9_31.txt
p.K278E,p.K278E	c.832 A>G	0	0	0	0	0.23	0.24	0	0,89,1,BMC_Genet_2008_Apr_10_9_31.txt
p.N279K,p.N279K	c.837 C>A	0	0	0	0	0	0.06	0	0,90,1,BMC_Genet_2008_Apr_10_9_31.txt
p.D294H,p.D294H	c.880 G>C	0.01	0	0	0	1	1.43	2.45	0,91,1,BMC_Genet_2008_Apr_10_9_31.txt
p.F300F,p.F300F	c.900 C>T	0	2.99	0	0	0	0	0	0,92,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T308M,p.T308M	c.923 C>T	0	0	0	0	0	0.06	0	0,93,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T314T,p.T314T	c.942 A>G	0.09	44.44	13.27	13.21	7.69	2.33...,94,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R151C,"...the allele frequency of the T allele of c.451C>T, p.R151C, was 1.9% in Greece but 10.2% in Britain/I...",171,673,BMC_Genet_2008_Apr_10_9_31.txt
p.L502V, 	 	c.1504C > G (p.L502V)	9193	31	60	38	1.5	58.57	37.59	2.3	0.00	0....,54,18,BMC_Genet_2013_Feb_19_14_6.txt
p.R124W, 	 	c.370C > T (p.R124W)	18217	32.3	58	39	1.77	58.36	0.48	39.35	0....,57,17,BMC_Genet_2013_Feb_19_14_6.txt
p.V320A,CBS	NM_000071.2	c.959 T > C (p.V320A)	8715	24.4	7	91	0.48	90.82	1.63	7.05	0.00	...,62,30,BMC_Genet_2013_Feb_19_14_6.txt
p.M470V,CFTR	NM_000492.3	c.1408 G > A (p.M470V)	9356	30.4	60	38	38.44	0.46	60.04	0.99	0.0...,64,32,BMC_Genet_2013_Feb_19_14_6.txt
p.D882G,DMD	NM_004006.2	c.2645A > G (p.D882G)	2974	19.6	5	93	4.98	0.87	92.67	1.48	0	0,67,30,BMC_Genet_2013_Feb_19_14_6.txt
p.R1745H, 	 	c.5234 G > A (p.R1745H)	4289	23.4	4	93	93.38	1.19	4.13	1.31	0	0,68,19,BMC_Genet_2013_Feb_19_14_6.txt
p.R2937Q, 	 	c.8810 G > A (p.R2937Q)	3235	20.1	4	94	94.03	1.08	4.33	0.56	0	0,71,19,BMC_Genet_2013_Feb_19_14_6.txt
p.H199R, 	 	c.596A > G (p.H199R)	11616	29.2	9	86	9.13	2.95	85.73	2.18	0.00...,74,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R223H, 	 	c.668 G > A (p.R223H)	10344	31.4	5	93	92.62	1.14	4.89	1.31	0.00...,75,18,BMC_Genet_2013_Feb_19_14_6.txt
p.S601L, 	 	c.1802C > T (p.S601L)	6027	21.4	59	34	2.17	59.25	4.35	34.23	0.0...,85,18,BMC_Genet_2013_Feb_19_14_6.txt
p.V780I, 	 	c.2338 G > A (p.V780I)	8957	10.2	11	83	82.93	3.74	10.73	2.57	0.0...,90,19,BMC_Genet_2013_Feb_19_14_6.txt
p.R184C, 	 	c.550C > T (p.R184C)	9215	19.6	39	54	2.59	38.77	4.75	53.88	0	0...,94,17,BMC_Genet_2013_Feb_19_14_6.txt
p.D248N, 	 	c.742 G > A (p.D248N)	15664	32.8	62	35	35.28	0.5	61.78	2.43	0	0...,96,18,BMC_Genet_2013_Feb_19_14_6.txt
p.T529M, 	 	c.1586C > T (p.T529M)	15938	25.7	16	78	2.41	16.18	3.38	78.02	0	...,98,18,BMC_Genet_2013_Feb_19_14_6.txt
p.T641A, 	 	c.1921A > G (p.T641A)	20556	23.6	2	97	2.13	0.88	96.5	0.49	0	0.0...,103,18,BMC_Genet_2013_Feb_19_14_6.txt
p.I562T, 	 	c.1685 T > C (p.I562T)	30664	31.2	58	39	1.99	38.95	1.47	57.58	0	...,109,19,BMC_Genet_2013_Feb_19_14_6.txt
p.T641A, 	 	c.1921A > G (p.T641A)	15648	23	2	96	2.19	1.04	96.42	0.35	0	0.01...,112,18,BMC_Genet_2013_Feb_19_14_6.txt
p.R259Q,GALT	NM_000155.2	c.776 G > A (p.R259Q)	27403	31.3	62	32	31.51	2.92	62.00	3.55	0....,113,31,BMC_Genet_2013_Feb_19_14_6.txt
p.D273H, 	 	c.817 G > C (p.D273H)	27824	32.3	61	38	0.68	37.71	60.85	0.73	0....,114,18,BMC_Genet_2013_Feb_19_14_6.txt
p.N409S, 	 	c.1226 A > G (p.N409S)	2864	20.4	62	36	61.91	0.8	36.03	1.26	0	0,116,19,BMC_Genet_2013_Feb_19_14_6.txt
p.L483P, 	 	c.1448 T > C (p.L483P)	3331	26.4	60	38	0.99	38.04	0.9	60.07	0	0,117,19,BMC_Genet_2013_Feb_19_14_6.txt
p.A495P, 	 	c.1483 G > C (p.A495P)	2569	16.3	53	44	1.01	44.45	53.41	1.05	0	0...,118,19,BMC_Genet_2013_Feb_19_14_6.txt
p.N409S, 	 	c.1226 A > G (p.N409S)	3813	22.9	71	23	70.52	1.1	26.86	1.52	0	0,121,19,BMC_Genet_2013_Feb_19_14_6.txt
p.L62S,HEXB	NM_000521.3	c.185 T > C (p.L62S)	21320	33.2	8	86	3.63	86.44	2.33	7.59	0.00	...,125,31,BMC_Genet_2013_Feb_19_14_6.txt
p.K121R, 	 	c.362A > G (p.K121R)	14201	27.9	66	32	65.63	1.11	31.86	1.39	0....,126,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R505W, 	 	c.1513C > T (p.R505W)	8306	30.9	62	37	0.52	61.77	0.92	36.78	0.0...,129,18,BMC_Genet_2013_Feb_19_14_6.txt
p.G549R, 	 	c.1645 G > A (p.G549R)	33259	34.6	84	15	15.46	0.47	83.69	0.36	0....,131,19,BMC_Genet_2013_Feb_19_14_6.txt
p.H33Q,IDUA	NM_000203.3	c.99 T > G / p.H33Q	34	10.2	6	91	2.94	0.00	91.18	5.88	0.00	0.00...,132,31,BMC_Genet_2013_Feb_19_14_6.txt
p.Q70X, 	 	c.208C > T (p.Q70X)	4106	9.4	49	46	2.65	49.05	1.90	46.40	0.00	...,133,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R105Q, 	 	c.314 G > A (p.R105Q)	10809	28.7	62	34	33.71	1.86	62.39	2.01	0....,135,18,BMC_Genet_2013_Feb_19_14_6.txt
p.A361T, 	 	c.1081 G > A (p.A361T)	9486	26.7	60	38	37.50	1.18	59.99	1.33	0.0...,142,19,BMC_Genet_2013_Feb_19_14_6.txt
p.T388T, 	 	c.1164 G > C (p.T388T)	3080	23.1	65	31	2.05	31.30	65.16	1.49	0.0...,143,19,BMC_Genet_2013_Feb_19_14_6.txt
p.W402X, 	 	c.1205 G > A (p.W402X)	2679	23.2	62	32	31.88	5.30	61.55	1.27	0.0...,144,19,BMC_Genet_2013_Feb_19_14_6.txt
p.S92P, 	 	c.274 T > C (p.S92P)	2505	11.9	14	75	4.79	74.61	6.43	14.17	0	0,149,18,BMC_Genet_2013_Feb_19_14_6.txt
p.S246S, 	 	c.738C > T (p.S246S)	10356	27.9	76	24	0.3	75.69	0.32	23.68	0	0...,150,17,BMC_Genet_2013_Feb_19_14_6.txt
p.E267D, 	 	c.801 G > C (p.E267D)	5788	28.6	64	34	0.57	34.45	63.99	0.93	0	0...,151,18,BMC_Genet_2013_Feb_19_14_6.txt
p.R1005Q, 	 	c.3014 G > A (p.R1005Q)	3027	27	50	48	47.9	1.06	50.21	0.83	0	0,155,19,BMC_Genet_2013_Feb_19_14_6.txt
p.L1043L, 	 	c.3127 T > C (p.L1043L)	13424	30.6	5	94	0.77	93.66	0.99	4.53	0	0...,156,19,BMC_Genet_2013_Feb_19_14_6.txt
p.S298P, 	 	c.892 T > C (p.S298P)	12564	31.7	60	38	0.93	37.61	1.13	60.31	0	...,164,18,BMC_Genet_2013_Feb_19_14_6.txt
p.R456H, 	 	c.1367 G > A (p.R456H)	8525	29.5	61	36	36.29	1.69	60.75	1.23	0	0...,165,19,BMC_Genet_2013_Feb_19_14_6.txt
p.V36A, 	 	c.107 T > C (p.V36A)	 	 	 	 	 	 	 	 	 	 ,167,18,BMC_Genet_2013_Feb_19_14_6.txt
p.R695X,ZEB2	NM_014795.3	c.2083C > T (p.R695X)	20800	24.9	75	24	0.51	75.22	0.4	23.88	0	0...,169,31,BMC_Genet_2013_Feb_19_14_6.txt
p.L502V,"...e nucleotide changes, such as ACADVL c.1504C > G (p.L502V), but also small deletions and insertion e...",237,941,BMC_Genet_2013_Feb_19_14_6.txt
p.L502V,...the SOLiD and Sanger data for ACADVL c.1504C > G (p.L502V) mutation. Panes 1B & 2B represent SOLiD a...,241,151,BMC_Genet_2013_Feb_19_14_6.txt
p.L502V,"...les we ran, there is a heterozygous c.1504 C > G (p.L502V) missense mutation in the ACADVL gene. Thi...",310,156,BMC_Genet_2013_Feb_19_14_6.txt
p.D273Rfs,...e to the fixation of a loss-of-function mutation (p.D273RfsX13) in the myostatin (MSTN) gene. MSTN e...,19,905,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,"...ed as high as 30-45% in BBC after fixation of the p.D273RfsX13 MSTN allele, and (ii) that this resid...",25,149,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...ase muscle mass of BBC. That homozygosity for the p.D273RfsX13 MSTN variant only accounts for part o...,25,306,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...esent-day BBM animals that are homozygous for the p.D273RfsX13 MSTN mutation (Additional file 1: Fig...,25,534,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...ations with effects of a magnitude similar to the p.D273RfsX13 MSTN mutation? Are Quantitative Trait...,27,253,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,"... muscle mass, hence mimicking the fixation of the p.D273RfsX13 MSTN mutation prior to 1985?) we aime...",30,216,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,"...n” BBC, (ii) 28 “old” BBC (all homozygous for the p.D273RfsX13 MSTN mutation), (iii) 52 animals from...",30,791,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...uscling in BBC as a result of the fixation of the p.D273RfsX13 MSTN variant. Of the 88 remaining (sm...,30,2364,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...continued to augment in BBC after fixation of the p.D273RfsX13 MSTN variant around 1985. We have not...,118,132,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...involve respectively (i) the fixation of the MSTN p.D273RfsX13 mutation in (old and new) BBC marked ...,118,576,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.L99P,"...gh differentiation, (ii) the fixation of the MC1R p.L99P mutation in (old and new) BBC, BBM and HF, ...",118,724,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,...That selection underlies the fixation of the MSTN p.D273RfsX13 mutation in (old and new) BBC and the...,118,1179,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.L99P,"...RfsX13 mutation in (old and new) BBC and the MC1R p.L99P mutation in (old and new) BBC, BBM and HF i...",118,1235,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,....5 to 21.5% of the additive genetic variance (the p.D273RfsX13 MSTN variant has an even larger effec...,131,299,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.D273Rfs,"...s scores of BBC (which are all homozygous for the p.D273RfsX13 MSTN mutation or mh/mh (red)), and du...",205,148,BMC_Genomics_2014_Sep_17_15(1)_796.txt
p.P19S,"...se variants are a missense mutation (rs384285149, p.P19S, Chr1:97,309,054 bp) in a highly conserved ...",101,1311,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.P19S,The p.P19S (rs384285149) variant in EIF5A2 is predicte...,103,5,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.P19S,... retardation and a reduced lifespan in mice [17]. p.P19S is therefore a plausible candidate mutation...,103,277,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.P19S,... Sanger sequencing confirmed homozygosity for the p.P19S variant in EIF5A2 and for the p.L258fs16 va...,119,379,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.W317R,"...ing variant (rs110793536) is a missense mutation (p.W317R) in SUGT1 encoding SGT1, suppressor of G2 ...",130,58,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.W317R,...early embryonic lethality in eukaryotes [24]. The p.W317R-variant is predicted to be highly damaging...,130,354,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.W317R,...he SGT1 protein sequence. The red arrow indicates p.W317R. Protein sequences were obtained from NCBI...,130,719,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.V327I,"... in LOC783918 (rs384792959, Chr10: 26,948,606 bp, p.V327I). Thirty-eight (out of 263) sequenced anim...",141,828,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.P19S,...n initiation factor 5A-2. Red color indicates the p.P19S-variant (rs384285149). Protein sequences we...,208,183,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.R961W,"...factor receptor (EGFR) inhibitors; however, a KDR p.R961W c.2881C>T mutation was noted as a variant ...",9,1242,Cureus_8(2)_e478.txt
p.R961W,"...actor receptor (EGFR) inhibitors, however the KDR p.R961W c.2881C>T mutation that was noted as a var...",26,712,Cureus_8(2)_e478.txt
p.R961W,...dictive biomarker of response to regorafenib. KDR p.R961W c.2881C>T mutation has been reported twice...,50,1091,Cureus_8(2)_e478.txt
p.Gln27Glu,...valuated the potential relevance of the c.79 C>G (p.Gln27Glu) polymorphism of this receptor gene for...,9,77,BMC_Med_Genet_2006_Mar_30_7_31.txt
p.Gln27Glu,The genotyping for the c.79 C>G (p.Gln27Glu) polymorphism of β2-AR was determined b...,27,34,BMC_Med_Genet_2006_Mar_30_7_31.txt
p.G1706A,"...[p.Q23fs], c.330A > G, [p.64-71del], c.5236G > A [p.G1706A], c.5242C > A [p.A1708E], c.589-590delCT ...",20,184,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.A1708E,"...p.64-71del], c.5236G > A [p.G1706A], c.5242C > A [p.A1708E], c.589-590delCT [p.S157X]; numbered Gene...",20,208,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.S157X,"....G1706A], c.5242C > A [p.A1708E], c.589-590delCT [p.S157X]; numbered GeneBank U14680) account for 46...",20,235,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.S157X,BRCA1 c.589-590delCT (p.S157X)	F ctcttcaggaggaaaagcac,40,23,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.G1706A,BRCA1 c.5236 G > C (p.G1706A,42,21,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.A1708E,BRCA1 c.5242 C > A (p.A1708E)	F ggacagcacttcctgatttt,43,21,BMC_Med_Genet_2007_Jun_29_8_40.txt
p.E34V,"...: c.101A>T, c.995G>C and c.670 T>G that result in p.E34V, p.G332A and W224G aminoacid substitutions ...",12,885,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G332A,"...>T, c.995G>C and c.670 T>G that result in p.E34V, p.G332A and W224G aminoacid substitutions in exons...",12,893,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G232R,...). One reported mutation was a missense mutation (p.G232R) and 2 were frameshift mutations: c.1082in...,12,1417,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,V	P	F	26	1.3	1.6	149	10.40	2411	+/-	c.101A>T/p.E34V,56,46,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,Si	F	31	1.2	2.1	539	6.00	1208	+/-	c.101A>T/p.E34V,57,45,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,VI	P	F	16	8.0	18.5	2619	10.12	ND	-/+	c.101A>T/p.E34V,58,47,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,VIII	P	F	40	2.4	4.2	874	5.50	1030	+/+	c.670T>G/p.W224R,67,48,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,D	F	15	0.9	1.4	34	1.28 (619)	ND	-/-	c.670T>G/p.W224R,69,47,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,A	F	45	2.5	2.3	450	11.77	893	+/+	c.670T>G/p.W224R,70,44,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,XXIII	P	F	24	6.4	8.2	1108	7.10	1529	+/+	c.503G>A/p.R168H,109,50,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,So	M	18	1.1	1.2	35	1.15 (619)	ND	-/-	c.503G>A/p.R168H,110,48,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,So	M	19	0.9	0.6	86	120	ND	-/-	c.503G>A/p.R168H,112,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,Si	F	35	ND	ND	ND	3.15	1281	+/-	c.503G>A/p.R168H,113,42,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.L178V,XXV	P	F	27	3.1	4.0	870	5.40	1592	+/-	c.532T>G/p.L178V,117,47,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.H106P,XXVI	P	F	39	4.4	6.2	307	5.33	1214	+/-	c.317A>C/p.H106P,118,48,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,V	P	18.48	55.58	c.101A>T/p.E34V,197,26,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,VIII	P	16.95	50.98	c.670T>G/p.W224R,201,29,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,D	18.12	54.19	c.670T>G/p.W224R,202,25,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,...tamic acid residue to a valine residue in exon 3 (p.E34V). The other was a G to C substitution at nu...,209,303,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G332A,... glycine residue to a alanine residue in exon 10 (p.G332A). The last one was a T to G change at nucl...,209,512,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224G,"...eading to a tryptophan to a glycine substitution (p.W224G) (Proband VIII, Figure 7). These mutations...",209,644,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,...ity seems to be unprobable in these cases. In the p.E34V and p.W224G mutations the glutamic acid and...,240,640,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224G,...o be unprobable in these cases. In the p.E34V and p.W224G mutations the glutamic acid and the trypto...,240,651,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G332A,"...dicted for human PPOX [50] In the other case, the p.G332A mutation, although the glycine residue is ...",240,815,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,"...ment of eukaryotic PPOXs, revealed that mutations p.E34V and p.G332A affect residues that are conser...",242,103,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G332A,"...aryotic PPOXs, revealed that mutations p.E34V and p.G332A affect residues that are conserved in mito...",242,114,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224G,"The last missense mutation, p.W224G affects a residue which is absent in the c...",244,29,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224X,...other two already described mutations causing VP: p.W224X [37] and p.W224R [39]. Recently was also s...,244,359,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,... described mutations causing VP: p.W224X [37] and p.W224R [39]. Recently was also suggested that thi...,244,376,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.I309Sfs,...delA leading to a stop codon 5 codons downstream (p.I309Sfs314X). Both mutations would produce unsta...,246,254,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G232R,"...ons were also found. One was a missense mutation, p.G232R [34,35]. The other 2 reported mutations we...",250,81,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E320Q,"...3. A pathogenic homozygous mutation (c.958G > C, [p.E320Q]) in SLC19A3 was identified in all four pa...",10,201,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.E320Q,"...we identified a homozygous mutation (c.958G > C, [p.E320Q]) in exon 3 of SLC19A3 in all patients, wh...",97,93,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.E320Q,"...racterization of a disease mutation (c.958G > C, [p.E320Q]). (A) The sequence analyses showed a G to...",99,82,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.E320Q,"...mic acid at codon 320 for glutamine (c.958G > C, [p.E320Q]), indicated by an arrow. (B) RsaI (GTAC)-...",99,283,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.E320Q,"... were caused by homozygous mutation (c.958G > C, [p.E320Q]) in SLC19A3. Our cases broaden the phenot...",114,330,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.S581Pfs,"...tations and 3 missense mutations: (a) c.1740delC (p.S581PfsX40), a cytosine deletion at position 174...",35,254,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,"... otoferlin at position 621; (b) c.2975_2978delAG (p.Q994VfsX6), a deletion of AG at exon 25 which le...",35,431,BMC_Med_Genet_2010_May_26_11_79.txt
p.D398E,"...mination codon at position 1000; (c) c.1194T > A (p.D398E), the consequence of a transversion from T...",35,612,BMC_Med_Genet_2010_May_26_11_79.txt
p.E594K,"...partate to glutamate in exon 13; (d) c.1780G > A (p.E594K), a transition from G to A at nucleotide 1...",35,784,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,"...yptophan. (Figure 2) Apart from c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (p.R1607 W), which we...",35,1105,BMC_Med_Genet_2010_May_26_11_79.txt
p.S581Pfs,16	c.1740delC	p.S581PfsX40	Frameshift	0501800	0	0/184,41,15,BMC_Med_Genet_2010_May_26_11_79.txt
p.E594K,16	c.1780 G > A	p.E594K	Missense	0501768	12	0/184,42,17,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,25	c.2975_2978	p.Q994VfsX6	Frameshift	0400695	1	0/184,43,16,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,40	c.4819C > T	p.R1607W	Missense	0400695	1	0/184,45,16,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,"...e patient No.0400695, which are c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (p.R1607W), inherited...",50,179,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,"...e c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (p.R1607W), inherited from the mother and father re...",50,209,BMC_Med_Genet_2010_May_26_11_79.txt
p.D398E,"... chromatograms of pathogenic variants c.1194T > A/p.D398E, c.1740delC/p.s581PfsX40 and c.1780G>A/p.E...",52,143,BMC_Med_Genet_2010_May_26_11_79.txt
p.E594K,"... A/p.D398E, c.1740delC/p.s581PfsX40 and c.1780G>A/p.E594K. Two columns are sequencing chromatograms ...",52,190,BMC_Med_Genet_2010_May_26_11_79.txt
p.R49W,"...fied, including 4 missense mutations: c.145C > T (p.R49W), c.157G > A (p.A53T), c.158C > T (p.A53V) ...",54,113,BMC_Med_Genet_2010_May_26_11_79.txt
p.A53T,"...sense mutations: c.145C > T (p.R49W), c.157G > A (p.A53T), c.158C > T (p.A53V) and c.244C > T (p.R82...",54,134,BMC_Med_Genet_2010_May_26_11_79.txt
p.A53V,"...5C > T (p.R49W), c.157G > A (p.A53T), c.158C > T (p.A53V) and c.244C > T (p.R82C). Some of these pol...",54,155,BMC_Med_Genet_2010_May_26_11_79.txt
p.R82C,"...> A (p.A53T), c.158C > T (p.A53V) and c.244C > T (p.R82C). Some of these polymorphisms have been pre...",54,179,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,"...TOF gene in the patient, namely c.2975_2978delAG (p.Q994VfsX6), and c.4819C > T (p.R1607W). The fram...",69,101,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,"... c.2975_2978delAG (p.Q994VfsX6), and c.4819C > T (p.R1607W). The frameshift mutation (c.2975_2978del...",69,132,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,...ring. The two mutant alleles of c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (p.R1607W) were not f...,69,415,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,...f c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (p.R1607W) were not found in our control group,69,445,BMC_Med_Genet_2010_May_26_11_79.txt
p.I515T,"...sponsible heterozygous mutation of the OTOF gene, p.I515T, was first found in two affected children ...",76,378,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,"...in function[8]. The paternally inherited mutation p.R1607W is a missense mutation, and p.R1607W was ...",76,1082,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,"...ted mutation p.R1607W is a missense mutation, and p.R1607W was the consequence of replacement of an ...",76,1119,BMC_Med_Genet_2010_May_26_11_79.txt
p.Q994Vfs,...AN revealed two mutant alleles: c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (p.R1607W). The speci...,81,359,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,...: c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (p.R1607W). The special mutation spectra of the OTO...,81,389,BMC_Med_Genet_2010_May_26_11_79.txt
p.G908R,"...ning 2 gene (NOD2, also known as CARD15), namely, p.G908R, p.R702W, and p.L1007fs [12-14]. These thr...",22,200,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,"...ne (NOD2, also known as CARD15), namely, p.G908R, p.R702W, and p.L1007fs [12-14]. These three varian...",22,209,BMC_Med_Genet_2011_May_6_12_63.txt
p.R381Q,"...In the IL23R gene, a rare non-synonymous variant, p.R381Q, appears to be protective against developi...",22,658,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,"...f CD, such as 1.9 (95% CI: 1.1-3.2; p = 0.03) for p.R702W, 3.2 (95% CI: 2.2-4.9; p = 6.4*10-9) for p...",41,433,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,"... p.R702W, 3.2 (95% CI: 2.2-4.9; p = 6.4*10-9) for p.G908R, and 5.2 (95% CI: 3.3-8.3; p = 2.0*10-12) ...",41,482,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,"...ants (D' = 0.99, r2 = 0.17 between rs17221417 and p.G908R and D' = 0.97, r2 = 0.15 between rs2076756...",41,1110,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,rs2066844	p.R702W	0.02	0.04	1.85 (1.08-3.18)	0.03,52,36,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,rs2066845	p.G908R	0.04	0.11	3.23 (2.15-4.85)	6.39*10-9,53,12,BMC_Med_Genet_2011_May_6_12_63.txt
p.T300A,rs1373692	p.T300A	0.61	0.67	1.29 (1.06-1.58)	0.012,71,36,BMC_Med_Genet_2011_May_6_12_63.txt
p.R381Q,The rare IL23R p.R381Q variant (rs11209026) was more frequently f...,96,16,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,"...hich are specific to AJ individuals [28,29], with p.R702W, pG908R, and p.L1007fs accounting for 81% ...",158,726,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,"...in our study conferred a slightly higher risk for p.R702W, p.G908R and p.L1007fs (OR of 1.85 (95% CI...",158,1662,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,"...udy conferred a slightly higher risk for p.R702W, p.G908R and p.L1007fs (OR of 1.85 (95% CI: 1.08-3....",158,1671,BMC_Med_Genet_2011_May_6_12_63.txt
p.R381Q,"...e IL23R non-synonymous coding variant rs11209026 (p.R381Q) [16], numerous reports including GWAS, ha...",160,134,BMC_Med_Genet_2011_May_6_12_63.txt
p.R381Q,...ciated with the minor allele at IL23R rs11209026 (p.R381Q) was comparable to that reported previousl...,160,366,BMC_Med_Genet_2011_May_6_12_63.txt
p.R2146Q,"...el compound heterozygous mutations, IVS11 + 1 and p.R2146Q, of MYO15A in one (SR903 family) of the 1...",10,67,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...). Of these, three variants in MYO15A (IVS11 + 1, p.R2146Q, and p.S3474G) were shared by both siblin...",67,187,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S3474G,"...hree variants in MYO15A (IVS11 + 1, p.R2146Q, and p.S3474G) were shared by both siblings. The p.S347...",67,201,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S3474G,"..., and p.S3474G) were shared by both siblings. The p.S3474G variant was ruled out because it was repo...",67,245,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2140Q,"...s and their family. One variant, corresponding to p.R2140Q, was heterozygotic in the patient’s fathe...",67,545,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...mpound heterozygous mutations, IVS11 + 1G > A and p.R2146Q, are carried by both affected siblings, S...",69,243,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...the mother (SR-903 M), and the other heterozygous p.R2146Q mutation is from the father (SR-903 F). (...",69,411,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...r (SR-903 F). (B) SR-285 carries the heterozygous p.S2161F mutation in MYO15A, and this mutation was...",69,496,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.Q445R,"...three candidate variants of known deafness genes (p.Q445R in GRHL2, p.T1321S in TECTA, and p.S2161F ...",71,66,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.T1321S,"...riants of known deafness genes (p.Q445R in GRHL2, p.T1321S in TECTA, and p.S2161F in MYO15A); only o...",71,84,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...s genes (p.Q445R in GRHL2, p.T1321S in TECTA, and p.S2161F in MYO15A); only one mutation, p.S2161F i...",71,107,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...ECTA, and p.S2161F in MYO15A); only one mutation, p.S2161F in MYO15A, was shared with an affected si...",71,147,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,"...s found to contain another MYO15A coding variant, p.G1220R, which was also shared by both affected s...",71,689,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...d heterozygous mutations in MYO15A, IVS11 + 1 and p.R2146Q, were found in the SR-903 family, while a...",74,58,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"... the SR-903 family, while a heterozygous variant, p.S2161F was identified in the SR-285 family. All ...",74,131,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...f the positive charge on the arginine side-chain (p.R2146Q). In the other variant, the polar side ch...",74,768,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,...placed with a non-polar phenylalanine side-chain (p.S2161F). Both alterations are predicted by SIFT ...,74,887,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,SR-903	Chr17:18049349	c.G6437A	p.R2146Q	Exon 29	MyTH4	0/409	Yes	0	0.99	-0.743,82,32,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,SR-285	Chr17:18049394	c.C6482T	p.S2161F	Exon 29	MyTH4	0/409	Yes	0	1	-0.543,84,32,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"Two missense mutations, p.S2161F and p.R2146Q, are located in exon 29, the...",109,25,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"Two missense mutations, p.S2161F and p.R2146Q, are located in exon 29, the first MyTH4 ...",109,38,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2124Q,"...the case of myosin XVA, it has been reported that p.R2124Q and p.P2073S mutations located in the MyT...",109,760,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.P2073S,"...yosin XVA, it has been reported that p.R2124Q and p.P2073S mutations located in the MyTH4 domain int...",109,773,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...present study, we identified two novel mutations, p.S2161F and p.R2146Q, which are located in the My...",109,1036,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"..., we identified two novel mutations, p.S2161F and p.R2146Q, which are located in the MyTH4 domain. T...",109,1049,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,...portant roles in the functions of myosin XVA. The p.R2146Q protein contains a prominent exposed hydr...,109,1219,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...FS and CEN [27]. Therefore, we speculate that the p.R2146Q mutation cripples the inter-MyTH4-FERM in...",109,1637,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,"...85, we identified two novel nonsynomous variants, p.G1220R and p.S2161F, in the MYO15A gene. Both of...",111,58,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...fied two novel nonsynomous variants, p.G1220R and p.S2161F, in the MYO15A gene. Both of these varian...",111,71,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,"...ted sibling. However, as the heterozygous variant p.G1220R was present in the Korean control exome d...",111,200,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...utation in this family. However, another variant, p.S2161F, was absent in 409 ethnically matched con...",111,395,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,...for the hearing loss observed in this family: (1) p.G1220R contributes to the phenotype of the SR-28...,111,729,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,...s-yet-unidentified hearing loss gene. Even though p.S2161F was not the causative mutation in this fa...,111,1236,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...iblings. (B) In family SR-285, only one mutation, p.S2161F in MYO15A, is shared with the affected si...",134,224,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.Pro240Leu,"...e two previously reported pathological mutations, p.Pro240Leu and p.Glu1595Lys, as well as one novel...",10,154,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"... reported pathological mutations, p.Pro240Leu and p.Glu1595Lys, as well as one novel mutation, p.Asn...",10,170,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"... and p.Glu1595Lys, as well as one novel mutation, p.Asn342Ser. The p.Pro240Leu mutation was found in...",10,215,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"..., as well as one novel mutation, p.Asn342Ser. The p.Pro240Leu mutation was found in both families. W...",10,232,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...tional file 3: Table S3). Two missense mutations, p.Pro240Leu and p.Glu1595Lys, were identified to b...",57,252,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...able S3). Two missense mutations, p.Pro240Leu and p.Glu1595Lys, were identified to be compound heter...",57,268,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...zygous mutations in the proband of SR-106 family. p.Pro240Leu was confirmed in the patient’s father ...,57,369,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...as detected. SR-209 family carried two mutations, p.Pro240Leu and p.Asn342Ser in the CDH23. Both var...",57,625,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...209 family carried two mutations, p.Pro240Leu and p.Asn342Ser in the CDH23. Both variants were also ...",57,641,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...riants were also found in an affected sibling and p.Pro240Leu was confirmed in the father by Sanger ...,57,724,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...wo patients and one patient were heterozygous for p.Pro240Leu (2.15%) and p.Glu1595Lys (1.07%), resp...",57,977,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...ent were heterozygous for p.Pro240Leu (2.15%) and p.Glu1595Lys (1.07%), respectively. Direct sequenc...",57,1001,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,...tched negative controls (over 700). The mutations p.Asn342Ser and p.Glu1595Lys were absent in all co...,57,1138,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...ontrols (over 700). The mutations p.Asn342Ser and p.Glu1595Lys were absent in all controls, and p.Pr...",57,1154,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...and p.Glu1595Lys were absent in all controls, and p.Pro240Leu was detected in 2 (0.24%) of 818 Korea...",57,1200,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...n family SR-106, compound heterozygous mutations, p.Pro240Leu and p.Glu1595Lys, were identified. One...",59,216,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"... compound heterozygous mutations, p.Pro240Leu and p.Glu1595Lys, were identified. One heterozygous p....",59,232,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...d p.Glu1595Lys, were identified. One heterozygous p.Pro240Leu mutation was confirmed in the father. ...",59,280,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...n family SR-209, compound heterozygous mutations, p.Pro240Leu and p.Asn342Ser, were carried by an af...",59,385,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"... compound heterozygous mutations, p.Pro240Leu and p.Asn342Ser, were carried by an affected sibling a...",59,401,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...carried by an affected sibling and a heterozygous p.Pro240Leu mutation by the father. All pathogenic...,59,469,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"c.C719T	p.Pro240Leu	8	EC3	ㅡ	DAMAGING/0.02	0.999	−1	SR-106,...",75,9,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,c.A1025G	p.Asn342Ser	11	EC3	DXNDN	DAMAGING/0	0.905	−1	SR-20...,76,10,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,c.G4783A	p.Glu1595Lys	36	EC15	DRE	DAMAGING/0	0.987	−1	SR-10...,77,10,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...g two previously reported pathological mutations, p.Pro240Leu and p.Glu1595Lys, and one novel mutati...",85,97,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"... reported pathological mutations, p.Pro240Leu and p.Glu1595Lys, and one novel mutation, p.Asn342Ser ...",85,113,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...o240Leu and p.Glu1595Lys, and one novel mutation, p.Asn342Ser (Table 2). The ConSeq server revealed ...",85,151,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...ium binding below the threshold of detection. The p.Glu1595Lys mutation reduces the numbers of oxyge...,85,761,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...e polar and uncharged amino acids themselves, the p.Asn342Ser mutation involves the change from a sm...",85,994,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...alcium affinity and impairs protein function like p.Glu1595Lys. The p.Pro240Leu mutation does not di...,85,1325,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...d impairs protein function like p.Glu1595Lys. The p.Pro240Leu mutation does not directly interfere w...,85,1343,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...is longer and more flexible (Figure 2). Thus, the p.Pro240Leu substitution may affect protein stabil...",85,1631,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,...re wild-type and those of B and D are mutant. The p.Asn342Ser in EC3 and p.Glu1595Lys in EC15 are as...,87,459,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...of B and D are mutant. The p.Asn342Ser in EC3 and p.Glu1595Lys in EC15 are associated with highly co...,87,482,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Ala361Ser,2	Chr10:73377097	11	c.G1081T	p.Ala361Ser	.	.	1/30	Novel,100,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val424Met,3	Chr10:73405717	12	c.G1270A	p.Val424Met	rs2305207	.	1/30	rs2305207,101,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp428Asn,4	Chr10:73405729	12	c.G1282A	p.Asp428Asn	rs188376296	1 (SR-68)	2/128	rs18837629...,102,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Gly490Ala,5	Chr10:73434888	14	c.G1469C	p.Gly490Ala	rs1227049	8	14/30	[5],103,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Ser496Asn,6	Chr10:73434906	14	c.G1487A	p.Ser496Asn	rs10999947	7	54/128	[5],104,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg964Gln,7	Chr10:73464825	24	c.G2891A	p.Arg964Gln2	.	1 (SR-153)	0/128	Novel,105,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1010His,8	Chr10:73466729	25	c.G3029A	p.Arg1010His	.	.	1/30	Novel,106,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Gly1118Ser,9	Chr10:73472553	27	c.G3352A	p.Gly1118Ser2	.	1 (SR-931)	0/328	Novel,107,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val1335Ala,10	Chr10:73492032	31	c.T4004C	p.Val1335Ala	.	.	1/30	Novel,108,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn1351Asp,11	Chr10:73492079	31	c.A4051G	p.Asn1351Asp	rs1227065	16	29/30	[5],109,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1437Gln,12	Chr10:73498355	33	c.G4310A	p.Arg1437Gln	rs56181447	5	8/30	[5],110,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1588Trp,13	Chr10:73501595	36	c.C4762T	p.Arg1588Trp	.	.	1/30	[5],111,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Ala1575Thr,14	Chr10:73501556	36	c.G4723A	p.Ala1575Thr	rs1227051	16	28/30	[5],112,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val1675Ile,15	Chr10:73537614	37	c.G5023A	p.Val1675Ile	rs17712523	8	7/30	[5],113,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1804Gln,16	Chr10:73544086	40	c.G5411A	p.Arg1804Gln	rs3802711	10	16/30	[5],114,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp1806Glu,17	Chr10:73544093	40	c.C5418G	p.Asp1806Glu	rs74145660	3	6/30	[5],115,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Thr1999Ser,18	Chr10:73550117	44	c.C5996G	p.Thr1999Ser	rs11592462	6	8/30	[5],116,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu2044Lys,19	Chr10:73550969	45	c.G6130A	p.Glu2044Lys	rs10466026	12	26/30	[5],117,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val2283Ile,20	Chr10:73558128	48	c.G6847A	p.Val2283Ile3	rs41281334	1 (SR-1016)	3/128	[5],118,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg2358Gln,21	Chr10:73558886	49	c.G7073A	p.Arg2358Gln	rs4747194	12	26/30	[5],119,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro2380Leu,22	Chr10:73558952	49	c.C7139T	p.Pro2380Leu	rs4747195	12	26/30	[5],120,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Met2531Val,23	Chr10:73562763	52	c.A7591G	p.Met2531Val	.	.	1/30	Novel,121,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Phe2801Val,24	Chr10:73567365	57	c.T8401G	p.Phe2801Val3	rs3802707	.	2/30	[5],122,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Ala3080Thr,25	Chr10:73571307	62	c.G9238A	p.Ala3080Thr	.	1 (SR-1016)	3/128	Novel,123,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Phe3125Leu,26	Chr10:73571765	64	c.T9373C	p.Phe3125Leu	rs45583140	2	15/30	rs45583140,124,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"We identified three CDH23 mutations, p.Pro240Leu, p.Glu1595Lys, and p.Asn342Ser, in 2 (...",132,38,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"We identified three CDH23 mutations, p.Pro240Leu, p.Glu1595Lys, and p.Asn342Ser, in 2 (15%) of 13 Ko...",132,51,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...e CDH23 mutations, p.Pro240Leu, p.Glu1595Lys, and p.Asn342Ser, in 2 (15%) of 13 Korean families with...",132,69,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...creened for eight mutations, including the three (p.Pro240Leu, p.Asn342Ser and p.Glu1595Lys) detecte...",132,342,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...ight mutations, including the three (p.Pro240Leu, p.Asn342Ser and p.Glu1595Lys) detected in the pres...",132,355,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...including the three (p.Pro240Leu, p.Asn342Ser and p.Glu1595Lys) detected in the present study, and f...",132,371,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg301Gln,"...) detected in the present study, and five others (p.Arg301Gln, p.Glu956Lys, p.Arg1417Trp, p.Gln1716P...",132,433,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu956Lys,"... the present study, and five others (p.Arg301Gln, p.Glu956Lys, p.Arg1417Trp, p.Gln1716Pro, and p.Arg...",132,446,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1417Trp,"...study, and five others (p.Arg301Gln, p.Glu956Lys, p.Arg1417Trp, p.Gln1716Pro, and p.Arg2029Trp) that...",132,459,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Gln1716Pro,"...e others (p.Arg301Gln, p.Glu956Lys, p.Arg1417Trp, p.Gln1716Pro, and p.Arg2029Trp) that occur at rela...",132,473,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg2029Trp,"...Gln, p.Glu956Lys, p.Arg1417Trp, p.Gln1716Pro, and p.Arg2029Trp) that occur at relatively high freque...",132,491,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"... one patient, respectively, were heterozygous for p.Pro240Leu and p.Glu1595Lys, and no other mutatio...",132,718,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...spectively, were heterozygous for p.Pro240Leu and p.Glu1595Lys, and no other mutation was detected. ...",132,734,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...p.Glu1595Lys, and no other mutation was detected. p.Pro240Leu was reported in Japanese families with...",132,784,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...ant causes of non-syndromic hearing loss and that p.Pro240Leu accounted for nearly 43.3% (45/105) of...,132,1015,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...with ARNSHL caused by CDH23 mutations carried the p.Pro240Leu mutation and, additionally, two of 93 ...",132,1189,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...atients were heterozygous for the mutation. Thus, p.Pro240Leu is the most common cause of CDH23-asso...",132,1303,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,... of CDH23-associated ARNSHL in Asian populations. p.Glu1595Lys was present in 1 of 93 patients. Astu...,132,1389,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...nd in the EC domain. Of the three mutations, two (p.Glu1595Lys and p.Asn342Ser) affected highly cons...",134,677,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...in. Of the three mutations, two (p.Glu1595Lys and p.Asn342Ser) affected highly conserved EC calcium-...",134,694,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...ification, and dimerization of CDH23 [15,16]. The p.Glu1595Lys mutation may disrupt a conserved LDRE...",134,913,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...dent interactions [16]. Molecular modeling of the p.Glu1595Lys mutation shows impairment of calcium ...,134,1147,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...ith either CDH23 or other proteins. Likewise, the p.Asn342Ser mutation is also located in a highly c...",134,1459,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp428Asn,...uld not conclude that it is a causative mutation. p.Asp428Asn in SR-68 was also heterozygous. DNA sa...,136,405,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val2283Ile,...onfirm its pathogenicity by segregation analysis. p.Val2283Ile and p.Phe2801Val were identified as c...,136,571,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Phe2801Val,...enicity by segregation analysis. p.Val2283Ile and p.Phe2801Val were identified as compound heterozyg...,136,588,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Gln778Ser,"...the coding region of MEFV gene, named c.2330dupG (p.Gln778Serfs*4 or Q778SfsX4) resulting in a mutat...",10,105,BMC_Med_Genet_2014_Jul_1_15_74.txt
p.Gln778Ser,...Gly-Gln-Gly-Pro-Asp-STOP to Gly-Ser-Gly-Ala-STOP (p.Gln778Serfs*4 or Q778SfsX4),40,1340,BMC_Med_Genet_2014_Jul_1_15_74.txt
p.Ser208Ala,"...391insGAGGGGAAC (p.Glu128_Asn130dup), 606_621dup (p.Ser208Alafs*39) and 761_764dupCCGC (p.Asn256Argf...",89,594,BMC_Med_Genet_2014_Jul_1_15_74.txt
p.Asn256Arg,"...606_621dup (p.Ser208Alafs*39) and 761_764dupCCGC (p.Asn256Argfs*70) [1,6,24]. Only one of these is a...",89,632,BMC_Med_Genet_2014_Jul_1_15_74.txt
p.Gln778Ser,"...orted before. Therefore, we think the c.2330dupG (p.Gln778Serfs*4) mutation should be listed in the ...",92,114,BMC_Med_Genet_2014_Jul_1_15_74.txt
p.R5205H,... a variant of DDHD1 on 14q. The variant of HMCN1 (p.R5205H) showed the best co-segregation in the fa...,10,398,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.A4704V,"...sequencing. Additionally, rare missense variants (p.A4704V, p.T5004I, and p.H5244Q) were detected in...",10,532,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.T5004I,".... Additionally, rare missense variants (p.A4704V, p.T5004I, and p.H5244Q) were detected in three unr...",10,542,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.H5244Q,"..., rare missense variants (p.A4704V, p.T5004I, and p.H5244Q) were detected in three unrelated Kosovo ...",10,556,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.V121I,"...r was a rare variant. The novel variant (c.G361A, p.V121I) is located in the Contactin 2 gene (CNTN2...",144,121,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.R5205H,"...e non-synonymous variant (rs150188026, c.G15614A, p.R5205H, MAF 0.018) is located in the Hemicentin ...",144,293,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.A4704V,"... very rare missense variants in HMCN1 (c.C14111T, p.A4704V, MAF 0.001; c.C15011T, p.T5004I, MAF 0.00...",144,587,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.T5004I,"...HMCN1 (c.C14111T, p.A4704V, MAF 0.001; c.C15011T, p.T5004I, MAF 0.008, and c.C15732G, p.H5244Q, MAF ...",144,619,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.H5244Q,"...1; c.C15011T, p.T5004I, MAF 0.008, and c.C15732G, p.H5244Q, MAF 0.005) (Table 2 and Table 3). The ot...",144,655,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.V393A,"... DDHD domain containing 1 gene (DDHD1) (c.T1178C, p.V393A) and it causes an amino acid substitution ...",144,818,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.R168*,"c.502C > T	p.R168*	Renal tubular dysgenesis, #267430",104,13,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.R928C,"c.2782C > T	p.R928C	Bethlem myopathy, #158810",107,14,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.E1586D,"c.4758A > C	p.E1586D	Alagille syndrome 2, #610205",111,14,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.R168*,"... The stop-gain mutation within AGTR1 (c.502C > T, p.R168*) would terminate the protein at R168 halvi...",114,248,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.R928C,"...utation in a collagen gene (COL6A3) (c.2782C > T, p.R928C) was identified. Collagen genes encode str...",116,69,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.E1586D,"... [17]. Likewise, the NOTCH2 mutation(c.4758A > C, p.E1586D) identified in the index patient and his ...",118,440,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.Gly243Arg,"...ants that were filtered to a homozygous mutation (p.Gly243Arg) in the FBXO32 gene, located within th...",11,196,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.His356Tyr,"...bases, resulting in only two homozygous variants; p.His356Tyr in OC90 and p.Gly243Arg in FBXO32. The...",64,579,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,... two homozygous variants; p.His356Tyr in OC90 and p.Gly243Arg in FBXO32. The OC90 variant was exclud...,64,603,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,"...glycine with arginine at amino acid position 243 (p.Gly243Arg, Fig. 5a). This missense mutation segr...",64,1368,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.G243R,"a The homozygous mutation (c.727G > C, p.G243R) is indicated by the arrow in the upper pa...",65,40,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...rediction analysis for functional consequences of p.Gly243Ar,71,73,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...tilized to predict the functional consequences of p.Gly243Arg (c.727G > C). The Polyphen2 program pr...,72,150,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...a score of −3.624. SNPs&GO analysis predicted the p.Gly243Arg change as “disease” with a reliability...,72,398,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,... an essential function (Fig. 5b). We also modeled p.Gly243Arg of FBXO32 on a template structure adap...,72,834,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...ral factors pertinent to the identified mutation (p.Gly243Arg) support the suggestion that FBXO32 is...,91,100,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Phe174Ser,...London 28710.1186/s12881-016-0287-1Case ReportThe p.Phe174Ser mutation is associated with mild forms...,3,122,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,"...gous for a known pathogenic mutation (c.724C > T, p.Arg242Cys) and a mutation that has only been rep...",8,248,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...ported once in a Portuguese patient (c.521 T > C, p.Phe174Ser) whose pathogenicity has not been yet ...",8,347,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...sessed. We compared the two patients carrying the p.Phe174Ser variant and concluded that this varian...,8,449,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"... this report, we confirm the pathogenicity of the p.Phe174Ser variant and we also provide evidence o...",11,317,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,"...gous for a known pathogenic mutation (c.724C > T, p.Arg242Cys) and a mutation that has only been rep...",23,142,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...d once in the Portuguese population (c.521 T > C, p.Phe174Ser) [11]",23,246,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...ealed the presence of two mutations: c.521 T > C (p.Phe174Ser), inherited from the mother and c.724C...",36,438,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,"...74Ser), inherited from the mother and c.724C > T (p.Arg242Cys), inherited from the father, confirmin...",36,494,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,Our case had two mutations in the DHCR7 gene: p.Arg242Cys and p.Phe174Ser. Whilst the p.Arg242Cy...,40,47,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,... two mutations in the DHCR7 gene: p.Arg242Cys and p.Phe174Ser. Whilst the p.Arg242Cys mutation has b...,40,63,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,...CR7 gene: p.Arg242Cys and p.Phe174Ser. Whilst the p.Arg242Cys mutation has been repeatedly reported ...,40,87,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...ported in patients affected by SLOS [14, 15], the p.Phe174Ser has only been reported in one Portugue...",40,180,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"a Chromatograms showing the c.521 T > C (p.Phe174Ser), and the c.724C > T (p.Arg242Cys) mut...",43,42,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,"...he c.521 T > C (p.Phe174Ser), and the c.724C > T (p.Arg242Cys) mutations. b In silico programs showi...",43,76,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...lico programs showing the predicted effect of the p.Phe174Ser mutation on the DHCR7. SNP&GO, http://...",43,157,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,... mutations or with two mutations in loop 8–9. The p.Phe174Ser and the p.Arg242Cys mutations are in t...,48,530,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,...wo mutations in loop 8–9. The p.Phe174Ser and the p.Arg242Cys mutations are in the TM3 and TM5 domai...,48,550,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...eviously reported Portuguese patient carrying the p.Phe174Ser mutation are both affected by a form o...,48,976,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...differences between our case and the one with the p.Phe174Ser mutation that was previously reported....,48,1139,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...e observations, it is possible to assume that the p.Phe174Ser variant is associated with mild forms ...",48,1260,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...able 1 Clinical features of patients carrying the p.Phe174Ser varian,48,1369,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...study offers further clinical significance to the p.Phe174Ser variant and provides evidence for its ...,71,369,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg42*,...on 2944 on cDNA sequence NM_020975.4; NP_009008.2:p.Arg42* indicates that Arginine at position 42 on...,40,397,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
p.Gly1349Asp,"...e, including mutation description syntaxes (e.g. 'p.Gly1349Asp'), reported gene name (e.g. 'CFTR'), ...",46,180,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
p.S110S,rs1780316	c.330 T > C	p.S110S	1.00	0.94	0.95,79,23,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.Y263H,rs3200254	c.787 T > C	p.Y263H	0.20	0.17	0.11,80,23,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.P292P,rs3200255	c.876A > G	p.P292P	0.20	0.17	0.11,81,22,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.V522A,rs34605986	c.1565 T > C	p.V522A	0.10	0.00	0.10,82,25,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.Arg247Pro,... two SMARCAL1 mutations: a novel missense change (p.Arg247Pro) and a well-known nonsense mutation (p...,7,450,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Glu848*,...(p.Arg247Pro) and a well-known nonsense mutation (p.Glu848*),7,499,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Arg247Pro,"...resulting in an arginine-to-proline substitution (p.Arg247Pro), inherited by the mother; and a nonse...",28,198,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Glu848*,... in the substitution of Glu848 with a stop codon (p.Glu848*) [9]. The healthy brother was wild type ...,28,364,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Arg247Pro,...pound heterozygous for a novel missense mutation (p.Arg247Pro) and a well-known nonsense mutation (p...,35,202,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Glu848*,"...(p.Arg247Pro) and a well-known nonsense mutation (p.Glu848*) [9], displayed a mild form. The missens...",35,251,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Arg247Pro,"...9], displayed a mild form. The missense mutation (p.Arg247Pro) within the first HARP domain (HARP1),...",35,313,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Glu848*,"...1 enzyme specificity [17]. The nonsense mutation, p.Glu848*, leading to a truncated SMARCAL1 protein...",35,1219,BMC_Nephrol_2014_Mar_3_15_41.txt
p.G2019S,... the Portuguese population the LRRK2 c.6055G > A; p.G2019S mutation has one of the highest frequenci...,6,204,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...ntly sporadic PD. The LRRK2 mutation c.6055G > A; p.G2019S, accounts for 1–2% of typical sporadic PD...",20,617,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,We had previously shown that the c.6055G > A; p.G2019S mutation in LRRK2 is common in Portuguese...,22,47,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...iously been found to carry the LRRK2 c.6055G > A; p.G2019S mutation (n = 11). This selection led to ...,25,1159,BMC_Neurol_2008_Jan_22_8_1.txt
p.E395X,...ed data consistent with a homozygous c.1183G > T; p.E395X mutation and a duplication of exon 9; beca...,45,607,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...amples tested positive for the LRRK2 c.6055G > A; p.G2019S mutation, sample S12 and sample S7. Notab...",67,56,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...vious report [15] we showed that the c.6055G > A; p.G2019S LRRK2 mutation underlies about 6% of late...,76,61,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...opulation. While we did not find any c.6055G > A; p.G2019S carriers in the 20 late-onset patients st...,76,190,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...tients studied here, we did identify c.6055G > A; p.G2019S in 2 of 46 early-onset cases. One of thes...",76,281,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,...amples previously found to carry the c.6055G > A; p.G2019S mutation we calculate that this mutation ...,76,688,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...r of mutations: the frequency of the c.6055G > A; p.G2019S is one of the highest in Europe, and in t...",85,208,BMC_Neurol_2008_Jan_22_8_1.txt
p.E64D,...llnik B Tong L Kruger R Riess O  Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson di...,114,189,BMC_Neurol_2008_Jan_22_8_1.txt
p.Q648X,... the identification of a novel nonsense mutation (p.Q648X) and three previously known mutations,10,233,BMC_Neurol_2011_Oct_1_11_119.txt
p.Q648X,...(c.1942 C>T) resulting in a premature stop codon (p.Q648X). In family MCP26 an already reported homo...,37,326,BMC_Neurol_2011_Oct_1_11_119.txt
p.Val1314Arg,...g a premature stop codon 50 base pair downstream (p.Val1314ArgfsX18) (Figure 3). Additionally two mi...,37,541,BMC_Neurol_2011_Oct_1_11_119.txt
p.Arg438His,... mutations were identified in exon 10 (c.1313G>A; p.Arg438His) and 11 (c.1531G>A; p.Asp511Asn) in fa...,37,647,BMC_Neurol_2011_Oct_1_11_119.txt
p.Asp511Asn,"...on 10 (c.1313G>A; p.Arg438His) and 11 (c.1531G>A; p.Asp511Asn) in families MCP35 and MCP3, respectiv...",37,679,BMC_Neurol_2011_Oct_1_11_119.txt
p.Val1314Arg,The p.Val1314ArgfsX18 truncating mutation identified i...,84,5,BMC_Neurol_2011_Oct_1_11_119.txt
p.Q648X,"...n family MCP67, harboring the truncating mutation p.Q648X, the affected subjects also have severe cl...",84,476,BMC_Neurol_2011_Oct_1_11_119.txt
p.Q78X,...tion in exon 3 of CTNNB1 (NM_001098209): c.C232T; p.Q78X (Fig. 1B).Fig. 1 Filtering strategy used fo...,128,1591,BMC_Neurol_2016_Mar_12_16_35.txt
p.Q78X,...panel (a). DNA electrophoregram with the c.C232T; p.Q78X mutation in exon 3 of CTNNB1 (b,128,1765,BMC_Neurol_2016_Mar_12_16_35.txt
p.Q78X,...atient has a de novo mutation in CTNNB1 (c.C232T; p.Q78X) which is localized in the N-terminal domai...,141,357,BMC_Neurol_2016_Mar_12_16_35.txt
p.R416W,"...same heterozygous missense mutation, c.1246C > T, p.R416W, despite of no neurological symptoms in he...",8,834,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,...rginine to tryptophan at amino acid position 416 (p.R416W). Her daughter’s genomic DNA showed the sa...,48,294,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,"...ine, Aarrowhead), leading to amino acid change in p.R416W (arginine > tryptophan",48,769,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,"... missense mutation in the GFAP gene, c.1246C > T, p.R416W was identified, which was already shown to...",53,189,BMC_Neurol_2016_Nov_4_16_211.txt
p.D78N,...	Male	62	Mild cervicomedullary atrophy	c.232G > A	p.D78N,79,65,BMC_Neurol_2016_Nov_4_16_211.txt
p.V87G,"...and spinal cord, Periventricular rim	c. 274 T > G	p.V87G",80,102,BMC_Neurol_2016_Nov_4_16_211.txt
p.V87G,"...e matter lesion, periventricular rim	c. 274 T > G	p.V87G",81,124,BMC_Neurol_2016_Nov_4_16_211.txt
p.R88C,a<4	Frontal white matter abnormality	c.276C > T	p.R88C,83,49,BMC_Neurol_2016_Nov_4_16_211.txt
p.E205K,...of medulla oblongata and cervical cord	c.613G > A	p.E205K,84,126,BMC_Neurol_2016_Nov_4_16_211.txt
p.R330G,"...eriventricular rim, atrophy of medulla	c.988C > G	p.R330G",85,75,BMC_Neurol_2016_Nov_4_16_211.txt
p.E332K,c.994G > A	p.E332K,86,12,BMC_Neurol_2016_Nov_4_16_211.txt
p.L331P,...ep frontal white matter and caudates	c.1006 T > C	p.L331P,87,111,BMC_Neurol_2016_Nov_4_16_211.txt
p.N386S,... cord medullaoblongata and cerebellar	c.1157A > G	p.N386S,88,103,BMC_Neurol_2016_Nov_4_16_211.txt
p.S398Y,... medulla oblongata and cervical cord	c. 1193C > A	p.S398Y,89,128,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,"...the cerebellum, medulla, pons changes	c.1260C > T	p.R416W",91,72,BMC_Neurol_2016_Nov_4_16_211.txt
p.P47L,c.154C > T	p.P47L,92,12,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,"... missense mutation of the GFAP gene, c.1246C > T, p.R416W, has been reported to be one of the causes...",99,408,BMC_Neurol_2016_Nov_4_16_211.txt
p.Ser1218Cys,"...6delCCCT), responsible of a premature stop codon (p.Ser1218CysfsX81)",65,432,BMC_Psychiatry_2015_May_7_15_107.txt
p.Glu809X,...2425G > T) responsible of a premature stop codon (p.Glu809X),80,728,BMC_Psychiatry_2015_May_7_15_107.txt
p.Gly12Asp,**WT: wildtype; G12D: p.Gly12Asp; G12V: p.Gly12Val; G12S: p.Gly12Ser,84,23,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Val,**WT: wildtype; G12D: p.Gly12Asp; G12V: p.Gly12Val; G12S: p.Gly12Ser,84,41,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Ser,...ldtype; G12D: p.Gly12Asp; G12V: p.Gly12Val; G12S: p.Gly12Ser,84,59,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly13Asp,G13D: p.Gly13Asp,86,7,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Asp,...ld-type result for sample 14 which was actually a p.Gly12Asp (G12D) mutation. While this sample was ...,90,79,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Asp,"...G > A change was visible by sequencing indicating p.Gly12Asp mutation, but was not reported because ...",90,406,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Asp,"...ild-type; two labs reported a mutation in exon 12 p.Gly12Asp, and three labs were consistent with th...",92,125,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Asp,"... re-testing. Laboratory #2 found the same result (p.Gly12Asp) in the second set of slides, but there...",92,478,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Leu1077Pro,...500-6-461Short ReportPhenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibr...,3,156,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The p.Leu1077Pro CFTR mutation was firstly described i...,4,5,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...tion collected in database CFTR2 lead to consider p.Leu1077Pro as a severe CF mutation. Although it ...,4,192,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...tation. Although it is typical of Southern Italy, p.Leu1077Pro is not included in the mutation panel...",4,272,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...atients. 4 patients who were heterozygous for the p.Leu1077Pro mutation were included in the study,7,106,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"In our Cystic Fibrosis Centre, the prevalence of p.Leu1077Pro is 3.6% among all mutations. All pati...",9,50,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,We found that the p.Leu1077Pro CFTR mutation is associated with a cl...,12,19,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...CFTR2 database. The relatively high prevalence of p.Leu1077Pro associated with the severe clinical c...,12,169,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The p.Leu1077Pro (L1077P) mutation consists in a trans...,21,5,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,... Bozon et al. [8] firstly found evidence that the p.Leu1077Pro was associated with a pancreatic suff...,23,192,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"... 40 patients with this mutation, lead to consider p.Leu1077Pro as a severe CF mutation, associated w...",25,119,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...it should be predictive of a severe CF phenotype, p.Leu1077Pro is not included in the mutation panel...",27,154,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...linical features in Sicilian patients bearing the p.Leu1077Pro CFTR mutation followed in our Cystic ...,29,114,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...range 7 – 20 years) who were heterozygous for the p.Leu1077Pro mutation were included in the study: ...,33,431,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Asn1303Lys,...tation in the second allele while one carried the p.Asn1303Lys (N1303K) mutation. The group included...,33,585,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,1	M	7 yrs	14.57 (Underweight)	Birth	p.Phe508del/p.Leu1077Pro	112	84/43,40,49,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,2	M	10	19.80 (Normal weight)	Birth	p.Phe508del/p.Leu1077Pro	101	155/215,41,48,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,3	M	12	19.63 (Normal weight)	Birth	p.Phe508del/p.Leu1077Pro	97	181/100,42,48,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Asn1303Lys,4	F	20	16.44 (Underweight)	4 months	p.Asn1303Lys/p.Leu1077Pro	108	NA,43,37,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,4	F	20	16.44 (Underweight)	4 months	p.Asn1303Lys/p.Leu1077Pro	108	NA,43,50,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...ing is routinely performed in our laboratory. The p.Leu1077Pro mutation was identified by denaturing...,62,541,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...icilian Cystic Fibrosis Centre, the prevalence of p.Leu1077Pro is 3.6% among all mutations",65,67,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The present study provides evidence that the p.Leu1077Pro is a relatively frequent mutation ass...,87,46,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The p.Leu1077Pro mutation consists in a transition T t...,89,5,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"Nevertheless p.Leu1077Pro mutation, although belonging to the c...",93,14,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"On this regard, the mutation p.Leu1077Pro is typical of Southern Italy, overall...",97,30,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...irth by sweat test. All of them had a p.Phe508del/p.Leu1077Pro genotype,103,230,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Asn1303Lys,...sweat test which resulted pathological. She had a p.Asn1303Lys/p.Leu1077Pro genotype,105,282,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...ich resulted pathological. She had a p.Asn1303Lys/p.Leu1077Pro genotype,105,295,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Asn1303Lys,"...on with a severe mutation such as p.Phe508del and p.Asn1303Lys, it is clear that only a follow-up co...",116,299,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The relatively high prevalence of p.Leu1077Pro associated with the severe clinical c...,118,35,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.I852T,"...three siblings share the same variant c.2555T >C (p.I852T) in the homozygous state. Accordingly, dia...",57,306,BMC_Res_Notes_2016_Feb_13_9_91.txt
p.I852T,...led a homozygote state of the variant c.2555T >C (p.I852T),70,405,BMC_Res_Notes_2016_Feb_13_9_91.txt
p.I852T,"...nd CRB1 mutations in 7.4 % of them, with the same p.I852T mutation (of our patients) in two patients...",72,188,BMC_Res_Notes_2016_Feb_13_9_91.txt
p.I852T,"...o have CRB1 mutations, especially the c.2555T >C (p.I852T) homozygote variant searching for any vasc...",83,235,BMC_Res_Notes_2016_Feb_13_9_91.txt
p.Arg528Cys,"...nced, and a novel missense mutation, c.1582C > T (p.Arg528Cys), in CACNA1S was detected. Detection o...",7,977,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Cys,"...dentified a novel dominant mutation, c.1582C > T (p.Arg528Cys), in CACNA1S that causes hypokalaemic ...",10,55,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Cys,"...novel missense mutation, c.1582C > T, in CACNA1S (p.Arg528Cys) (Figure 1). In his family, the mutati...",35,394,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Cys,"...aled a missense mutation in CACNA1S, resulting in p.Arg528Cys. This mutation had not been reported p...",42,644,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528His,"...ons involve the 528th codon of CACNA1S, including p.Arg528His and p.Arg528Gly [5, 13]. The arginine ...",42,1032,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Gly,"...528th codon of CACNA1S, including p.Arg528His and p.Arg528Gly [5, 13]. The arginine residue encoded ...",42,1048,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Cys,"...ralysis, we identified a novel dominant mutation, p.Arg528Cys, of CACNA1S causing HOPPK, which is th...",47,157,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg650Cys,"...sting was performed and that showed a c.1948 C>T (p.Arg650Cys) mutation in fibrillin-1 gene, confirm...",47,87,Cureus_8(5)_e619.txt
p.R206H,"...1 causes an arginine-to-histidine substitution at p.R206H in ALK2 within the GS domain in FOP, makin...",29,1735,Bone_Res_2015_Apr_14_3_15005.txt
p.L196P,"...e positions of the mutation in the GS domain are: p.L196P, p.P198-F199delinsL, p.R202I, and p.Q207E....",29,2642,Bone_Res_2015_Apr_14_3_15005.txt
p.R202I,"...n the GS domain are: p.L196P, p.P198-F199delinsL, p.R202I, and p.Q207E.70–72 Moreover, several mutat...",29,2671,Bone_Res_2015_Apr_14_3_15005.txt
p.Q207E,"...in are: p.L196P, p.P198-F199delinsL, p.R202I, and p.Q207E.70–72 Moreover, several mutations noticed ...",29,2684,Bone_Res_2015_Apr_14_3_15005.txt
p.R258S,"...ed in the serine/threonine kinase domain, such as p.R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R375...",29,2781,Bone_Res_2015_Apr_14_3_15005.txt
p.G325A,"... serine/threonine kinase domain, such as p.R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R375P.73–75Fi...",29,2790,Bone_Res_2015_Apr_14_3_15005.txt
p.G328E,"...hreonine kinase domain, such as p.R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R375P.73–75Figure 2 sh...",29,2799,Bone_Res_2015_Apr_14_3_15005.txt
p.G356D,"...se domain, such as p.R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R375P.73–75Figure 2 shows that the ...",29,2812,Bone_Res_2015_Apr_14_3_15005.txt
p.R375P,"...ch as p.R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R375P.73–75Figure 2 shows that the FOP mutations...",29,2825,Bone_Res_2015_Apr_14_3_15005.txt
p.Thr52Pro,"...giectasia type 2 with a novel mutation, c.154A>C (p.Thr52Pro), in the ALK1/ACVRL1 gene Neurol Clin N...",240,149,Bone_Res_2015_Apr_14_3_15005.txt
p.V600E,"...ino acid 600 in the kinase domain of the protein (p.V600E, previously known as p.V599E; Smalley and ...",17,441,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V599E,"...main of the protein (p.V600E, previously known as p.V599E; Smalley and Herlyn, 2004). The resulting ...",17,470,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,"...id 600 within the BRAF gene. The assay can detect p.V600E, p.V600K and p.V600D mutations within the ...",43,385,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,"...thin the BRAF gene. The assay can detect p.V600E, p.V600K and p.V600D mutations within the BRAF gene...",43,394,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600D,"...F gene. The assay can detect p.V600E, p.V600K and p.V600D mutations within the BRAF gene, but does n...",43,406,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,"... HT29 cell line, known to be heterozygous for the p.V600E mutation. Human genomic DNA (Roche, Basel,...",49,120,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,"... cell line HT29 (known to be heterozygous for the p.V600E mutation), several serial dilution studies...",71,60,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,"...plex g.1798-1799GT>AA changes resulting in a BRAF p.V600K alteration, rather than the more common p....",74,521,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,"...F p.V600K alteration, rather than the more common p.V600E (g.1799T>A). Sequencing detected two sampl...",74,569,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.N581S,...ecific ARMS assays in this study: BRAF g.1742A>T (p.N581S) and g.1801A>G (p.K601E). Eighteen mutatio...,74,742,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.K601E,...is study: BRAF g.1742A>T (p.N581S) and g.1801A>G (p.K601E). Eighteen mutations were detected by ARMS...,74,766,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,...S. Sequencing had confirmed these mutations to be p.V600E in 42 cases and p.V600K in 3 cases. A furt...,76,158,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,...med these mutations to be p.V600E in 42 cases and p.V600K in 3 cases. A further tumour sample was sh...,76,182,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.K601E,"...s. A further tumour sample was shown to harbour a p.K601E mutation, which was not detectable by the ...",76,249,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.Gly12Val,"...used as reference for mutations in KRAS codon 12 (p.Gly12Val, heterozygous) and 13 (p.Gly13Asp, hete...",42,204,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"... KRAS codon 12 (p.Gly12Val, heterozygous) and 13 (p.Gly13Asp, heterozygous), respectively. DNA obtai...",42,238,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...ion melting analysis was able to discriminate the p.Gly12Val (H441) and the p.Gly13Asp (HCT116) DNA ...,54,63,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,...ble to discriminate the p.Gly12Val (H441) and the p.Gly13Asp (HCT116) DNA from KRAS-WT DNA (PC-9). F...,54,89,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...3%. We were able to detect as little as 3% of MUT p.Gly12Val DNA in a WT background,54,429,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...all four samples showing aberrant melting curves (p.Gly12Val n=2; p.Gly12Asp n=1 and p.Gly13Asp n=1)...,56,808,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Asp,... showing aberrant melting curves (p.Gly12Val n=2; p.Gly12Asp n=1 and p.Gly13Asp n=1),56,824,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,...elting curves (p.Gly12Val n=2; p.Gly12Asp n=1 and p.Gly13Asp n=1),56,843,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,...tated patient who achieved a stable disease had a p.Gly13Asp mutation. The disease control rate (obj...,61,505,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"...The horizontal line indicates WT control, and the p.Gly13Asp p.Gly12Val labelled lines indicate in d...",83,126,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,"...tal line indicates WT control, and the p.Gly13Asp p.Gly12Val labelled lines indicate in duplicate th...",83,137,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,"...ions of DNA from H441 cells that harbour the KRAS p.Gly12Val mutation, mixed with the KRAS WT PC-9 c...",85,135,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"...pond to HRMA mutated samples (from top to bottom: p.Gly13Asp, p.Gly12Val and the p.Gly12Asp). Corres...",87,290,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,"... mutated samples (from top to bottom: p.Gly13Asp, p.Gly12Val and the p.Gly12Asp). Corresponding WT s...",87,302,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Asp,"...rom top to bottom: p.Gly13Asp, p.Gly12Val and the p.Gly12Asp). Corresponding WT sequencing electroph...",87,321,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"...p to bottom, the first electropherogram shows the p.Gly13Asp HRMA-mutated sample, the second the p.G...",87,476,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Asp,"...he p.Gly13Asp HRMA-mutated sample, the second the p.Gly12Asp HRMA-mutated samples and the third and ...",87,523,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...mutated samples and the third and fourth show two p.Gly12Val HRMA-mutated samples,87,589,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly2891Asp,...se activity. One missense ATM mutation c.8672G>A (p.Gly2891Asp) and a c.1A>G substitution were ident...,10,374,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...ion were identified. In the modelling system, the p.Gly2891Asp mutant protein was expressed and show...",10,460,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2424Gly,"...The presence of the missense mutation, c.7271T>G (p.Val2424Gly), further increases the risk (Stankov...",21,261,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"Two ATM mutations, c.8672G>A. (p.Gly2891Asp) and c.1A>G (Figure 3), were identifi...",56,32,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...RNA was able to allow translation. The c.8672G>A (p.Gly2891Asp) is a missense mutation located in th...,58,444,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...ells from patient A-T213 came from the c.8672G>A (p.Gly2891Asp) allele. Truncated ATM associated wit...,68,452,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...scured by the full-length ATM from the c.8672G>A (p.Gly2891Asp) allele (Figure 5, compare lanes 5 an...",68,634,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Arg3047X,"...he second allele that was essentially full-length p.Arg3047X (c.9139C>T) (Figure 5, lanes 9 and 10)",68,953,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...in cells of patient A-T213 is from the c.8672G>A (p.Gly2891Asp) allele,70,327,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...mutant protein associated with the c.1A>G and the p.Gly2891Asp mutant protein are shown in Figure 6A...,72,257,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...ant proteins were low, although expression of the p.Gly2891Asp mutant protein was significantly high...",72,581,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...nalyse ATM kinase activity in the higher level of p.Gly2891Asp produced when it was expressed with N...,72,896,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...s expressed with N-terminal tags (Figure 6B). The p.Gly2891Asp mutant protein was autophosphorylated...,72,978,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...eins in A-T213, there was clear evidence that the p.Gly2891Asp mutant protein was active. Consequent...",74,107,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...d presentation, the two ATM mutations, c.8672G>A (p.Gly2891Asp) and c.1A>G, in patient A-T213 are bo...",77,668,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2424Gly,"..., were homozygous for the ATM mutation c.7271T>G (p.Val2424Gly). The mutation was also identified in...",85,1052,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2716Ala,"...s et al, 2011). Only one ATM mutation (c.8147T>C (p.Val2716Ala)), which also has some ATM kinase act...",87,697,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...ng ATM, the presence of two mutant ATM proteins, (p.Gly2891Asp and the c.1A>G derived protein) raise...",89,313,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...reducing the activity of the more abundant active p.Gly2891Asp protein, using the levels of phosphor...",89,600,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2424Gly,...nt ATM protein; this could also apply to both the p.Val2424Gly and the p.Val2716Ala ATM mutations,89,1150,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2716Ala,...could also apply to both the p.Val2424Gly and the p.Val2716Ala ATM mutations,89,1171,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.His2555Gln,...mutation (and also null mutation c.7665delinsGTGA;p.His2555Gln ins*) is slightly truncated (lanes 7 ...,112,564,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Arg3047X,...M from c.2T>C in patient AT187 is obscured by the p.Arg3047X (c.9139C>T) mutant protein (lanes 9 and...,112,702,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,... from c.1A>G in patient A-T213 is obscured by the p.Gly2891Asp (c.8672G>A) mutant protein (lanes 5 a...,112,828,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Arg3047X,...ient A-T187 with a c.2T>C mutation and c.9139C>T (p.Arg3047X). (B) Histogram of relative levels of A...,112,1433,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,Figure 6 The p.Gly2891Asp protein has residual ATM kinase activ...,114,14,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...relative to the wt protein (pTAM2, lane 2) or the p.Gly2891Asp protein (8672G>A, lane 5). No ATM pro...",114,481,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...ced levels of both wt protein (pTAM2, lane 2) and p.Gly2891Asp protein (8672G>A, lane 4) were increa...",114,747,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...agged (compare with Supplementary Figure 2A). The p.Gly2891Asp (8672G>A) protein was expressed at a ...,114,894,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...MEP4) all with N-terminal tags. Expression of the p.Gly2891Asp (8672G>A) protein (lane 5) was compar...,114,1225,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...ble to that of wt ATM (pTAM2, lanes 1 and 7). The p.Gly2891Asp (8672G>A) protein autophosphorylated ...",114,1326,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...lation of ATM targets Smc1, KAP-1 and Nbs1 by the p.Gly2891Asp (8672G>A) protein were substantially ...",114,1550,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.H1047R,GLC82	PIK3CA	p.H1047R	R,128,14,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.E545K,H460	PIK3CA	p.E545K	R,129,13,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.Q61H, 	KRAS	p.Q61H	 ,130,8,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12S,A549	KRAS	p.G12S	R,131,11,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.Q546K, 	PIK3CA	p.Q546K	 ,132,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.Q61K,H1299	NRAS	p.Q61K	S,133,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G13D,HCT15	KRAS	p.G13D	R,135,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.E545K, 	PIK3CA	p.E545K	 ,136,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12D,LS174T	KRAS	p.G12D	R,137,13,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.H1047R, 	PIK3CA	p.H1047R	 ,138,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12A,GEO	KRAS	p.G12A	S,139,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12V,SW480	KRAS	p.G12V	S,140,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G13D,HCT116	KRAS	p.G13D	S,141,13,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.H1047R, 	PIK3CA	p.H1047R	 ,142,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12V,SW620	KRAS	p.G12V	S,143,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.Arg119Ser,"...length of 373 amino acids in NSDHL (c.357_358del, p.Arg119Serfs*1d), predicted damaging in silico. T...",35,756,Br_J_Dermatol_2015_Jul_28_173(1)_304-307.txt
p.Arg94X,"...carrying a heterozygous RPS19 mutation (c.280C>T, p.Arg94X), and healthy control samples were from o...",77,289,Br_J_Haematol_2015_Nov_25_171(4)_517-529.txt
p.Ile2047Asn,The presence of one novel missense mutation (p.Ile2047Asn) was analysed in 100 control chromoso...,58,46,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,ARDM-135	42	24	0.4	0.6	STGD	c.5882G>A(42)	p.Gly1961Glu	c.1029_1030insT(8)	p.Asn344fsX	NP,76,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,ARDM-240	15	13	0.2	0.16	STGD	c.5882G>A(42)	p.Gly1961Glu	c.2285C>A(15)	p.Ala762Glu	Yes,77,44,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala762Glu,....16	STGD	c.5882G>A(42)	p.Gly1961Glu	c.2285C>A(15)	p.Ala762Glu	Yes,77,71,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,ARDM-225	32	25	0.25	0.50	STGD	c.5882G>A(42)	p.Gly1961Glu	c.6559C>T(48)	p.Gln2187X	Yes,78,45,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln2187X,....50	STGD	c.5882G>A(42)	p.Gly1961Glu	c.6559C>T(48)	p.Gln2187X	Yes,78,72,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,ARDM-164	21	11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Yes,79,38,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln234X,...11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Yes,79,63,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,ARDM-162	50	16	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	Yes,80,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,ARDM-198	27	19	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	NP,81,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Thr1019Met,ARDM-146	32	13	0.06	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.6140T>A(44)	p.Ile2047Asn	Yes,86,44,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ile2047Asn,...0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.6140T>A(44)	p.Ile2047Asn	Yes,86,71,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Thr1019Met,ARDM-40	46	9	0.1	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315X	Yes,87,41,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln1315X,...0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315X	Yes,87,68,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1977Ser,ARDM-90	26	8	Hand moving	STGD	c.5929G>A (43)	p.Gly1977Ser	IVS21-2A>T		Yes,88,46,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1108His,ARDM-181	57	16	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,45,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala1598Asp,...DM-197	35	15	0.1	0.1	STGD	c.4793C>A(34) (false +)	p.Ala1598Asp (false +)	c.5172G>T(36)	p.Trp1724Cys	...,90,53,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Trp1724Cys,...4) (false +)	p.Ala1598Asp (false +)	c.5172G>T(36)	p.Trp1724Cys	Yes,90,90,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Leu2027Phe,ARDM-183	63	55	0.150	0.175	STGD	c.6079C>T(44)	p.Leu2027Phe	c.5929G>A(43) (false –)	p.Gly1977Ser ...,91,47,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1977Ser,....6079C>T(44)	p.Leu2027Phe	c.5929G>A(43) (false –)	p.Gly1977Ser (false –)	NP,91,84,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg602Trp,ARDM-38	35	6	0.01	0.02	STGD	c.1804C>T(13)	p.Arg602Trp	c.4739delT(33)	p.Leu1580fs	Yes,92,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Pro1486Leu,ARDM-163	48	32	0.01	0.32	STGD	c.4457C>T(30)	p.Pro1486Leu	ND	ND	Yes,93,45,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg2107His,ARDM-166	42	39	NA	STGD	c.6320G>A(46)	p.Arg2107His	ND	ND	Yes,94,38,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val931Met,ARDM-222	26	23	NA	STGD	c.2791G>A(19)	p.Val931Met	ND	ND	NP,95,38,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1640Gln,ARDM-205	NA	NA	NA	STGD	c.4919G>A(35)	p.Arg1640Gln	ND	ND	NP,98,38,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,ARDM-247	30	12	0.05	0.1	CRD	c.3386G>T(23)	p.Arg1129Leu	c.6410G>A(47)	p.Cys2137Tyr	Yes,99,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,...	0.1	CRD	c.3386G>T(23)	p.Arg1129Leu	c.6410G>A(47)	p.Cys2137Tyr	Yes,99,70,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val1433Ile,ARDM-99	59	46	0.05	0.05	CRD	c.4297G>A(29)	p.Val1433Ile	ND	ND	NP,100,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Thr901Ala,ARDM-131	27	15	0.9	0.7	CRD	c.2701A>G(18)	p.Thr901Ala	ND	ND	Yes,101,42,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,RP-773	38	20	0.05	0.05	RP	c.33N86G>T(23)	p.Arg1129Leu	ND	ND	NP,104,42,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ile156Val,RP-959	53	10	0.1	0.1	RP	c.466A>G(5)	p.Ile156Val	ND	ND	Yes,105,37,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val1433Ile,RP-1058	37	6	0.2	0.6	RP	c.4297G>A(29)	p.Val1433Ile	ND	ND	NP,106,39,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly88Gly,3	c.264 A>T	p.Gly88Gly	This study,113,13,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Asn343Asn,8	c.1029T>C	p.Asn343Asn	This study,117,13,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Glu433Glu,10	c.1299A>G	p.Glu433Glu	This study,118,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val552Ile,12	c.1654G>A	p.Val552Ile	This study,119,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Pro944Pro,19	c.2832A>G	p.Pro944Pro	This study,121,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Leu988Leu,20	c.2964C>T	p.Leu988Leu	18,122,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln1169Gln,23	c.3507G>A	p.Gln1169Gln	This study,123,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln234X,"...as null mutations: three were nonsense mutations (p.Gln234X, p.Gln1315X “de novo” and p.Gln2187X); t...",130,91,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln1315X,"...ations: three were nonsense mutations (p.Gln234X, p.Gln1315X “de novo” and p.Gln2187X); two splice-s...",130,102,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln2187X,"...se mutations (p.Gln234X, p.Gln1315X “de novo” and p.Gln2187X); two splice-site mutations (IVS22-2A>T...",130,127,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala762Glu,"...ce (fig 2). Three missense changes were detected (p.Ala762Glu, p.Ile2047Asn and p.Cys2137Tyr) in pat...",130,494,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ile2047Asn,"...hree missense changes were detected (p.Ala762Glu, p.Ile2047Asn and p.Cys2137Tyr) in patients but not...",130,507,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...nges were detected (p.Ala762Glu, p.Ile2047Asn and p.Cys2137Tyr) in patients but not in the 100 ethni...",130,524,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ile2142Val,...ntrol chromosomes. We identified the heterozygous p.Ile2142Val change in one out of 100 control chro...,130,640,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Trp1724Cys,"...wo previously described mutations [c.4537delC and p.Trp1724Cys], not included in the array by the ti...",130,870,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1977Ser,"...he time of the screening, and one false negative [p.Gly1977Ser] were detected (1/62; 1.6%)",130,965,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val552Ile,"...ified. Additionally, one novel change in exon 12 (p.Val552Ile) was found in one STGD patient by mean...",134,162,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,"...el ABCA4 variants detected in this screening, the p.Arg1129Leu mutation was found to be the most fre...",138,117,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala1598Asp,"...longing to family ARDM-197, the chip detected the p.Ala1598Asp mutation. However, dHPLC and direct s...",147,176,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Trp1724Cys,"... not present (false positive). Interestingly, the p.Trp1724Cys mutation was detected by dHPLC in thi...",147,321,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1977Ser,"..., the dHPLC technique led to the detection of the p.Gly1977Ser mutation in the patient from the fami...",147,442,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala1598Asp,"...rm these results by sequencing, a false positive [p.Ala1598Asp] was identified. Altogether, the comb...",150,196,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"...4–25 years. Moreover, both patients presented the p.Gly1961Glu mutation, which is considered an alle...",154,663,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,The p.Arg1129Leu mutation was found to be the most fre...,167,5,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,"...n previous studies of the Spanish population, the p.Arg1129Leu variant was identified as a major mut...",167,196,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,"...d patient (ARDM-247), double heterozygous for the p.Arg1129Leu and p.Cys2137Tyr alleles, who present...",167,624,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...47), double heterozygous for the p.Arg1129Leu and p.Cys2137Tyr alleles, who presented a CRD phenotyp...",167,641,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...7Tyr alleles, who presented a CRD phenotype. This p.Cys2137Tyr change was located more towards the a...",167,699,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,...ssociated with an earlier onset of disease.16 The p.Cys2137Tyr change in combination with the p.Arg1...,167,962,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,...6 The p.Cys2137Tyr change in combination with the p.Arg1129Leu allele produced a CRD phenotype. Ther...,167,1006,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...phenotype. Therefore, we speculate that the novel p.Cys2137Tyr variant could be a severe allele whic...",167,1091,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"... prevalent missense disease-associated allele was p.Gly1961Glu (3/62; 4.8%), presenting a lower freq...",169,66,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln2187X,"... least one putative null mutation (c.1030insT and p.Gln2187X), who presented symptoms at the age of ...",169,280,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"... Thus, we could suspect a moderate effect for the p.Gly1961Glu allele, as previously reported.",169,392,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg212Cys,"...se, compound heterozygous for the c.3211insGT and p.Arg212Cys variants, showing symptoms at the age ...",171,1262,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val1433Ile,"...enotypes respectively, we identified the missense p.Val1433Ile mutation, located in the second trans...",179,104,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ile156Val,"...ly analysed by the genotyping microarray, and the p.Ile156Val allele was detected.20 This variant ha...",181,77,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val552Ile,"...pected in about 1/50.24 So many variants, such as p.Val552Ile, could be really a mutation found in n...",191,184,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.R402C,"...BA1A-associated classic lissencephaly have either p.R402C mutations, resulting in frontal pachygyria...",62,727,Brain_2012_May_16_135(5)_1348-1369.txt
p.R402H,"... and posterior agyria with a cell-sparse zone, or p.R402H mutations, resulting in nearly complete ag...",62,827,Brain_2012_May_16_135(5)_1348-1369.txt
p.Val374Rfs,...Exome	Exon 6 to 8 duplication; c.836-?_1119+?dup; p.Val374Rfs*8	Exon 6 to 8 duplication; c.836-?_111...,103,70,Brain_2013_Jan_3_136(1)_269-281.txt
p.Val374Rfs,...Rfs*8	Exon 6 to 8 duplication; c.836-?_1119+?dup; p.Val374Rfs*8,103,128,Brain_2013_Jan_3_136(1)_269-281.txt
p.Pro149Leu,"...s state: g.chr7: 16255759 T>A, c.446 C>T, causing p.Pro149Leu, which is located in exon 2 and g.chr7...",116,371,Brain_2013_Jan_3_136(1)_269-281.txt
p.Gln215*,"...ted in exon 2 and g.chr7:16445774 G>A, c.643 C>T, p.Gln215* in exon 3. Exome sequencing in Case 5 sh...",116,447,Brain_2013_Jan_3_136(1)_269-281.txt
p.Arg395*,"...tation in exon 9: g.chr7:16255759 T>A, c.1183A>T, p.Arg395* and a heterozygous in-frame triplet dele...",116,590,Brain_2013_Jan_3_136(1)_269-281.txt
p.Arg126His,"....chr7:16445843 C>T, which is c.377G>A, leading to p.Arg126His. Interestingly, the second compound he...",116,881,Brain_2013_Jan_3_136(1)_269-281.txt
p.Arg395*,"...7:16255759 T>A, leading to c.1183 A>T and causing p.Arg395*. The second compound heterozygous mutati...",121,132,Brain_2013_Jan_3_136(1)_269-281.txt
p.Ala53Thr,...found by Sanger sequencing to be c.157G>A causing p.Ala53Thr located in exon 1. All ISPD mutations f...,121,239,Brain_2013_Jan_3_136(1)_269-281.txt
p.Tyr226Cys,...xon 1 and a missense mutation in exon 3 c.677A>G (p.Tyr226Cys). The heterozygous carrier status of t...,123,639,Brain_2013_Jan_3_136(1)_269-281.txt
p.Glu396*,"...ISPD substantially, as a homozygous stop mutation p.Glu396* has been reported to cause a Walker–Warb...",132,2263,Brain_2013_Jan_3_136(1)_269-281.txt
p.R95H,... y	c.[284G>A] (M) + c.[148G> A];c.[364-1G>A]a (P)	p.R95H (M) + p.E50K;Splice errors a (P)	30 min	Mil...,47,58,Brain_2014_May_18_137(5)_1350-1360.txt
p.E50K,"... (M) + c.[148G> A];c.[364-1G>A]a (P)	p.R95H (M) + p.E50K;Splice errors a (P)	30 min	Mills et al., 20...",47,71,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"2	5 y 2 m	c.[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann et al., 2007",48,34,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"2	5 y 2 m	c.[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann et al., 2007",48,43,Brain_2014_May_18_137(5)_1350-1360.txt
p.P213S,3	2 y 7 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	90 min	Novel,49,36,Brain_2014_May_18_137(5)_1350-1360.txt
p.P213S,3	2 y 7 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	90 min	Novel,49,46,Brain_2014_May_18_137(5)_1350-1360.txt
p.P213S,4*	4 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	None*	Novel,50,33,Brain_2014_May_18_137(5)_1350-1360.txt
p.P213S,4*	4 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	None*	Novel,50,43,Brain_2014_May_18_137(5)_1350-1360.txt
p.R95C,"5	1 y	c.[283C>T] (M) + c.[283C>T] (P)	p.R95C (M) + p.R95C (P)	2 h	Khayat et al., 2008",51,40,Brain_2014_May_18_137(5)_1350-1360.txt
p.R95C,"...	1 y	c.[283C>T] (M) + c.[283C>T] (P)	p.R95C (M) + p.R95C (P)	2 h	Khayat et al., 2008",51,53,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,(ii)	7	6 y 5 m	c.[347G>A] (M) + c.[347G>A] (P)	p.R116Q (M) + p.R116Q (P)	5 m	Novel,53,48,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,...5 m	c.[347G>A] (M) + c.[347G>A] (P)	p.R116Q (M) + p.R116Q (P)	5 m	Novel,53,62,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,(iii)	8	9 y	c.[347G>A] + c.[347G>A]	p.R116Q + p.R116Q	3 h	Novel,54,37,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,(iii)	8	9 y	c.[347G>A] + c.[347G>A]	p.R116Q + p.R116Q	3 h	Novel,54,47,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"9	2 y	c.[98A>T] + c.[998A>T]	p.D33V + p.D33V	3 w	Hoffmann et al., 2007",55,31,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"9	2 y	c.[98A>T] + c.[998A>T]	p.D33V + p.D33V	3 w	Hoffmann et al., 2007",55,40,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"10	23 y	c.[98A>T] + c.[358G>A]	p.D33V + p.E120K	2 m	Hoffmann et al., 2007 + novel...",56,33,Brain_2014_May_18_137(5)_1350-1360.txt
p.E120K,"10	23 y	c.[98A>T] + c.[358G>A]	p.D33V + p.E120K	2 m	Hoffmann et al., 2007 + novel",56,42,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,...1	21 y	c.[98A>T] (P) + c.264-21_ 264-1delinsC (M)	p.D33V (P) + Splice errors (M)	3 h	Hoffmann et al....,57,53,Brain_2014_May_18_137(5)_1350-1360.txt
p.D33V,"12	41 y	c.[98A>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q + p.R225Cb	14 d	Hoffmann et al., ...",58,47,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,"...1 y	c.[98A>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q + p.R225Cb	14 d	Hoffmann et al., 2007 + no...",58,56,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225C,"...>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q + p.R225Cb	14 d	Hoffmann et al., 2007 + novel + Veer...",58,66,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,13	9 y	c.[674G>A] + c.[674G>A]	p.R225H + p.R225H	24 h	Novel,59,33,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,13	9 y	c.[674G>A] + c.[674G>A]	p.R225H + p.R225H	24 h	Novel,59,43,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,... y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min	Novel,60,56,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,...7G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min	Novel,60,64,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,...74G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min	Novel,60,74,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,... c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min	Novel,60,82,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,... y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	10 h	Novel,61,56,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,...7G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	10 h	Novel,61,64,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,...74G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	10 h	Novel,61,74,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,... c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	10 h	Novel,61,82,Brain_2014_May_18_137(5)_1350-1360.txt
p.Leu772*,"...gous frame-shift deletion in CCDC88A (c.2313delT, p.Leu772*ter). Analysis of cDNA extracted from pat...",13,668,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.Leu772X,Figure 2 Discovery of a c.2313delT/p.Leu772X mutation in CCDC88A in individuals with ...,33,36,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.Leu772X,"...ntrol, carrier parent and affected child with the p.Leu772X mutation. (D) Reverse transcriptase poly...",33,642,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.Leu772X,...g a TAG stop codon at the site of the frameshift (p.Leu772X) (Fig. 2B). Segregation of the mutation ...,77,785,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.Leu772X,"... reduced amount of full length mRNA, carrying the p.Leu772X in the lymphocytes of Patient 1 (Fig. 2D...",81,745,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.Leu772X,Having proven the potential pathogenicity of the p.Leu772X mutation in cellular models we asked if ...,84,50,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.Leu772X,...n a frameshift and incorporation of a stop codon (p.Leu772X). Our results confirm an autosomal reces...,92,328,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.E286Q,TP53	5	(10)	17	GAA>CAA/p.E286Q	X	NA	X	Missense	Transversion	1.00	 	Yes,129,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.M246T, 	 	 	 	ATG>ACG/p.M246T	X	NA	X	Missense	Transition	1.00	 	Yes,130,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.E68K, 	 	 	 	GAG>AAG/p.E68K	NA	NA	X	Missense	Transition	0.09	 	ND,131,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.Y234C, 	 	 	 	TAC>TGC/p.Y234C	NA	NA	X	Missense	Transition	0.97	 	ND,132,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.R2605Q, 	 	 	 	CGG>CAG/p.R2605Q	X	X	X	Missense	Transition	1.00	 	No cover...,135,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.M3430I, 	 	 	 	ATG>ATA/p.M3430I	NA	X	X	Missense	Transition	0.00	 	ND,136,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.Q3082*, 	 	 	 	CAG>TAG/p.Q3082*	NA	X	X	Nonsense	Transition	 	4.05	ND,137,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.Y1058C,FBXO38	2	(4)	5	TAT>TGT/p.Y1058C	X	X	X	Missense	Transition	1.00	 	Yes,138,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.E20Q, 	 	 	 	GAA>CAA/p.E20Q	NA	X	X	Missense	Transversion	0.96	 	ND,139,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.E476K,THSD4	2	(4)	15	GAG>AAG/p.E476K	X	X	X	Missense	Transition	1.00	 	Yes,140,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.E652K, 	 	 	 	GAG>AAG/p.E652K	NA	X	X	Missense	Transition	0.96	 	ND,141,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.F303L,TRMT5	2	(4)	14	TTT>CTT/p.F303L	X	X	X	Missense	Transition	0.04	 	Yes,142,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.E152Q, 	 	 	 	GAG>CAG/p.E152Q	NA	X	X	Missense	Transversion	0.03	 	ND,143,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.L540V,PIK3CA	2	(4)	3	CTC>GTC/p.L540V	NA	NA	X	Missense	Transversion	0.99	 	ND,144,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.Q546P, 	 	 	 	CAG>CCG/p.Q546P	NA	NA	X	Missense	Transversion	1.00	 	ND,145,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.A267T,FOXO3	1	(2)	6	GCA>ACA/p.A267T	NA	NA	X	Missense	Transition	0.97	 	ND,146,23,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.P292S, 	 	 	 	CCT>TCT/p.P292S	NA	NA	X	Missense	Transition	0.34	 	ND,147,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.L528V, 	 	 	 	TTG>GTG/p.L528V	NA	NA	X	Missense	Transversion	0.03	 	ND,148,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.R674C,BBS12	1	(2)	4	CGC>TGC/p.R674C	X	X	X	Missense	Transition	1.00	 	Yes,149,23,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.P77S,BBS9	1	(2)	7	CCA>TCA/p.P77S	X	X	X	Missense	Transition	1.00	 	No coverag...,150,22,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.D1420N,CASP8AP2	1	(2)	6	GAT>AAT/p.D1420N	X	X	X	Missense	Transition	1.00	 	No cover...,151,26,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.A406T,EIF2B5	1	(2)	3	GCA>ACA/p.A406T	X	*	X	Missense	Transition	0.05	 	Yes,152,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.A659P,FMN2	1	(2)	1	GCT>CCT/p.A659P	X	*	*	Missense	Transversion	0.74	 	No cove...,153,22,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.T468M,HSP90B1	1	(2)	12	ACG>ATG/p.T468M	X	 	X	Missense	Transition	0.98	 	Yes,154,26,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.D571Y,IKBKE	1	(2)	1	GAC>TAC/p.D571Y	X	*	X	Missense	Transversion	0.68	 	Yes,155,23,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.N167S,PCF11	1	(2)	11	AAT>AGT/p.N167S	X	X	X	Missense	Transition	0.02	 	Yes,156,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.K279N,PLCL1	1	(2)	2	AAG>AAT/p.K279N	X	X	X	Missense	Transversion	0.98	 	No cove...,157,23,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.R864L,PTPN21	1	(2)	14	CGA>CTA/p.R864L	X	X	X	Missense	Transversion	1.00	 	Yes,158,25,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.R217C,SEC63	1	(2)	6	CGC>TGC/p.R217C	NA	X	X	Missense	Transition	1.00	 	ND,159,23,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.D339A,ST7L	1	(2)	1	GAT>GCT/p.D339A	X	X	X	Missense	Transversion	1.00	 	Yes,161,22,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.N3400K,UBR4	1	(2)	1	AAC>AAA/p.N3400K	X	X	X	Missense	Transversion	0.98	 	Yes,163,22,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.Q1582P,ZFYVE26	1	(2)	14	CAA>CCA/p.Q1582P	X	X	X	Missense	Transversion	0.00	 	Yes,164,26,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.V637E,The mouse Braf p.V637E missense mutant protein is the murine coun...,129,16,Cancer_Cell_2013_Jul_8_24(1)_15-29.txt
p.V600E,...otein is the murine counterpart of the human BRAF p.V600E oncogenic variant. V637 is encoded in Braf...,129,92,Cancer_Cell_2013_Jul_8_24(1)_15-29.txt
p.Y657S,...er and activator of transcription 3 (STAT3) gene (p.Y657S) Eur. J. Pediat. 2011 170 661 666 10.1007/...,129,230,Cancers_(Basel)_2014_Mar_6_6(1)_494-525.txt
p.V600E,...ical staining for BRAFV600E mutation. We detected p.V600E-mutated cells in the perivascular region o...,12,970,Case_Rep_Dermatol_2015_Sep_12_7(3)_237-240.txt
p.V600E,...drochloride and its enhancer. We could not detect p.V600E mutation in the BRAF gene by quantitative ...,17,999,Case_Rep_Dermatol_2015_Sep_12_7(3)_237-240.txt
p.V617F,7 Lange T.  Edelmann A.  Siebolts U.    JAK2 p.V617F allele burden in myelo proliferative neopl...,53,46,Case_Rep_Hematol_2015_Aug_9_2015_703457.txt
p.Ser459Ter,"c.1376C>G, p.Ser459Ter",52,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Trp897Ter,"c.2691G>A, p.Trp897Ter",55,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Arg277Ter,"c.829C>T, p.Arg277Ter",65,11,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Tyr328Ter,"c.984C>A, p.Tyr328Ter",67,11,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Arg630X,"c.2455C>T, p.Arg630X",68,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Phe1200Leu,"c.3600delT, p.Phe1200LeufsX33",69,13,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Arg1488X,"c.4462C>T, p.Arg1488X",70,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Trp1689X,"c5067G>A, p.Trp1689X",71,11,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Glu693X,"c.2076_2077InsT, p.Glu693X",72,18,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Lys1450X,"c.4975A>T, p.Lys1450X",75,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.K376Q,"c.1126A>C, p.K376Q",79,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.G375Afs,"c.1124delG, p.G375AfsX5",81,13,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Y328X,"c.984C>A, p.Y328X	Ahmad et al., 2007 [15]",85,11,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.R896Q,"c.2687G>A, p.R896Q",89,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.I1493Sfs,"c.4474delA, p.I1493SfsX8",92,13,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Arg523Ter,"c.1567C>T, p.Arg523Ter	Kurban et al., 2010 [17]",96,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Met899Ile,"c.2697G>A, p.Met899Ile",100,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Met932Leu,"c.2796A→C, p.Met932Leu",102,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Arg523Ter,"c.1567C>T, p.Arg523Ter",112,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Gly1200Ser,"...erozygous mutation in the COL2A1 gene (c.3598G>A; p.Gly1200Ser). This missense mutation, creating a ...",26,174,Case_Rep_Obstet_Gynecol_2015_Sep_8_2015_935204.txt
p.L541P,"... in the ABCA4 gene with complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozygous state",15,670,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.A1038V,"...ith complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozygous state",15,690,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.L541P,"... in exons 12 and 21 of the ABCA4 gene (c.1622T>C, p.L541P; c.3113C>T, p.A1038V), (2) a heterozygous ...",29,599,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.A1038V,"...of the ABCA4 gene (c.1622T>C, p.L541P; c.3113C>T, p.A1038V), (2) a heterozygous variant in exon 2 of...",29,619,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.K249N,...ygous variant in exon 6 of the RGR gene (c.747A>T p.K249N). Based on previous knowledge of these thr...,29,772,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.L541P,"...as concluded that the ABCA4 mutations (c.1622T>C, p.L541P; c.3113C>T, p.A1038V) were those that like...",29,886,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.A1038V,"...e ABCA4 mutations (c.1622T>C, p.L541P; c.3113C>T, p.A1038V) were those that likely caused RP in this...",29,906,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.Leu541Pro,"...sing alleles in the ABCA4 gene, L541P (c.1622T>C, p.Leu541Pro, rs61751392) and A1038V (c.3113C>T, p....",33,193,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.Ala1038Val,"..., p.Leu541Pro, rs61751392) and A1038V (c.3113C>T, p.Ala1038Val, rs61751374), were identified in cis-...",33,241,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
p.Gly12Ser,"...e nucleotide substitution c.34G > A, resulting in p.Gly12Ser amino acid change representing a mutati...",91,85,Case_Rep_Pediatr_2015_Feb_28_2015_934865.txt
p.Arg112His,"...otide position 5234 (exon 2: g.5234G>A, c.335G>A, p.Arg112His) described in the literature [9].",46,391,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
p.Arg112His,"...ation but also within families. In this case, the p.Arg112His genotype could be identified in the in...",77,224,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
p.Glu66Gln,...utation in addition to a functional polymorphism (p.Glu66Gln) frequently seen in the Asian populatio...,77,1144,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
p.Arg112His,"..., further 6 families (19 patients) comprising the p.Arg112His genotype are known. Five of the 6 inde...",79,64,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
p.Arg112His,"... a relatively mild phenotype, consistent with the p.Arg112His genotype",82,235,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
p.Pro251Leu,"...wed two polymorphisms, a homozygote polymorphism (p.Pro251Leu), and a heterozygote silent polymorphi...",40,173,Case_Reports_Immunol_2012_Nov_21_2012_196417.txt
p.T522M,"...y 1 missense mutation (rs138651238; c.1565C>T and p.T522M) was discovered (Fig. 6). In total, 18 het...",87,231,Cell_Adh_Migr_2016_Feb_6_10(1-2)_395-55.txt
p.N306I,"....917 A>T), leading to an amino-acid substitution (p.N306I), may have a role in EV.4, 5 It has also b...",7,723,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.N306I,...th decision. We also analyzed the effect of EVER2 p.N306I polymorphism on these mechanisms,13,266,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.N306I,"...ent of an asparagine with an isoleucine residue, (p.N306I), has been associated with β-HPV persisten...",62,329,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.I306N,...We therefore investigated the effect of the EVER2 p.I306N polymorphism on TNF-α-induced apoptosis an...,62,472,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.N306I,"...ffectively than EVER2 N306 (Figure 6d). Thus, the p.N306I polymorphism was sufficient to modulate th...",64,785,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.Lys116Arg,...on 3 (c.346 delA) leading to an early frameshift (p.Lys116Argfs*81) (Figure 1B). To determine whethe...,23,1293,Cell_Rep_2014_Aug_7_8(3)_647-655.txt
p.Thr172Val,"...ent, either in the full-length or truncated form (p.Thr172Valfs*51), showing that this mutation is n...",25,486,Cell_Rep_2014_Aug_7_8(3)_647-655.txt
p.T172Vfs,(D) The protein change p.T172Vfs*51 is predicted to generate a 223 amino ...,99,24,Cell_Rep_2014_Aug_7_8(3)_647-655.txt
p.R1113X,...in the rod domain of DSP. Two of these mutations (p.R1113X and p.R1934X) affect all three isoforms; ...,70,102,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1934X,...main of DSP. Two of these mutations (p.R1113X and p.R1934X) affect all three isoforms; another three...,70,115,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1255K,"...R1934X) affect all three isoforms; another three (p.R1255K, p.R1267X and p.N1324fsZ23) affect DSPI a...",70,167,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1267X,"...fect all three isoforms; another three (p.R1255K, p.R1267X and p.N1324fsZ23) affect DSPI and DSPIa a...",70,177,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1775I,"...and p.N1324fsZ23) affect DSPI and DSPIa and four (p.R1775I, p.K1583R, p.L1654P and p.Q1446X) affect ...",70,236,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.K1583R,"...4fsZ23) affect DSPI and DSPIa and four (p.R1775I, p.K1583R, p.L1654P and p.Q1446X) affect only DSPI ...",70,246,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.L1654P,"...fect DSPI and DSPIa and four (p.R1775I, p.K1583R, p.L1654P and p.Q1446X) affect only DSPI while leav...",70,256,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q1446X,"... DSPIa and four (p.R1775I, p.K1583R, p.L1654P and p.Q1446X) affect only DSPI while leaving DSPIa and...",70,269,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q1446X,"...the single nonsense mutation affecting only DSPI, p.Q1446X, causes recessive cardio-cutaneous diseas...",70,508,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q673X,"...se when inherited with another nonsense mutation, p.Q673X, which affects all isoforms (Asimaki et al...",70,607,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q673X,"...plete ablation of DSP expression from one allele (p.Q673X) and ablation of DSPI only, allowing expre...",70,773,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q1446X,...ression of DSPII and DSPIa from the other allele (p.Q1446X). This contrasts with the homozygous p.R1...,70,871,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1267X,"...le (p.Q1446X). This contrasts with the homozygous p.R1267X nonsense mutation, which leads to complet...",70,917,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1267X,"...neous disease (Uzumcu et al. 2006). In this case (p.R1267X/p.R1267X), the cutaneous phenotype is rel...",70,1111,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1267X,"...ease (Uzumcu et al. 2006). In this case (p.R1267X/p.R1267X), the cutaneous phenotype is relatively m...",70,1120,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q673X,...neous phenotype is relatively mild (compared with p.Q673X/p.Q1446X) presumably because of normal DSP...,70,1189,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q1446X,...enotype is relatively mild (compared with p.Q673X/p.Q1446X) presumably because of normal DSPII expre...,70,1197,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q673X,... DSPII expression (which is haplo-insufficient in p.Q673X/p.Q1446X and results in more severe cutane...,70,1285,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q1446X,...xpression (which is haplo-insufficient in p.Q673X/p.Q1446X and results in more severe cutaneous dise...,70,1293,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1267X,...diac phenotype might be considered more severe in p.R1267X/p.R1267X with cardiac failure at age 4 ye...,70,1421,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1267X,...otype might be considered more severe in p.R1267X/p.R1267X with cardiac failure at age 4 years compa...,70,1430,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q673X,...mpared with cardiac failure at age 9 years in the p.Q673X/p.Q1446X case and therefore we are tempted...,70,1527,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q1446X,...ith cardiac failure at age 9 years in the p.Q673X/p.Q1446X case and therefore we are tempted to spec...,70,1535,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Ser597Leu,... heterozygous mutation was found in the DSP gene: p.Ser597Leu. This residue is conserved across vert...,387,1666,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
p.S358L,P 13 — Deleterious effects of theTMEM43mutation p.S358L found in a German family with arrhythmogen...,1137,49,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
p.S358L,...r of the previously identified TMEM43 c. 1073C>T (p.S358L) mutation (Merner et al. 2008; Christensen...,1153,399,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
p.S358L,...clearly been demonstrated. The female carriers of p.S358L presented a rather mild arrhythmogenic phe...,1153,574,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
p.Met2229Ile,...dicted effect on splicing and c.6686_6687insCAAC; p.Met2229Ilefs*43 which may result in loss of expr...,15,519,Cerebellum_Ataxias_2015_Apr_30_2_5.txt
p.Trp181Ter,"...ms. The c.542G>A locates on exon 6, the resultant p.Trp181Ter nonsense mutation results in premature...",22,131,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
p.R649X,...ate founder mutations for RPGRIP1L (c. 1945 C > T p.R649X) and CC2D2A (c. 3540delA p.R1180SfsX6). Tw...,13,288,Cilia_2012_Oct_1_1_18.txt
p.R1180Sfs,...L (c. 1945 C > T p.R649X) and CC2D2A (c. 3540delA p.R1180SfsX6). Two missense mutations in TMEM67 (c...,13,321,Cilia_2012_Oct_1_1_18.txt
p.M252T,"...). Two missense mutations in TMEM67 (c. 755 T > C p.M252T, and c. 1392 C > T p.R441C) are also proba...",13,383,Cilia_2012_Oct_1_1_18.txt
p.R441C,"...n TMEM67 (c. 755 T > C p.M252T, and c. 1392 C > T p.R441C) are also probable founder mutations. Thes...",13,410,Cilia_2012_Oct_1_1_18.txt
p.R73L,...KS2	11q13.1	TMEM216	TMEM216	JBTS2	[2]	Ashkenazi - p.R73L	[2],26,52,Cilia_2012_Oct_1_1_18.txt
p.T615P,"...PGRIP1L	RPGRIP1L	JBTS7, NPHP8	[6]	Mixed European -p.T615P	[11]",30,65,Cilia_2012_Oct_1_1_18.txt
p.H96R,42 + 43	Pakistani	TMEM138	c. A287G p.H96R	c. A287G p.H96R	+	+	 	+	 	 	 ,66,36,Cilia_2012_Oct_1_1_18.txt
p.H96R,...2 + 43	Pakistani	TMEM138	c. A287G p.H96R	c. A287G p.H96R	+	+	 	+	 	 	 ,66,52,Cilia_2012_Oct_1_1_18.txt
p.R441C,319	British	TMEM67	c. 1392 C > T p.R441C	c. 1392 C > T p.R441C	 	+	 	+	 	 	some dia...,73,34,Cilia_2012_Oct_1_1_18.txt
p.R441C,...ritish	TMEM67	c. 1392 C > T p.R441C	c. 1392 C > T p.R441C	 	+	 	+	 	 	some dialation of pancreatic d...,73,56,Cilia_2012_Oct_1_1_18.txt
p.R441C,347	Pakistani	TMEM67	c. 1392 C > T p.R441C	c. 1392 C > T p.R441C	 	 	 	 	 	 	diagnose...,74,36,Cilia_2012_Oct_1_1_18.txt
p.R441C,...istani	TMEM67	c. 1392 C > T p.R441C	c. 1392 C > T p.R441C	 	 	 	 	 	 	diagnosed with MKS,74,58,Cilia_2012_Oct_1_1_18.txt
p.Q376P,P95	Pakistani	TMEM67	c. 1127A > C p.Q376P	c. 1127A > C p.Q376P	+	+	 	+	 	 	 ,76,35,Cilia_2012_Oct_1_1_18.txt
p.Q376P,...akistani	TMEM67	c. 1127A > C p.Q376P	c. 1127A > C p.Q376P	+	+	 	+	 	 	 ,76,56,Cilia_2012_Oct_1_1_18.txt
p.R549C,205	Chinese	TMEM67	c. 1615 C > T p.R549CN	c. 1615 C > T p.R549CN	 	+	 	+	 	 	hypopl...,79,34,Cilia_2012_Oct_1_1_18.txt
p.R549C,"...inese	TMEM67	c. 1615 C > T p.R549CN	c. 1615 C > T p.R549CN	 	+	 	+	 	 	hypoplastic cerebellum, small...",79,57,Cilia_2012_Oct_1_1_18.txt
p.G92R,"C28	Pakistani	TMEM67	c. 274 G > A p.G92RN	c. 274 G > A p.G92RN	 	 	 	 	 	 	MTS, colo...",80,35,Cilia_2012_Oct_1_1_18.txt
p.G92R,"...akistani	TMEM67	c. 274 G > A p.G92RN	c. 274 G > A p.G92RN	 	 	 	 	 	 	MTS, coloboma, mental retardat...",80,56,Cilia_2012_Oct_1_1_18.txt
p.R477X,39	Pakistani/Mirpuri	CEP290	c. 1429 C > T p.R477XN	c. 1429 C > T p.R477XN	 	+	 	+	 	 	 ,81,43,Cilia_2012_Oct_1_1_18.txt
p.R477X,...rpuri	CEP290	c. 1429 C > T p.R477XN	c. 1429 C > T p.R477XN	 	+	 	+	 	 	 ,81,66,Cilia_2012_Oct_1_1_18.txt
p.G1915Ffs,333	Pakistani	CEP290	c. 5744insT p.G1915FfsX1N	c. 5744insT p.G1915FfsX1N	+	 	 	 	 	...,83,34,Cilia_2012_Oct_1_1_18.txt
p.G1915Ffs,...tani	CEP290	c. 5744insT p.G1915FfsX1N	c. 5744insT p.G1915FfsX1N	+	 	 	 	 	 	 ,83,60,Cilia_2012_Oct_1_1_18.txt
p.R649X,207	Pakistani	RPGRIP1L	c. 1945 C > T p.R649XN	c. 1945 C > T p.R649XN	+	+	+	 	 	 	small ...,84,38,Cilia_2012_Oct_1_1_18.txt
p.R649X,...ani	RPGRIP1L	c. 1945 C > T p.R649XN	c. 1945 C > T p.R649XN	+	+	+	 	 	 	small cerebellum,84,61,Cilia_2012_Oct_1_1_18.txt
p.R649X,336	Pakistani	RPGRIP1L	c. 1945 C > T p.R649XN	c. 1945 C > T p.R649XN	 	 	 	 	 	 	diagno...,85,38,Cilia_2012_Oct_1_1_18.txt
p.R649X,...ani	RPGRIP1L	c. 1945 C > T p.R649XN	c. 1945 C > T p.R649XN	 	 	 	 	 	 	diagnosed with MKS,85,61,Cilia_2012_Oct_1_1_18.txt
p.R1180Sfs,158	Pakistani	CC2D2A	c. 3540delA p.R1180SfsX6N	c. 3540delA p.R1180SfsX6N	+	+	+	+	+	...,86,34,Cilia_2012_Oct_1_1_18.txt
p.R1180Sfs,"...tani	CC2D2A	c. 3540delA p.R1180SfsX6N	c. 3540delA p.R1180SfsX6N	+	+	+	+	+	 	low set ears, pulmonary ...",86,60,Cilia_2012_Oct_1_1_18.txt
p.R1180Sfs,180	Pakistani	CC2D2A	c. 3540delA p.R1180SfsX6N	c. 3540delA p.R1180SfsX6N	+	+	+	 	 	...,87,34,Cilia_2012_Oct_1_1_18.txt
p.R1180Sfs,...tani	CC2D2A	c. 3540delA p.R1180SfsX6N	c. 3540delA p.R1180SfsX6N	+	+	+	 	 	+	 ,87,60,Cilia_2012_Oct_1_1_18.txt
p.Q356Pfs,261	Jordanian	TMEM237	c. 1066_1067dupC p.Q356PfsX23	c. 1066_1067dupC p.Q356PfsX23	 	 	 	 ...,88,40,Cilia_2012_Oct_1_1_18.txt
p.Q356Pfs,"...37	c. 1066_1067dupC p.Q356PfsX23	c. 1066_1067dupC p.Q356PfsX23	 	 	 	 	 	 	meningomyelocele, develop...",88,70,Cilia_2012_Oct_1_1_18.txt
p.R549C,178	Pakistani/Mirpuri	TMEM67	c. 1615 C > T p.R549CN	not detected	 	 	 	 	 	 	diagnosed with M...,89,44,Cilia_2012_Oct_1_1_18.txt
p.R85X,162 + 163	British	TMEM216	c. 253 C > T p.R85X†	c. 253 C > T p.R85X†	+	+	+	+	+	 	facial dy...,96,40,Cilia_2012_Oct_1_1_18.txt
p.R85X,"...British	TMEM216	c. 253 C > T p.R85X†	c. 253 C > T p.R85X†	+	+	+	+	+	 	facial dysmorphism, postural d...",96,61,Cilia_2012_Oct_1_1_18.txt
p.P476S,176 + 177	British	TMEM67	c. 1426 C > T p.P476S††	c. 2440–3 C > A	+	+	+	+	 	 	flexion defo...,97,40,Cilia_2012_Oct_1_1_18.txt
p.M252T,186	British	TMEM67	c. 755 T > C p.M252T	c. 653 G > T p.R208X†††	+	+	 	 	 	 	 ,98,33,Cilia_2012_Oct_1_1_18.txt
p.R208X,...	British	TMEM67	c. 755 T > C p.M252T	c. 653 G > T p.R208X†††	+	+	 	 	 	 	 ,98,54,Cilia_2012_Oct_1_1_18.txt
p.M252T,302	British	TMEM67	c.755 T > C p.M252T	c.651 + 5 G > A p.V217VfsN	 	+	 	+	 	+	age...,99,32,Cilia_2012_Oct_1_1_18.txt
p.V217Vfs,...ritish	TMEM67	c.755 T > C p.M252T	c.651 + 5 G > A p.V217VfsN	 	+	 	+	 	+	agenesis of corpus callosum...,99,56,Cilia_2012_Oct_1_1_18.txt
p.M252T,83527	Norwegian-Indian	TMEM67	c. 755 T > C p.M252T	c. 2882 C > A p.S961YN	+	+	 	+	 	 	 ,100,44,Cilia_2012_Oct_1_1_18.txt
p.S961Y,...-Indian	TMEM67	c. 755 T > C p.M252T	c. 2882 C > A p.S961YN	+	+	 	+	 	 	 ,100,66,Cilia_2012_Oct_1_1_18.txt
p.R451X,74406a + b	 	TMEM67	c. 1351 C > T p.R451X	c. 2108 T > A p.V673A	 	+	 	+	 	 	mental r...,101,35,Cilia_2012_Oct_1_1_18.txt
p.V673A,"... + b	 	TMEM67	c. 1351 C > T p.R451X	c. 2108 T > A p.V673A	 	+	 	+	 	 	mental retardation, retinal co...",101,57,Cilia_2012_Oct_1_1_18.txt
p.E227Sfs,210 + 239	Dutch	CEP290	c. 679_680delGA p.E227SfsX2	c. 1984 C > T p.Q662X	 	+	 	+	 	+	abno...,102,40,Cilia_2012_Oct_1_1_18.txt
p.Q662X,"...	CEP290	c. 679_680delGA p.E227SfsX2	c. 1984 C > T p.Q662X	 	+	 	+	 	+	abnormal cerebellum, wide nasa...",102,66,Cilia_2012_Oct_1_1_18.txt
p.R751X,153 + 154	French	CEP290a	c. 2251 C > T p.R751X	c. 4864insTdelCG p.R1622FfsX9N	 	+	 	 	 	 ...,103,40,Cilia_2012_Oct_1_1_18.txt
p.R1622Ffs,...ch	CEP290a	c. 2251 C > T p.R751X	c. 4864insTdelCG p.R1622FfsX9N	 	+	 	 	 	 	 ,103,65,Cilia_2012_Oct_1_1_18.txt
p.H610P,166	British	RPGRIP1L	c. 1829A > C p.H610P	c. 721_724delAATG p.N241fsX25	+	+	+	 	 	+	...,104,35,Cilia_2012_Oct_1_1_18.txt
p.W1182R,128	British	CC2D2A	c. 3544 T > C p.W1182R	c. 3774_3774insT p.E1259fsX1	 	 	 	 	 	 	...,105,34,Cilia_2012_Oct_1_1_18.txt
p.R156C,36 + 36A	Pakistani/Gujarati	RPGRIP1L	c. 466 C > T p.R156C*N	not detected	+	+	 	 	 	 	 ,106,51,Cilia_2012_Oct_1_1_18.txt
p.D1264N,"...lycystic kidneys; * in cis with c. 3790 G > A het p.D1264N, ** in cis with c. 3893 T > A p.V1298D; †...",109,190,Cilia_2012_Oct_1_1_18.txt
p.V1298D,"... G > A het p.D1264N, ** in cis with c. 3893 T > A p.V1298D; † p.R85X allele was present in 2/10,266 ...",109,229,Cilia_2012_Oct_1_1_18.txt
p.R85X,"....D1264N, ** in cis with c. 3893 T > A p.V1298D; † p.R85X allele was present in 2/10,266 European/Afr...",109,241,Cilia_2012_Oct_1_1_18.txt
p.P476S,"...ls in the Exome Variant Server (EVS) database, †† p.P476S allele present in 6/7,012 European/America...",109,361,Cilia_2012_Oct_1_1_18.txt
p.R208X,"... in 6/7,012 European/American controls (EVS), ††† p.R208X allele present in 8/7,012 European/America...",109,433,Cilia_2012_Oct_1_1_18.txt
p.L63R,...ative pathogenic mutation in TMEM216 c. 188 T > G p.L63R,109,850,Cilia_2012_Oct_1_1_18.txt
p.R549C,...178 has the single heterozygous missense mutation p.R549C that is likely to be pathogenic because th...,113,659,Cilia_2012_Oct_1_1_18.txt
p.R441C,"...]. We identified the homozygous missense mutation p.R441C in two families (319 and 347), a mutation ...",121,225,Cilia_2012_Oct_1_1_18.txt
p.R441L,"...e mutation affecting the same amino-acid residue, p.R441L, has also been reported previously in an M...",122,65,Cilia_2012_Oct_1_1_18.txt
p.R649X,"...gin. The RPGRIP1L nonsense mutation c. 1945 C > T p.R649X was observed in families 207 and 336, whic...",126,156,Cilia_2012_Oct_1_1_18.txt
p.R1180Sfs,...ed. The frameshift mutation in CC2D2A c. 3540delA p.R1180SfsX6 occurred in the unrelated families 15...,126,284,Cilia_2012_Oct_1_1_18.txt
p.M252T,1c). The heterozygous missense mutation p.M252T accounted for 30% of identified alleles in...,130,41,Cilia_2012_Oct_1_1_18.txt
p.R649X,...probable founder mutations RPGRIP1L c. 1945 C > T p.R649X and CC2D2A c. 3540delA p.R1180SfsX6 should...,138,957,Cilia_2012_Oct_1_1_18.txt
p.R1180Sfs,...IP1L c. 1945 C > T p.R649X and CC2D2A c. 3540delA p.R1180SfsX6 should also be prioritized. For famil...,138,988,Cilia_2012_Oct_1_1_18.txt
p.M252T,"...nsanguinity, testing the TMEM67 missense mutation p.M252T may be useful, but the most common mutatio...",138,1170,Cilia_2012_Oct_1_1_18.txt
p.R440Q,"...rthermore, some MKS mutations, such as the TMEM67 p.R440Q missense mutation, are allelic for Joubert...",138,1456,Cilia_2012_Oct_1_1_18.txt
p.L63R,...third heterozygous putative mutation c. 188 T > G p.L63R in TMEM216. This was the only occurrence of...,143,74,Cilia_2012_Oct_1_1_18.txt
p.C282Y,"...nth month of life. She was carrying the c.845G>A (p.C282Y) mutation in heterozygosis, conferring the...",27,212,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
p.R248G,"...dy showed a missense mutation in BMPR2, c.742A>G (p.R248G) located in exon six, and another mutation...",33,163,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
p.D254N,"...on six, and another mutation in ACVRL1, c.760G>A (p.D254N. These mutations are described for the fir...",33,235,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
p.Cys1298Phe,"...e replacement of a cysteine with a phenylalanine (p.Cys1298Phe), causing the loose of a cysteine in ...",52,744,Clin_Case_Rep_2016_Sep_28_4(11)_1045-1048.txt
p.Cys1298Phe,"The p.Cys1298Phe mutation was recently reported, but t...",63,5,Clin_Case_Rep_2016_Sep_28_4(11)_1045-1048.txt
p.V600E,...-Rodzewicz Z  Von Deimling A    Detection of BRAF p.V600E mutations in melanomas: comparison of four...,212,71,Clin_Cosmet_Investig_Dermatol_2015_Jan_30_8_35-46.txt
p.Cys134Trp,...losa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402>CG) PLoS One 2010 5 e8789 20098...,80,186,Clin_Exp_Reprod_Med_2016_Mar_31_43(1)_1-8.txt
p.Leu244Pro,A c.731T>C CAPN5 mutation resulted in a p.Leu244Pro substitution in calpain-5. The eye sho...,10,41,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
p.Leu244Pro,"...other (Figure 1). This family carried a c.731T>C, p.Leu244Pro mutation in the CAPN5 gene.1 Over the ...",28,221,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
p.V587G,... (GTC) in place of glycine (GGC) at position 587 (p.V587G). The arrow pointin,58,57,Clin_Pediatr_Endocrinol_2015_Oct_24_24(4)_191-193.txt
p.V587G,... revealed a novel heterozygous missense mutation (p.V587G) i,61,73,Clin_Pediatr_Endocrinol_2015_Oct_24_24(4)_191-193.txt
p.E632X,"heterozygous nonsense mutation, c1894G>T (p.E632X), in exon 3 (Fig. 1A, B, CFig. 1. Molecula...",49,43,Clin_Pediatr_Endocrinol_2016_Oct_18_25(4)_135-138.txt
p.E632X,NR3C2 mutation (c.1894G>T; p.E632X). The arrow indicates th,50,28,Clin_Pediatr_Endocrinol_2016_Oct_18_25(4)_135-138.txt
p.E632X,We identified a novel mutation (p.E632X) in NR3C2 in a Japanese famil,69,33,Clin_Pediatr_Endocrinol_2016_Oct_18_25(4)_135-138.txt
p.R1267X,...ng both isoforms. A homozygous nonsense mutation (p.R1267X) in the DSP-1 specific region of exon 23 ...,72,287,Clin_Res_Cardiol_2011_Dec_26_100(12)_1087-1093.txt
p.R1267X,"... DSP-1 specific region of exon 23, similar to the p.R1267X mutation. Since both alleles are affected...",72,602,Clin_Res_Cardiol_2011_Dec_26_100(12)_1087-1093.txt
p.N288K,"...of these occurred in a family with a c.846 C > G, p.N288K SMARCB1 mutation that we have previously r...",59,1098,Clin_Sarcoma_Res_2012_Oct_4_2_17.txt
p.K587R,"...esence of a tuberous sclerosis 1 (TSC1):c.1760A >Gp.K587R mutation. Owing to the TSC1 mutation, ther...",37,192,Clin_Sarcoma_Res_2015_Oct_19_5_22.txt
p.Asn149Pro,p.Asn149Profs	Two copies	One copy	One copy	Framesh...,47,1,Cold_Spring_Harb_Mol_Case_Stud_2016_Jul_2(4)_a000885.txt
p.Ala944Thr,p.Ala944Thr	One copy	One copy	Zero copies	Missense...,51,1,Cold_Spring_Harb_Mol_Case_Stud_2016_Jul_2(4)_a000885.txt
p.W577R,...ial hypercholesterolaemia carrying the homozygous p.W577R LDL-receptor gene mutation. Clin. Transpla...,345,141,Curr_Vasc_Pharmacol_2015_Nov_13(6)_759-770.txt
p.Gly1324Ser,... loss-of-function von Willebrand disease variant (p.Gly1324Ser) of the von Willebrand factor A1 doma...,3,211,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...the von Willebrand disease (vWD) type 2M mutation p.Gly1324Ser has been recently published in the Jo...,3,1577,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...ction, quality control and crystallization of the p.Gly1324Ser vWD variant of the A1 domain of VWF. ...",5,93,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...p.Gly1324Ser vWD variant of the A1 domain of VWF. p.Gly1324Ser A1 was expressed in Escherichia coli ...,5,143,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...hy and crystallized. The crystal structure of the p.Gly1324Ser mutant of the A1 domain is deposited ...,5,393,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,Experimental factors	VWF A1-p.Gly1324Ser was expressed in E. coli as inclusion...,15,29,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...i-NTA and Heparin affinity chromatography. VWF A1-p.Gly1324Ser purity and absence of aggregates were...,15,224,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,Experimental features	The crystal structure of p.Gly1324Ser was determined via X-ray crystallogra...,16,48,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...ed process for expression and purification of the p.Gly1324Ser A1 domain is described,23,61,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...A1 domain harboring the loss-of-function mutation p.Gly1324Ser,27,165,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...1 domain containing the loss-of-function mutation p.Gly1324Ser. Furthermore, the data shows quality ...",34,142,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...btained parameters. Finally, the structure of the p.Gly1324Ser A1 domain variant is compared to prev...",34,404,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,2.1 Production of p.Gly1324Ser A1 in Escherichia col,37,19,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...1 domain containing the loss-of-function mutation p.Gly1324Ser was expressed in E. coli M15 cells as...,38,74,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,p.Gly1324Ser A1 was shipped on ice overnight for c...,56,1,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...ear aggregates and then concentrated to 20 mg/mL. p.Gly1324Ser A1 was screened against the Wizard Cl...,56,175,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,4.1 Comparison of p.Gly1324Ser A1 with other crystal structures of t...,59,19,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...g. 3, compares the obtained crystal structure for p.Gly1324Ser with the structures mentioned above. ...",60,791,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...ructures mentioned above. Fig. 3 illustrates that p.Gly1324Ser is identical to all published structu...,60,865,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...tical gel filtration and reverse phase HPLC of A1 p.Gly1324Ser. The upper panel shows a chromatogram...,72,63,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...24Ser. The upper panel shows a chromatogram of A1 p.Gly1324Ser obtained from analytical gel filtrati...,72,120,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...Vitamin B12 (1.35 kDa) (●). The retention time of p.Gly1324Ser A1 is indicated by (o). The lower pan...,72,418,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,Fig. 1Fig. 2 Photograph of the VWF A1 p.Gly1324Ser crystals taken with a polarized light...,74,39,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...s taken with a polarized light microscope. VWF A1 p.Gly1324Ser grew as needle clusters in the presen...,74,109,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...[11], [12], [13], [14], [15], [16], [17]; (G1324S=p.Gly1324Ser)",76,153,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...ection data, and refinement parameters for VWF A1 p.Gly1324Ser (5BV8)",78,83,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,Table 1VWF A1 p.Gly1324Ser (5BV8),80,15,Data_Brief_2016_May_10_7_1700-1706.txt
p.E66Q,...i M  Yokoseki A  Kuwano R  Narita I   Role of the p.E66Q variant of GLA in the progression of chroni...,138,106,Dement_Geriatr_Cogn_Dis_Extra_2016_Jan_19_6(1)_10-19.txt
p.M1V,...to conversion of the initiation codon ATG to GTG (p.M1V) (Inhoff et al. in press),66,1136,Dermatoendocrinol_2011_Apr_1_Apr-Jun_3(2)_53-61.txt
p.Arg43His,"...h of the three probands: R43H and G68D (c.128G>A, p.Arg43His and c.203G>A, p.Gly68Asp), E248 K and I...",34,111,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.Gly68Asp,"...R43H and G68D (c.128G>A, p.Arg43His and c.203G>A, p.Gly68Asp), E248 K and I225M (c.742G>A, p.Glu248L...",34,136,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.Glu248Lys,"....203G>A, p.Gly68Asp), E248 K and I225M (c.742G>A, p.Glu248Lys and c.675C>G, p.Ile225Met), and G261R ...",34,177,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.Ile225Met,"... K and I225M (c.742G>A, p.Glu248Lys and c.675C>G, p.Ile225Met), and G261R and D217N (c.781G>A, p.Gly...",34,203,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.Gly261Arg,"...C>G, p.Ile225Met), and G261R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). Of these s...",34,248,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.Asp217Asn,"...1R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). Of these six mutations, five had bee...",34,274,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.Tyr213Thr,... a single base pair deletion mutation (c.636delC; p.Tyr213ThrfsX20) in exon 5 of BSCL2 gene causing ...,10,77,Diagn_Pathol_2013_May_9_8_78.txt
p.Tyr213Thr,...0 non-specific amino acid residues BSCL2 protein (p.Tyr213ThrfsX20). Mutation analysis of BSCL2 exon...,79,542,Diagn_Pathol_2013_May_9_8_78.txt
p.Tyr213Thr,...he liver were comparable to a homozygous mutation p.Tyr213ThrfsX20 identified in an Indian family [5...,86,139,Diagn_Pathol_2013_May_9_8_78.txt
p.N88S,"...pe caused by heterozygous mutations in BSCL2 gene p.N88S in Austrian and German families, these pati...",88,280,Diagn_Pathol_2013_May_9_8_78.txt
p.N88S,...n a large Dutch family with heterozygous mutation p.N88S in the BSCL2 gene and segregating autosomal...,88,590,Diagn_Pathol_2013_May_9_8_78.txt
p.S90W,...[21]. Very recently another heterozygous mutation p.S90W identified in two Korean CMT type 2 disease...,88,925,Diagn_Pathol_2013_May_9_8_78.txt
p.S90L,...y different from the previously reported mutation p.S90L in three Italian patients representing CMT ...,88,1133,Diagn_Pathol_2013_May_9_8_78.txt
p.Thr78Ala,2	c.232A>G	p.Thr78Ala	CGL2	[27],98,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Asn88Ser,"2	c.263A>G	p.Asn88Ser	dHMN	[16,18,28]",99,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Ser90Leu,"2	c.269C>T	p.Ser90Leu	dHMN, CMT2	[18,29,30]",100,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Ser90Trp,"2	c.269C>G	p.Ser90Trp	dHMN, CMT2	[22]",101,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Leu91Pro,2	c.272T>C	p.Leu91Pro	CGL2	[27],102,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Arg138X,3	c.412C>T	p.Arg138X	CGL2	[5],103,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Tyr187Cys,4	c.560A>G	p.Tyr187Cys	CGL2	[15],104,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Glu189X,4	c.565G>T	p.Glu189X	CGL2	[14],105,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Ala212Pro,"5	c.634G>C	p.Ala212Pro	CGL2	[5,25]",106,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Arg275X,7	c.823C>T	p.Arg275X	CGL2	[31],108,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Gln391X,10	c.1171C>T	p.Gln391X	CGL2	[27],109,14,Diagn_Pathol_2013_May_9_8_78.txt
p.Tyr53Ser,1	c.154_155insTT	p.Tyr53SerfsX39	CGL2	[7],111,18,Diagn_Pathol_2013_May_9_8_78.txt
p.Met101Lys,3	c.301_302insAA	p.Met101LysfsX10	CGL2	[5],112,18,Diagn_Pathol_2013_May_9_8_78.txt
p.Thr109Asn,3	c.325insA	p.Thr109AsnfsX5	CGL2	[5],113,13,Diagn_Pathol_2013_May_9_8_78.txt
p.Ile262His,6	c.782dupG	p.Ile262HisfsX12	CGL2	[7],114,13,Diagn_Pathol_2013_May_9_8_78.txt
p.Tyr106Ser,3	c.315_316delGT	p.Tyr106SerfsX7	CGL2	[5],116,18,Diagn_Pathol_2013_May_9_8_78.txt
p.Tyr213Thr,5	c.636delC	p.Tyr213ThrfsX20	CGL2	[5],118,13,Diagn_Pathol_2013_May_9_8_78.txt
p.Ala218Trp,5	c.652_662del11	p.Ala218TrpfsX51	CGL2	[32],119,18,Diagn_Pathol_2013_May_9_8_78.txt
p.Tyr213Thr,The identified mutation c.636delC (p.Tyr213ThrfsX20) in exon 5 of BSCL2 gene is the f...,140,36,Diagn_Pathol_2013_May_9_8_78.txt
p.C134W,...encing conditions is available on request. A FOXL2p.C134W mutation was nonetheless not detectable,138,431,Diagn_Pathol_2014_Jun_3_9_107.txt
p.Q223R,...l Duarte SF  Francischetti EA  Genelhu-Abreu V    p.Q223R leptin receptor polymorphism associated wi...,141,61,Dis_Markers_2013_Nov_6_35(6)_673-677.txt
p.Q223R,"...i EA  Genelhu VA  Cabello PH  Pimentel MMG   LEPR p.Q223R, β 3-AR p.W64R and LEP c.-2548G>A gene var...",142,78,Dis_Markers_2013_Nov_6_35(6)_673-677.txt
p.W64R,"...  Cabello PH  Pimentel MMG   LEPR p.Q223R, β 3-AR p.W64R and LEP c.-2548G>A gene variants in obese B...",142,94,Dis_Markers_2013_Nov_6_35(6)_673-677.txt
p.Ala12Thr,NGPS is caused by a homozygous mutation (c.34G<A; p.Ala12Thr) in BANF1 (barrier to autointegration F...,68,51,Dis_Model_Mech_2016_Jul_1_9(7)_719-735.txt
p.G719S,3	M	exon18 (p.G719S and p.E709A)	PR	First scan	E−	Yes	Yes	Yes	...,79,13,EJNMMI_Res_2016_Feb_9_6_10.txt
p.E709A,3	M	exon18 (p.G719S and p.E709A)	PR	First scan	E−	Yes	Yes	Yes,79,25,EJNMMI_Res_2016_Feb_9_6_10.txt
p.P848L,4	M	exon21 (p.P848L)	–	First scan	E−	Yes	Yes	Yes,82,13,EJNMMI_Res_2016_Feb_9_6_10.txt
p.T790M,6	F	exon19 (p.delE746-A750) and exon20 (p.T790M)	Slow PD	First scan	E+	Yes	Yes	Yes,88,41,EJNMMI_Res_2016_Feb_9_6_10.txt
p.T790M,7	M	exon19 (p.E746-S752) and exon20 (p.T790M)	SD	First scan	E−	NA	NA	NA	Aberrant arteri...,91,38,EJNMMI_Res_2016_Feb_9_6_10.txt
p.G719S,8	M	exon18 (p.G719S) and exon20 (p.S768I)	SD	First scan	E−	Yes...,95,13,EJNMMI_Res_2016_Feb_9_6_10.txt
p.S768I,8	M	exon18 (p.G719S) and exon20 (p.S768I)	SD	First scan	E−	Yes	Yes	Yes,95,34,EJNMMI_Res_2016_Feb_9_6_10.txt
p.P753Q,10	F	exon19 (p.delL747-S752 and p.P753Q) and exon20 (p.T790M)	Slow PD	First scan	E...,101,33,EJNMMI_Res_2016_Feb_9_6_10.txt
p.T790M,...F	exon19 (p.delL747-S752 and p.P753Q) and exon20 (p.T790M)	Slow PD	First scan	E+	Yes	Yes	NA	No [15O]...,101,54,EJNMMI_Res_2016_Feb_9_6_10.txt
p.L861Q,11	F	exon21 (p.L861Q)	SD	First scan	E−	Yes	Yes	Yes,104,14,EJNMMI_Res_2016_Feb_9_6_10.txt
p.L858R,13	F	exon21 (p.L858R) and exon20 (p.T790M)	Slow PD	First scan	E...,110,14,EJNMMI_Res_2016_Feb_9_6_10.txt
p.T790M,13	F	exon21 (p.L858R) and exon20 (p.T790M)	Slow PD	First scan	E−	Yes	Yes	Yes,110,35,EJNMMI_Res_2016_Feb_9_6_10.txt
p.Ala20Glu,...acids and incorrect subsequent 20–56 amino acids (p.Ala20Glufs; Figure 3B) and is thus unlikely to r...,94,1102,eLife_2014_Mar_4_3_e01566.txt
p.Ala20Glu,... frame-shift after 20th amino acid (a.a.) reside (p.Ala20Glufs). (B) Schematic representation of C. ...,95,321,eLife_2014_Mar_4_3_e01566.txt
p.A2815Gfs,n2	1bp insertion	1.000/1.000	p.A2815GfsX3	3048,61,30,eLife_4_e09406.txt
p.Q7597Gfs,n3	2bp deletion	1.000/1.000	p.Q7597GfsX8	9693,62,29,eLife_4_e09406.txt
p.E15193Gfs,c1	2bp deletion	0.996/1.000	p.E15193GfsX8	17996,63,29,eLife_4_e09406.txt
p.T18311Gfs,c2	4bp deletion	1.000/0.995	p.T18311GfsX8	21215,64,29,eLife_4_e09406.txt
p.A29052Rfs,c3	8bp insertion	1.000/0.996	p.A29052RfsX8	32003,65,30,eLife_4_e09406.txt
p.N34S,...eatitis and its association with CTRC and SPINK1 (p.N34S) variants Eur J Gastroenterol Hepatol 2009 ...,242,149,EMBO_Mol_Med_2011_Aug_3(8)_451-464.txt
p.L133H,"...ropathy (McLaughlin et al, 2010). Three variants (p.L133H, p.Y173SfsX7 and p.I302M) were found in KA...",38,267,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.Y173Sfs,"...McLaughlin et al, 2010). Three variants (p.L133H, p.Y173SfsX7 and p.I302M) were found in KARS, with ...",38,276,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.I302M,"..., 2010). Three variants (p.L133H, p.Y173SfsX7 and p.I302M) were found in KARS, with the former two c...",38,292,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.A734E,"...ng-defective, recessive sticky missense mutation (p.A734E) in AARS (alanyl-tRNA synthetase) in a mou...",38,479,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.R329H,"...didate genes identified a novel mutation in AARS, p.R329H. The mutant AARS exhibits reduced aminoacy...",38,1180,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.N71Y,"...w pathological mutations were identified in AARS: p.N71Y, p.E778A and p.D893N (Lin et al, 2011; McLa...",38,1387,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.E778A,"...ogical mutations were identified in AARS: p.N71Y, p.E778A and p.D893N (Lin et al, 2011; McLaughlin e...",38,1395,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.D893N,"...ions were identified in AARS: p.N71Y, p.E778A and p.D893N (Lin et al, 2011; McLaughlin et al, 2012; ...",38,1407,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.F52L,"...blastic anemia. A pathogenic, recessive mutation (p.F52L) in the YARS2 gene (mitochondrial tyrosyl-t...",100,328,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.L200V,"... synthetase) at two highly conserved amino acids (p.L200V and p.V368L), and an alternative splice-de...",103,367,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.V368L,"... at two highly conserved amino acids (p.L200V and p.V368L), and an alternative splice-derived deleti...",103,379,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.D390G,"...scle specimens. A pathogenic, recessive mutation (p.D390G) in the enzymatic active site of SARS2 (mi...",106,562,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.R592W,"...e, was sequenced. A homozygous missense mutation (p.R592W) was identified in AARS2 (mitochondrial al...",109,306,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.L155R,...und heterozygous with a second missense mutation (p.L155R). The mutations in AARS2 cause perinatal o...,109,572,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.R225*,"...), predicted to introduce a premature stop codon (p.R225*). XRCC4 transcript levels were profoundly ...",9,852,EMBO_Mol_Med_2015_Jul_14_7(7)_918-929.txt
p.R225*,...ange is predicted to create in both a stop codon (p.R225*) with loss of one-third of the protein at ...,88,903,EMBO_Mol_Med_2015_Jul_14_7(7)_918-929.txt
p.Arg448Trp,"...1 and PROKR2. We identified three FGFR1 variants (p.Arg448Trp, p.Ser107Leu and p.Pro772Ser) in four ...",3,2145,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"... We identified three FGFR1 variants (p.Arg448Trp, p.Ser107Leu and p.Pro772Ser) in four unrelated pat...",3,2158,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...hree FGFR1 variants (p.Arg448Trp, p.Ser107Leu and p.Pro772Ser) in four unrelated patients (two males...",3,2174,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,...ted patients (two males) and two PROKR2 variants (p.Arg85Cys and p.Arg248Glu) in two unrelated femal...,3,2251,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,...wo males) and two PROKR2 variants (p.Arg85Cys and p.Arg248Glu) in two unrelated female patients. Fiv...,3,2266,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...onal studies indicated that the new FGFR1 variant p.Arg448Trp is a loss-of-function variant, while p...",3,2495,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"... p.Arg448Trp is a loss-of-function variant, while p.Ser107Leu and p.Pro772Ser present signalling act...",3,2544,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...a loss-of-function variant, while p.Ser107Leu and p.Pro772Ser present signalling activity similar to...",3,2560,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,...s from previous functional studies indicated that p.Arg85Cys moderately compromises receptor signall...,3,2714,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,+ pathways while p.Arg248Glu decreases calcium mobilization but has...,4,18,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"Three missense variants, p.Ser107Leu, p.Arg448Trp and p.Pro772Ser, were ide...",47,26,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"Three missense variants, p.Ser107Leu, p.Arg448Trp and p.Pro772Ser, were identified in a ...",47,39,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...e missense variants, p.Ser107Leu, p.Arg448Trp and p.Pro772Ser, were identified in a heterozygous sta...",47,55,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,... 1). Results of in silico analysis indicated that p.Arg448Trp is deleterious according to the Mutati...,47,247,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"...tation Taster, SIFT and Polyphen-2 tools, whereas p.Ser107Leu and p.Pro772Ser were predicted to be d...",47,343,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...IFT and Polyphen-2 tools, whereas p.Ser107Leu and p.Pro772Ser were predicted to be disease-causing o...",47,359,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,"Two missense variants, p.Arg85Cys and p.Arg248Glu, were found in a hetero...",50,24,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,"Two missense variants, p.Arg85Cys and p.Arg248Glu, were found in a heterozygous state in...",50,39,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,... 1). Results of in silico analysis indicated that p.Arg85Cys is damaging according to Mutation Taste...,50,212,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,"...g to Mutation Taster, SIFT and Polyphen-2 whereas p.Arg248Glu was predicted to be benign using the t...",50,293,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...atients with congenital HH (9, 16, 17). The FGFR1 p.Pro772Ser variant was found in five out of 400 (...",52,107,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,"...razilian healthy controls, and the PROKR2 variant p.Arg85Cys was found in one out of 400 (0.25%). Th...",52,215,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"Regarding population genetics, the FGFR1 variant p.Ser107Leu has a minor allele frequency (MAF) of ...",54,50,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...nese population, which is 2.8%. The FGFR1 variant p.Pro772Ser has a MAF of 0.5% (ALL 1000GENOMES) an...",54,312,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...ing Project (ESP6500). To date, the FGFR1 variant p.Arg448Trp has not been described in population d...",54,479,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,The PROKR2 variant p.Arg85Cys has been described in the databases of ...,56,20,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,...e African-American population. The PROKR2 variant p.Arg248Glu has no MAF described in databases. Phe...,56,199,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,p.Ser107Leu varian,59,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,The FGFR1 variant p.Ser107Leu was identified in a female patient bor...,60,19,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,p.Arg448Trp varian,62,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,The p.Arg448Trp variant was identified in a 4-year-old...,63,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,p.Pro772Ser varian,65,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,We identified the FGFR1 variant p.Pro772Ser in heterozygous state in two unrelated...,66,33,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,p.Arg85Cys varian,71,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,The p.Arg85Cys variant was identified in a 19-year-old...,72,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,p.Arg248Glu varian,74,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,The female patient with p.Arg248Glu variant first presented at 10 years of...,75,25,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,...nstream of the MAPK pathway. Cells expressing the p.Ser107Leu and p.Pro772Ser variants elicited dose...,81,326,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,...APK pathway. Cells expressing the p.Ser107Leu and p.Pro772Ser variants elicited dose–response curves...,81,342,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...milar to the WT FGFR1c curve (Fig. 1A and B). The p.Arg448Trp variant, on the other hand, demonstrat...",81,445,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...erall protein expression and maturation levels of p.Arg448Trp were similar to those for the WT, indi...",81,791,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"...tients harbouring three different FGFR1 variants (p.Ser107Leu, p.Arg448Trp and p.Pro772Ser) and two ...",84,528,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...ring three different FGFR1 variants (p.Ser107Leu, p.Arg448Trp and p.Pro772Ser) and two patients with...",84,541,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...rent FGFR1 variants (p.Ser107Leu, p.Arg448Trp and p.Pro772Ser) and two patients with PROKR2 variants...",84,557,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,...Pro772Ser) and two patients with PROKR2 variants (p.Arg85Cys and p.Arg248Glu),84,609,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,...two patients with PROKR2 variants (p.Arg85Cys and p.Arg248Glu),84,624,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Val102Iso,"...n this study, two heterozygous missense variants (p.Val102Iso and p.Ser107Leu) were also found in tw...",88,601,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,...o heterozygous missense variants (p.Val102Iso and p.Ser107Leu) were also found in two unrelated pati...,88,617,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"...in luciferase assays (Table 3). The FGFR1 variant p.Ser107Leu was also found in our cohort, in a pat...",88,900,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"... in vitro data, it is unlikely that this variant (p.Ser107Leu) alone is causing the phenotype",88,1460,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"Concerning the p.Pro772Ser variant, due to its finding in five of...",90,16,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"The p.Arg448Trp variant, on the other hand, has not be...",92,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Thr112Thr,"...tients was examined. Three heterozygous variants (p.Thr112Thr, p.Ser450Phe and p.Pro483Ser) were fou...",94,169,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser450Phe,"...amined. Three heterozygous variants (p.Thr112Thr, p.Ser450Phe and p.Pro483Ser) were found in FGFR1 i...",94,182,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro483Ser,"...terozygous variants (p.Thr112Thr, p.Ser450Phe and p.Pro483Ser) were found in FGFR1 in three differen...",94,198,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Leu173Arg,"...) and found three heterozygous missense variants (p.Leu173Arg, p.Arg85His and p.Ala51Thr). The first...",101,215,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85His,"...hree heterozygous missense variants (p.Leu173Arg, p.Arg85His and p.Ala51Thr). The first two showed d...",101,228,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ala51Thr,"...us missense variants (p.Leu173Arg, p.Arg85His and p.Ala51Thr). The first two showed deleterious effe...",101,243,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Leu,"...variants in 11 unrelated patients, three of them (p.Arg85Leu, Leu173Arg and Arg268Cys) proved to be ...",101,558,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Leu173Arg,"...s in functional studies. In the latter study, the p.Leu173Arg variant was inherited by the patient f...",101,668,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,"...submitted to functional studies (16, 26, 27). The p.Arg85Cys variant showed modest but a significant...",103,232,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,"...ilar dose–response curves to WT PROKR2. Also, the p.Arg85Cys variant does not interfere with PROK2 l...",103,474,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,The p.Arg248Glu variant is located within the last int...,105,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,...re means±s.e.m. of three independent experiments. p.Ser107Leu (A) and p.Pro772Ser (B) variants had n...,120,192,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,...hree independent experiments. p.Ser107Leu (A) and p.Pro772Ser (B) variants had normal signalling act...,120,212,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...B) variants had normal signalling activity, while p.Arg448Trp had reduced maximal signalling activit...",120,275,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...y transfected with empty vector (EV), FGFR1 WT or p.Arg448Trp constructs. UT, untreated; EH, EndoH t...",120,470,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,... of total protein and maturation levels of WT and p.Arg448Trp receptors. Plotted are means±s.e.m. of...,120,629,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,...nts. (G) Cell-surface expression levels of WT and p.Arg448Trp receptors assessed in live transiently...,120,756,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,c.320C>T	p.Ser107Leu	Ig-like C2-type 1 domain	Disease-causi...,140,11,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,c.1342C>T	p.Arg448Trp	Juxta-membrane domain	Disease-causing	...,144,12,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,c.2314C>T	p.Pro772Ser	C-terminal tail	Disease-causing	Tolera...,147,12,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,c.2314C>T	p.Pro772Ser	C-terminal tail	Disease-causing	Tolera...,150,12,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,c.253C>T	p.Arg85Cys	First intracellular loop	Disease-causin...,153,11,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,c.743G>A	p.Arg248Glu	Third intracellular loop	Polymorphism	...,156,11,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Thr112Thr,p.Thr112Thr	NS	NS	10,215,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser450Phe,p.Ser450Phe	⇊	=				0,221,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro483Ser,p.Pro483Ser	⇊	=				0,222,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Val102Ile,p.Val102Ile	↓	NS	69	3	100	2,223,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,p.Ser107Leu	=	NS				1,226,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,p.Ser107Leu	=	NS	156	2	400	0	Present study,227,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,p.Arg448Trp	↓	NS				0,228,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,p.Pro772Ser	=	NS				1.25,229,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ile249Thr,...zygous missense mutation of the CTSK gene (exon 6 p.Ile249Thr). Histomorphometry of a transiliac bon...,31,1657,Endocrine_2016_Feb_18_52_414-426.txt
p.Ala386Glu,"...und heterozygous for two CYP11B1 novel mutations, p.Ala386Glu (exon 7), inherited from the father an...",4,662,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Leu471Arg,"...Ala386Glu (exon 7), inherited from the father and p.Leu471Argin (exon 9) from the mother. Hydrocorti...",4,714,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Ala386Glu,"Two CYP11B1 inactivating novel mutations, p.Ala386Glu and p.Leu471Arg are reporte",9,43,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Leu471Arg,"...1B1 inactivating novel mutations, p.Ala386Glu and p.Leu471Arg are reporte",9,59,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Ala386Glu,...evealed two novel genetic alterations: c.1157C>A (p.Ala386Glu) in exon 7 and c.1412T>G (p.Leu471Arg)...,57,973,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Leu471Arg,... c.1157C>A (p.Ala386Glu) in exon 7 and c.1412T>G (p.Leu471Arg) in exon 9 (Fig. 1) Targeted genotypin...,57,1011,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Ala386Glu,...ping performed in proband's parents revealed that p.Ala386Glu was inherited from the father (carrier...,57,1108,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Leu471Arg,...Glu was inherited from the father (carrier) while p.Leu471Arg was inherited from the mother. Neither...,57,1166,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Ala386Glu,...ported a Greek girl carrying two novel mutations (p.Ala386Glu and p.Leu471Arg) of the CYP11B1 gene w...,80,83,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Leu471Arg,...irl carrying two novel mutations (p.Ala386Glu and p.Leu471Arg) of the CYP11B1 gene who shows a typic...,80,99,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.Met918Thy,"...a somatic RET mutation in exon 16 (RET c.2753T>C, p.Met918Thy) was detected by targeted next generat...",4,1189,Endocrinol_Diabetes_Metab_Case_Rep_2016_Jan_18_2016_150117.txt
p.Met918Thy,"...a somatic RET mutation in exon 16 (RET c.2753T>C, p.Met918Thy), further validated by Sanger sequenci...",31,246,Endocrinol_Diabetes_Metab_Case_Rep_2016_Jan_18_2016_150117.txt
p.N148K,... novo heterozygous mutations (STAR c.444C>A (STAR p.N148K) and STAR c.557C>T (STAR p.R193X)) in the ...,4,902,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.R193X,"...R c.444C>A (STAR p.N148K) and STAR c.557C>T (STAR p.R193X)) in the STAR gene, causing lipoid CAH. Ne...",4,935,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,TAR exons 4 and 5. Overexpression of the STAR p.N148K mutant in nonsteroidogenic COS-1 cells sup...,5,47,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,...lysis showed that the finger printing of the STAR p.N148K mutant is also different from the WT prote...,5,317,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.R188C,"...st common mutation causing this phenotype is STAR p.R188C. Thus, the spectrum of clinical presentati...",23,454,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.A218V,"...have reported five Japanese alleles carrying STAR p.A218V (1). However, other STAR mutations appear ...",25,185,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.Q258X,"...h Tsp45 I and BstN1 to screen for the common STAR p.Q258X and STAR p.R182L mutations, as previously ...",34,384,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.R182L,"...N1 to screen for the common STAR p.Q258X and STAR p.R182L mutations, as previously described (1). Th...",34,401,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,[35S]-Methionine (Met)-labeled WT and STAR p.N148K were synthesized in a cell-free system (CF...,40,44,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...e (A) (dbSNP – rs775130992), resulted in the STAR p.N148K mutation (Fig. 1), which was observed befo...",44,886,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.M225T,"...vo mutations. Some STAR mutations, including STAR p.M225T in exon 4, induce only a 45% reduction in ...",48,177,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,...Measurement of pregnenolone synthesis by the STAR p.N148K mutant. (A) The pregnenolone synthesis by ...,50,60,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,...utant. (A) The pregnenolone synthesis by the STAR p.N148K mutant was compared with WT STAR after the...,50,119,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.M225T,"...ilar to that of the WT protein. For example, STAR p.M225T is folded similarly to WT protein. Thus, w...",54,183,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...l emerge. As shown in Fig. 4, the WT and the STAR p.N148K mutant have different proteolysis patterns...",54,857,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...nt proteolysis patterns, suggesting that the STAR p.N148K mutant is folded differently from the WT S...",54,934,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,Figure 4 Analysis of STAR p.N148K mutant conformation by protein finger prin...,56,27,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...free synthesized, radiolabeled WT and mutant STAR p.N148K were proteolyzed, and the proteolytic patt...",56,138,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.Q258X,...etic clusters identified to date include the STAR p.Q258X mutation in Japanese and Korean population...,62,386,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.R182L,... Japanese and Korean populations (1) and the STAR p.R182L mutation among Palestinian Arabs (1). The ...,62,455,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,...e present study is the first to identify the STAR p.N148K mutation in a patient of Scandinavian orig...,62,553,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...vector or buffer control. In addition to the STAR p.N148K mutation, a second mutation STAR p.R193X, ...",62,933,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.R193X,"...the STAR p.N148K mutation, a second mutation STAR p.R193X, a nonsense mutation, was identified",62,974,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,...e altered conformation that results from the STAR p.N148K mutation prevents its interaction with VDA...,67,1111,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.Lys1385Thr,"...rozygous ABCC8 gene missense mutation (c.4154A>T/ p.Lys1385Thr), who was initially responsive to dia...",4,573,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
p.Lys1385Thr,...el missense mutation in the ABCC8 gene (c.4154A>T/p.Lys1385Thr). Since the lysine residue is highly ...,31,394,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
p.Cys194Met,...7/s00405-015-3782-7Letter to the EditorPathogenic p.Cys194Metfs*17 variant argues against TMPRSS3/GJ...,3,216,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
p.Cys194Met,"...but based on the nomenclature used (c.579dupA and p.Cys194Metfs*17, rs397517376), we assume that the...",10,229,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
p.C194*,...RSS3 mutations (NM_024022.2:c.582T>A; NP_076927.1:p.C194* and NM_024022.2:c.581G>T; NP_076927.1:p.C1...,10,999,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
p.C194F,...7.1:p.C194* and NM_024022.2:c.581G>T; NP_076927.1:p.C194F) were detected in the region corresponding...,10,1045,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
p.Ala561Thr,...stitution at position 561 of the encoded protein (p.Ala561Thr) and is located in the pore-forming re...,35,1193,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Ala561Thr,"...in, by the hydrophilic amino acid threonine (Thr; p.Ala561Thr). Results of genomic DNA sequencing in...",36,664,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Ala561Thr,...n of the Ikr potassium channel showing that KCNH2 p.Ala561Thr mutation is located in the S5 transmem...,36,903,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Ala614Val,"... consistent with recent reports of LQT1 and LQT2 (p.Ala614Val) hiPSC-based modelling.32,38 However, ...",94,207,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Ala561Thr,...t differences between our work with KCNH2 G1681A (p.Ala561Thr) LQT2–hiPSCs when compared with the KC...,94,325,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Ala614Val,...a561Thr) LQT2–hiPSCs when compared with the KCNH2 p.Ala614Val mutation.38 We identified isoprenaline...,94,379,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Val174Ala,... were different at different races. The c.521T>C (p.Val174Ala) SNP and c.388A>G (p.Asn130Asp) SNP we...,148,197,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
p.Asn130Asp,...ces. The c.521T>C (p.Val174Ala) SNP and c.388A>G (p.Asn130Asp) SNP were the common mutation in Asian...,148,228,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
p.Val174Ala,"...n more and more studies. Specially, the c.521T>C (p.Val174Ala) SNP has been associated with a marked...",150,123,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
p.Arg307Gln,...s mass extension. We found association of c.946A (p.Arg307Gln) with lower LS-BMD at baseline (P=0.00...,3,2590,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,"... report that describes association of the c.946A (p.Arg307Gln) LOF SNP with low LS-BMD, and that oth...",3,3048,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Glu496Ala,"...C, produces an amino acid change at position 496 (p.Glu496Ala) in the C terminus, which impairs mult...",18,287,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.I568N,"...rom macrophages.17, 33, 34 The c.1729T>A variant (p.I568N) abolishes trafficking of the receptor to ...",18,526,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,"...ptor to the cell surface,35 the c.946G>A variant (p.Arg307Gln) abolishes ATP binding to the extracel...",18,618,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Thr357Ser,"...ellular domain of P2X7R,36 the c.1096C>G variant (p.Thr357Ser) results in reduced pore formation tha...",18,716,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.His155Tyr,"... in ablated ATP response.37 The c.489C>T variant (p.His155Tyr), located in the extracellular domain ...",18,1188,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Glu496Ala,"One LOF P2RX7 polymorphism, the c.1513C allele (p.Glu496Ala) has recently been associated with inc...",20,49,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Ile568Gln,"... bone, the c.1513C allele and the c.1729A allele (p.Ile568Gln) have been shown to be associated with...",20,228,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,P2RX7 c.946G>A (p.Arg307Gln) SNP is associated with lower LS BMD i...,43,17,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,...usly published P2RX7 SNPs revealed that c.946G>A (p.Arg307Gln) was significantly associated with low...,44,77,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Glu496Ala,"...al22 demonstrated that two P2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), are associat...",50,871,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.I568N,"...2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), are associated with an increased 10-year...",50,899,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,"...iation of a major LOF SNP in P2RX7, the c.946G>A (p.Arg307Gln), with low BMD in the LS in post-menop...",52,88,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.H155Y,rs208294	c.489C>T (p.H155Y)	0.43	0.99 (0.01)	1.01 (0.01)	1.00 (0.02)	...,89,20,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.R307Q,rs28360457	c.946G>A (p.R307Q)	0.02	1.00 (0.01)	0.88 (0.03)	*	0.004 (0.0...,90,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.T357S,rs2230911	c.1096C>G (p.T357S)	0.07	1.00 (0.01)	1.03 (0.02)	1.09 (0.12)	...,91,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.E496A,rs3751143	c.1513A>C (p.E496A)	0.17	1.00 (0.01)	1.00 (0.02)	1.01 (0.06)	...,92,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.I568N,rs1653624	c.1729T>A (p.I568N)	0.02	1.00 (0.01)	0.99 (0.03)	1.25**	0.9	0...,93,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.H155Y,rs208294	c.489C>T (p.H155Y)	0.43	0.96 (0.01)	0.98 (0.01)	0.97 (0.02)	...,106,20,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.R307Q,rs28360457	c.946G>A (p.R307Q)	0.02	0.97 (0.01)	0.84 (0.04)	*	0.002 (0.0...,107,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.T357S,rs2230911	c.1096C>G (p.T357S)	0.07	0.97 (0.01)	0.98 (0.02)	1.00 (0.16)	...,108,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.E496A,rs3751143	c.1513A>C (p.E496A)	0.17	0.97 (0.01)	0.97 (0.01)	0.99 (0.06)	...,109,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.I568N,rs1653624	c.1729T>A (p.I568N)	0.02	0.97 (0.01)	0.93 (0.02)	1.22**	0.63	...,110,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Gly542*, G542X	c.1624G>T	p.Gly542*,162,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly551Asp, G551D	c.1652G>A	p.Gly551Asp,163,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asn1303Lys, N1303K	c.3909C>G	p.Asn1303Lys,164,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Trp1282*, W1282X	c.3846G>A	p.Trp1282*,165,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser18Arg," CFTRdele2,3	c.54-5940_273+10250del21080	p.Ser18Argfs*16",167,42,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Glu60*, E60X	c.178G>T	p.Glu60*,168,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly85Glu, G85E	c.254G>A	p.Gly85Glu,169,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu88Ile, 394delTT	c.262_263delTT	p.Leu88Ilefs*22,170,26,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg347Pro, R347P	c.1040G>C	p.Arg347Pro,172,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ala455Glu, A455E	c.1364C>A	p.Ala455Glu,173,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gln493*, Q493X	c.1477C>T	p.Gln493*,174,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg553*, R553X	c.1657C>T	p.Arg553*,176,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg560Thr, R560T	c.1679G>C	p.Arg560Thr,177,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Lys684Ser, 2183AA>G	c.2051_2052delAAinsG	p.Lys684Serfs*38,179,32,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Met1101Lys, M1101K	c.3302 T>A	p.Met1101Lys,182,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1162*, R1162X	c.3484C>T	p.Arg1162*,183,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Lys1177Ser, 3659delC	c.3528delC	p.Lys1177Serfs*15,184,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gln39*, Q39X	c.115C>T	p.Gln39*,186,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Pro67Leu, P67L	c.200C>T	p.Pro67Leu,187,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg75*, R75X	c.223C>T	p.Arg75*,188,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Glu92*, E92X	c.274G>T	p.Glu92*,191,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Glu92Lys, E92K	c.274G>A	p.Glu92Lys,192,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gln98*, Q98X	c.292C>T	p.Gln98*,193,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Tyr109Gly, 457TAT>G	c.325_327delTATinsG	p.Tyr109Glyfs*4,194,31,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp110His, D110H	c.328G>C	p.Asp110His,195,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117Cys, R117C	c.349C>T	p.Arg117Cys,196,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Tyr122*, Y122X	c.366 T>A	p.Tyr122*,197,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ile148Leu, 574delA	c.442delA	p.Ile148Leufs*5,198,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ile105Ser, 444delA	c.313delA	p.Ile105Serfs*2,199,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ile177Met, 663delT	c.531delT	p.Ile177Metfs*12,200,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly178Arg, G178R	c.532G>A	p.Gly178Arg,201,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.His199Tyr, H199Y	c.595C>T	p.His199Tyr,205,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Pro205Ser, P205S	c.613C>T	p.Pro205Ser,206,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu206Trp, L206W	c.617 T>G	p.Leu206Trp,207,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gln220*, Q220X	c.658C>T	p.Gln220*,208,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly241Glu, 852del22	c.720_741delAGGGAGAATGATGATGAAGTAC	p.Gly241Glufs*13,209,46,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Phe316Leu, 1078delT	c.948delT	p.Phe316Leufs*12,210,21,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly330*, G330X	c.988G>T	p.Gly330*,211,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg334Trp, R334W	c.1000C>T	p.Arg334Trp,212,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ile336Lys, I336K	c.1007 T>A	p.Ile336Lys,213,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Thr338Ile, T338I	c.1013C>T	p.Thr338Ile,214,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Phe342His, 1154insTC	c.1021_1022dupTC	p.Phe342Hisfs*28,215,29,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser341Pro, S341P	c.1021 T>C	p.Ser341Pro,216,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg347His, R347H	c.1040G>A	p.Arg347His,217,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Trp361Gly, 1213delT	c.1081delT	p.Trp361Glyfs*8,218,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gln378Ala, 1259insA	c.1130dupA	p.Gln378Alafs*4,220,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Trp401*, W401X(TAG)	c.1202G>A	p.Trp401*,221,23,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Trp401*, W401X(TGA)	c.1203G>A	p.Trp401*,222,23,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ile444Arg, 1461ins4	c.1329_1330insAGAT	p.Ile444Argfs*3,224,30,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser466*, S466X	c.1397C>A or c.1397C>G	p.Ser466*,226,31,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu467Pro, L467P	c.1400 T>C	p.Leu467Pro,227,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser489*, S489X	c.1466C>A	p.Ser489*,228,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser492Phe, S492F	c.1475C>T	p.Ser492Phe,229,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Tyr515*, 1677delTA	c.1545_1546delTA	p.Tyr515*,230,29,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Val520Phe, V520F	c.1558G>T	p.Val520Phe,231,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser549Arg, S549R	c.1645 A>C	p.Ser549Arg,234,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser549Asn, S549N	c.1646G>A	p.Ser549Asn,235,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser549Arg, S549R	c.1647 T>G	p.Ser549Arg,236,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gln552*, Q552X	c.1654C>T	p.Gln552*,237,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ala559Thr, A559T	c.1675G>A	p.Ala559Thr,238,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg560Lys, R560K	c.1679G>A	p.Arg560Lys,241,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Glu585*, E585X	c.1753G>T	p.Glu585*,242,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu671*, 2143delT	c.2012delT	p.Leu671*,244,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gln685Thr, 2184insA	c.2052_2053insA	p.Gln685Thrfs*4,245,27,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Lys684Asn, 2184delA	c.2052delA	p.Lys684Asnfs*38,246,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg709*, R709X	c.2125C>T	p.Arg709*,247,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Lys710*, K710X	c.2128 A>T	p.Lys710*,248,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Glu726Arg, 2307insA	c.2175dupA	p.Glu726Argfs*4,249,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu732*, L732X	c.2195 T>G	p.Leu732*,250,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Val739Tyr, 2347delG	c.2215delG	p.Val739Tyrfs*16,251,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg764*, R764X	c.2290C>T	p.Arg764*,252,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu818Trp, 2585delT	c.2453delT	p.Leu818Trpfs*3,253,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Glu822*, E822X	c.2464G>T	p.Glu822*,254,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Glu831*, E831X	c.2491G>T	p.Glu831*,256,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Trp846*, W846X	c.2537G>A	p.Trp846*,257,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Trp846*, W846X(2670TGG>TGA)	c.2538G>A	p.Trp846*,258,31,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg851*, R851X	c.2551C>T	p.Arg851*,259,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Phe861Leu, 2711delT	c.2583delT	p.Phe861Leufs*3,260,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser945Leu, S945L	c.2834C>T	p.Ser945Leu,261,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gln890*, Q890X	c.2668C>T	p.Gln890*,263,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu927Pro, L927P	c.2780 T>C	p.Leu927Pro,264,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ala959His, 3007delG	c.2875delG	p.Ala959Hisfs*9,265,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly970Arg, G970R	c.2908G>C	p.Gly970Arg,266,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu1065Pro, L1065P	c.3194 T>C	p.Leu1065Pro,271,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1066Cys, R1066C	c.3196C>T	p.Arg1066Cys,272,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1066His, R1066H	c.3197G>A	p.Arg1066His,273,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu1077Pro, L1077P	c.3230 T>C	p.Leu1077Pro,274,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Trp1089*, W1089X	c.3266G>A	p.Trp1089*,275,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Tyr1092*, Y1092X	c.3276C>A	p.Tyr1092*,276,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Glu1104*, E1104X	c.3310G>T	p.Glu1104*,277,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1158*, R1158X	c.3472C>T	p.Arg1158*,278,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser1196*, S1196X	c.3587C>G	p.Ser1196*,279,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Trp1204*, W1204X(3743G>A)	c.3611G>A	p.Trp1204*,280,28,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Trp1204*, W1204X(3744G>A)	c.3612G>A	p.Trp1204*,281,28,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Thr1220Lys, 3791delC	c.3659delC	p.Thr1220Lysfs*8,282,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly1244Glu, G1244E	c.3731G>A	p.Gly1244Glu,284,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Lys1250Arg, 3876delA	c.3744delA	p.Lys1250Argfs*9,285,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser1251Asn, S1251N	c.3752G>A	p.Ser1251Asn,286,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu1258Phe, 3905insT	c.3773dupT	p.Leu1258Phefs*7,287,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser1297Phe, 4016insT	c.3889dupT	p.Ser1297Phefs*5,289,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gln1313*, Q1313X	c.3937C>T	p.Gln1313*,290,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Glu1418Arg, 4382delA	c.4251delA	p.Glu1418Argfs*14,293,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117His, R117H	c.350G>A	p.Arg117His,296,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu227Arg, L227R	c.680 T>G	p.Leu227Arg,297,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu558Ser, L558S	c.1673 T>C	p.Leu558Ser,299,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Tyr569Asp, Y569D	c.1705 T>G	p.Tyr569Asp,300,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp579Gly, D579G	c.1736 A>G	p.Asp579Gly,301,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp614Gly, D614G	c.1841 A>G	p.Asp614Gly,302,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser977Phe, S977F	c.2930C>T	p.Ser977Phe,303,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Phe1052Val, F1052V	c.3154 T>G	p.Phe1052Val,304,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly1069Arg, G1069R	c.3205G>A	p.Gly1069Arg,305,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1070Gln, R1070Q	c.3209G>A	p.Arg1070Gln,306,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp1152His, D1152H	c.3454G>C	p.Asp1152His,307,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ile1234Val, I1234V	c.3700 A>G	p.Ile1234Val,308,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg31Cys, R31C	c.91C>T	p.Arg31Cys,312,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg74Trp, R74W	c.220C>T	p.Arg74Trp,313,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg75Gln, R75Q	c.224G>A	p.Arg75Gln,314,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ile148Thr, I148T	c.443 T>C	p.Ile148Thr,315,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Met470Val, M470V	c.1408 A>G	p.Met470Val,316,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly576Ala, G576A	c.1727G>C	p.Gly576Ala,317,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg668Cys, R668C	c.2002C>T	p.Arg668Cys,318,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Val754Met, V754M	c.2260G>A	p.Val754Met,319,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu997Phe, L997F	c.2991G>C	p.Leu997Phe,320,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ile1027Thr, I1027T	c.3080 T>C	p.Ile1027Thr,321,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1070Trp, R1070W	c.3208C>T	p.Arg1070Trp,322,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1162Leu, R1162L	c.3485G>T	p.Arg1162Leu,323,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser1235Arg, S1235R	c.3705 T>G	p.Ser1235Arg,324,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp1270Asn, D1270N	c.3808G>A	p.Asp1270Asn,325,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu206Trp,"...e508del, p.Gly542★…); LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with ...",396,100,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117His,"...ith variable disease penetrance (IVS8-5 T allele, p.Arg117His-7 T …); U, variants of unproven or unc...",396,196,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Pro1013His,"...s of unproven or uncertain CF clinical relevance (p.Pro1013His, p.Arg1162Leu …); A, accepted; R, ref...",396,276,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1162Leu,"...or uncertain CF clinical relevance (p.Pro1013His, p.Arg1162Leu …); A, accepted; R, refused",396,290,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117His,...in intron 9) (30%) or with the variants R117H-7T (p.Arg117His associated with a 7T allele (c.1210-12...,462,816,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ile507Val,...mozygosity for p.Ile507del due to the presence of p.Ile507Val (I597V) (c.1519A>G),480,300,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117H,"Thauvin-Robinet C, Munck A, Huet F et al: CFTR p.Arg117H is associated with CBAVD and other CFTR-...",513,48,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.R74W,"...C, Chevalier-Ports F, Des Georges M: Are p.148 T, p.R74W and p.D1270N CF causing mutations ? BMC Med...",529,96,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.D1270N,"...r-Ports F, Des Georges M: Are p.148 T, p.R74W and p.D1270N CF causing mutations ? BMC Med Genet",529,107,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.L997F,"...is variants in population-based screening panels: p.L997F, further genotype/phenotype correlation da...",575,131,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp19His,...orted rs11887534:G>C (NM_022437.2(ABCG8):c.55G>C (p.Asp19His). This amino-acid variant is believed t...,92,780,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
p.Tyr54Cys,...an earlier report of NM_022437.2(ABCG8):c.161A>G (p.Tyr54Cys) (r2~0.2 between rs4299376:G>T and rs41...,92,1079,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
p.Gln604Glu,...10 and rs6720173:G>C NM_022436.2(ABCG5)c.1810C>G (p.Gln604Glu). The ABCG5/ABCG8 transporter is impor...,92,1304,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
p.Ala723Asp,"p.Ala723Asp	2,4	2, 4",377,1,Eur_Urol_2014_Oct_66(4)_752-768.txt
p.A256V,"56,293,847	exon 7	C	T	T	T	T	missense (p.A256V)	rs32980940",295,39,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.R262X,"56,293,864	exon 7	C	T	T	T	T	nonsense (p.R262X)	rs32980941",296,39,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.L266V,"56,295,441	exon 8	C	G	G	G	G	missense (p.L266V)	rs31110637",297,39,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.K794Q,"56,429,368	exon 23	A	C	C	C	C	missense (p.K794Q)	rs31090430",305,40,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.V811M,"56,535,958	exon 24	G	A	A	A	A	missense (p.V811M)	rs32985345",306,40,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.A256V,"the effects of the p.A256V, p.L266V, p.K794Q, and p.V811M amino acid ...",314,20,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.L266V,"the effects of the p.A256V, p.L266V, p.K794Q, and p.V811M amino acid substitut...",314,29,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.K794Q,"the effects of the p.A256V, p.L266V, p.K794Q, and p.V811M amino acid substitutions caus...",314,38,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.V811M,"the effects of the p.A256V, p.L266V, p.K794Q, and p.V811M amino acid substitutions cause",314,51,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.R262X,the OCA2 protein (p.R262X) (Fig. 4Fig. 4. Sequence chromatograms of ...,319,19,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.Cys1263Ser,"...ised 11 variants. Among these, TET2 (p.Thr1027fs, p.Cys1263Ser) and RUNX1 (p.Asn109Ser) were identif...",10,338,Exp_Hematol_Oncol_2014_Jul_11_3_18.txt
p.Asn109Ser,"...hese, TET2 (p.Thr1027fs, p.Cys1263Ser) and RUNX1 (p.Asn109Ser) were identified in in the peripheral ...",10,363,Exp_Hematol_Oncol_2014_Jul_11_3_18.txt
p.Cys1263Ser,"[14]TET2 (p.Thr1027fs, p.Cys1263Ser) and RUNX1 (p.Asn109Ser) were detecte...",44,24,Exp_Hematol_Oncol_2014_Jul_11_3_18.txt
p.Asn109Ser,"[14]TET2 (p.Thr1027fs, p.Cys1263Ser) and RUNX1 (p.Asn109Ser) were detected. Although detectable by...",44,49,Exp_Hematol_Oncol_2014_Jul_11_3_18.txt
p.Cys1263Ser,"The 2-bp insertion (p.Thr1027fs) and the SNV (p.Cys1263Ser) in TET2, and the SNV (p.Asn109Ser) i...",51,47,Exp_Hematol_Oncol_2014_Jul_11_3_18.txt
p.Asn109Ser,"... and the SNV (p.Cys1263Ser) in TET2, and the SNV (p.Asn109Ser) in RUNX1 were confirmed in PB and the...",51,83,Exp_Hematol_Oncol_2014_Jul_11_3_18.txt
p.Asp216His,...ustres M  Tuffery-Giraud S  Collod-Beroud G   The p.Asp216His TOR1A allele effect is not found in th...,83,201,F1000_Biol_Rep_2010_Jun_16_2_41.txt
p.D420Y,11	c.1258G>T	p.D420Y	1	6.5	10.5	Y	N/Y	3	ND	N	Unknown	[31],157,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.R496C,"11	c.1486C>T	p.R496C	1	0.3	3.4	Y	N/N	43	ND	Y	Neutral	[31, 32]",158,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.D1739G,20	c.5216A>G	p.D1739G	1	97.3	32.5	Y	Y/Y	2	ND	ND	Cancer-associat...,161,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.P1812R,23	c.5435C>G	p.P1812R	1	4.6	7.5	Y	Y/Y	0	ND	ND,162,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.E462G,"10	c.1385A>G	p.E462G	1	37.8	17.8	Y	Y/N	35	N	Y	Neutral	[29, 33, ...",165,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.I2490T,15	c.7469T>C	p.I2490T	1	13.6	19.9	Y	N/N	238	ND	ND,166,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.S2704F,18	c.8111C>T	p.S2704F	1	11.5	7.3	Y	N/N	1	ND	ND,167,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.V2908G,21	c.8723T>G	p.V2908G	1	1.2	9.8	N	Y/N	8	N	N	Neutral	[34],168,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.D1739G,"...ilities above 20% with BRCAPRO and Myriad II, the p.D1739G variant in BRCA1 has been classified as c...",189,103,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.R496C,"...nst them being deleterious. This is the case for: p.R496C in BRCA1 [31, 32] and p.E462G [29, 33, 34]...",189,458,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.E462G,"...is is the case for: p.R496C in BRCA1 [31, 32] and p.E462G [29, 33, 34] and p.V2908G [34] in BRCA2",189,488,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.V2908G,"...6C in BRCA1 [31, 32] and p.E462G [29, 33, 34] and p.V2908G [34] in BRCA2",189,513,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.Ala22Gly, 1	F22	NA	Exon 1	g.2121dupC	p.Ala22GlyfsX9	Bil	Yes	RT	Epithelial	B (59),78,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Glu54X, 2	F11	1 (37)	Exon 2	g.5446G>T	p.Glu54X	Bil	Yes	Enucl	Epithelial	Bl (52),79,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Ala74Glu, 3	F12	1 (12)	Exon 2	g.5505_5506dup	p.Ala74GlufsX4	Bil	Yes	RT + CH	Other	(44),80,37,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Leu199Tyr," 4	F16	4 (59, 40, 14, 6)	Exon 6	g.45855delT	p.Leu199TyrfsX2	Bil	No	RT	Osteosarcoma	(5)",81,45,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg255X, 5a	F31	NA	Exon 8	g.59695C>T	p.Arg255X	Bil	Yes	RT	Osteosarcoma	(12),82,30,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Asn258Arg," 6	F17	2 (4f, 29)	Exon 8	g.59702_59703dup	p.Asn258ArgfsX7	Ul	Yes	Enucl	Epithelial	Pa (56)",83,43,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Asn258Arg, 7	F17		Exon8	g.59702_59703dup	p.Asn258ArgfsX7	Bil	No	RT	Epithelial	Bl (51),84,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Asn258Arg, 8	F17		Exon8	g.59702_59703dup	p.Asn258ArgfsX7	Bil	No	RT + CH	Epithelial	L (39),85,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg320X, 9a	F4	0	Exon 10	g.64348C>T	p.Arg320X	Bil	Yes	Enucl	Epithelial	C (49),86,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg320X, 10a	F4		Exon 10	g.64348C>T	p.Arg320X	Bil	No	RT	Melanoma	(25),87,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg358X," 11a	F5	2 (26, 1f)	Exon 11	g.65386C>T	p.Arg358X	Bil	Yes	RT + CH	Sarcoma	LMS (41)",88,39,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Gln383X," 12	F6	2 (47, 41)	Exon 12	g.70261C>T	p.Gln383X	Ul	Yes	Enucl	Epithelial	Bl (62)",89,38,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X," 13a	F8	3 (26, 11, 49)	Exon 14	g.76430C>T	p.Arg445X	Bil	Yes	Enucl	Epithelial	L (65)",90,43,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 14a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	Enucl	Melanoma	(23),91,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 15a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(37),92,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 16a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(45),93,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 17a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(21),94,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg467X, 18a	F23	NA	Exon 15	g.76898C>T	p.Arg467X	Bil	No	RT + CH	Melanoma	(28),95,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg552X, 19a	F9	1 (54)	Exon 17	g.78238C>T	p.Arg552X	Bil	Yes	RT	Sarcoma	LMS (33),96,35,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg552X, 20a	F9		Exon 17	g.78238C>T	p.Arg552X	Bil	No	RT + CH	Osteosarcoma	(12),97,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg579X, 21a	F10	0	Exon 18	g.150037C>T	p.Arg579X	Ul	Yes	Missing	Other	(59),98,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg579X, 22a	F10		Exon 18	g.150037C>T	p.Arg579X	Bil	No	RT	Melanoma	(35),99,31,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg579X, 23a	F24	NA	Exon 18	g.150037C>T	p.Arg579X	Bil	No	RT	Osteosarcoma	(10),100,33,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Tyr606X, 24	F25	NA	Exon 19	g.153211T>A	p.Tyr606X	Bil	No	RT	Melanoma	(35),101,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Thr687Pro,delGC	p.Thr687ProfsX4	Bil	No	Enucl	Epithelial	O (72),103,7,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Thr687Pro,delGC	p.Thr687ProfsX4	Ul	No	Enucl	Sarcoma	Unknown locati...,105,7,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Glu737X," 27	F14	2 (53, 50)	Exon 21	g.160832G>T	p.Glu737X	Ul	Yes	Enucl	Epithelial	O (58)",106,40,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Glu737X, 28	F14		Exon 21	g.160832G>T	p.Glu737X	Bil	No	RT	Osteosarcoma	(20),107,30,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg787X, 29a	F27	NA	Exon 23	g.162237C>T	p.Arg787X	Bil	No	RT + CH	Sarcoma	LMS (32),108,33,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg787X, 30a	F28	NA	Exon 23	g.162237C>T	p.Arg787X	Bil	No	RT	Sarcoma	Lipo (12),109,33,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Leu797Tyr, 31	F26	NA	Exon 23	g.162266delC	p.Leu797TyrfsX13	Bil	No	RT + CH	Osteosarcoma	(26),110,33,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Gln444Gln, 32	F7	1 (29)	Exon 13	g.73869G>A	p.Gln444Gl,112,34,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.C121G,"...ne, c.T361G, leads to an amino acid substitution (p.C121G) and absence of activity of the encoded 7β...",68,1596,FEBS_Lett_2016_Jun_27_590(11)_1651-1662.txt
p.C121G,"... homozygous for the inactivating missense variant p.C121G (c.T361G) in the UGT3A1 gene, which encode...",165,548,FEBS_Lett_2016_Jun_27_590(11)_1651-1662.txt
p.C121G,"...ents, including the two with the homozygosity for p.C121G (Fig. 4A), consistent with the hypothesis ...",187,613,FEBS_Lett_2016_Jun_27_590(11)_1651-1662.txt
p.C121G,...homozygous for the missense polymorphism/mutation p.C121G (c.T361G) in UGT3A1 because these patients...,225,1384,FEBS_Lett_2016_Jun_27_590(11)_1651-1662.txt
p.Asp645Glu,"... and Huie, 1999), and a common defect, c.1935C>A (p.Asp645Glu), is shared by Chinese patients in Tai...",25,160,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
p.Arg854Ter,"... common mutation in African-Americans, c.2560C>T (p.Arg854Ter), most likely originated in their ance...",25,295,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
p.C150R,...arcopenic patient with rigid spine syndrome and a p.C150R mutation in the four-and-half LIM domain p...,33,122,Front_Aging_Neurosci_2015_Aug_13_7_153.txt
p.C150R,...arcopenic patient with rigid spine syndrome and a p.C150R Mutation in FHL1 Gene . Front. Aging Neuro...,142,172,Front_Aging_Neurosci_2015_Aug_13_7_153.txt
p.E38X,"...auwen et al., 2015). The first mutation, c.G112T (p.E38X), is linked to lipodystrophy and leads to a...",45,423,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.P158P,"...008). Two of the frameshift mutations, c.474delA (p.P158P fsX22), and c.473delC (p.P158H fsX22), gen...",45,579,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.P158H,"...ations, c.474delA (p.P158P fsX22), and c.473delC (p.P158H fsX22), generate a novel 21 amino acid-lon...",45,610,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.F160X,"...2). The third non-sense mutation, c.479_480delTT (p.F160X), introduces a premature stop codon that r...",45,793,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.Thr226Arg,...letal deformities are expressed with the mutation p.Thr226Arg and not by p.Thr226Ala and p.Thr226Met...,32,624,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.Thr226Ala,...xpressed with the mutation p.Thr226Arg and not by p.Thr226Ala and p.Thr226Met mutations. Vast differ...,32,647,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.Thr226Met,...e mutation p.Thr226Arg and not by p.Thr226Ala and p.Thr226Met mutations. Vast differences in the sev...,32,663,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.Val408Ala,"...damo et al., 1999). By inserting the heterozygous p.Val408Ala mutation in one Kv1.1 allele a mouse m...",84,1137,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.Val408Ala,"...animals similar to EA1 (Herson et al., 2003). The p.Val408Ala is a homozygous lethal mutation that c...",84,1399,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.T312M,"...s in other PAI genes (Table 2); patient 3 carried p.T312M in MCM4, patient 4 carried p.R181P in CYP1...",201,141,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.R181P,"...ient 3 carried p.T312M in MCM4, patient 4 carried p.R181P in CYP11B1, patient 12 had three variants,...",201,176,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.L361D,"....R181P in CYP11B1, patient 12 had three variants, p.L361D in CYP17A1, and p.V126I and p.I993V in NNT...",201,227,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.V126I,"...nt 12 had three variants, p.L361D in CYP17A1, and p.V126I and p.I993V in NNT, patient 15 had two, p....",201,251,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.I993V,"...ree variants, p.L361D in CYP17A1, and p.V126I and p.I993V in NNT, patient 15 had two, p.Q364R in CYP...",201,263,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.Q364R,"...d p.V126I and p.I993V in NNT, patient 15 had two, p.Q364R in CYP11A1 and p.L649R in MCM4, and patien...",201,299,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.L649R,"...n NNT, patient 15 had two, p.Q364R in CYP11A1 and p.L649R in MCM4, and patient 17 had two, p.H24_Y25...",201,322,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.S386F,"...atient 17 had two, p.H24_Y25delinsQI in NR5A1 and p.S386F in TXNRD2. The contribution of these varia...",201,394,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.Y447*,...) cell deficiency in Irish Travelers (17) and the p.Y447* variant in TXNRD2 responsible for FGD in a...,207,847,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.L206R,"...e sequencing in ACA-S (14). The somatic mutation, p.L206R/c.617A > G was present in more than one-th...",19,598,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.L206R,...atalytic and regulatory subunits of PKA (25). The p.L206R point mutation results in the introduction...,19,1031,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.L206R,...A) Alterations in the PKA pathway caused by PRKACAp.L206R and PRKACALeu199_Cys200insTrp mutations in...,23,157,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.L206R,...the synthesis of cortisol and other steroids. The p.L206R and Leu199_Cys200insTrp mutations in the P...,23,638,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.R619X,...nd germline levels in different cases (p.R315 and p.R619X) and two without status available (Figure ...,30,1699,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.R267X,"... least three studies suggesting a founder effect: p.R267X and p.R898W (15, 27–32)",30,1953,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.R898W,"... studies suggesting a founder effect: p.R267X and p.R898W (15, 27–32)",30,1965,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.L58P,"...entified a homozygous STX11 mutation, c.173T > C (p.L58P), in three patients presenting clinically w...",11,832,Front_Immunol_2014_Jan_14_4_515.txt
p.Pro271Ser,UNC13D	c.811C > T p.Pro271Ser htz	None detected	None detected,51,19,Front_Immunol_2014_Jan_14_4_515.txt
p.R928C,c.2782C > T p.R928C hmz,52,14,Front_Immunol_2014_Jan_14_4_515.txt
p.L58P,"... three patients with homozygous STX11 c.173T > C, p.L58P mutations, relatives (n = 10, all six paren...",79,177,Front_Immunol_2014_Jan_14_4_515.txt
p.L58P,"...omozygous for a novel STX11 mutation, c.173T > C (p.L58P) (Table 1). The L58P localizes to an α-heli...",83,169,Front_Immunol_2014_Jan_14_4_515.txt
p.P271S,... A was heterozygous for a rare UNC13D c.811C > T (p.P271S; frequency 0.001 in a Caucasian population...,83,454,Front_Immunol_2014_Jan_14_4_515.txt
p.R928C,"...nd homozygous for an uncommon UNC13D c.2782C > T (p.R928C, frequency 0.01 in a Caucasian population ...",83,611,Front_Immunol_2014_Jan_14_4_515.txt
p.L58P,...el autosomal recessive missense STX11 c.173T > C (p.L58P) mutation causative of FHL4 in three childr...,96,68,Front_Immunol_2014_Jan_14_4_515.txt
p.G67R,52	MLH1	c.199 G > A	p.G67R	2	Causal	ACI	No cancers,43,21,Front_Oncol_2016_Aug_24_6_189.txt
p.R226X,6	MLH1a	c.676 C > T	p.R226X	8	Causal	ACI	CRC (36),44,21,Front_Oncol_2016_Aug_24_6_189.txt
p.R226Q,"8	MLH1	c.677 G > A	p.R226Q	8	Causal	ACI	CRC (38), EC (52)",45,20,Front_Oncol_2016_Aug_24_6_189.txt
p.K751Sfs,P	MLH1a	c.2252_2253delAA	p.K751SfsX3	19	Causal	ACI	EC (52),50,26,Front_Oncol_2016_Aug_24_6_189.txt
p.E56X,"4	MSH2	c.166 G > T	p.E56X	1	Causal	ACI	CRC (44), EC (51)",53,20,Front_Oncol_2016_Aug_24_6_189.txt
p.Q97X,"3	MSH2	c.289 C > T	p.Q97X	2	Causal	ACI	CRC (49), SKC (51), UT (52)",54,20,Front_Oncol_2016_Aug_24_6_189.txt
p.G162Arg,SS	MSH2	c.484 G > A	p.G162Arg	2	Causal	ACII	No cancers,55,21,Front_Oncol_2016_Aug_24_6_189.txt
p.Q130Val,"49	MSH2	c.388_389delCA	p.Q130ValfsX2	3	Causal	ACI	CRC (51), SKC (48), SIC...",56,24,Front_Oncol_2016_Aug_24_6_189.txt
p.P349R,DA	MSH2	c.1046C > G	p.P349R	6	Causal	ACI	BC (41),57,21,Front_Oncol_2016_Aug_24_6_189.txt
p.R621X,"N	MSH2	c.1861C > T	p.R621X	11	Causal	ACII	EC (34), CRC (59), SIC (79)...",59,20,Front_Oncol_2016_Aug_24_6_189.txt
p.R638Gfs,"45	MSH2	c.1910delC	p.R638GfsX47	12	Causal	ACII	CRC (39), EC (41), SIC...",60,20,Front_Oncol_2016_Aug_24_6_189.txt
p.V684Dfs,5	MSH2	c.2046_2047 delTG	p.V684DfsX14	13	Causal	ACII	CRC (42),61,26,Front_Oncol_2016_Aug_24_6_189.txt
p.V600E,...nventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations . BMC Cance...,240,172,Front_Pediatr_2014_Sep_9_2_96.txt
p.V600E,...r sequencing for the detection of p.V600E and non-p.V600E BRAF mutations . BMC Cancer  (2014 ) 14 :1...,240,188,Front_Pediatr_2014_Sep_9_2_96.txt
p.R270H,"...O mice. We reported two non-synonymous mutations, p.R270H and p.R67C, by exon sequencing of FFAR4 in...",28,2133,Front_Pharmacol_2014_Nov_6_5_236.txt
p.R67C,"...eported two non-synonymous mutations, p.R270H and p.R67C, by exon sequencing of FFAR4 in obese and l...",28,2145,Front_Pharmacol_2014_Nov_6_5_236.txt
p.R270H,"...Subsequent in vitro experiments revealed that the p.R270H mutant, which was significantly associated...",28,2268,Front_Pharmacol_2014_Nov_6_5_236.txt
p.R67C,"... the ability to transduce LCFA signals unlike the p.R67C mutant, which was not associated with obesi...",28,2389,Front_Pharmacol_2014_Nov_6_5_236.txt
p.V60L,Figure 1 P2RX2 p.V60L attenuates ATP evoked inward current. HEK29...,50,16,Front_Physiol_2016_May_24_7_186.txt
p.G353R,... mutant P2RX2 V60L. Cells expressing mutant P2RX2 p.G353R show a lower inward current peak than thos...,50,405,Front_Physiol_2016_May_24_7_186.txt
p.Arg870His,NM_000257.3(MYH7):c.2609G > A (p.Arg870His) rs36211715	Pathogenic/Likely pathogen...,57,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Met515Thr,NM_000257.3(MYH7):c.1544T > C (p.Met515Thr) rs863224900	Likely pathogenic	Rai et ...,58,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Val606Met,NM_000257.3(MYH7):c.1816G > A (p.Val606Met) rs121913627	Pathogenic / Likely patho...,59,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Gly716Arg,NM_000257.3(MYH7):c.2146G > A (p.Gly716Arg) rs121913638	Conflicting interpretatio...,60,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Asp896Asn,"NM_000257.3(MYH7):c.2686G > A (p.Asp896Asn) rs606231340	Pathogenic	Rani et al., 2...",61,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Trp1214Ter,NM_000256.3(MYBPC3):c.3641G > A (p.Trp1214Ter) rs730880597	Pathogenic	Bashyam et al...,64,35,Front_Physiol_2016_Oct_28_7_499.txt
p.Asp770Asn,NM_000256.3 (MYBPC3):c.2308G > A (p.Asp770Asn) rs36211723	Pathogenic/Likely pathogen...,66,36,Front_Physiol_2016_Oct_28_7_499.txt
p.Pro453Cys,NM_000256.3 (MYBPC3):c.1357_1358delCC (p.Pro453Cysfs) rs727503203	Pathogenic	Waldmüller e...,68,41,Front_Physiol_2016_Oct_28_7_499.txt
p.Arg144Trp,NM_001001430.2 (TNNT2):c.430C >T (p.Arg144Trp) rs483352832	Conflicting interpretatio...,70,36,Front_Physiol_2016_Oct_28_7_499.txt
p.Ile106Met,NM_001001430.2 (TNNT2):c.318C > G (p.Ile106Met) rs3729547	Uncertain significance	Rani...,72,37,Front_Physiol_2016_Oct_28_7_499.txt
p.Arg141Gln,NM_000363.4 (TNNI3):c.422G > A (p.Arg141Gln) rs397516347	Pathogenic/Likely pathoge...,76,34,Front_Physiol_2016_Oct_28_7_499.txt
p.Arg162Gln,NM_000363.4 (TNNI3):c.485G > A (p.Arg162Gln) rs397516354	Pathogenic/Likely pathoge...,77,34,Front_Physiol_2016_Oct_28_7_499.txt
p.Ser215Leu,NM_001018005.1 (TPM1):c.644C > T (p.Ser215Leu) rs199476316	Conflicting interpretatio...,79,36,Front_Physiol_2016_Oct_28_7_499.txt
p.R870H,...i G. R. Gopikrishna M. Narasimhan C.   (2007 ). A p.R870H mutation in the beta-cardiac myosin heavy ...,180,72,Front_Physiol_2016_Oct_28_7_499.txt
p.B5M,DRM2-B	B05:141574185.141584809	Araip.B5M84	1821	9	607,90,36,Front_Plant_Sci_2016_Feb_3_7_7.txt
p.V0N,CMT1-B	B05:3729600.3739701	Araip.V0N49	2460	19	820,96,32,Front_Plant_Sci_2016_Feb_3_7_7.txt
p.Z24E,DMElike-B	B08:4956310.4963917	Araip.Z24EK	2151	19	717,106,35,Front_Plant_Sci_2016_Feb_3_7_7.txt
p.G34E,"...13 and, in 1 selected patient, the CTNNB1 region (p.G34E mutation), with correlation to parallel res...",46,235,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
p.Q56P,"...ndation One) showed the MAP2K1:NM_002755:c.167A>C_p.Q56P (0.13,1125, PIK3CA:NM 006218:c.331A>G p.K11...",77,155,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
p.K111E,"...7A>C_p.Q56P (0.13,1125, PIK3CA:NM 006218:c.331A>G p.K111E [0.13,765]), and CTNNB1:NM_001904:c.101G>A...",77,200,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
p.G34E,"....K111E [0.13,765]), and CTNNB1:NM_001904:c.101G>A_p.G34E (0.06,851) mutational profile. TP53, SMAD4,...",77,251,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
p.G34E,...rformed targeted sequencing of the CTNNB1 region (p.G34E mutation) within the whole-genome–amplified...,77,508,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
p.Val438Met,MCCC1	1	A2	F	Homozygous	c.1315G>A	p.Val438Met	Nonsyn	This study,88,35,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gln584X,c.1894C>T	p.Gln584X,90,11,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Pro632Ser,p.Pro632Ser	Stop; Nonsyn	This study,91,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg385Ser,c.974T>G*	p.Arg385Ser,94,11,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Met325Arg,p.Met325Arg	Nonsyn; Nonsyn/splicing	This study,95,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg281X,A9	F	Compound Het.	c.841C>T; c.558delA	p.Arg281X,96,40,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gln186His,p.Gln186Hisfs*6	Stop/Nonsyn	This study,97,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Val397Gly,c.834A>G	p.Val397Glyfs*19,99,10,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gln129Arg,p.Gln129Arg	Nonsyn; Nonsyn	This study,100,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Cys509Ser,A18	F	Compound Het. 	c.1526delG; UND	p.Cys509Serfs*14	Nonsyn	This study,101,38,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gly180Val,A19	F	Compound Het.	c.539G>T; c.558delA	p.Gly180Val,102,41,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gln186His,p.Gln186Hisfs*6	Nonsyn; Nonsyn	This study,103,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Cys509Ser,A21	F	Homozygous	c.1526delG	p.Cys509Serfs*14	Nonsyn	This study,104,29,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ala291Val,A23	F	Compound Het.	c.872C>T; UND	p.Ala291Val	Nonsyn	This study,105,35,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ala289Val,2	S20	M	Compound Het.	c.866C>T; c.974T>G*	p.Ala289Val,107,43,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Met325Arg,p.Met325Arg	Nonsyn; Nonsyn/splicing	Ref. 15,108,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg385Ser,"3	S4	F	Homozygous	c.1155A>C*	p.Arg385Ser	Nonsyn	Refs. 15,16",110,30,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Asp532His,S5	F	Homozygous	c.1594G>C*	p.Asp532His	Nonsyn/splicing	Ref. 15,111,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Leu437Pro,"S6	M	Homozygous	c.1310T>C*	p.Leu437Pro	Nonsyn	Refs. 4,15",112,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gln372X,c.1882G>T	p.Gln372X,114,11,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Glu628X,p.Glu628X	Stop; stop	Ref. 18,115,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gln198X,MCCC2	1	A6	F	Homozygous	c.592C>T	p.Gln198X	Stop	This study,117,34,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Leu355Phe,A7	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,118,27,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Leu355Phe,A11	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,119,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ser101Phe,A13	F	Compound Het.	c.302C>T; UND	p.Ser101Phe	Nonsyn	This study,120,35,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg72X,A14	F	Compound Het.	c.214C>T*; UND	p.Arg72X	Nonsyn	This study,121,36,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ala456Val,A16	F	Homozygous	c.1367C>T	p.Ala456Val	Nonsyn	Ref. 6,122,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ser173Phe,c.599T>A*	p.Ser173Phefs*25,124,11,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ile200Asn,p.Ile200Asn	Frameshift; Nonsyn	This study,125,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gln496His,c.351_353delTGG	p.Gln496His,127,17,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ser173Phe,c.994C>T	p.Ser173Phefs*25,131,10,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg332X,"p.Arg332X	Frameshift/stop; stop	Refs. 6,13,15",132,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg155Gln,c.929C>G*	p.Arg155Gln,134,11,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Pro310Arg,"p.Pro310Arg	Nonsyn; Nonsyn	Refs. 2,15",135,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ser173Phe,S22	F	Homozygous	c.517_518insT	p.Ser173Phefs*25	Frameshift/stop	Ref. 15,136,32,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Glu99Gln,S25	F	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Ref. 15,137,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Glu99Gln,"3	S8	M	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Refs. 3,15",139,29,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Val339Met,"S9	M	Compound Het.	c.1015G>A*; UND	p.Val339Met	Nonsyn	Refs. 15,17",140,36,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Val339Met,S10	F	Compound Het.	c.1015G>A*; UND	p.Val339Met	Nonsyn	Ref. 15,141,37,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gly352Arg,"S17	F	Homozygous	c.1054G>A	p.Gly352Arg	Nonsyn/splicing	Refs. 6,20",142,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ile437Val,"S23	M	Compound Het.	c.1309A>G*; UND	p.Ile437Val	Nonsyn	Refs. 14,15",143,37,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ser39Phe,S28	M	Homozygous	c.116C>T	p.Ser39Phe	Nonsyn	Ref. 19,144,27,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Val548Ala,"...valence of a specific mutation (c.1643_1644delTG, p.Val548AlafsX25) in the XPC gene in North Africa....",77,969,Genet_Mol_Biol_2014_Mar_20_37(1_Suppl)_220-233.txt
p.E368K,"...tions in two patients, both in exon 8, one known (p.E368K) and one novel (p.F372C), which is found i...",32,1125,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.F372C,"...oth in exon 8, one known (p.E368K) and one novel (p.F372C), which is found in a position of presumed...",32,1149,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.F372C,"...ncing of DNM2 uncovered the mutation c.1115T > G, p.F372C, in exon 8, in a heterozygous state (Figur...",42,2085,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.F372C,"...paresis. (C) heterozygous DNM2 mutation c.1115TG, p.F372C found in Patient 1. (D) heterozygous DNM2 ...",44,259,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.E368K,"...nt 1. (D) heterozygous DNM2 mutation c.1102G > A, p.E368K found in Patient 2",44,331,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.E368K,"...NM2 showed the heterozygous mutation c.1102G > A, p.E368K, already known to be pathogenic in dominan...",48,1017,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.E368K,"The mutation found in Patient 2 (p.E368K, in exon 8) is the second most frequent in...",52,34,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.F372C,"...l., 2011). The novel mutation found in Patient 1 (p.F372C, in exon 8) changes phenylalanine to cyste...",52,577,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.F372C,"...on has been reported so far. Moreover, this novel p.F372C appeared de novo, sustaining its pathogeni...",52,1075,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.G12V,14	Synchronous	MSS	KRAS p.G12V	4	May 2014						May 2014,70,25,Genome_Biol_2015_Feb_12_16(1)_32.txt
p.G12V,15	Synchronous	MSS	KRAS p.G12V	4	May 2014				8 cycles of XELOX	Partial res...,71,25,Genome_Biol_2015_Feb_12_16(1)_32.txt
p.R790*,"... Gardner syndrome, along with a somatic nonsense (p.R790*) APC mutation in the tumor. Somatic mutati...",11,147,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,... and biochemical assays demonstrated that the MAX p.R60Q and BRAF p.K483E mutations were activating ...,11,438,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"... assays demonstrated that the MAX p.R60Q and BRAF p.K483E mutations were activating mutations, where...",11,454,Genome_Med_2016_Oct_31_8_116.txt
p.R790*,"...APC tumor suppressor was identified (c.2368A > T, p.R790*) in the tumor. Additional somatic mutation...",110,365,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,"... included missense mutations in TP53 (c.743G > A, p.R248Q), MAX (c.179G > A, p.R60Q), BRAF (c.1447A ...",110,493,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...s in TP53 (c.743G > A, p.R248Q), MAX (c.179G > A, p.R60Q), BRAF (c.1447A > G, p.K483E), and RPTOR (c...",110,520,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...8Q), MAX (c.179G > A, p.R60Q), BRAF (c.1447A > G, p.K483E), and RPTOR (c.2252C > T, p.A751V), and a ...",110,548,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...F (c.1447A > G, p.K483E), and RPTOR (c.2252C > T, p.A751V), and a nonsense mutation in ROS1 (c.1176 ...",110,582,Genome_Med_2016_Oct_31_8_116.txt
p.C392*,"...), and a nonsense mutation in ROS1 (c.1176 T > A, p.C392*). The TP53 (p.R248Q) and APC (p.R790*) mut...",110,639,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,"...tation in ROS1 (c.1176 T > A, p.C392*). The TP53 (p.R248Q) and APC (p.R790*) mutations had allelic f...",110,659,Genome_Med_2016_Oct_31_8_116.txt
p.R790*,"...1176 T > A, p.C392*). The TP53 (p.R248Q) and APC (p.R790*) mutations had allelic frequencies consist...",110,677,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,The identified TP53 (p.R248Q) mutation is a previously described gain-o...,112,22,Genome_Med_2016_Oct_31_8_116.txt
p.R790*,...ent of many tumor types [30–32]. The somatic APC (p.R790*) mutation has also been previously reporte...,112,187,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,"...ggested by the high allelic frequencies for TP53 (p.R248Q) and APC (p.R790*) mutations, we confirmed...",117,414,Genome_Med_2016_Oct_31_8_116.txt
p.R790*,"...h allelic frequencies for TP53 (p.R248Q) and APC (p.R790*) mutations, we confirmed segmental loss of...",117,432,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,Functional characterization of MAX p.R60,127,36,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"... and differentiation (reviewed in [37, 38]). MAX (p.R60Q) is the most common MAX gene mutation repor...",128,362,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...sight into the functional consequence of the MAX (p.R60Q) mutation, we performed in silico modeling ...",128,727,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...espectively. In all structures presented, the MAX p.R60Q mutation is shown in magenta. Dashed lines ...",128,2660,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"... left. e, f Structures of wild-type BRAF and BRAF p.K483E mutant. e Model of the BRAF kinase domain ...",128,3282,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,While the MAX p.R60Q mutation abolishes MAX homodimerization and...,133,15,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...s of the H-bond between Arg 60 and DNA in the MAX p.R60Q mutant. Overall, our analysis predicts that...",135,302,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...tant. Overall, our analysis predicts that the MAX p.R60Q mutant could form a stable heterodimer with...",135,361,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,... both C-MYC and MXD1. To formally evaluate if MAX p.R60Q could form functional heterodimers with C-M...,135,461,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...ural and biochemical results suggest that the MAX p.R60Q mutation inhibits MAX homodimerization, but...",135,863,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,Structural assessment of RPTOR p.A751,137,32,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...f mTOR [47, 48]. Analysis of the identified RPTOR p.A751V mutation by PolyPhen, SIFT, and PROVEAN [4...",138,370,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...tus of alanine and valine. Furthermore, the RPTOR p.A751V residue is localized to a flexible polypep...",138,658,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...R or mTOR substrates [52]. In addition, the RPTOR p.A751V mutation has been reported in The 1000 Gen...",138,901,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,...00 Genomes project database indicating that RPTOR p.A751V may represent a genetic variant of RPTOR t...,138,995,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...nt within the human population [53]. Hence, RPTOR p.A751V mutation would not be expected to negative...",138,1107,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,Functional characterization of BRAF p.K483,140,37,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,...nstream MEK/ERK pathway [56]. The identified BRAF p.K483E mutation in the patient’s tumor is localiz...,141,194,Genome_Med_2016_Oct_31_8_116.txt
p.K483M,...al effect on the kinase activity. Since both BRAF p.K483M and BRAF p.D594A mutants (Additional file ...,141,752,Genome_Med_2016_Oct_31_8_116.txt
p.D594A,"...kinase activity. Since both BRAF p.K483M and BRAF p.D594A mutants (Additional file 1: Figure S2C, D)...",141,769,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...lly inactive [57, 58], we predicted that the BRAF p.K483E mutation is a kinase inactivating mutation...",141,926,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...activating mutation. However, given that the BRAF p.K483E mutation is present at the high allelic fr...",141,1007,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,...alogued in the COSMIC database suggests that BRAF p.K483E may paradoxically result in downstream pat...,141,1222,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...functionally evaluate the consequence of the BRAF p.K483E mutation, we transiently expressed wild-ty...",143,54,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,... BRAF null cells. These results suggest that BRAF p.K483E mutation activates downstream signaling th...,143,798,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,...rrogation of identified somatic mutations in MAX (p.R60Q) and BRAF (p.K483E) predicted these mutatio...,164,134,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,...ified somatic mutations in MAX (p.R60Q) and BRAF (p.K483E) predicted these mutations to be deleterio...,164,152,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...iochemical investigation. In the case of the MAX (p.R60Q) and BRAF (p.K483E) mutations, in silico mo...",164,444,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...gation. In the case of the MAX (p.R60Q) and BRAF (p.K483E) mutations, in silico modeling of the muta...",164,462,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,...is confirms previous studies showing that the MAX p.R60Q mutation disrupts the ability of MAX to hom...,167,446,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...o homodimerize [43], and we further show that MAX p.R60Q retains the ability to efficiently bind C-M...",167,541,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...ability to efficiently bind C-MYC. Hence, the MAX p.R60Q mutation promotes an imbalance of the MAX t...",167,610,Genome_Med_2016_Oct_31_8_116.txt
p.V600E,... function as either activated monomers (e.g. BRAF p.V600E) or constitutive dimers with wild-type BRA...,169,80,Genome_Med_2016_Oct_31_8_116.txt
p.D594A,"...RAF mutants with no kinase activity, such as BRAF p.D594A, are able to promote ERK phosphorylation b...",169,231,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"... of the dimer [58, 76]. We demonstrated that BRAF p.K483E expression increased ERK1/2 activation des...",169,378,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,...sion increased ERK1/2 activation despite the BRAF p.K483E mutant harboring a catalytically dead kina...,169,442,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...inhibitors [77]. Therefore, we conclude that BRAF p.K483E is an activating mutation with effects lik...",169,922,Genome_Med_2016_Oct_31_8_116.txt
p.R790*,"...ns in APC, including a somatic nonsense mutation (p.R790*) as well as a novel germline frameshift va...",171,62,Genome_Med_2016_Oct_31_8_116.txt
p.G12V,... Detection of a somatic KRAS mutation (c.35G > T; p.G12V) in DNA extracted from micro-dissected tumo...,26,1573,Gynecol_Oncol_Res_Pract_2016_May_5_3_5.txt
p.Arg265Cys,Perera S Bapat B The MLH1 variants p.Arg265Cys and p.Lys618Ala affect protein stabili...,107,36,Hered_Cancer_Clin_Pract_2012_Jul_23_10(1)_9.txt
p.Lys618Ala,...erera S Bapat B The MLH1 variants p.Arg265Cys and p.Lys618Ala affect protein stability while p.Leu74...,107,52,Hered_Cancer_Clin_Pract_2012_Jul_23_10(1)_9.txt
p.Leu749Gln,...ys and p.Lys618Ala affect protein stability while p.Leu749Gln affects heterodimer formation Hum Muta...,107,95,Hered_Cancer_Clin_Pract_2012_Jul_23_10(1)_9.txt
p.C634Y,"The RET mutations (p.C634Y [n = 10], p.C634R [n = 9], p.C634F [n = 2]...",10,20,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R,"The RET mutations (p.C634Y [n = 10], p.C634R [n = 9], p.C634F [n = 2], p.C618Y [n = 8],...",10,38,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F,"...RET mutations (p.C634Y [n = 10], p.C634R [n = 9], p.C634F [n = 2], p.C618Y [n = 8], p.C618R [n = 3],...",10,55,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618Y,"...C634Y [n = 10], p.C634R [n = 9], p.C634F [n = 2], p.C618Y [n = 8], p.C618R [n = 3], and p.M918T [n =...",10,72,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618R,"....C634R [n = 9], p.C634F [n = 2], p.C618Y [n = 8], p.C618R [n = 3], and p.M918T [n = 1]) were confirm...",10,89,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,"...4F [n = 2], p.C618Y [n = 8], p.C618R [n = 3], and p.M918T [n = 1]) were confirmed in 20 symptomatic ...",10,110,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...ozygous missense mutations; 7 families had MEN2A (p.C634Y [n = 3], p.C634R [n = 2], p.C634F [n = 1],...",45,480,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R,"...mutations; 7 families had MEN2A (p.C634Y [n = 3], p.C634R [n = 2], p.C634F [n = 1], p.C618R [n = 1])...",45,497,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F,"...lies had MEN2A (p.C634Y [n = 3], p.C634R [n = 2], p.C634F [n = 1], p.C618R [n = 1]), 1 family had FM...",45,514,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618R,"....C634Y [n = 3], p.C634R [n = 2], p.C634F [n = 1], p.C618R [n = 1]), 1 family had FMTC (p.C618Y [n = ...",45,531,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618Y,"...34F [n = 1], p.C618R [n = 1]), 1 family had FMTC (p.C618Y [n = 1]), and 1 family had MEN2B (p.M918T ...",45,568,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,"...d FMTC (p.C618Y [n = 1]), and 1 family had MEN2B (p.M918T [n = 1]). Of the 33 MEN2 patients, 32 (97%...",45,610,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F,  F1	2	1/1	28-58	p.C634F	43.0	1/26,66,18,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y, F2	1	1/0	35	p.C634Y	35.0	1/35,67,14,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y, F3	6	2/4	9-44	p.C634Y	30.2	1/36,68,16,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y, F4	3	2/1	18-44	p.C634Y	27.3	1/47,69,17,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R, F5	3	2/1	19-32	p.C634R	24.7	2/40.5,70,17,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R, F6	6	4/2	19-65	p.C634R	33.5	1/21,71,17,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618R, F7	3	1/2	21-36	p.C618R	27.3	1/40,72,17,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618Y, F8	8	2/6	24-78	p.C618Y	45.3	-,74,17,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T, F9	1	1/0	33	p.M918T	33	-,76,14,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F, p.C634F/Y/R	21	12	9,106,2,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...ed with PHEOs, including 5 males and 3 females (7 p.C634Y/R/F and 1 p.C618R RET-mutations) (Table 4)...",186,82,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618R,...luding 5 males and 3 females (7 p.C634Y/R/F and 1 p.C618R RET-mutations) (Table 4). The mean age at ...,186,100,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618Y,"... heterozygous missense mutations within exons 10 (p.C618Y [n = 8] and p.C618R [n = 3]), 11 (p.C634Y ...",227,177,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618R,"...se mutations within exons 10 (p.C618Y [n = 8] and p.C618R [n = 3]), 11 (p.C634Y [n = 10], p.C634R [n...",227,197,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...ons 10 (p.C618Y [n = 8] and p.C618R [n = 3]), 11 (p.C634Y [n = 10], p.C634R [n = 9], and p.C634F [n ...",227,219,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R,"... = 8] and p.C618R [n = 3]), 11 (p.C634Y [n = 10], p.C634R [n = 9], and p.C634F [n = 2]), 16 (p.M918T...",227,237,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F,"...= 3]), 11 (p.C634Y [n = 10], p.C634R [n = 9], and p.C634F [n = 2]), 16 (p.M918T [n = 1]). It was sur...",227,258,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,"...= 10], p.C634R [n = 9], and p.C634F [n = 2]), 16 (p.M918T [n = 1]). It was surprising to find that i...",227,280,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...amilies, only proband (F2-II1 and F9-II3) had the p.C634Y or p.M918T mutation, while his consanguine...",227,397,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,"...ly proband (F2-II1 and F9-II3) had the p.C634Y or p.M918T mutation, while his consanguineous parents...",227,408,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618Y,"...[for example, F8-III5, F8-IV5 and F8 other 6 with p.C618Y]. This may occur by the accumulation of ge...",232,733,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R,"...e early stages of research, the MEN2A family (F6, p.C634R) was mistaken for the FMTC family; however...",236,66,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...s in codon 634 and is most commonly identified as p.C634Y, and almost never p.C634R [25]. It has bee...",236,261,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R,"... commonly identified as p.C634Y, and almost never p.C634R [25]. It has been previously suggested tha...",236,287,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...T mutations [30]. In the current study, in 2 (F2 [p.C634Y] and F9 [p.M918T]) of 9 families (Figure 1...",238,177,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,"... In the current study, in 2 (F2 [p.C634Y] and F9 [p.M918T]) of 9 families (Figure 1), only 2 proband...",238,194,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...ll the other consanguineous family members had no p.C634Y or p.M918T mutations, which suggested that...",238,317,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,"...r consanguineous family members had no p.C634Y or p.M918T mutations, which suggested that both patie...",238,328,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,...al germ cell mosaicism [31]. The age at which the p.M918T mutation was diagnosed in our patient was ...,238,495,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.G1890*,"... UAE, particularly the potential founder mutation p.G1890* (Table 2 and Figure 2)",62,965,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R48K,"... rare among Arabs, as only one missense mutation (p.R48K) has been reported (Table 2, Figure 2)",64,1009,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R479S,"...r is Syrian. Two heterozygous missense mutations, p.R479S and p.I641N, were detected in TCTN3 and AH...",88,609,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.I641N,"... Two heterozygous missense mutations, p.R479S and p.I641N, were detected in TCTN3 and AHI1, respecti...",88,621,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G2663Afs,"...di Arabia carrying one possible founder mutation (p.G2663Afs*40) have been reported (Table 2, Figure...",92,753,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R512W,c.1543G>A	p.R512,228,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R515W,p.R515,231,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R515W,p.R515,239,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R512Q,JS_D	1	H	c.1535G>A	p.R512Q	Yes,244,21,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Y534D,c.1862G>A	p.Y534,250,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R621Q,p.R621Q	No,252,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R563H,MTI-008	4	H	c.1688G>A	p.R563H	Yes,258,24,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.K580E,MTI-627	3 (1 died)	H	c.1738A>G	p.K580E	Yes,264,33,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.C641R,p.C641,273,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.C641R,p.C641,283,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R351*,p.R351,292,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R351*,p.R351,302,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R435*,c.1303C>T	p.R435*	Yes,308,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.V443D,p.V443,317,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.V443D,p.V443,327,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.V443D,p.V443,337,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.V443D,p.V443,347,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.I641N,p.I641,357,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.I641N,p.I641,364,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.D719G,K8103	2	H	c.2156A>G	p.D719G	Yes,370,22,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R48K,A2229	1	H	c.143G>A	p.R48K	Yes,393,21,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.E1572*,JS_3	1	H	c.4714G>T	p.E1572*	Yes,403,21,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G1890*,p.G1890,412,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G1890*,p.G1890,422,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G1890*,p.G1890,433,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G1890*,p.G1890,441,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G1890*,p.G1890,449,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G1890*,p.G1890,458,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R1978*,p.R1978*	No	novel	Emirati	This study,460,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Q1942*,MTI-133	2 (2 died)	H	c.5824C>T	p.Q1942*	Yes,463,33,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.S630P,A1371	2	H	c.1888T>C	p.S630P	Yes,468,22,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G821S,ND	Ht	c.2461G>A	p.G821S	No	digenic	Egyptian,476,18,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Q550R,JS_F1	3	H	c.1649A>G	p.Q550R	Yes,486,22,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.P721S,JBS-006	1	H	c.2161C>T	p.P721S	Yes,491,24,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R1019*,p.R1019,502,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R1019*,p.R1019,513,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.P1122S,p.P1122,523,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.P1122S,p.P1122,534,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.L1551P,F871	1	H	c.4652T>C	p.L1551P	Yes,541,21,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R1528C,c.4582C>T	p.R1528C	Yes,548,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R1528H,c.1412delG	p.R1528,556,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.K472Rfs,p.K472Rfs*	Yes	Novel	Emirati	This study,558,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.A73Pfs,E	2	H	c.217delG	p.A73Pfs*109	Yes,560,18,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.L78Pfs,Fam9	1	H	c.233_234del	p.L78Pfs*2	Yes,566,24,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.A966Pfs,p.A966Pfs*8,575,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.A966Pfs,p.A966Pfs*8,585,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G115Kfs,p.G115Kfs*,602,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G115Kfs,p.G115Kfs*,613,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Q356Pfs,c.1066dupC	p.Q356Pfs*23	Yes,620,13,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Q318Pfs,MTI-131	2	H	c.953_954AGdel	p.Q318Pfs*5	Yes	novel	Emirati	This study,635,29,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.A126T,p.A126,652,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.A126T,p.A126,663,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.A127V,c.380C>T	p.A127V	Yes,671,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Y130C,p.Y130,679,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Y130C,p.Y130,690,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Y130C,p.Y130,699,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R2660*,c.7978C>T	p.R2660*	Yes,717,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G2663Afs,p.G2663Afs*4,725,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G2663Afs,p.G2663Afs*4,734,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R479S,c.1437G>C	p.R479S	No	digenic	F (Emirati,741,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.M843Efs,ND	1	H	c.2527_2528delAT	p.M843Efs*25	Yes,745,26,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.E750Lfs,ND	3 (1 died)	H	c.2244_2247delAAGA	p.E750Lfs*7	Yes,749,37,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R925*,ND	1	H	c.2773C>T	p.R925*	Yes,753,19,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.L292P,... impairment. Here we describe a missense variant (p.L292P) within a mutation-rich region of FRMD7 de...,15,192,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,"... structural and functional predictions, we report p.L292P as a variant potentially disrupting FRMD7 ...",15,415,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,...ution of leucine (L) by proline (P) at codon 292 (p.L292P). This variant co-segregated in all three ...,21,845,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,"We focused on the prediction of effects of p.L292P, which is a highly conserved residue in mu...",27,44,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,...y-committee/best-practice-guidelines/). The FRMD7 p.L292P mutant protein was predicted with high con...,27,977,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,"Taking these lines of evidence together, p.L292P appears to exert a marked effect on FRMD7 ...",29,42,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,"...us caballus and Gallus gallus. The FRMD7 variant, p.L292P, is indicated above the aligned sequence, ...",39,940,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.I240T,"...Z, Sun J et al. Identifcation of a novel mutation p.I240T in the FRMD7 gene in a family with congeni...",91,88,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.Q27X,...ent no. 3 had two mutations: a nonsense mutation (p.Q27X) in exon 5 and a splicing error in intron 6...,26,541,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Gln27X,"...a not shown). Novel mutations, including c.79C>T (p.Gln27X), c.109_110insG (p.Ala2GlyfsX19), IVS5+1G...",26,705,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Ala2Gly,"...ons, including c.79C>T (p.Gln27X), c.109_110insG (p.Ala2GlyfsX19), IVS5+1G>T, IVS5+2T>G, c.551_552in...",26,731,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Glu9Arg,"...a2GlyfsX19), IVS5+1G>T, IVS5+2T>G, c.551_552insG (p.Glu9ArgfsX15), c.802G>T (p.Glu268X) and IVS11+1G...",26,785,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Glu268X,"...5+2T>G, c.551_552insG (p.Glu9ArgfsX15), c.802G>T (p.Glu268X) and IVS11+1G>T, were identified in the ...",26,812,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg44Gln,"...ly reported, the two missense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) were found in...",26,938,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Asn17Ser,...ense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) were found in two sporadic patients,26,963,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Q27X,"...ent no. 3 had two mutations, a nonsense mutation (p.Q27X) in exon 5 and a splicing error in exon 6. ...",35,137,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Q27X,... may be present in one allele and the former one (p.Q27X) first terminates the PAX6 protein,35,1008,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Asn17Ser,1	 	Sporadic	Exon5	c.50A>G	Missense	p.Asn17Ser	PD	No	9	F	Total/total	−/−	+/+	−/−	+/+	−...,51,37,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg44Gln,2	 	Sporadic	Exon5	c.131G>A	Missense	p.Arg44Gln	PD	No	21	M	Total/total	−/−	+/+	−/−	+/+	...,52,38,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Gln27X,3	 	Sporadic	Exon5	c.79C>T	Nonsense	p.Gln27X	PD	Yes	9	M	Total/total	−/−	+/+	−/−	+/+	−/...,53,37,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg103X,12	 	Sporadic	Exon6	c.307C>T	Nonsense	p.Arg103X	PD	Yes	13	M	Total/total	−/−	+/+	−/−	+/+	...,63,39,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg203X,14	 	Sporadic	Exon8	c.607C>T	Nonsense	p.Arg203X	LNK	Yes	11	M	Total/total	−/−	+/+	−/−	+/+...,65,39,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg203X,15	 	Sporadic	Exon8	c.607C>T	Nonsense	p.Arg203X	LNK	Yes	9	F	Partial/partial	−/−	+/+	−/−	...,66,39,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg240X,16	 	Sporadic	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	27	F	Total/total	−/−	+/+	−/−	+/+	...,67,39,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg240X,17	4	Familial	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	29	M	Total/total	−/−	+/+	−/−	+/+	...,68,39,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg240X,18	4	 	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	5	F	Total/total	−/−	+/+	−/−	+/+	−...,69,32,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Glu268X,19	 	Sporadic	Exon10	c.802G>T	Nonsense	p.Glu268X	PST	Yes	6	F	Total/total	−/−	−/−	−/−	+/+	...,70,40,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Gln277X,20	 	Sporadic	Exon10	c.829C>T	Nonsense	p.Gln277X	PST	Yes	13	F	Total/total	−/−	+/+	−/−	+/+...,71,40,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg317X,21	 	Sporadic	Exon11	c.949C>T	Nonsense	p.Arg317X	PST	Yes	10	M	Total/total	−/−	−/−	+/+	+/+...,72,40,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.N1007S,...an syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene J. Med. Genet. 2007 44...,66,181,Hum_Mol_Genet_2009_Apr_15_18(R1)_R60-R64.txt
p.R796X,"...t predicted a premature stop mutation (c.2386C>T; p.R796X), whereas the maternally transmitted varia...",3,2460,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
p.D1854N,...ant predicted a missense substitution (c.5560G>A; p.D1854N) at a conserved residue within the cataly...,3,2559,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
p.R796X,"...o result in premature termination of translation (p.R796X). The second variant, a c.5560G>A in exon ...",46,1560,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
p.D1854N,...n 48 is predicted to result in a missense change (p.D1854N) in the kinase-binding domain of the prot...,46,1658,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
p.D1854N,"...e activity of the mutant enzyme, we generated the p.D1854N mutant form of the human PI4KA enzyme and...",79,66,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
p.D1854N,...KA enzymes expressed in COS-7 cells. Wild-type or p.D1854N mutant enzymes were prepared and assayed ...,80,203,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
p.G608G,"... mutation in exon 11 of the LMNA gene (c.1824C>T, p.G608G). Although this mutation does not result i...",10,332,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
p.G608G,"...ommon progeroid lamin A mutation, LMNA c.1824C>T; p.G608G, to test the hypothesis that neuropatholog...",87,551,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
p.N410H,...A. et al  (2014 ) Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration . Acta. ...,123,191,Hum_Mol_Genet_2015_Nov_1_24(21)_6198-6212.txt
p.A152T,"...generative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia...",178,208,Hum_Mol_Genet_2015_Nov_1_24(21)_6198-6212.txt
p.Ala239Thr,...LD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant . Acta. Neuropathol...,181,210,Hum_Mol_Genet_2015_Nov_1_24(21)_6198-6212.txt
p.Q578*,"...st lines with mutations in AP5Z1 : (i) c.1732C>T (p.Q578*), (ii) c.[412C>T];[1322G>A] (p.[R138*];[W4...",18,506,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.R27Lfs,"...8*];[W441*]) and (iii) c.[80_83del4; 79_84ins22] (p.R27Lfs*3) (Fig. 1B), along with gender-matched a...",18,599,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.Q578*,...ale bar = 20 µm. (B) Patient-derived fibroblasts (p.Q578*) and their control (control_1) were plated...,25,758,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.Q578*,...se in the area of LAMP1 puncta quantified for the p.Q578* line on the automated microscope (Fig. 2C)...,29,1189,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.Q578*,Figure 3. Ultrastructure of AP5Z1 p.Q578* fibroblasts. (A) EM of patient-derived fib...,30,35,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.Q578*,...ctures measured (96 for control_1 and 191 for the p.Q578* line); the individual data are shown for e...,30,733,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.Q578*,...ctures measured (96 for control_1 and 191 for the p.Q578* line). Note the increase in the number of ...,30,1204,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.Q578*,...f endolysosomes per unit area of cytoplasm in the p.Q578* line. (D) Examples of AP5Z1 p.Q578* fibrob...,30,1302,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.Q578*,...oplasm in the p.Q578* line. (D) Examples of AP5Z1 p.Q578* fibroblasts showing the clustering of endo...,30,1338,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.R27Lfs,"...t fibroblasts with mutations in AP5Z1 (Patient 3: p.R27Lfs*3), SPG11 or SPG15 were probed with antib...",43,402,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.Q578*,...ectron microscopy of patient-derived fibroblasts (p.Q578*) labelled with antibodies against the late...,51,133,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.Q578*,Patient p.Q578* is a man in his early 70s (age of symptom ...,81,9,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.R27Lfs,... form of HSP with cognitive decline (12). Patient p.R27Lfs*3 is a woman in her 80s who initially pre...,81,287,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.N2100Efs,...rtuguese origin carries the homozygous c.6296dup (p.N2100Efs*12) mutation (48) and another from Syri...,83,197,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.L1679Rfs,...her from Syria carries the homozygous c.5036delT (p.L1679Rfs*1687) mutation (10). One SPG11 patient ...,83,284,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.Arg2034*,"...nt from Morocco carries the homozygous c.6100C>T (p.Arg2034*) nonsense variant (6), and the second S...",83,381,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.Q811*,...ted from Latvia and has a heterozygous c.2431C>T (p.Q811*) variant in trans of a deletion affecting ...,83,498,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.G148R,"Active site	p.G148R	c.442G>A	1.31	1.80	B	3	ECE: tetramer, 0–5....",17,13,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,p.G305R	c.913G>A	3.58	4.90	B	1,18,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G307S,p.G307S	c.919G>A	0.16	0.50	B	88	ECE: undetectable ...,19,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.H65R,Heme binding pocket	p.H65R	c.194A>G	22.01	30.30	S	3	PE: 11.5% WT activ...,20,21,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.T262R,p.T262R	c.785C>G	0.14	0.20	B	1,21,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,p.R266K	c.797G>A	1.76	2.90	B	10	PE: Vmax 28–114% o...,22,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E144K,Other locations in active core	p.E144K	c.430G>A	0.10	0.20	B	12	ECE: <1%WT activit...,23,32,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.C165Y,p.C165Y	c.494G>A	1.85	3.00	B	8	ECE: 0–3%WT activit...,24,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.N228K,"p.N228K	c.684C>G/A	0.06	0.10	B	4	ECE: aggregates, ...",25,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,p.I278T	c.833T>C	0.00	0.00	B	146	PE: Vmax 0.8–1.4%...,26,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P49L,p.P49L	c.146C>T	35.01	61.90	S	3,27,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,p.K102N	c.306G>C	17.74	43.40	S	1	ECE: 21–34%WT act...,28,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,p.R125Q	c.374G>A	8.57	16.60	S	13	ECE: 0–1.9%WT act...,29,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.T191M,p.T191M	c.572C>T	6.93	11.20	S	137	ECE: 1%WT activi...,30,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E302K,p.E302K	c.904G>A	15.03	24.50	S	6	ECE: shorter prod...,31,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,p.R369C	c.1105C>T	4.55	10.90	S	4	SCE: does not aff...,32,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P78R,Dimer-dimer interface	p.P78R	c.233C>G	47.79	65.80	S	2	ECE: 13–61%WT acti...,33,23,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,p.A114V	c.341C>T	8.94	18.07	S	10	ECE: tetramer + a...,34,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E176K,"p.E176K	c.526G>A	16.35	26.60	S	2	ECE: aggregates, ...",35,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,p.V180A	c.539T>C	5.15	15.50	S	1	ECE: 3–8% WT activ...,36,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P422L,Regulatory domain-first CBS domain	p.P422L	c.1265C>T	4.89	8.70	B	1	ECE: ∼160% WT acti...,38,36,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I435T,p.I435T	c.1304T>C	16.11	38.50	S	1	ECE: tetramer [J...,39,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R439Q,p.R439Q	c.1316G>A	36.79	71.20	S	3	ECE: 30%WT activ...,40,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.D444N,p.D444N	c.1330G>A	18.73	45.80	S	13	PE: 1.5 × of WT...,41,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,p.S466L	c.1397C>T	0.23	0.40	B	1	ECE: ∼310% WT acti...,42,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.L539S,Regulatory domain-second CBS domain	p.L539S	c.1616T>C	1.93	5.70	B	2,43,37,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,"...92]. Seven mutant plasmids, namely, the c.341C>T (p.A114V), c.442G>A (p.G148R), c.526G>A (p.E176K), ...",58,159,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G148R,"...asmids, namely, the c.341C>T (p.A114V), c.442G>A (p.G148R), c.526G>A (p.E176K), r.1224_1358del; p.W4...",58,179,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E176K,"...c.341C>T (p.A114V), c.442G>A (p.G148R), c.526G>A (p.E176K), r.1224_1358del; p.W409_G453del, c.1265C>...",58,199,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I435T,"... p.W409_G453del, c.1265C>T (p. P422L), C.1304T>C (p.I435T), and c.1397C>T (p.S466L) were prepared us...",58,274,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,"...T (p. P422L), C.1304T>C (p.I435T), and c.1397C>T (p.S466L) were prepared using the previously descri...",58,299,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,"...t with the wild-type CBS and four mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have c...",65,246,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,"...e wild-type CBS and four mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have compared t...",65,255,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,"...pe CBS and four mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have compared the effect...",65,264,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,"...ur mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have compared the effects of the foll...",65,277,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,"...or this analysis contained the wild-type CBS, the p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p...",78,617,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,"...nalysis contained the wild-type CBS, the p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p.R125Q va...",78,626,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E302K,"...ontained the wild-type CBS, the p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p.R125Q variant pro...",78,635,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,"...the wild-type CBS, the p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p.R125Q variant proteins exp...",78,644,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G307S,"...type CBS, the p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p.R125Q variant proteins expressed at...",78,653,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,"... p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p.R125Q variant proteins expressed at 18°C",78,666,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,"...utation Database was selected; these included the p.A114V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I27...",88,351,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,"...atabase was selected; these included the p.A114V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I278T, p.G30...",88,360,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E144K,"...as selected; these included the p.A114V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I278T, p.G307S, p.W40...",88,369,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.T191M,"...ed; these included the p.A114V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I278T, p.G307S, p.W409_G453del...",88,378,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,"... included the p.A114V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D...",88,387,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,"... the p.A114V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D444N. Thi...",88,396,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G307S,"...14V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D444N. This set was...",88,405,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.D444N,"...M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D444N. This set was expanded by additional 18 le...",88,434,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.C165Y,"...e larger than 9% (with the exception of mutations p.C165Y, p.P422L, and p.S466L that belong to burie...",108,1562,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P422L,"...than 9% (with the exception of mutations p.C165Y, p.P422L, and p.S466L that belong to buried mutatio...",108,1571,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,"... the exception of mutations p.C165Y, p.P422L, and p.S466L that belong to buried mutations) buried mu...",108,1584,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.H65R,... are grouped here (with the exception of mutation p.H65R that belong to solvent exposed mutations). ...,108,1727,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,"...details, see Table 2). Only three mutant proteins—p.G305R, p.T262R, and p.N228K—did not exhibit any ...",118,230,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.T262R,"...see Table 2). Only three mutant proteins—p.G305R, p.T262R, and p.N228K—did not exhibit any measurabl...",118,239,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.N228K,"... Only three mutant proteins—p.G305R, p.T262R, and p.N228K—did not exhibit any measurable residual ac...",118,252,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G148R,Active site	B	p.G148R	0.2±0.1	0.2±0.2	0.3±0.3	0.4±0.1	N/A	N/A,127,15,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,B	p.G305R	n.d.	n.d.	n.d.	0.4±0.02	N/A	N/A,128,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G307S,B	p.G307S	0.3±0.02	0.2±0.1	0.4±0.01	0.5±0.2	N/A	N/A,129,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.H65R,Heme binding pocket	S	p.H65R	5.6±1.9	4.4±1.6	1.9±0.7	0.8±0.2	N/A	N/A,130,23,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.T262R,B	p.T262R	n.d.	n.d.	n.d.	0.2±0.2	N/A	N/A,131,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,B	p.R266K	25.3±4.2	82.3±23.0	29.4±0.03	47.8±24.7	325...,132,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E144K,Other locations in active core	B	p.E144K	0.6±0.4	0.9±0.6	0.5±0.5	3.3±2.8	N/A	N/A,133,34,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.C165Y,B	p.C165Y	1.1±0.1	0.6±0.04	0.9±0.01	0.5±0.05	N/A	N/A...,134,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.N228K,B	p.N228K	n.d.	n.d.	n.d.	0.4±0.005	N/A	N/A,135,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,B	p.I278T	0.4±0.04	0.6±0.1	0.4±0.1	0.9±0.2	N/A	N/A,136,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P49L,S	p.P49L	147.9±38.9	512.8±147.3	170.9±34.1	103.4±43....,137,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,S	p.K102N	8.8±1.7	25.7±4.3	9.2±0.9	13.6±10.2	58.2±44...,138,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,S	p.R125Q	2.3±0.3	8.1±2.5	2.7±0.3	19.4±8.8	141.8±78....,139,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.T191M,S	p.T191M	0.4±0.02	0.2±0.2	n.d.	0.6±0.03	N/A	N/A,140,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E302K,S	p.E302K	136.2±19.3	147.5±10.1	112.3±4.3	81.5±28.9	...,141,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,S	p.R369C	2.5±0.4	6.4±0.3	2.4±0.1	13.1±0.4	57.5±8.1	...,142,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P78R,Dimer–dimer interface	S	p.P78R	13.8±5.0	43.4±12.2	13.2±4.9	26.4±9.2	149.7±...,143,25,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,S	p.A114V	109.7±10.5	303.3±36.7	117.0±19.0	13.0±1.2	...,144,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E176K,S	p.E176K	4.9±0.6	2.7±0.3	4.4±0.6	11.5±8.3	7.9±5.6	N...,145,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,S	p.V180A	13.1±3.5	24.5±5.3	21.7±0.05	127.3±15.2	457...,146,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P422L,Regulatory domain – first CBS domain	B	p.P422L	65.5±12.6	165.8±38.1	67.0±16.6	113.2±77.9	...,148,40,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I435T,S	p.I435T	196.5±48.2	268.872±.9	186.6±52.8	215.4±72....,149,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R439Q,S	p.R439Q	167.3±28.4	774.0±56.4	179.8±0.04	76.4±14.8...,150,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.D444N,S	p.D444N	233.7±39.9	817.9±101.5	313.6±22.6	117.0±27...,151,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,B	p.S466L	346.2±69.1	325.2±63.1	353.7±59.9	208.7±98....,152,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.L539S,Regulatory domain – second CBS domain	B	p.L539S	1.2±0.1	1.2±0.1	1.6±0.2	4.1±0.2	N/A	N/A,153,41,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E176K,"...onse to either one of the adenosyl compounds: the p.E176K was inhibited by AdoMet, the p.E302K was i...",165,375,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E302K,"...mpounds: the p.E176K was inhibited by AdoMet, the p.E302K was inhibited by AdoHcy, and the p.H65R, p...",165,412,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.H65R,"...Met, the p.E302K was inhibited by AdoHcy, and the p.H65R, p.T191M and p.C165Y appeared to be inhibit...",165,453,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.T191M,"... p.E302K was inhibited by AdoHcy, and the p.H65R, p.T191M and p.C165Y appeared to be inhibited by bo...",165,461,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.C165Y,"... inhibited by AdoHcy, and the p.H65R, p.T191M and p.C165Y appeared to be inhibited by both adenosyl ...",165,473,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E302K,"...y both adenosyl compounds. In addition, mutations p.E302K, p.W409_G453del, p.I435T, p.L539S, p.E144K...",165,557,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I435T,".... In addition, mutations p.E302K, p.W409_G453del, p.I435T, p.L539S, p.E144K, p.G148R, p.G307S, p.I27...",165,582,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.L539S,"...tion, mutations p.E302K, p.W409_G453del, p.I435T, p.L539S, p.E144K, p.G148R, p.G307S, p.I278T, and p...",165,591,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E144K,"...ations p.E302K, p.W409_G453del, p.I435T, p.L539S, p.E144K, p.G148R, p.G307S, p.I278T, and p.S466L we...",165,600,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G148R,"...E302K, p.W409_G453del, p.I435T, p.L539S, p.E144K, p.G148R, p.G307S, p.I278T, and p.S466L were not ac...",165,609,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G307S,"...W409_G453del, p.I435T, p.L539S, p.E144K, p.G148R, p.G307S, p.I278T, and p.S466L were not activated b...",165,618,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,"...del, p.I435T, p.L539S, p.E144K, p.G148R, p.G307S, p.I278T, and p.S466L were not activated by AdoMet ...",165,627,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,"... p.L539S, p.E144K, p.G148R, p.G307S, p.I278T, and p.S466L were not activated by AdoMet to an extent ...",165,640,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,"...amers/oligomers of the wild-type CBS, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p....",168,1066,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,"...gomers of the wild-type CBS, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p.I435T. Ho...",168,1075,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,"... the wild-type CBS, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p.I435T. However, th...",168,1084,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P78R,"...-type CBS, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p.I435T. However, this foldin...",168,1093,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,"...S, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p.I435T. However, this folding promot...",168,1101,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I435T,"...e p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p.I435T. However, this folding promoting effect of...",168,1114,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,"...d type at 18°C (see Table 2). The mutant proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exh...",170,208,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,"... 18°C (see Table 2). The mutant proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exhibited mo...",170,217,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,"...e Table 2). The mutant proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exhibited more than a...",170,226,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,"...). The mutant proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exhibited more than approximat...",170,235,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P78R,"... proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exhibited more than approximately twofold i...",170,248,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,"...rroring the increased amounts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V...",175,654,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.H65R,"...he increased amounts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). Ho...",175,663,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,"...ased amounts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). However, c...",175,671,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P78R,"...nts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). However, changes in...",175,680,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,"...etramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). However, changes in amounts...",175,688,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,"...., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). However, changes in amounts of tetramers...",175,701,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,...J  Kozich V  Kruger WD   Cystathionine β-synthase p.S466L mutation causes hyperhomocysteinemia in mi...,206,81,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,...requency and pathogenicity of mutation c.1105C T (p.R369C) in the cystathionine β-synthase gene J Pe...,212,176,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.Ser2Gly,"...d caused by the invariant c.4A>G missense change (p.Ser2Gly) in SHOC2 [Cordeddu et al., 2009], a sca...",12,2282,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
p.Ser2Gly,... relevance is the fact that the invariant c.4A>G (p.Ser2Gly) SHOC2 mutation was observed to provoke ...,84,1151,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
p.Glu6Lys,...aused by an amino acid substitution (HBB c.19G>A; p.Glu6Lys) occurring at the same position. HbAC ca...,27,93,Hum_Mutat_2013_Jul_8_34(7)_937-944.txt
p.Glu26Lys,...ctural variant of normal hemoglobin (HBB c.79G>A; p.Glu26Lys) affecting the production rate of HbA. ...,29,64,Hum_Mutat_2013_Jul_8_34(7)_937-944.txt
p.Arg398Ser,"...homozygous frameshift mutation (c.1194_1195delAG, p.Arg398Serfs*9) in TUB in a child from a consangu...",9,494,Hum_Mutat_2014_Mar_20_35(3)_289-293.txt
p.Arg398Ser,"...ft variant in TUB (MIM #601197) c.1194_1195delAG, p.Arg398Serfs*9 (numbered according to Ensembl tra...",23,1159,Hum_Mutat_2014_Mar_20_35(3)_289-293.txt
p.Arg398Ser,"...causative mutations [Xi et al., 2006] and the TUB p.Arg398Serfs*9 variant was also not present in ov...",27,508,Hum_Mutat_2014_Mar_20_35(3)_289-293.txt
p.Arg398Ser,The TUB p.Arg398Serfs*9 variant falls within the highly co...,29,9,Hum_Mutat_2014_Mar_20_35(3)_289-293.txt
p.Arg398Ser,"...ound that when transfected into HEK293 cells, the p.Arg398Serfs*9 variant was expressed but at a red...",29,396,Hum_Mutat_2014_Mar_20_35(3)_289-293.txt
p.Arg398Ser,"...the cytoplasm and at the plasma membrane, GFP–TUB p.Arg398Serfs*9 localized predominantly to the nuc...",29,587,Hum_Mutat_2014_Mar_20_35(3)_289-293.txt
p.Arg398Ser,...firmed this mislocalization; the level of GFP–TUB p.Arg398Serfs*9 was reduced in the plasma membrane...,29,736,Hum_Mutat_2014_Mar_20_35(3)_289-293.txt
p.Arg398Ser,"...in the chromatin-bound fraction (Fig.2D). GFP–TUB p.Arg398Serfs*9, but not WT, was also found in the...",29,860,Hum_Mutat_2014_Mar_20_35(3)_289-293.txt
p.Arg398Ser,"... not possible in humans, it is plausible that the p.Arg398Serfs*9 variant, which disrupts the C-term...",35,965,Hum_Mutat_2014_Mar_20_35(3)_289-293.txt
p.Asp388Glu,...dicted to cause the truncation of VILL protein to p.Asp388Glu.fs.*64 (Fig. 2E). The presence of this...,57,598,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
p.Ala1008Pro,"...dues Ala1008 and Asn1009, which harbor variations p.Ala1008Pro and p.Asn1009Lys, interact with NADP....",99,589,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,"...Asn1009, which harbor variations p.Ala1008Pro and p.Asn1009Lys, interact with NADP. H‐NNT residues h...",99,606,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.His365Pro,"...d in orange. B: Residue His365, which harbors the p.His365Pro substitution, is a rim interface resid...",104,371,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,"...e opposite domain I. C: Phe215, which harbors the p.Phe215Ser substitution, is a conserved interface...",104,520,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Arg27His,"p.Arg27His	1	Pro(50.0%), Arg(20.0%), Thr, Lys and ...",114,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Lys63Arg,"p.Lys63Arg	4	Lys(77.8%), Arg(16.7%), Gln(5.6%)	0.4...",115,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ser193Asn,p.Ser193Asn	9	Ser(100.0%)	0 D	0.754 Poss D	60 D	Li...,116,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly200Ser,p.Gly200Ser	9	Gly(100.0%)	0.02 D	0.252 T	90 D	Like...,117,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,p.Phe215Ser	9	Phe(100.0%)	0 D	1.00 D	47 Poss D	Lik...,118,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asp277Tyr,"p.Asp277Tyr	5	Asp(77.8%), Asn(16.7%), Pro(5.6%)	0 ...",119,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr357Ala,"p.Thr357Ala	8	Thr(88.9%), Ser(5.6%), Ile(5.6%)	0 D...",120,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.His365Pro,"p.His365Pro	1	His(61.1%), Val and Lys(11.1%), Tyr,...",121,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Tyr388Ser,"p.Tyr388Ser	7	Tyr(94.4%), Phe(5.6%)	0 D	1.00 D	85 ...",122,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Pro437Leu,"p.Pro437Leu	7	Pro(94.4%), Gly(5.6%)	0 D	0.942 Poss...",123,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala533Val,"p.Ala533Val	8	Ala(94.4%), Phe(5.6%)	0 D	0.986 D	80...",124,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr589Ser,"p.Thr589Ser	2*	Thr(62.5%), Asp(25.0%), Gln(6.3%), ...",125,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu663Phe,"p.Leu663Phe	5	Gly(77.8%), Phe(11.1%), Val(5.6%), L...",126,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly664Arg,p.Gly664Arg	8	Gly(100.0%)	0 D	1.00 D	56 D	Likely d...,127,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly678Arg,"p.Gly678Arg	1	Gly(61.1%), Leu(22.2%), Thr, Ser and...",128,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr731Met,"p.Thr731Met	1	Thr(52.9%), Glu(23.5%), Ala(11.8%), ...",129,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly862Asp,p.Gly862Asp	9	Gly(100.0%)	0 D	1.00 D	87 D	Likely d...,130,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu977Pro,p.Leu977Pro	9	Leu(100.0%)	0 D	1.00 D	92 D	Likely d...,131,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ile993Val,"p.Ile993Val	9	Ile(94.4%), Leu(5.6%)	0.04 D	0.804 p...",132,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala1008Pro,"p.Ala1008Pro	9	Ala(94.4%), Ser(5.6%)	0 D	1.00 D	94...",133,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,p.Asn1009Lys	9	Asn(100.0%)	0 D	1.00 D	84 D	Likely ...,134,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ser193Asn,"p.Ser193Asn, homozygous in FGD patient [Meimaridou...",138,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly200Ser,"p.Gly200Ser, homozygous in patients with combined ...",141,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,"p.Phe215Ser, homozygous in FGD patient [Yamaguchi ...",144,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asp277Tyr,"p.Asp277Tyr, identified in a patient with left ven...",147,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr357Ala,"p.Thr357Ala, found in compound heterozygosity in a...",150,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Met880Ter,"...d heterozygosity in an FGD patient in addition to p.Met880Ter, which is predicted to cause nonsense‐...",150,80,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.His365Pro,"p.His365Pro, homozygous in an FGD patient [Meimari...",153,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Tyr388Ser,"p.Tyr388Ser, reported in a patient with combined a...",156,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Pro437Leu,"p.Pro437Leu, found in compound heterozygosity in a...",159,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gln557Ter,"...d heterozygosity in an FGD patient in addition to p.Gln557Ter, which is predicted to cause nonsense‐...",159,80,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala533Val,"p.Ala533Val, homozygous in an FGD patient [Meimari...",162,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly664Arg,"p.Gly664Arg, found in compound heterozygosity in a...",165,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr689Leu,"...d heterozygosity in an FGD patient in addition to p.Thr689LeufsTer320, which is predicted to cause n...",165,80,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly678Arg,"p.Gly678Arg, found in a patient with FGD in compou...",168,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly862Asp,...ient with FGD in compound heterozygosity with the p.Gly862Asp change described below [Meimaridou et ...,168,78,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly862Asp,p.Gly862Asp Gly862 is an invariant residue located...,171,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu977Pro,"p.Leu977Pro, homozygous in an FGD patient [Meimari...",174,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala1008Pro,p.Ala1008Pro and p.Asn1009Lys. Both variations wer...,177,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,p.Ala1008Pro and p.Asn1009Lys. Both variations were found in patien...,177,18,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala1008Pro,"... Both variations were found in patients with FGD: p.Ala1008Pro was present in homozygosity, whereas ...",177,81,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,"...p.Ala1008Pro was present in homozygosity, whereas p.Asn1009Lys was in compound heterozygosity with p...",177,131,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.His370Ter,"... p.Asn1009Lys was in compound heterozygosity with p.His370Ter, which is predicted to cause nonsense‐...",177,180,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Lys63Arg,p.Lys63Arg	ENST00000264663.5:c.188A > G	PASS	Misse...,185,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu663Phe,p.Leu663Phe	ENST00000264663.5:c.1987C > T	PASS	Mis...,186,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ile993Val,p.Ile993Val	ENST00000264663.5:c.2977A > G	PASS	Mis...,187,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr731Met,p.Thr731Met	ENST00000264663.5:c.2192C > T	PASS	Mis...,188,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Arg27His,p.Arg27His	ENST00000264663.5:c.80G > A	PASS	Missen...,189,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr589Ser,p.Thr589Ser	ENST00000264663.5:c.1765A > T	PASS	Mis...,190,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Arg27His,p.Arg27His (rs34241095) Arg27 could not be mapped ...,192,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Arg27His,...anshydrogenases. Position 27 is not conserved and p.Arg27His is predicted benign by most prediction ...,192,264,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Lys63Arg,p.Lys63Arg (rs35201656) Lys63 is a positive surfac...,195,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Lys63Arg,"...n site, nor in proximity to NAD binding site. The p.Lys63Arg substitution is likely to be tolerated ...",195,235,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr589Ser,p.Thr589Ser (rs370370846) Thr589 is part of a loop...,198,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu663Phe,p.Leu663Phe (rs41271083) Leu663 is in the TM7 alph...,201,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr731Met,p.Thr731Met (rs75710404) Thr731 is part of a loop ...,204,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ile993Val,p.Ile993Val (rs78818665) Ile993 is located within ...,207,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala1008Pro,"...isms could only be identified for two variations (p.Ala1008Pro and p.Asn1009Lys), which are located ...",216,95,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,"...e identified for two variations (p.Ala1008Pro and p.Asn1009Lys), which are located in the NADP bindi...",216,112,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,"...ted [David and Sternberg 2015], as in the case of p.Phe215Ser",218,770,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly664Arg,"...to be the case for three variations in domain II (p.Gly664Arg, p.Gly678Arg, and p.Gly862Asp). We pre...",220,253,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly678Arg,"...e for three variations in domain II (p.Gly664Arg, p.Gly678Arg, and p.Gly862Asp). We predicted that t...",220,266,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly862Asp,"...tions in domain II (p.Gly664Arg, p.Gly678Arg, and p.Gly862Asp). We predicted that these substitution...",220,283,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.D806N,... and one deletion mutation. The missense mutation p.D806N was observed in four patients with hypospa...,13,145,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.Q1028Q,...o patients showed the presence of silent mutation p.Q1028Q present in exon 14. Another silent mutati...,13,253,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...1028Q present in exon 14. Another silent mutation p.T428T was observed in a patient with gonadal dys...,13,306,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...ients. The pathogenicity of the missense mutation p.D806N was carried out using in-silico approach. ...,13,488,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,"....999 indicating to be pathogenic mutation. Since, p.D806N mutation was found to be important residue...",13,809,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...n identified. The missense mutation (c.2416 G > A p.D806N; rs702689) was identified in exon 14 [Figu...,40,340,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.Q1028Q,...nts (2-4 and 7). The silent mutation (c.3084A > G p.Q1028Q; rs3822625) was also identified in patien...,40,475,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...; whereas the other silent mutation (c. 1284G > A p.T428T; rs832575) was identified in exon 6 [Figur...,40,609,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...romatogram showing the presence of mutations. (a) p.D806N mutation in exon 14 of mitogen activated p...,42,93,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.Q1028Q,... two nucleotides A (wild type) and G (mutant) (b) p.Q1028Q mutation in exon 14 of MAP3K1 (c) p.T428T...,42,350,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...t) (b) p.Q1028Q mutation in exon 14 of MAP3K1 (c) p.T428T heterozygous mutation in exon 6 of MAP3K1 ...,42,393,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,In-silico analysis of p.D806N missense mutation has been carried out to ...,44,23,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,... sequence alignment and weblogo revealed that the p.D806N was well conserved across species [Figure ...,44,1268,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...tation site. (a) A multiple sequence alignment of p.D806N mutation showing the conserved aspartate (...,46,175,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...aded box) (b) WebLogo showing the conservation of p.D806N mutation showing the conserved aspartate (...,46,315,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,"In four of our patients, a missense mutation p.D806N was identified in exon 14 which of caused ...",55,46,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.Q1028Q,A silent mutation (p.Q1028Q) was identified on exon 14 of MAP3K1 in p...,57,20,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...eletion mutation (p.T942ins) and silent mutation (p.T428T) were identified in patient 10. The clinic...,59,103,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.Pro62Arg,"...ct the basic domain. The sixth missense mutation, p.Pro62Arg, alters the PY motif in the transactiva...",47,1167,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
p.Cys39Gly,...re screened for the presence of a BRCA1 mutation (p.Cys39Gly). The overall carrier frequency was 1.6...,123,482,Int_J_Circumpolar_Health_2012_Aug_16_71_10_3402_ijch_v71i0_19155.txt
p.W557G,... the amino acid tryptophan by glycine (c.1669T >G;p.W557G) (arrow,38,1455,Int_J_Colorectal_Dis_2012_Jun_29_27(6)_689-700.txt
p.Val501Gly,"...87186Clinical StudyA Novel, Homozygous c.1502T>G (p.Val501Gly) Mutation in the Thyroid peroxidase Ge...",3,187,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...ine at a highly conserved amino acid residue 501 (p.Val501Gly). Other healthy family members were ei...,17,1121,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...yses using PolyPhen-2 and SIFT predicted that the p.Val501Gly mutation is functionally “damaging.” T...,17,1339,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,"... the mutant TPO. In conclusion, a novel mutation, p.Val501Gly, in the TPO gene was detected expandin...",17,1507,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,"...hus, Denmark). The potential functional impact of p.Val501Gly was predicted using Polymorphism Pheno...",36,161,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,... a homology model of the human TPO containing the p.Val501Gly mutation was also generated for struct...,38,645,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,"... change from valine to glycine at amino acid 501 (p.Val501Gly). In addition, other documented polymo...",42,223,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...yses using PolyPhen-2 and SIFT predicted that the p.Val501Gly mutation is functionally “possibly dam...,46,65,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...ing site (His-494) [32] were also detected in the p.Val501Gly mutant (Figure 5(c)),48,518,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...ere goitrous CH. Family members with heterozygous p.Val501Gly were asymptomatic supporting the reces...,51,331,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...analysis showed that the iron binding site of the p.Val501Gly mutant TPO is slightly exposed than th...,55,414,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,"...ide chain, due to Gly-501 lacking a side chain in p.Val501Gly mutant TPO, could alter the hydrophobi...",55,810,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Pro499Leu,"...terestingly, Rivolta et al. in 2003 reported that p.Pro499Leu mutation in the TPO which is also loca...",55,980,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...l activity of the protein. The mechanism by which p.Val501Gly in the TPO may induce MNG remains to b...,55,1238,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,"...onstrated a novel, homozygous c.1502T>G mutation (p.Val501Gly) in the TPO gene which could be associ...",58,72,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...substitution of valine by glycine at residue 501 (p.Val501Gly),66,400,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...mal species. The position of the mutated residue (p.Val501Gly) is indicated by the arrow. This figur...,70,264,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...w indicates the positions of the mutated residue (p.Val501Gly),72,270,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...Arg-503 are displayed in sticks for wild type and p.Val501Gly mutant TPO proteins. H-bonds are shown...,74,166,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...n arrow. (b) Ribbon presentation of wild type and p.Val501Gly mutant TPO proteins. The residues Val-...,74,361,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...eme (Glu-399) and iron (His-494) in wild type and p.Val501Gly mutant. Residues on the top layer are ...,74,982,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Q36H,"...ieck L  Chiesa A  Targovnik HM   Three mutations (p.Q36H, p.G418fsX482, and g.IVS19-2A>C) in the dua...",81,104,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Pro142His,"...Two non-conservative missense variants, c.425C>A (p.Pro142His",132,115,Int_J_Med_Sci_2008_Jul_8_5(4)_197-202.txt
p.Gly1358Lys,"and c.4072G>A (p.Gly1358Lys), and an intronic transversion with w...",133,32,Int_J_Med_Sci_2008_Jul_8_5(4)_197-202.txt
p.A348V,1	IDH3B	chr20:2640199	NM_174855	Exon11	c.1043C>T	p.A348V	Damaging	Het	–	AR	RP46,70,50,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.N1469D,ABCA4	chr1:94495135	NM_000350	Exon30	c.4405A>G	p.N1469D	Tolerated	Het	–	AR	CORD3/STGD1/RP19,72,49,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.R2210H,CEP290	chr12:88453691	NM_025114	Exon48	c.6629G>A	p.R2210H	Probably damaging	Het	–	AR	BBS14/LCA10,75,51,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.R17Q,CNGB1	chr16:58001141	NM_001135639	Exon2	c.50G>A	p.R17Q	Tolerated	Het	–	AR	RP45,76,50,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.P994A,EYS	chr6:65596602	NM_001142800	Exon19	c.2980C>G	p.P994A	Probably damaging	Het	0.0010	AR	RP25,77,50,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.R261H,HARS	chr5:140056309	NM_001289093	Exon7	c.782G>A	p.R261H	Tolerated	Het	0.0010	AD/AR	UHS3B,78,50,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.H361R,NR2E3	chr15:72106440	NM_014249	Exon8	c.1082A>G	p.H361R	Tolerated	Het	0.0023	AD/AR	RP37,79,49,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.A156V,OPA1	chr3:193336676	NM_130831	Exon4	c.467C>T	p.A156V	Probably damaging	Het	0.0103	AD	OPA1,80,47,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.V78M,...SEMA4A	chr1:156126297	NM_001193300	Exon3	c.232G>A	p.V78M	Probably damaging	Het	–	AD/AR	CORD10/RP35,81,52,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.E4784K,USH2A	chr1:215822102	NM_206933	Exon66	c.14350G>A	p.E4784K	Probably damaging	Het	–	AR	RP39,82,51,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.F329I,WFS1	chr4:6302507	NM_001145853	Exon8	c.985T>A	p.F329I	Probably damaging	Het	–	AD/AR	Wolfram synd...,83,48,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.R373C,...Carmona R  Zhang K  White E    The PROM1 mutation p.R373C causes an autosomal dominant bull's eye ma...,106,136,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.M337V,p.M337V-hTDP-43 mt-TAR5/6	M337V-hTDP-43	Thy 1.2	O	...,183,1,Int_J_Mol_Sci_2013_Oct_9_14(10)_20079-20111.txt
p.M337V,... Kumar-Singh S   Overexpression of ALS-associated p.M337V human TDP-43 in mice worsens disease featu...,316,155,Int_J_Mol_Sci_2013_Oct_9_14(10)_20079-20111.txt
p.Gly228Trp,...pulations. The only missense mutation 6 c.682T>G (p.Gly228Trp) was reported in an Italian family wit...,14,409,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
p.Arg257X,"c.769 C>T (p.Arg257X)	Finnish, Northern Italian	Nagamine et a...",97,12,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
p.Tyr85Cys,"c.254A>G (A374G, p.Tyr85Cys)	Iranian Jewish	Björses et al. (2000) [...",98,18,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
p.Arg139X,c.415C>T (p.Arg139X)	Sardinia	Meloni et al. (2012) [1],105,11,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
p.Y77X,...on instead of tyrosine at amino acid position 77 (p.Y77X),42,847,Int_J_Pediatr_Endocrinol_2011_Jul_6_2011(1)_5.txt
p.Cys191Tyr,...She was found to carry a known mutation c.572G>A (p.Cys191Tyr) in the SDHB gene. This case illustrat...,5,1180,Int_J_Pediatr_Endocrinol_2013_Oct_3_2013(Suppl_1)_P112.txt
p.Val259Phe,...g of a heterozygous HNF-1α NM 000545.5: c.775G>T (p.Val259Phe) mutation. She and her mother now succ...,9,146,Int_J_Pediatr_Endocrinol_2015_Apr_28_2015(Suppl_1)_P19.txt
p.Val259Phe,...3 with heterozygous HNF-1α NM 000545.5: c.775G>T (p.Val259Phe) mutation. The patient was initiated o...,16,136,Int_J_Pediatr_Endocrinol_2015_Apr_28_2015(Suppl_1)_P19.txt
p.L33P,"...in GPIIIa gene causes an amino acid substitution (p.L33P), leads to the creation of two distinct for...",27,535,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
p.G202R,"...tion 202 in exon 6 of the ABCA3 gene (c.604G > A; p.G202R). Furthermore, 70 normal individuals have ...",7,306,Iran_J_Pediatr_2016_Mar_5_26(2)_e2493.txt
p.Gly202Arg,"...cid exchange of glycine to argenine at codon 202 (p.Gly202Arg/G202R). In this way, his healthy paren...",221,260,Iran_J_Pediatr_2016_Mar_5_26(2)_e2493.txt
p.R249S,...DA  Shi H  Hautefeuille AH    Effects of the TP53 p.R249S mutant on proliferation and clonogenic pro...,237,60,ISRN_Oncol_2012_May_13_2012_421673.txt
p.Ser2Gly,"...riant mutation in SHOC2, c.4A > G, predicting the p.Ser2Gly change in the encoded protein, underlies...",12,105,Ital_J_Pediatr_2012_Sep_20_38_48.txt
p.Ser2Gly,"...esence of the disease-causing mutation (c.4A > G, p.Ser2Gly), thus confirming diagnosis of NS/LAH. A...",45,339,Ital_J_Pediatr_2012_Sep_20_38_48.txt
p.Ser2Gly,"...esence of the disease-causing mutation (c.4A > G, p.Ser2Gly)",66,174,Ital_J_Pediatr_2012_Sep_20_38_48.txt
p.Val244Leu,...on 23710.1186/s13052-016-0237-8Case ReportA novel p.Val244Leu mutation in MFN2 leads to Charcot-Mari...,3,136,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,...ntified a novel heterozygous mutation c.730G > C (p.Val244Leu) in MFN2 in the patient but not in his...,8,580,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,...his mutation likely occurred de novo. c.730G > C (p.Val244Leu) in MFN2 is a likely pathogenic mutati...,8,707,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,The c.730G > C (p.Val244Leu) mutation in MFN2 is a likely pathogen...,11,17,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Met,...0th nucleotide in the encoding region (c.730G > A/p.Val244Met) [8],19,599,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,"...ntified a novel heterozygous mutation c.730G > C (p.Val244Leu) in MFN2, which occurred de novo",21,212,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,...ntified a novel heterozygous mutation c.730G > C (p.Val244Leu) in MFN2. This mutation was not presen...,50,204,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Met,"...with specific clinical features [11]. c.730G > A (p.Val244Met), a mutation occurring at the same pos...",53,942,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,"... leucine and may affect protein features. Second, p.Val244Leu in MFN2 was predicted to be disease-ca...",55,338,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Met,"...causing mutation at the same position (c.730G > A/p.Val244Met). In summary, the de novo pattern is c...",55,680,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,The c.730G > C (p.Val244Leu) mutation in MFN2 is a likely pathogen...,61,17,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.His586Pro,"...e patient, predicting the amino acid substitution p.His586Pro in the desmoplakin polypeptide",13,205,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.His586Pro,...rough a Django interface. The desmoplakin variant p.His586Pro was confirmed by means of Sanger seque...,40,998,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.His586Pro,...) predicting the amino acid substitution mutation p.His586Pro in the desmoplakin polypeptide,52,813,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Asp2070Asn,"...issense SNP in DSP, predicting the protein change p.Asp2070Asn (Table I). This SNP (rs41302885) was ...",56,144,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.His586Pro,...are consistent with the de novo missense mutation p.His586Pro in DSP being the causative genetic les...,58,659,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.His586Pro,"...he arrow), predicting the amino acid substitution p.His586Pro at the protein level. C, Primary struc...",98,334,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.His586Pro,...3 major domains of the protein are indicated. The p.His586Pro mutation lies within the plakin domain...,98,484,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Asp2070N,DSP	Desmoplakin	p.Asp2070N	Het	rs41302885	0.0026,109,17,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.His586Pro,p.His586Pro	Het	None	None,110,3,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Met11Val,DSG1	Desmoglein 1	p.Met11Val	Hom	rs1426310	0.3626,111,19,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Ile293Val,DSG2	Desmoglein 2	p.Ile293Val	Het	rs2230234	0.0323,112,19,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Arg773Lys,p.Arg773Lys	Het	rs2278792	0.2400,113,3,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Thr912Ala,DSG3	Desmoglein 3	p.Thr912Ala	Hom	rs1380866	0.0008,114,19,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Ile644Leu,DSG4	Desmoglein 4	p.Ile644Leu	Hom	rs4799570	0.0341,115,19,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Met659Thr,DSC1	Desmocollin 1	p.Met659Thr	Het	rs28620831	0.0220,116,20,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Cys848Phe,p.Cys848Phe	Het	rs985861	0.0933,117,3,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Ile776Val,DSC2	Desmocollin 2	p.Ile776Val	Het	rs1893963	0.1965,118,20,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Arg142His,JUP	Plakoglobin	p.Arg142His	Het	rs41283425	0.0240,120,17,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Met697Leu,p.Met697Leu	Hom	rs1126821	0.4167,121,3,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Gly95Arg,PKP3	Plakophilin 3	p.Gly95Arg	Het	rs11246148	0.3608,124,20,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Gln433Arg,EVPL	Envoplakin	p.Gln433Arg	Het	rs2071192	0.3241,127,17,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Ser4Asn,EVPLL	Envoplakin-like	p.Ser4Asn	Het	rs570145	0.4766,128,23,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Arg819Ser,PPL	Periplakin	p.Arg819Ser	Hom	rs2734742	0.0617,129,16,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Ala1007Val,p.Ala1007Val	Het	rs2075639	0.1194,130,3,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Asp263His,"...quencing cohort): 4 different missense mutations, p.Asp263His (family 3), p.Arg300Trp (families 2, 4...",60,518,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,"...erent missense mutations, p.Asp263His (family 3), p.Arg300Trp (families 2, 4, 5, 11), p.Ile322Thr (f...",60,542,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Ile322Thr,"...s (family 3), p.Arg300Trp (families 2, 4, 5, 11), p.Ile322Thr (family 10), p.Leu401Pro (family 8); 1...",60,578,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Leu401Pro,"... (families 2, 4, 5, 11), p.Ile322Thr (family 10), p.Leu401Pro (family 8); 1 nonsense mutation, p.Tyr...",60,603,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Tyr365*,"...10), p.Leu401Pro (family 8); 1 nonsense mutation, p.Tyr365* (family 6); and 2 single-base deletions ...",60,648,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Leu386Arg,"...leading to a frameshift and premature stop codon, p.Leu386Argfs*21 (family 7) and p.Asn235Metfs*11 (...",60,748,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asn235Met,"...ature stop codon, p.Leu386Argfs*21 (family 7) and p.Asn235Metfs*11 (family 9) (Figure 3). All missen...",60,780,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,... Taster (33). The 2 missense mutations in exon 5 (p.Asp263His and p.Arg300Trp) both affect highly co...,60,970,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,...e 2 missense mutations in exon 5 (p.Asp263His and p.Arg300Trp) both affect highly conserved amino ac...,60,986,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,"... TGFB1, TGFB2, and TGFB3 proteins (Figure 3). The p.Asp263His alteration disrupts the Arg-Gly-Asp (R...",60,1172,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,"(36). The second missense mutation in exon 5, p.Arg300Trp, affects the last amino acid of the LA...",61,47,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Ile322Thr,"...ic aneurysms (8). The 2 other missense mutations, p.Ile322Thr and p.Leu401Pro, affect highly conserv...",61,380,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Leu401Pro,".... The 2 other missense mutations, p.Ile322Thr and p.Leu401Pro, affect highly conserved amino acids l...",61,396,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Tyr365*,"...omes, and the Genome of the Netherlands. Although p.Tyr365* in family 6 occurred de novo, we previou...",63,215,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Ala250Thr,"...e novo, we previously identified a SMAD3 variant (p.Ala250Thr) of unknown significance in the proban...",63,297,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,"Missense mutations p.Arg300Trp, p.Ile322Thr, and p.Leu401Pro are also...",67,20,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Ile322Thr,"Missense mutations p.Arg300Trp, p.Ile322Thr, and p.Leu401Pro are also predicted to...",67,33,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Leu401Pro,"Missense mutations p.Arg300Trp, p.Ile322Thr, and p.Leu401Pro are also predicted to alter TGFB3 func...",67,50,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,We subsequently investigated the effect of the p.Asp263His mutation on aortic wall architecture a...,73,48,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,"...rtic wall of a patient carrying a TGFB3 mutation (p.Asp263His), we performed immunohistochemical ana...",75,91,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg263His,"...sting that the TGFB3 mutation disrupting the RGD (p.Arg263His) might also lead to LOF. Similarly, mo...",80,526,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Cys409Tyr,"...ypothesized that the mutated, inactivated allele (p.Cys409Tyr) leads to a nonfunctional protein, dec...",80,1379,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,"...s on height, as 1 patient in this study (3-III:1, p.Asp263His) has short stature and received growth...",82,102,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Cys409Tyr,...and the patient reported by Rienhoff et al. (16) (p.Cys409Tyr) presented with short stature (5th per...,82,235,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,"...d proteins is given for the 4 missense mutations (p.Arg300Trp: Family 2, 4, 5 and 11; p.Asp263His: F...",125,307,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,"...se mutations (p.Arg300Trp: Family 2, 4, 5 and 11; p.Asp263His: Family 3; p.Leu401Pro: Family 8; p.Il...",125,343,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Leu401Pro,"...rp: Family 2, 4, 5 and 11; p.Asp263His: Family 3; p.Leu401Pro: Family 8; p.Ile322Thr: Family 10). Pr...",125,366,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Ile322Thr,...11; p.Asp263His: Family 3; p.Leu401Pro: Family 8; p.Ile322Thr: Family 10). Previously published muta...,125,389,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Leu386Arg,... mutation are in purple. Residues affected by the p.Leu386Argfs21* mutation are in yellow (note that...,129,192,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Tyr365*,... that cannot be modeled). Residues deleted by the p.Tyr365* mutation are shown in orange and yellow ...,129,338,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asn235Met,...s following Tyr365). Residues deleted by mutation p.Asn235Metfs*11 are shown in grey-olive in the se...,129,482,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,"...es, which cannot be modeled). The point mutations p.Asp263His, p.Arg300Trp, p.Ile322Thr, and p.Leu40...",129,653,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,"...not be modeled). The point mutations p.Asp263His, p.Arg300Trp, p.Ile322Thr, and p.Leu401Pro are show...",129,666,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Ile322Thr,"...d). The point mutations p.Asp263His, p.Arg300Trp, p.Ile322Thr, and p.Leu401Pro are shown in red with...",129,679,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Leu401Pro,"...ations p.Asp263His, p.Arg300Trp, p.Ile322Thr, and p.Leu401Pro are shown in red with their side chain...",129,696,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Arg300Trp,"... whereas the mutant side chain is in red. For the p.Arg300Trp mutation, side chains of nearby negati...",129,951,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Leu401Pro,"... nearby negative residues are also shown. For the p.Leu401Pro mutation, nearby hydrophobic residues ...",129,1037,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,... in a Human Subject With TGFB3 Mutation (3-III:1; p.Asp263His,131,141,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Q463X,"...yosin-binding protein C (MYBPC3) gene (c.1387C>T, p.Q463X) (Figure5A) was identified in patient III4...",72,75,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
p.E334K,"... 4 carried a missense MYBPC3 mutation (c.1000G>A, p.E334K) (Figure5B), which was already described t...",72,779,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
p.E334K,"....1387C>T, p. Q463X) and (B) patient 4 (c.1000G>A, p.E334K)",74,141,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
p.Arg240*,"... resulting in a change of arginine to stop codon (p.Arg240*). In patients p4 and p7, another heteroz...",73,370,J_Appl_Genet_2013_Aug_13_54(3)_345-351.txt
p.Arg317*,"...s in a premature termination of the PAX6 protein (p.Arg317*). According to the database, the identif...",73,590,J_Appl_Genet_2013_Aug_13_54(3)_345-351.txt
p.Arg240*,... al. 2009). The heterozygous mutation c.718C > T (p.Arg240*) in patient p1 occurred in the protein H...,103,432,J_Appl_Genet_2013_Aug_13_54(3)_345-351.txt
p.Arg317*,"..., identical heterozygous substitution c.949C > T (p.Arg317*) in the PST domain coding region was dis...",103,572,J_Appl_Genet_2013_Aug_13_54(3)_345-351.txt
p.W658X,...g a nonsense heterozygous point mutation c.G1974A(p.W658X) in the TP63 gen,45,3392,J_Appl_Genet_2014_Oct_27_55(1)_105-115.txt
p.R332W,"...8), who identified a homozygous missense variant (p.R332W) in all affected members of the Turkish co...",72,755,J_Appl_Genet_2014_Oct_27_55(1)_105-115.txt
p.T329R,...tly reported novel homozygous mutation in WNT10B (p.T329R) was detected in a consanguineous Pakistan...,72,1712,J_Appl_Genet_2014_Oct_27_55(1)_105-115.txt
p.I12T,"...er D1S1661 were obtained. BSND mutation, that is, p.I12T, cosegregated in all extant members of our ...",15,1064,J_Biomed_Biotechnol_2011_Apr_4_2011_304612.txt
p.I12T,"...ion 12 (I12T) (Figure 2). BSND mutation; that is, p.I12T cosegregated in all extant members of the p...",50,1145,J_Biomed_Biotechnol_2011_Apr_4_2011_304612.txt
p.Thr173Met,"...Two novel missense LRP5 HBM mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) were identi...",51,735,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"...BM mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) were identified, plus three previous...",51,760,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"...usly reported missense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; ...",51,858,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...P5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated ...",51,883,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"...p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated with HBM in 11 adults fro...",51,908,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ser177X,...el heterozygous nonsense SOST mutation (c.530C>A; p.Ser177X) predicted to prematurely truncate scler...,51,1323,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,...onsequent effect on SOST‐LRP5 binding. We predict p.Asn198Ser and p.Ala242Thr directly disrupt SOST ...,51,1552,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,... on SOST‐LRP5 binding. We predict p.Asn198Ser and p.Ala242Thr directly disrupt SOST binding; both co...,51,1568,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"... disruptive structural alterations predicted from p.Arg266Cys, p.Thr173Met, and p.Gln89Arg were asso...",51,1756,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"...tructural alterations predicted from p.Arg266Cys, p.Thr173Met, and p.Gln89Arg were associated with l...",51,1769,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"...ions predicted from p.Arg266Cys, p.Thr173Met, and p.Gln89Arg were associated with less severe phenot...",51,1786,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"...ied two novel missense LRP5 mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) as well as ...",81,61,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"...P5 mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) as well as three previously reported...",81,86,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"...usly reported missense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; ...",81,173,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...P5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated ...",81,198,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"...p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated with HBM in 11 adults amo...",81,223,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,... Information S5). He has a heterozygous c.593A>G; p.Asn198Ser mutation that is predicted to be funct...,350,64,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,...rkedly thickened skull in male aged 30 years with p.Asn198Ser substitution (pedigree 1). (B) Mandibl...,352,136,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,...Mandible enlargement in female aged 49 years with p.Ala242Thr substitution (pedigree 2). (C) Asymmet...,352,229,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,...V and VII impairment in female aged 21 years with p.Ala242Thr substitution (pedigree 3),352,386,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...s, Inc.The most frequent LRP5 mutation, c.724G>A; p.Ala242Thr, was identified in three unrelated fam...",354,84,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"..., C). Interestingly, the novel mutation c.796C>T; p.Arg266Cys, was identified in a 65 year old man w...",355,52,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,A heterozygous c.266A>G; p.Gln89Arg mutation was identified in an active ma...,357,26,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,...hritis; he has never fractured. A novel c.518C>T; p.Thr173Met mutation was identified in a man aged ...,357,170,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,The p.Asn198Ser mutation directly affects the SOST int...,360,5,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,B). The similarly severe p.Ala242Thr mutation is predicted instead to disru...,362,26,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,...acking in this region is favored. The site of the p.Ala242Thr mutation is only 10 Å from the SOST pe...,363,153,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"...dels of the LRP5‐SOST complex (A) with mutations; p.Asn198Ser (B), p.Ala242Thr (C), p.Arg266Cys (D),...",365,73,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...SOST complex (A) with mutations; p.Asn198Ser (B), p.Ala242Thr (C), p.Arg266Cys (D), p.Gln89Arg (E), ...",365,90,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"...with mutations; p.Asn198Ser (B), p.Ala242Thr (C), p.Arg266Cys (D), p.Gln89Arg (E), and p.Thr173Met (...",365,107,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"....Asn198Ser (B), p.Ala242Thr (C), p.Arg266Cys (D), p.Gln89Arg (E), and p.Thr173Met (F)",365,124,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"...a242Thr (C), p.Arg266Cys (D), p.Gln89Arg (E), and p.Thr173Met (F)",365,144,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"...ight © 2015 Wiley Periodicals, Inc.The mutations, p.Arg266Cys, p.Gln89Arg, and p.Thr173Met, were ass...",367,56,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"...iley Periodicals, Inc.The mutations, p.Arg266Cys, p.Gln89Arg, and p.Thr173Met, were associated with ...",367,69,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"..., Inc.The mutations, p.Arg266Cys, p.Gln89Arg, and p.Thr173Met, were associated with less severe HBM ...",367,85,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,The p.Gln89Arg mutation introduces an arginine side ch...,371,5,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,... the mutant arginine side chain can be tolerated. p.Gln89Arg is a reported SNP (rs41494349) with min...,372,90,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,The p.Thr173Met mutation site lies in one of the β‐pro...,374,5,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"...enotypes associated with individuals carrying the p.Arg266Cys, p.Gln89Arg, and p.Thr173Met mutations...",375,152,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"...ciated with individuals carrying the p.Arg266Cys, p.Gln89Arg, and p.Thr173Met mutations may be due t...",375,165,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"...viduals carrying the p.Arg266Cys, p.Gln89Arg, and p.Thr173Met mutations may be due to less disruptiv...",375,181,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ser177X,...eterozygous nonsense variant in exon 2 (c.530C>A; p.Ser177X) in a woman aged 70 years who reported d...,378,74,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Val10Ile,"...n exon 1 in eight HBM cases (rs17882143, c.28G>A; p.Val10Ile, MAF T = 0.047%), predicted to be benig...",380,99,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"... functional consequences presented here. The LRP5 p.Asn198Ser mutation, seen in our most extreme HBM...",388,191,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...e in LRP5 HBM.43 Our most frequent LRP5 mutation (p.Ala242Thr), associated with BMD Z‐scores +3.1 to...",388,765,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,We identified an isolated HBM case with an LRP5 p.Arg266Cys variant; although having an allocated ...,390,49,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,LRP5 mutation p.Gln89Arg was identified in one HBM case (no DNA ...,393,15,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,... DNA was available from relatives). Interestingly p.Gln89Arg was also identified in one of the first...,393,110,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"...AF 8% in the Japanese population.45 Subsequently, p.Gln89Arg was associated with lower (not higher) ...",393,289,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,...s.48 Importantly functional analyses suggest that p.Gln89Arg does not play a functional role in cano...,393,675,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,...tional role in canonical Wnt signaling.49 Whether p.Gln89Arg shares a rare haplotype with a function...,393,756,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"LRP5 mutation p.Thr173Met, identified in one isolated HBM case, ...",396,15,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"...nly previous LRP5 protein modeling to date (using p.Asn198Ser and p.Ala242Thr mutations, although wi...",398,176,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...5 protein modeling to date (using p.Asn198Ser and p.Ala242Thr mutations, although without modeling t...",398,192,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"...ctions.41 Furthermore, functional studies support p.Asn198Ser diminishing LRP5‐SOST binding; althoug...",398,487,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"...to be maximal. Interestingly, two LRP5 HBM cases (p.Arg266Cys; p.Asn198Ser) still had high BMD despi...",400,1251,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,".... Interestingly, two LRP5 HBM cases (p.Arg266Cys; p.Asn198Ser) still had high BMD despite long‐term ...",400,1264,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.L450X,... gene that caused truncation of the Wip1 protein (p.L450,111,56,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
p.R458X,in HCT116 and p.R458X in U2OS cells; Fig.,112,15,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
p.R458X,"S1). All identified Wip1-truncating mutations (p.R458X, p.L484X",290,48,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
p.L484X,"...ll identified Wip1-truncating mutations (p.R458X, p.L484X",290,57,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
p.K535X,"p.K535X, and p.F534X) and showed a striking simila...",291,1,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
p.F534X,"p.K535X, and p.F534X) and showed a striking similarity to mutat...",291,14,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
p.R59H,...atients: possible common origin for the prevalent p.R59H mutation among gypsies Hum Mutat 2006 27 10...,102,234,J_Cell_Mol_Med_2008_Sep_14_12(5a)_1661-1671.txt
p.F99S,...dysfunctional as well due to a missense mutation (p.F99S) or normal (henceforth designated XPB−/− an...,24,242,J_Cell_Mol_Med_2010_Oct_16_Jan-Feb_14(1-2)_403-416.txt
p.F99S,...ical differences among XPB patients with the same p.F99S mutation. Primary human diploid fibroblasts...,24,421,J_Cell_Mol_Med_2010_Oct_16_Jan-Feb_14(1-2)_403-416.txt
p.E1099K,"... than one thousand paediatric cancer genomes, NSD2p.E1099K alteration was detected in 14% of t(12;21...",72,75,J_Cell_Mol_Med_2014_Jul_9_18(7)_1239-1246.txt
p.Glu1099Lys,"...e 36 (H3K36) dimethylation. Interestingly, an NSD2p.Glu1099Lys (p.E1099K) variant was also detected ...",72,331,J_Cell_Mol_Med_2014_Jul_9_18(7)_1239-1246.txt
p.E1099K,"...imethylation. Interestingly, an NSD2p.Glu1099Lys (p.E1099K) variant was also detected in non-translo...",72,345,J_Cell_Mol_Med_2014_Jul_9_18(7)_1239-1246.txt
p.E1099K,"...nd to harbour somatic mutations in NSD2, with the p.E1099K alteration being most prevalent (15/19 ca...",72,1138,J_Cell_Mol_Med_2014_Jul_9_18(7)_1239-1246.txt
p.Tyr4864His,...vealed a novel heterozygous mutation [c.14590T>C (p.Tyr4864His)] in exon 101 (Fig. 1B). This mutatio...,26,436,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.Arg4893Gln,...1 revealed the heterozygous mutation [c.14678G>A (p.Arg4893Gln)] in exon 102 (Fig. 1B). This mutatio...,33,162,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.Tyr4864His,"To the best of our knowledge, the p.Tyr4864His mutation identified in case 1 of this...",40,35,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.Tyr4864Cys,... missense mutation affecting the same amino acid (p.Tyr4864Cys) has been reported previously in an E...,40,170,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.Arg4893Gln,...so had facial muscle weakness.6 A known mutation (p.Arg4893Gln) of case 2 has previously been found ...,40,553,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.Arg4893Trp,"... different amino acid change of the same residue (p.Arg4893Trp) presented as respiratory impairment,...",40,872,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.K659E,"154	55	OC	Endometrioid	IA	G1	FGFR2 p.K659E, c.1975T>C	FGFR2 p.K659E, c.1975T>C (1)",38,36,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.K659E,"...Endometrioid	IA	G1	FGFR2 p.K659E, c.1975T>C	FGFR2 p.K659E, c.1975T>C (1)",38,61,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H1047R,"155	45	OC	Serous	IC	G1	PIK3CA p.H1047R, c.3140A>G	PIK3CA p.H1047R, c.3140A>G (3)...",39,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H1047R,"...OC	Serous	IC	G1	PIK3CA p.H1047R, c.3140A>G	PIK3CA p.H1047R, c.3140A>G (3)",39,58,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R248Q,"152	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,30,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R248Q,"...2	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,53,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H168R,"140	44	OC	Serous	IIIA	G3	TP53 p.H168R, c.503A>G	TP53 p.H168R, c.503A>G (3)",41,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H168R,"...	44	OC	Serous	IIIA	G3	TP53 p.H168R, c.503A>G	TP53 p.H168R, c.503A>G (3)",41,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.V272E,"149	57	OC	Serous	IIIA	G3	TP53 p.V272E, c.815T>A	TP53 p.V272E, c.815T>A (3)",42,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.V272E,"...	57	OC	Serous	IIIA	G3	TP53 p.V272E, c.815T>A	TP53 p.V272E, c.815T>A (3)",42,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.V216M,"148	71	OC	Serous	IIIB	G3	TP53 p.V216M, c.646G>A	TP53 p.V216M, c.646G>A (1)",43,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.V216M,"...	71	OC	Serous	IIIB	G3	TP53 p.V216M, c.646G>A	TP53 p.V216M, c.646G>A (1)",43,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.C135Y,"143	52	OC	Serous	IIIC	G3	TP53 p.C135Y, c.404G>A	TP53 p.L194R, c.581T>G (3)",45,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.L194R,"...	52	OC	Serous	IIIC	G3	TP53 p.C135Y, c.404G>A	TP53 p.L194R, c.581T>G (3)",45,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G245V,"158	49	OC	Serous	IIIC	G3	TP53 p.G245V, c.734G>T	TP53 p.G245V, c.734G>T (3)",46,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G245V,"...	49	OC	Serous	IIIC	G3	TP53 p.G245V, c.734G>T	TP53 p.G245V, c.734G>T (3)",46,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.W257C,"130	72	OC	Serous	IIIC	G2	PPP2R1A p.W257C, c.771G>T	PPP2R1A p.W257C, c.771G>T (1)",47,34,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.W257C,"...	Serous	IIIC	G2	PPP2R1A p.W257C, c.771G>T	PPP2R1A p.W257C, c.771G>T (1)",47,60,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.M237I,"132	64	OC	Serous	IIIC	G2	NA	TP53 p.M237I, c.711G>C (1)",48,34,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H193P,"139	70	OC	Serous	IIIC	G3	TP53 p.H193P, c.578A>C	TP53 p.H193P, c.578A>C (1)",49,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H193P,"...	70	OC	Serous	IIIC	G3	TP53 p.H193P, c.578A>C	TP53 p.H193P, c.578A>C (1)",49,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G245S,"144	43	OC	Serous	IIIC	G3	TP53 p.G245S, c.733G>A	KRAS p.G12C, c.34G>T (1)",50,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12C,"...	43	OC	Serous	IIIC	G3	TP53 p.G245S, c.733G>A	KRAS p.G12C, c.34G>T (1)",50,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R273H,"168	58	OC	Serous	IIIC	G3	TP53 p.R273H, c.818G>A	TP53 p.R273H, c.818G>A (1)",52,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R273H,"...	58	OC	Serous	IIIC	G3	TP53 p.R273H, c.818G>A	TP53 p.R273H, c.818G>A (1)",52,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12A,"197	73	OC	Serous	IIIC	G3	NA	KRAS p.G12A, c.35G>C (1)",53,34,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H179R,"137	61	OC	Serous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H179R,"...	61	OC	Serous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.Q61R,"...C	Malignant mixed Müllerian tumor	IIIC	G3	NA	NRAS p.Q61R, c.182A>G (1)",55,59,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.T1025N,"...gnant mixed Müllerian tumor	IIIA1(i)	G3	NA	PIK3CA p.T1025N, c.3074C>A (1)",56,65,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G13D,"...31	55	OC	Endometrioid, partly serous	IIIC	G2	KRAS p.G13D, c.38G>A	KRAS p.G13D, c.38G>A (1)",57,52,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G13D,"..., partly serous	IIIC	G2	KRAS p.G13D, c.38G>A	KRAS p.G13D, c.38G>A (1)",57,73,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12D,"147	60	OC	Endometrioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,37,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12D,"...OC	Endometrioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,58,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.A159I,"204	61	OC	Clear cell	IIIC	G3	NA	TP53 p.A159I, c.475_476GC>AT (1)",59,38,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.M1004V,"198	59	OC	Serous	IVB	G3	NA	PIK3CA p.M1004V, c.3010A>G (1)",60,35,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G262V,"172	55	OC	Serous	IV	G3	NA	TP53 p.G262V, c.785G>T (1)",61,32,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.E17K,"...1	OC LMP	Serous low malignant potential			NA	AKT1 p.E17K, c.49G>A (1)",62,56,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R282W,"...a	Signet ring carcinoma, spread in ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,64,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R282W,"..., spread in ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,87,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R130*,"199	73	EC	EC	IA	G2	PTEN p.R130*, c.388C>T	PTEN p.R130*, c.388C>T (1)",65,25,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R130*,"199	73	EC	EC	IA	G2	PTEN p.R130*, c.388C>T	PTEN p.R130*, c.388C>T (1)",65,48,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H1047Y,"200	70	EC	EC	IA	G2	PIK3CA p.H1047Y, c.3139C>T	PIK3CA p.H1047Y, c.3139C>T (1)...",66,27,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H1047Y,"...	70	EC	EC	IA	G2	PIK3CA p.H1047Y, c.3139C>T	PIK3CA p.H1047Y, c.3139C>T (1)",66,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.Q1469*,"201	70	EC	EC	IA	G2	APC p.Q1469*, c.4405C>T	APC p.Q1469*, c.4405C>T (1)",67,24,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.Q1469*,"201	70	EC	EC	IA	G2	APC p.Q1469*, c.4405C>T	APC p.Q1469*, c.4405C>T (1)",67,48,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.Y315*,"202	63	EC	EC	IA	G1	NA	PTEN p.Y315*, c.945T>A (1)",68,28,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.S37F,"203	55	EC	EC	IA	G1	NA	CTNNB1 p.S37F, c.110C>T (1)",69,30,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R505S,"165	61	B	Fibroma			NA	FBXW7 p.R505S, c.1513C>A (1)",70,29,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12V,"175	50	B	Ovarian cyst, teratoma			—	KRAS p.G12V, c.35G>T (1)",71,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12C,"177	31	B	Secondary infertility			NA	KRAS p.G12C, c.34G>T (1)",72,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12C,"178	46	B	Uterus myomatosus, ovarian cyst			—	KRAS p.G12C, c.34G>T (1)",73,51,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12V,"...infertility, polyp of the cervix mucosa			NA	KRAS p.G12V, c.35G>T (1)",74,70,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12V,"184	78	B	Ovarian cyst			—	KRAS p.G12V, c.35G>T (1)",75,32,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R348*,"190	58	B	Teratoma			—	PIK3R1 p.R348*, c.1042C>T (1)",76,30,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12D,"193	54	B	Inclusion cysts			—	KRAS p.G12D, c.35G>A (1)",77,35,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.C242F,"...	39	BC	Breast cancer, uterine leiomyoma			NA	TP53 p.C242F, c.725G>T (1)	Germline mutation",78,55,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.N239D,"...ing carcinoma, squamous cell carcinoma)			NA	TP53 p.N239D, c.715A>G (1)	Two or more malignant tumors...",79,116,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.C176Y,"150	51	OC	Serous	IIIC	G3	TP53 p.C176Y, c.527G>A	—",81,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.C238R,"163	67	OC	Serous	IIIC	G3	TP53 p.C238R, c.712T>C	—",82,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R342*,"174	69	OC	Serous	IV	G3	TP53 p.R342*, c.1024C>T	—",85,29,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.Q104*,"142*	58	OC	Serous	IIIC	G2	TP53 p.Q104*, c.310C>T	—	Tubal ligation",108,32,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.L194R,"...issue specimen. For patient 143, a mutation (TP53 p.L194R) was found that was present in a metastati...",138,372,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.Ala726Thr,"...reported (25) paternally inherited ABCC8 variant (p.Ala726Thr), but current evidence suggests that t...",112,783,J_Clin_Res_Pediatr_Endocrinol_2016_Jun_6_8(2)_197-204.txt
p.V600E,...nventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations BMC Cancer ...,183,285,J_Exp_Clin_Cancer_Res_2014_May_21_33(1)_44.txt
p.V600E,...r sequencing for the detection of p.V600E and non-p.V600E BRAF mutations BMC Cancer 2014 14 13 10.11...,183,301,J_Exp_Clin_Cancer_Res_2014_May_21_33(1)_44.txt
p.F858L,...variant [15] in one patient and the c.2572 T > C (p.F858L) missense mutation [16] in other two patie...,29,576,J_Exp_Clin_Cancer_Res_2016_Sep_6_35(1)_135.txt
p.Ser49Cys,...exander BH  Doody MM    The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cance...,287,109,J_Exp_Clin_Cancer_Res_2016_Sep_6_35(1)_135.txt
p.Arg63Trp,...19110.1084/jem.20102191Brief Definitive ReportThe p.Arg63Trp polymorphism controls Vav1 functions an...,3,174,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Arg63Trp,... the substitution of an arginine by a tryptophan (p.Arg63Trp). This p.Arg63Trp polymorphism is assoc...,9,588,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Arg63Trp,...of an arginine by a tryptophan (p.Arg63Trp). This p.Arg63Trp polymorphism is associated with increas...,9,606,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Arg63Trp,...on of an arginine by a tryptophan at position 63 (p.Arg63Trp or R63W). Associated with this substitu...,15,564,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Arg63Trp,"... in the N-terminal calponin homology (CH) domain (p.Arg63Trp or R63W). Altogether, these results str...",29,1919,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Thr1356Ala,C3	Ex32/c.4109 A>G	p.Thr1356Ala	G	A	A	A	A	G	A,41,20,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Arg63Trp,Vav1a	Ex1/c.244 C>Ta	p.Arg63Trpa	T	C	C	C	C	C	C,48,22,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.L1206V,ATM	c.3616T>G	p.L1206V	10	Tolerated	Benign,31,15,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Y1216H,ATM	c.3646T>C	p.Y1216H	12	Tolerated	Damaging (probably),32,15,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.V849A,BRCA2	c.2546T>C	p.V849A	33	Tolerated	Benign,33,17,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.M3322I,BRCA2	c.9966G>T	p.M3322I	36	Tolerated	Damaging (probably),34,17,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Q336L,CHEK2	c.1007A>T	p.Q336L	54	Damaging	Benign,35,17,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.A9G,DDB1	c.26C>G	p.A9G	86	Damaging	Damaging (possibly),37,14,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.K471R,EXO1	c.1412A>G	p.K471R	18	Tolerated	Benign,38,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S540G,MSH2	c.1618A>G	p.S540G	20	Tolerated	Benign,39,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L833V,MSH2	c.2497C>G	p.L833V	50	Damaging	Benign,40,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.K543R,MSH6	c.1628A>G	p.K543R	29	Damaging	Benign,41,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.F3418L,PRKDC	c.10252T>C	p.F3418L	31	Damaging	Damaging (probably),43,18,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.F134V,TP53	c.400T>G	p.F134V	47	Damaging	Damaging (probably),45,15,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R273C,TP53	c.817C>T	p.R273C	67	Damaging	Damaging (probably),46,15,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R273H,TP53	c.818G>A	p.R273H	38	Damaging	Damaging (probably),47,15,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.T283A,XRCC5	c.847A>G	p.T283A	29	Damaging	Damaging (probably),48,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R335W,"... NER pathways. The “Other” category refers to the p.R335W mutation in the DNTT gene, which encodes f...",50,327,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Q336L,...ent targeted SOLiD sequencing. In addition to the p.Q336L somatic mutation and the p.E528K germline ...,61,162,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.E528K,"... addition to the p.Q336L somatic mutation and the p.E528K germline variant, identified by SOLiD, 11 ...",61,195,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D293X,"...in CHEK2 included a somatic frameshift insertion (p.D293X), a splice-site mutation (c.319+2T>A), and...",61,469,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I364T,"...e mutation (c.319+2T>A), and a missense mutation (p.I364T) located in the kinase domain of CHEK2 (Ta...",61,541,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.E528K,"...of CHEK2 (Table 2). Five rare variants, including p.E528K, were specific for the patient cohort, as ...",61,629,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R117G,"...errant splicing of CHEK2 transcripts, whereas the p.R117G and p.D438Y substitutions were shown to ha...",61,881,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D438Y,"...ing of CHEK2 transcripts, whereas the p.R117G and p.D438Y substitutions were shown to have deleterio...",61,893,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I157T,"...ol samples, including a c.1100delC deletion and a p.I157T substitution (Table 2) that was previously...",61,1129,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R180C,"...ples derived from healthy blood donors, where the p.R180C and p.I157T substitutions, previously iden...",61,1390,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I157T,"... from healthy blood donors, where the p.R180C and p.I157T substitutions, previously identified by ge...",61,1402,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D293X,c.876dupT	p.D293X	Novel	1/171	Somatic	Swedish	0	0	-	-,67,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Q336L,c.1007A>T	p.Q336L	Novel	1/64	Somatic	Chinese	0	0	Damaging	Da...,68,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I364T,c.1091T>C	p.I364T	Novel	1/171	ND	Swedish	0	0	Damaging	Damagi...,69,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R3W,c.7C>T	p.R3W	rs199708878	1/171	Germline	Swedish	0	0	Damag...,70,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R117G,c.349A>G	p.R117G	rs28909982	1/171	ND	Swedish	0	0	Damaging	D...,71,10,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D438Y,c.1312G>T	p.D438Y	rs200050883	2/164	ND	Swedish	0	0	Damaging	...,73,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.E528K,c.1582G>A	p.E528K	rs138040612	1/64	Germline	Chinese	0	0	Tole...,74,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I157T,c.470T>C	p.I157T	rs17879961	3/171	Germline (1)	Swedish	0.00...,75,10,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R180C,c.538C>T	p.R180C	rs77130927	1/171	ND	Swedish	0.006	0.001	Da...,76,10,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.T367Mfs,c.1100delC	p.T367Mfs*15	Reported	3/163	ND	Swedish	0.006	0	-	-...,77,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.H371Y,c.1111C>T	p.H371Y	Reported	2/64	Somatic/germline	Chinese	0.0...,78,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D438Y,"...sh or 429 Chinese controls, with an exception for p.D438Y, p.E528K, and c.1100delC variants, which w...",79,207,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.E528K,"... Chinese controls, with an exception for p.D438Y, p.E528K, and c.1100delC variants, which were scree...",79,216,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.K633X,...eam of the catalytic domain of the PARP1 protein (p.K633X) and a p.I919T substitution located in the...,81,268,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I919T,...lytic domain of the PARP1 protein (p.K633X) and a p.I919T substitution located in the catalytic doma...,81,283,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Y930C,...tic domain of PARP1 (Table 3). Two rare variants (p.Y930C and p.L1013M) were also identified in two ...,81,375,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L1013M,...f PARP1 (Table 3). Two rare variants (p.Y930C and p.L1013M) were also identified in two different tu...,81,387,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.K633X,PARP1	c.1897A>T	p.K633X	Sanger	Novel	Somatic	Chinese	0	-	-,86,17,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S776G,c.2326A>G	p.S776G	Selector & Sanger	Novel	Germline	Chinese	0...,88,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I919T,c.2756T>C	p.I919T	Sanger	Novel	ND	Chinese	0	Damaging	Damagin...,89,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Y930C,c.2789A>G	p.Y930C	Sanger	rs189410139	ND	Chinese	0.003	Damagi...,90,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L1013M,c.3037C>A	p.L1013M	Sanger	rs138906127	ND	Swedish	0.001	Toler...,91,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.P439L,MSH2	c.1316C>T	p.P439L	Sanger	Novel	ND	Chinese	0	Damaging	Damagin...,92,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S540G,c.1619A>G	p.S540G	Selector & Sanger	Novel	Somatic	Chinese	0	...,93,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L833V,c.2498C>G	p.L833V	Selector & Sanger	Novel	Somatic	Chinese	0	...,94,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I169V,c.505A>G	p.I169V	Sanger	rs63750716	ND	Chinese	0	Tolerated	B...,95,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.A9G,DDB1	c.26C>G	p.A9G	Selector	Novel	Somatic	Chinese	0	Damaging	Da...,96,14,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.M1120I,c.3360G>A	p.M1120I	454 amplicon	Novel	ND	Swedish	0	Tolerated...,98,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R179Q,DCLRE1C	c.536G>A	p.R179Q	454 amplicon	rs150854849	ND	Swedish	0	Dama...,99,18,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.C40Y,MLH3	c.119G>A	p.C40Y	Selector	Novel	Germline	Chinese	0	Damaging	...,101,15,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.K122R,c.365A>G	p.K122R	454 amplicon	Novel	ND	Chinese	0	Damaging	D...,102,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.V741I,c.2221G>T	p.V741I	454 amplicon	rs28756990	ND	Swedish	0.004	T...,103,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S946F,c.2837C>T	p.S946F	Selector	rs201441389	Germline	Chinese	0.00...,104,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I988M,c.2964C>G	p.I988M	Selector	Novel	Germline	Chinese	0	Damaging...,105,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L1111F,c.3331C>T	p.L1111F	Selector	Novel	Germline	Chinese	0	Damagin...,106,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.T283A,XRCC5	c.847A>G	p.T283A	Selector	Novel	Somatic	Chinese	0	Damaging	...,107,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S349Y,c.1046C>A	p.S349Y	454 amplicon	Novel	Germline	Chinese	0	Dama...,108,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I508V,c.1522A>G	p.I508V	454 amplicon	rs2287558	ND	Swedish	0.003	To...,109,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S540G,...encing. In addition to the two somatic mutations (p.S540G and p.L833V) discovered by the latter appr...,112,158,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L833V,"...ddition to the two somatic mutations (p.S540G and p.L833V) discovered by the latter approach, anothe...",112,170,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.P439L,... in two tumor samples: a novel missense mutation (p.P439L) and a rare variant (p.I169V; Table 3),112,309,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I169V,...l missense mutation (p.P439L) and a rare variant (p.I169V; Table 3),112,338,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.V741I,"...rs, respectively. The MLH3 missense rare variant (p.V741I) was previously shown to segregate with di...",114,640,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R847K,"...e sequencing–presented somatic mutations in PMS1 (p.R847K) and MLH1 (p.A223D), respectively. The DLB...",124,1117,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.A223D,"...ted somatic mutations in PMS1 (p.R847K) and MLH1 (p.A223D), respectively. The DLBCL sample with a p....",124,1136,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.P439L,"... (p.A223D), respectively. The DLBCL sample with a p.P439L mutation in MSH2 was analyzed with Promega...",124,1184,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.H371Y,"...rers confirmed all genotypes. For the c.1100delC, p.H371Y and p.D438Y CHEK2 variants control typing ...",174,818,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D438Y,"...ed all genotypes. For the c.1100delC, p.H371Y and p.D438Y CHEK2 variants control typing was performe...",174,830,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R175Q,...leading to an arginine to glutamine substitution (p.R175Q) in the LID domain of the AK2 protein (Fig...,57,575,J_Exp_Med_2015_Jul_27_212(8)_1185-1202.txt
p.K16Rfs,"... with premature terminations, ak2hg14 (c.45delAA, p.K16RfsX62) and ak2hg15 (c.41insACGG, p.K16TfsX64...",110,271,J_Exp_Med_2015_Jul_27_212(8)_1185-1202.txt
p.K16Tfs,"...c.45delAA, p.K16RfsX62) and ak2hg15 (c.41insACGG, p.K16TfsX64), denoted here as ak2del2 and ak2ins4,...",110,310,J_Exp_Med_2015_Jul_27_212(8)_1185-1202.txt
p.L124P,"...(ak2hg16, denoted as ak2L124P) carrying a c.T371C/p.L124P missense mutation within ak2 exon 4 from a...",110,457,J_Exp_Med_2015_Jul_27_212(8)_1185-1202.txt
p.R486X,"...iency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C1207T/C1207T; P4, p>R173W/R173W; P...",96,274,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
p.C186Y,"...486X; P3, c.C1207T/C1207T; P4, p>R173W/R173W; P5, p.C186Y/C186Y) have been previously reported (Oued...",96,327,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
p.Pro106Leu,...mbocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene Br J Haematol 2009 144...,127,186,J_Hematol_Oncol_2013_Jan_25_6_11.txt
p.Q248X,"...A, carry a homozygous nonsense mutation c.742C>T (p.Q248X) in exon 1 of the HOXD13 gene (Fig.4a). Af...",42,344,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
p.Q248X,"...A, carry a homozygous nonsense mutation c.742C>T (p.Q248X) in exon 1 of the HOXD13 gene. Affected an...",75,122,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
p.S610X,"...ng detectable. There were two nonsense mutations (p.S610X, p.L727X), three deletion frameshift mutat...",32,251,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.L727X,"...able. There were two nonsense mutations (p.S610X, p.L727X), three deletion frameshift mutations (c.3...",32,260,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.P76S,"There were 24 missense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E...",34,35,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.T94I,"There were 24 missense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372...",34,43,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.P123S,"There were 24 missense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N39...",34,51,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.M147V,"...e 24 missense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G39...",34,60,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.P297Q,"...ense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T41...",34,69,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.K369E,"...tions (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A43...",34,78,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.A372V,"...P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G43...",34,87,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.N392Y,"...94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S44...",34,96,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.G396E,"...23S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S448L, p.T52...",34,105,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.T410M,"...47V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I52...",34,114,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.A434T,"...97Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S53...",34,123,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.G439R,"...69E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C56...",34,132,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S448L,"...72V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R58...",34,141,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.T527P,"...92Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S65...",34,150,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.I529S,"...96E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V65...",34,159,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S532I,"...10M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S66...",34,168,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.C565Y,"...34T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T72...",34,177,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.R581S,"...39R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T721M, p.H72...",34,186,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S657N,"...48L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T721M, p.H723R and p....",34,195,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.V659L,"...27P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T721M, p.H723R and p.H723Y). T...",34,204,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S666F,"...29S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T721M, p.H723R and p.H723Y). To evaluat...",34,213,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.T721M,"...32I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T721M, p.H723R and p.H723Y). To evaluate the evo...",34,222,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...65Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T721M, p.H723R and p.H723Y). To evaluate the evolutionary...",34,231,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723Y,"..., p.S657N, p.V659L, p.S666F, p.T721M, p.H723R and p.H723Y). To evaluate the evolutionary conservatio...",34,243,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...ts with normal hearing, but with the exception of p.H723R in 1 case, no mutations were detected",34,705,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"The most frequent mutation was p.H723R that accounted for 36.0%, and the second w...",38,32,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...are two frequent mutations in east Asians, namely p.H723R and c.919-2A>G. p.H723R is most prevalent ...",56,306,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...ns in east Asians, namely p.H723R and c.919-2A>G. p.H723R is most prevalent in the Japanese and Kore...",56,330,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...ients homozygous for the most prevalent mutation, p.H723R, hearing level at low frequency varied fro...",60,739,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.Gln1137*,1	EX25	c.3408_3409delinsGT	p.Gln1137*	Small insertions,85,28,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Ile2113*,3	EX44	c.6337delA	p.Ile2113*	Small deletions,87,19,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Ile892Phe,4	EX21	c.2674delA	p.Ile892Phefs*4	Small deletions,88,19,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Gln2565*,5	EX53	c.7693C>T	p.Gln2565*	nonsence,89,18,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Arg145Pro,6	EX6	c.434G>C	p.Arg145Pro	missense,90,16,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Cys3337Trp,7	EX69	c.10011C>G	p.Cys3337Trp	missense,91,19,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Gly1256Trp,9	EX27	c.3765dupT	p.Gly1256Trpfs*15	Small insertions,93,19,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Glu1304*,10	EX28	c.3909dupT	p.Glu1304*	Small insertions,94,20,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Asp2944Gly,12	EX59	c.8821_8822insAGGCCACTTCAAG	p.Asp2944Glyfs*6	Small insertions,96,37,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Lys3273*,13	EX68	c.9816dupT	p.Lys3273*	Small insertions,97,20,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Ser800Arg,15	EX20	c.2591delC	p.Ser800Argfs*9	Small deletions,99,20,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Asp937*,16	EX22	c.2808dupT	p.Asp937*	Small insertions,100,20,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Thr547Ile,17	EX14	c.1632-15_1639dup52	p.Thr547Ilefs*16	Small insertions,101,29,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Ile892Phe,18	EX21	c.2673_2674delAAinsG	p.Ile892Phefs*4	Small insertions,102,30,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Leu3485Glu,19	EX74	c.10453_10454delCT	p.Leu3485Glufs*5	Small deletions,103,28,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Arg811Leu,21	EX20	c.2430_2443delCCGGTGGATCGAAT	p.Arg811Leufs*6	Small deletions,105,38,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Lys2329Ser,22	EX48	c.6986delA	p.Lys2329Serfs*9	Small deletions,106,20,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Leu1152Lys,23	EX26	c.3454_3479del26	p.Leu1152Lysfs*17	Small deletions,107,26,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Ala2308Glu,24	EX48	c.6923_6933del11	p.Ala2308Glufs*6	Small deletions,108,26,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Leu3485Arg,25	EX74	c.10454delT	p.Leu3485Argfs*11	Small deletions,109,21,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Gln1087Ala,26	EX24	c.3257dupA	p.Gln1087Alafs*11	Small insertions,110,20,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Leu3485Prp,27	EX74	c.10453dupC	p.Leu3485Prpfs*6	Small insertions,111,21,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Val1805Gly,28	EX38	c.5413dupG	p.Val1805Glyfs*10	Small insertions,112,20,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Lys578*,29	EX15	c.1732A>T	p.Lys578*	Nonsence,113,19,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Lys871Thr,30	EX20	c.2612A>C	p.Lys871Thr	Missense,114,19,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
p.Arg128His,"...ncing. This study identified a novel heterozygous p.Arg128His mutation in one NPSLE patient, admitte...",80,314,J_Immunol_Res_2015_Dec_21_2015_745647.txt
p.Arg128His,...ike headache [45]. The authors suggested that the p.Arg128His mutation is responsible for neurologic...,80,478,J_Immunol_Res_2015_Dec_21_2015_745647.txt
p.Leu156Arg,... al. 2010). The m.8993T>G point mutation leads to p.Leu156Arg. Leu156 is highly conserved in eukaryo...,95,882,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu156Pro,...006; Debray et al. 2007). The mutation results in p.Leu156Pro. Opposite to the positive charged argi...,97,210,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu183Pro,"...veral yeast models with NARP-MILS mutations (atp6-p.Leu183Pro (Kucharczyk et al. 2009a, b, c), atp6-...",99,2154,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu183Arg,"...p.Leu183Pro (Kucharczyk et al. 2009a, b, c), atp6-p.Leu183Arg (Rak et al. 2007a, b), atp6-p.Leu247Ar...",99,2204,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu247Arg,"... c), atp6-p.Leu183Arg (Rak et al. 2007a, b), atp6-p.Leu247Arg (Kucharczyk et al. 2009a, b, c), atp6-...",99,2244,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu247Pro,"...p.Leu247Arg (Kucharczyk et al. 2009a, b, c), atp6-p.Leu247Pro (Kucharczyk et al. 2010), and Δatp6 (R...",99,2294,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu220Pro,... species (ROS) (Sikorska et al. 2009). m.9185T>C (p.Leu220Pro) results in a phenotype varying from m...,101,482,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu222Pro,...lemi et al. 2005; Childs et al. 2007). m.9191T>C (p.Leu222Pro) has been described in a patient with ...,101,719,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Trp55X,...ature stopcodon in a conserved region of MT-ATP8 (p.Trp55X) (Jonckheere et al. 2008). This resulted ...,108,376,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Trp94Arg,...nserved tryptophan to an arginine at position 94 (p.Trp94Arg) of the nuclear encoded complex V assem...,115,105,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Trp94Arg,"...ater, it has been shown in a yeast model that the p.Trp94Arg mutation decreases the solubility of th...",115,745,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Tyr12Cys,"Recently, a homozygous missense mutation c.35A>G (p.Tyr12Cys) has been described in exon 2 of the AT...",121,51,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Arg386Cys,"... are reported to be missense mutations c.1156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T...",164,736,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
p.Gly301Cys,"...ense mutations c.1156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T (p.Ile113Phe) (Tomatsu ...",164,760,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
p.Ile113Phe,"...Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T (p.Ile113Phe) (Tomatsu et al 2005a). However, their...",164,788,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
p.Ile113Phe,"... population-dependent. For example, the c.337A>T (p.Ile113Phe) mutation was actually found to be muc...",164,1060,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
p.Ile113Phe,"...d changes, such as the common pathogenic mutation p.Ile113Phe, highlighting the difficulty in predic...",182,660,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
p.W273R,...ncevska A  Novel beta-galactosidase gene mutation p.W273R in a woman with mucopolysaccharidosis type...,242,70,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
p.R152W,"M	5.0	0.7	7.6	454 C > T (p.R152W), exon 2	454 C > T (p.R152W), exon 2	Slow	...",55,27,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R152W,"....0	0.7	7.6	454 C > T (p.R152W), exon 2	454 C > T (p.R152W), exon 2	Slow	231 (318)	N	Y	N	1	1	Y	N",55,55,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.N301K,"2	F	1.5	1.8	2.1	903 C > G (p.N301K) exon 5, S384N, 1152 G > A, exon 6	903 C >...",56,28,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.N301K,"...01K) exon 5, S384N, 1152 G > A, exon 6	903 C > G (p.N301K) exon 5, S384N, 1152 G > A, exon 6	Rapid	9...",56,82,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.G324V,"3	M	.6	1.9	2.3	971 G > T (p.G324V), exon 5	971 G > T (p.G324V), exon 5	Rapid...",57,27,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.G324V,"....6	1.9	2.3	971 G > T (p.G324V), exon 5	971 G > T (p.G324V), exon 5	Rapid	739 (254)	N	Y	N	1	2	N	Y",57,55,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.V323G,"4	M	1.2	2.8	3.0	995 T > G (p.V323G), exon5	995 T > G (p.V323G), exon5	Rapid	5...",58,28,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.V323G,"...1.2	2.8	3.0	995 T > G (p.V323G), exon5	995 T > G (p.V323G), exon5	Rapid	554 (194)	Y	Y	N	4	4	Y	N",58,55,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,"6	M	.8	5.1	5.9	629 A > G (p.Y210C), exon 3	979C > T (p.R327X)	Slow	207 (145)...",60,27,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R327X,"...	.8	5.1	5.9	629 A > G (p.Y210C), exon 3	979C > T (p.R327X)	Slow	207 (145)	Y	N	Y	4	4	N	Y",60,54,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,"M	3.0	5.8	6.2	629 A > G (p.Y210C), exon 3	979C > T (p.R327X)	Slow	158 (145)...",62,27,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R327X,"...3.0	5.8	6.2	629 A > G (p.Y210C), exon 3	979C > T (p.R327X)	Slow	158 (145)	N	Y	Y	6	5	Y	N",62,54,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,"8	F	3.0	7.4	7.8	629A > G (p.Y210C), exon 3	979C > T (p.R327X)	Slow	214 (124)...",63,27,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R327X,"...	3.0	7.4	7.8	629A > G (p.Y210C), exon 3	979C > T (p.R327X)	Slow	214 (124)	N	N	Y	6	5	Y	N",63,54,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R152W,"9	F	2.0	7.8	8.3	454C > T (p.R152W), exon 2	454C > T (p.R152W), exon 2	Slow	2...",64,27,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R152W,"...	2.0	7.8	8.3	454C > T (p.R152W), exon 2	454C > T (p.R152W), exon 2	Slow	254 (124)	N	Y	N	3	2	Y	N",64,54,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R152W,"10	M	7.0	10.1	18.3	454 C > T (p.R152W), exon2	454 C > T (p.R152W), exon2	Slow	10...",65,31,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R152W,"...0	10.1	18.3	454 C > T (p.R152W), exon2	454 C > T (p.R152W), exon2	Slow	106 (107)	N	N	N	1	1	Y	Y",65,58,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,11	M	9.0	10.2	10.7	629 A > G (p.Y210C)	937 (C > G) (p.P313A)	Slow	193 (107)	N	N	...,66,31,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.P313A,...	M	9.0	10.2	10.7	629 A > G (p.Y210C)	937 (C > G) (p.P313A)	Slow	193 (107)	N	N	Y	6	5	N	N,66,53,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R152W,"...consisted of patients who were homozygous for the p.R152W mutation (n = 3, all of Turkish Ancestry)....",108,132,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,... all of Turkish Ancestry). The second group had a p.Y210C mutation combined with either p.P313A or p...,108,206,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.P313A,"...group had a p.Y210C mutation combined with either p.P313A or p.R327X (n = 4, all of Dutch Ancestry)....",108,244,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R327X,"... p.Y210C mutation combined with either p.P313A or p.R327X (n = 4, all of Dutch Ancestry). The third ...",108,255,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,... patients with other mutations. Patients with the p.Y210C mutation had the highest total intelligenc...,108,368,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,"...tion, we note that the group of patients with the p.Y210C mutation performed best (Karageorgos et al...",159,101,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,...t was reported by Swiedler et al. (2005) that the p.Y210C mutation was associated with low GAG excre...,159,430,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,"...and better growth. In three of the four children, p.Y210C was combined with p.R327X, a nonsense muta...",159,535,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R327X,"...e of the four children, p.Y210C was combined with p.R327X, a nonsense mutation leading to no product...",159,561,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.G324V,"...ly disrupt splicing; the other was homozygous for p.G324V, which leads to reduced synthesis of aryls...",159,1019,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.G12S,...0.1038/jid.2013.430nihpa529559ArticleSomatic HRAS p.G12S Mutation Causes Woolly Hair and Epidermal N...,3,166,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...ry Methods). A somatic heterozygous HRAS c.34G>A, p.G12S substitution was found in each (Figure 2a)....",15,330,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...from affected individual WHN101, finding the HRAS p.G12S mutation in curly hair only (Figure 2d, Sup...",15,813,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...and NRAS (Hafner et al., 2012) including the HRAS p.G12S mutation found in WHN (Hafner et al., 2011)...",17,267,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...m germline heterozygous HRAS mutations, including p.G12S (Gripp and Lin, 2012; Siegel et al., 2012)....",17,564,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...and Barbacid, 2003). Though comparison of the WHN p.G12S mutation and the common NS p.G13R mutation ...",19,811,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G13R,"...ison of the WHN p.G12S mutation and the common NS p.G13R mutation has not been performed, HRAS codon...",19,845,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G13R,...tion. We found 88 HRAS and 9 KRAS mutations. HRAS p.G13R was present in 85 NS and p.G12S was not fou...,21,165,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,...S mutations. HRAS p.G13R was present in 85 NS and p.G12S was not found (Supplementary Table 2). In p...,21,197,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...ts, 64 additional samples were screened, and HRAS p.G12S mutations were not found (Levinsohn et al.,...",21,307,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"... al., 2013). In one report, 3 specimens with HRAS p.G12S mutations were identified; in 2 there was a...",21,420,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G13R,"...were identified; in 2 there was a concurrent HRAS p.G13R mutation, and in one, the lesion was on the...",21,487,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...lasia found in NS, and the more mildly activating p.G12S mutation causes woolly hair phenotypes",21,818,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"In summary, we find somatic HRAS c.34G>A, p.G12S mutation in affected tissue from two cases ...",23,43,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...nt with reports of WHN and in KEN, the identified p.G12S mutation causes an EN phenotype on the body...",23,183,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,Figure 2 Somatic HRAS p.G12S mutation causes WHN. (a) In WHN100 and WHN1...,50,23,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...e-wide significance (1.7 × 10<sup>-6</sup>), HRAS p.G12S in each case. (b, c) Sanger sequencing of b...",50,619,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...d tissue of WHN100 and WHN101 confirmed this HRAS p.G12S mutation. (c) In WHN100, there is a small m...",50,726,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,...raight and curly hair from WHN101 shows that HRAS p.G12S mutation is specific to curly hair,50,1030,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.Thr1280Thr,"...L7A1, a paternal frameshift mutation c. 3840delC (p.Thr1280Thrfs*44) and a maternal acceptor splice ...",18,261,J_Invest_Dermatol_2014_May_6_134(5)_1246-1254.txt
p.S200N,"...tin et al., 2001). Note that Variant 1 (c.599G7A; p.S200N) was present in three patients, and, there...",14,1395,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.L228R,"...8 patients studied (12.5%). Among these variants, p.L228R and p.S802R are previously unpublished",14,1560,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.S802R,"...tudied (12.5%). Among these variants, p.L228R and p.S802R are previously unpublished",14,1572,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.L156P,...s by the analysis of two mutations (p.E138del and p.L156P) previously identified in patients with fa...,16,624,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.L228R,"...ne of the putative variants, Variant 2 (c.683T>G; p.L228R), present in a patient with definitive PRP...",16,917,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.R682W,...-galactosidase determination (Fig. 1b). Mutations p.R682W and p.S200N were not capable of upregulati...,16,1168,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.S200N,"...se determination (Fig. 1b). Mutations p.R682W and p.S200N were not capable of upregulation of NF-κB,...",16,1180,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.S200N,"1a	72/F	47/57	20	2	rs114688446	c.599G>A, p.S200N	A: 0.8	Benign	Tolerated	Neutral	Neutral	Ne...",42,42,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.L228R,"2	75/M	70/70	2	1	rs142246283	c.683T>G, p.L228R	no data	Probably damaging	Tolerated	Pathol...",45,40,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.R682W,"3	46/F	21/21	2	1	rs117918077	c.2044C>T, p.R682W	T: 1.2	Probably damaging	Damaging	Patholog...",46,41,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.S802R,"4	35/F	32/32	1	1	no data	c.2406C>A, p.S802R	no data	Benign	Damaging	Pathological	Neutr...",47,37,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.Arg567X,"...vealed that c.1363G>T (p. Glu455X) and c.1699C>T (p.Arg567X) were nonsense mutations, and that c.160...",36,81,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
p.Pro534Leu,"...67X) were nonsense mutations, and that c.1601C>T (p.Pro534Leu) and c.64G>T (p. Ala22Ser) were missen...",36,137,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
p.Pro534Leu,...oded by one of 47 CpGs in the PHEX gene (15). The p.Pro534Leu mutation seems to affect the local hyd...,43,211,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
p.Gly303Arg,... of the nine predicted transmembrane domains. The p.Gly303Arg mutation was previously reported in Ja...,29,231,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Pro227Ser,... highly conserved sterol-sensing domain (14). The p.Pro227Ser mutation is located in the second cyto...,29,424,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Gln224Lys,...d previously described mutations in this loop are p.Gln224Lys and p. Arg228Trp (18). Three mutations...,29,540,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Thr93Met,"...g228Trp (18). Three mutations including IVS-1G→C, p.Thr93Met, and p.Val326Leu account for 50% of the...",29,611,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Val326Leu,"...ree mutations including IVS-1G→C, p.Thr93Met, and p.Val326Leu account for 50% of the spectrum of mut...",29,627,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Arg325Gln,"...ns in Caucasian patients (19). On the other hand, p.Arg325Gln is the most common mutation in Japanes...",29,731,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Arg352Trp,...arbored compound heterozygous mutations including p.Arg352Trp and p.Lys376ArgfsX37 (12). DHCR7 mutat...,29,900,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Lys376Arg,... heterozygous mutations including p.Arg352Trp and p.Lys376ArgfsX37 (12). DHCR7 mutation patterns in ...,29,916,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
p.Leu2148*,...acid substitution from a leucine to a stop codon (p.Leu2148*) (Fig. 7). The patient was diagnosed wi...,11,2607,J_Korean_Med_Sci_2013_Nov_31_28(11)_1682-1686.txt
p.Leu2148*,... 7 The patient had mutant allele with stop codon (p.Leu2148*) compared to normal allele,34,55,J_Korean_Med_Sci_2013_Nov_31_28(11)_1682-1686.txt
p.Q79X,"...nd, compound heterozygous mutations (p.M515fsX563/p.Q79X) have been identified. In the present study...",53,213,J_Lipid_Res_2015_Nov_56(11)_2172-2182.txt
p.Ile71Phe,"...a novel heterozygous missense mutation (c.211A/T, p.Ile71Phe). Genetic screening of our patient’s fa...",10,170,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ile71Phe,"...a novel heterozygous missense mutation (c.211A/T, p.Ile71Phe) in exon 3 (Figure 1a). Mutation was co...",26,964,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ile71Phe,... protein sequences in the region of the mutation (p.Ile71Phe) from different species indicates that ...,28,438,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ile71Phe,"...[10]. A heterozygous missense mutation (c.211A/T, p.Ile71Phe) was detected in our patient in exon 3 ...",33,332,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ile71Phe,"...11,12]. The novel heterozygous missense mutation (p.Ile71Phe) reported here is located close to the ...",35,641,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Trp68Cys,"... in this region in patients with hyperekplexia 1 (p.Trp68Cys and p.Arg72His) [3], and in spasmodic m...",35,908,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Arg72His,"... in patients with hyperekplexia 1 (p.Trp68Cys and p.Arg72His) [3], and in spasmodic mice (p.Ala52Ser...",35,923,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ala52Ser,"...68Cys and p.Arg72His) [3], and in spasmodic mice (p.Ala52Ser) [13]. The functional analysis performe...",35,963,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ala52Ser,...d on the spasmodic mouse model suggested that the p.Ala52Ser missense mutation results in reduced gl...,35,1063,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Trp68Cys,...reported missense mutations in this region (human p.Trp68Cys and p.Arg72His and murine p.Ala52Ser) a...,35,1604,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Arg72His,...se mutations in this region (human p.Trp68Cys and p.Arg72His and murine p.Ala52Ser) are all associat...,35,1619,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ala52Ser,...egion (human p.Trp68Cys and p.Arg72His and murine p.Ala52Ser) are all associated with the recessive ...,35,1641,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ile71Phe,"...at this novel missense sequence change (c.211A/T, p.Ile71Phe) identified in the index patient is a d...",37,205,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Asp18Asn,...i N Hiragi T Ohshima Y Heike T Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurologica...,113,109,J_Med_Case_Rep_2014_Nov_22_8_381.txt
p.A359Hfs,...a homozygous deletion in the exon 13 (c.1074delT; p.A359HfsX50; Figure,45,103,J_Med_Case_Rep_2014_Sep_3_8_291.txt
p.R495Q,MYBPC3	NM_000256:c.G1484A:p.R495Q	3	0.008333333	0	0.001833766	Not present	Ye...,221,27,J_Med_Genet_2013_Apr_8_50(4)_228-239.txt
p.A104V,TNNT2	NM_001001432:c.C296T:p.A104V	3	0.008333333	0	0.001833766	Not present	Ye...,222,28,J_Med_Genet_2013_Apr_8_50(4)_228-239.txt
p.R663H,MYH7	NM_000257:c.G1988A:p.R663H	3	0.008333333	0	0.001833766	Not present	Ye...,223,25,J_Med_Genet_2013_Apr_8_50(4)_228-239.txt
p.Asp180Gly,...nt 1	F	64	?	TNNI3	55665408 A>G	NM_000363.4	539A>G	p.Asp180Gly	Probably damaging	Possibly damaging	94...,119,56,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Arg152Cys,...ent 3	M	44	?	EMD	153609246 C>T	NM_000117.2	454C>T	p.Arg152Cys	Benign	Benign	180	0.00	C55	Not found	V...,122,55,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Val1543Ala,...†	F	22	51	SCN5A	38595955  T>C	NM_198056.2	4628T>C	p.Val1543Ala	Benign	Benign	64	0.00	C65	Not found	V...,126,60,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Val139Leu,...t 10	F	27	30	MYH7	23901935 G>T	NM_000257.2	415G>T	p.Val139Leu	Probably damaging	Probably damaging	32...,129,57,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Gly221Arg,F	–	–	LAMP2	119581776 G>A	NM_002294.2	661G>A	p.Gly221Arg	Probably damaging	Probably damaging	12...,130,47,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Val139Leu,... 12	F	52	38	MYH7	23901935  G>T	NM_000257.2	415G>T	p.Val139Leu	Probably damaging	Probably damaging	32...,132,58,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Thr1620Met,...4	M	35	21	SCN5A	38593004  C>T	NM_198056.2	4859C>T	p.Thr1620Met	Probably damaging	Probably damaging	8...,134,60,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Lys255Arg,...nt 16	F	73	?	LDB3	88451727 A>G	NM_007078.2	764A>G	p.Lys255Arg	Benign	Benign	26	0.00	C25	Not found	VU...,136,56,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Met659Thr,... 19§	V	?	?	MYH7	23896054  T>C	NM_000257.2	1976T>C	p.Met659Thr	Probably damaging	Probably damaging	81...,139,58,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Lys259Glu,...0	M	?	?	?	TPM1	63356265 A>G	NM_001018020.1	775A>G	p.Lys259Glu	Not reliable	Not reliable	56	0.00	C55	...,160,60,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Gly515Ser,...	F	58	16	Yes	VCL	75854219 G>A	NM_014000.2	1543G>A	p.Gly515Ser	Probably damaging	Probably damaging	56...,162,61,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Ser189Leu,...25	M	44	20	?	LDB3	88441437 C>T	NM_007078.2	566C>T	p.Ser189Leu	Benign	Benign	145	0.1	C0	2/10 806	VUS3...,165,59,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Ile1131Thr,MYBPC3	47354463 T>C	NM_000256.3	3392T>C	p.Ile1131Thr	Benign	Possibly damaging	89	0.03	C55	...,167,46,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Arg293Cys,...	M	67	28	?	TNNT2	201328349 C>T	NM_000364.2	877C>T	p.Arg293Cys	Probably damaging	Probably damaging	18...,170,61,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Pro955Arg,...PC3	47356633_47356634del	NM_000256.3	2864_2865del	p.Pro955ArgfsX95						n.a	Pathogenic	Dutch founder...,216,76,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.A139V,...T10A	NM_025216.2	c.[682T>A];[c.416C>T]	p.[F228I];[p.A139V]	Compound heterozygous	78 and novel	S30,130,70,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
p.I2159Mfs,...) and a novel LAMA3 frameshift-inducing deletion (p.I2159Mfs*46) that is absent in her mother (figur...,166,602,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
p.V499M,... identified a novel homozygous missense mutation (p.V499M) in CNNM4 in patient V2.05 who was born to...,176,68,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
p.T312S,... identified a known pathogenic missense mutation (p.T312S) and a likely pathogenic intronic variant ...,182,169,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
p.R386C,"...ingle de novo known pathogenic mutation in GALNS (p.R386C), suggesting the presence of a second muta...",183,76,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
p.Tyr333*,"...a novel heterozygous nonsense mutation in CTNNB1 (p.Tyr333*), which encodes beta-catenin, a member o...",187,411,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
p.Cys873Gly,"...of network centrality for phenotype prediction is p.Cys873Gly in MSH2 (UniProt: P43246), which has b...",81,105,J_Mol_Biol_2014_Jul_15_426(14)_2692-2701.txt
p.E197X,"...mozygous for a novel nonsense mutation, c.589G>T; p.E197X, in exon 3 of the UMOD gene (Figure 2). Th...",30,352,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.E197X,"...s revealed a heterozygote substitution, c.589G>T; p.E197X. Glutamic acid 197 resides in a highly con...",45,127,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys315Arg,2	c.943T>C (p.Cys315Arg)	Pathogeni,100,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys300Gly,3	c.898T>G (p.Cys300Gly)	Pathogeni,102,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Val273Phe,4	c.817G>T (p.Val273Phe)	Pathogeni,104,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys255Tyr,5	c.764G>A (p.Cys255Tyr)	Pathogeni,106,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys248Ser,6	c.743G>C (p.Cys248Ser)	Pathogeni,108,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys217Gly,7	c.649T>G (p.Cys217Gly)	Pathogeni,110,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys217Arg,8	c.649T>C (p.Cys217Arg)	Pathogeni,112,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys148Tyr,9	c.443G>A (p.Cys148Tyr)	Pathogeni,114,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Asn128Ser,10	c.383A>G (p.Asn128Ser)	Pathogeni,116,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys126Arg,11	c.376T>C (p.Cys126Arg)	Pathogeni,118,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Gly103Cys,12	c.307G>T (p.Gly103Cys)	Pathogeni,120,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys77Tyr,13	c.230G>A (p.Cys77Tyr)	Pathogeni,122,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.R1441C,...ytemans K Rademakers R Theuns J  Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene ...,68,53,J_Mol_Neurosci_2011_Nov_26_45(3)_516-521.txt
p.E64D,...Bauer A  Woitalla D  Mietz EM    Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson di...,198,84,J_Mov_Disord_2012_Oct_30_5(2)_33-41.txt
p.A152T,Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for...,132,33,J_Neurol_Neurosurg_Psychiatry_2014_May_5_85(5)_506-508.txt
p.Q61K,"...fied missense mutations included MAP3K5 and NRAS (p.Q61K; Figure 3; see also supplementary material,...",116,865,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.G12C,"...changing KRAS mutations; MAP polyp 1B4S carried a p.G12C, while FAP polyps 12A11S and 9A5S carried p...",116,1186,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.A146T,"... p.G12C, while FAP polyps 12A11S and 9A5S carried p.A146T and p.G13D changes, respectively. All of t...",116,1235,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.G13D,"...le FAP polyps 12A11S and 9A5S carried p.A146T and p.G13D changes, respectively. All of these variant...",116,1247,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.G12C,...our MAP polyps were found to carry canonical KRAS p.G12C mutations resulting from a somatic G:C → T:...,116,2128,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.E411X,...ed truncating somatic WTX mutations (at positions p.E411X and p.E558X,130,883,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.E558X,...g somatic WTX mutations (at positions p.E411X and p.E558X,130,895,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.R1054*,"...the first homozygous SALL1 mutation, c.3160C > T (p.R1054*), in 2 female siblings presenting with mu...",10,65,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,...identified homozygous SALL1 mutation c.3160C > T (p.R1054*). The mutation leads to a reduced amount ...,20,262,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,"...ntified a homozygous SALL1 mutation, c.3160C > T (p.R1054*), in both affected siblings that segregat...",45,809,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,"...ic cause in our patients, a novel and homozygous (p.R1054*) SALL1 mutation",48,813,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,...tures were present in any of 12 heterozygotes for p.R1054* from the extended pedigree. This observat...,50,653,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,"...he idea that the truncated protein resulting from p.R1054*, thus, must preserve some degree of SALL1...",50,869,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,"...r, the residual SALL1 function resulting from the p.R1054* mutation is not sufficient to prevent hom...",50,1052,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,"...ore severely affected. In addition, the truncated p.R1054* protein does not seem to exert overt domi...",50,1346,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,"... seem to exert overt dominant-negative effects in p.R1054* heterozygotes. In contrast, a mild TBS ph...",50,1421,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,...nts with reported coding mutations just 3′ of the p.R1054* mutation in SALL1. Three of these mutatio...,50,1549,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,...ons that remove the same 2 protein domains as the p.R1054* mutation does.10 A comparable reduction i...,50,1693,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.C1139Wfs,"...found for 1 of these mutations (c.3414_3415delAT, p.C1139Wfs*14).5,8,10 We hypothesize that mild TBS...",50,1816,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,"...n summary, we conclude that heterozygotes for the p.R1054* SALL1 mutation are unaffected as the trun...",50,2466,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,...4* SALL1 mutation are unaffected as the truncated p.R1054* protein preserves some degree of residual...,50,2522,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,"...nant-negative effects, both sufficient to prevent p.R1054* heterozygotes from TBS features. We consi...",50,2667,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,"...to be unrelated to his being heterozygous for the p.R1054* SALL1 mutation, as it is represents an is...",50,2826,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,"...notype with CNS involvement.6,14 The phenotype in p.R1054* homozygotes resembles the phenotype of ho...",52,1103,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,"...1ΔZn2-10 mice. We, therefore, hypothesize that in p.R1054* homozygotes the truncated protein exerts ...",52,1216,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,"...homotor development and death in early infancy in p.R1054* homozygotes, CNS-TBS might constitute the...",52,1765,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,"...by a novel homozygous late 3′-truncating mutation p.R1054*. B, Amount of wild-type (white) and trunc...",68,610,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.R1054*,...allele and no wild-type protein due to homozygous p.R1054* mutation which partially undergoes NMD. C...,68,1017,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.C1139Wfs,"...gous gene deletion. Patients with mild TBS due to p.C1139Wfs*14 mutation, which partially undergo NM...",68,1502,J_Pediatr_2013_Mar_162(3)_612-617.txt
p.Arg59X,c.175C>T; p.Arg59X	0.56	0.04	0.5	49	1	2	0,167,12,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Cys157Tyr,c.470G>A;p.Cys157Tyr	0.92,172,11,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Cys157Tyr,c.470G>A;p.Cys157Tyr	1.31	0.27	0.58	62	2	1	2,176,11,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Cys64Phe,c.191G>T; p.Cys64Phe	1.17	0.17	0.78	84	2	1	0,179,12,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Arg1215X,c.3643C>T p.Arg1215X	0.85	0.31	0.42	73	2	2	1,187,12,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Asp371Gly,c.1112A>G p.Asp371Gly	0.91	0.3	0.67	77	1	1	0,192,12,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Ser1008Leu,c.3023C>T; p.Ser1008Leu	1.15,195,13,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Val62Ile,"...owing SNPs CFH −331C>T (rs3753394), CFH c.184G>A; p.Val62Ile (rs800292), CFH c.1204T>C; p.Tyr402His ...",220,140,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Tyr402His,"...H c.184G>A; p.Val62Ile (rs800292), CFH c.1204T>C; p.Tyr402His (rs1061170), CFH c.2016A>G; p.Gln672Gl...",220,178,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Gln672Gln,"....1204T>C; p.Tyr402His (rs1061170), CFH c.2016A>G; p.Gln672Gln (rs3753396), CFH IVS15 −543G>A intron ...",220,218,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Glu936Asp,"...S15 −543G>A intron 15 (rs1410996), CFH c.2808G>T; p.Glu936Asp (rs1065489), CD46 −652A>G (rs2796267),...",220,299,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Arg1215X,The CFH variant p.Arg1215X (patient 7) has been reported 1 and res...,248,17,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Asp371Gly,The CFB variant p.Asp371Gly (patient 8) has not previously been de...,250,17,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Y402H,... Concolino P Capoluongo E Rapid detection of CFH (p.Y402H) and ARMS2 (p.A69S) polymorphisms in age-r...,209,87,J_Transl_Med_2013_Sep_25_11_228.txt
p.A69S,...ngo E Rapid detection of CFH (p.Y402H) and ARMS2 (p.A69S) polymorphisms in age-related macular degen...,209,107,J_Transl_Med_2013_Sep_25_11_228.txt
p.L858R,"...n 21 that changes the leucine 858 in an arginine (p.L858R). Concerning rare alterations, about 3% of...",23,201,J_Transl_Med_2014_May_16_12_131.txt
p.G719X,"...tion of glycine by a cysteine, alanine or serine (p.G719X) or at codon 861 (p.L861Q",23,361,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,"...ine, alanine or serine (p.G719X) or at codon 861 (p.L861Q",23,387,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,...edictive value of frequent alterations (DEL19 and p.L858R) is more or less equivalent but some studi...,25,62,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,...ious mechanisms among which the emergence of EGFR p.T790M clones seems to be the most frequent. This...,31,531,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,...agnostic are not sensitive enough to detect minor p.T790M subclones (<1%) and this alteration is rar...,32,91,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,".... Indeed, the reported frequency of baseline EGFR p.T790M mutations varies widely in the literature,...",32,227,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,...mor. The prognostic significance of baseline EGFR p.T790M has not been reported. In the acquired res...,34,160,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...ng, it has been demonstrated that the presence of p.T790M predicts a favorable prognosis and indolen...",34,273,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"... indolent progression, compared to the absence of p.T790M after TKI failur",34,365,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...nce: -i- is EGFR mutation distribution, including p.T790M, heterogeneous within the primary tumor?; ...",39,123,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,P20	p.G719A	1	0	4	0	5	5	0	 ,101,5,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,P21	p.G719A	5	0	2	0	7	7	0	 ,102,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P28	p.L858R	4	0	2	0	6	6	0	 ,109,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P29	p.L858R	1£ + 1£	0	0	0	2	2	0	 ,110,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P30	p.L858R	2	0	0	0	2	2	0	 ,111,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P31	p.L858R	3	0	0	0	3	3	0	 ,112,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P32	p.L858R	0	3	0	1	4	4	0	 ,113,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P33	p.L858R	0	3	0	0	3	3	0	 ,114,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P34	p.L858R	1£	1	0	1	3	3	0	 ,115,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P35	p.L858R	4	0	2	0	6	6	0	 ,116,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P36	p.L858R	2	0	1	0	3	3	0	 ,117,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P37	p.L858R	3	0	0	0	3	3	0	 ,118,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P38	p.L858R	3	0	0	0	3	3	0	 ,119,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P39	p.L858R	3	0	0	0	3	3	0	 ,120,5,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,P40	p.L861Q/p.T790M	19	0	0	0	19	19	0	 ,121,5,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,P40	p.L861Q/p.T790M	19	0	0	0	19	19	0	 ,121,13,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,"...tions (DEL19), exon 20 insertions (INS20) and the p.L858R mutation along with KRAS and HER2 exon 20 ...",130,135,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...EGFR codons 719, 861 and mutated samples for EGFR p.T790M. The 153 fragments generated from mutated ...",130,297,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,"...for the entire EGFR mutation panel (DEL19, INS20, p.L858R, p.L861Q and p.G719X)",130,516,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,"...ntire EGFR mutation panel (DEL19, INS20, p.L858R, p.L861Q and p.G719X)",130,525,J_Transl_Med_2014_May_16_12_131.txt
p.G719X,"...utation panel (DEL19, INS20, p.L858R, p.L861Q and p.G719X)",130,537,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,"...ic TaqMan PCR technology (CAST). Point mutations: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p....",132,534,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,"... PCR technology (CAST). Point mutations: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p.T790M wer...",132,543,J_Transl_Med_2014_May_16_12_131.txt
p.G719C,"...nology (CAST). Point mutations: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p.T790M were analyze...",132,552,J_Transl_Med_2014_May_16_12_131.txt
p.G719S,"...AST). Point mutations: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p.T790M were analyzed using s...",132,561,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,"...nt mutations: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p.T790M were analyzed using similar te...",132,570,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p.T790M were analyzed using similar technology. CA...",132,582,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,"...en patients had an exon 19 deletion (DEL19), 12 a p.L858R point mutation, 6 an exon 20 insertion (IN...",143,294,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,"...int mutation, 6 an exon 20 insertion (INS20), 2 a p.G719A mutation and 1 a p.L861Q/p.T790M double al...",143,354,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,"...0 insertion (INS20), 2 a p.G719A mutation and 1 a p.L861Q/p.T790M double alteration. For those 40 pa...",143,379,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...ion (INS20), 2 a p.G719A mutation and 1 a p.L861Q/p.T790M double alteration. For those 40 patients, ...",143,387,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,"...here was no discordance for samples with expected p.L858R, p.L861Q/p.T790M or p.G719A mutations (Tab...",144,102,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,"...no discordance for samples with expected p.L858R, p.L861Q/p.T790M or p.G719A mutations (Table",144,111,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...rdance for samples with expected p.L858R, p.L861Q/p.T790M or p.G719A mutations (Table",144,119,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,"...samples with expected p.L858R, p.L861Q/p.T790M or p.G719A mutations (Table",144,130,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,All specimens were tested for the p.T790M mutation. This alteration was identified i...,148,35,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,"...40). Patient was naïve of EGFR-TKI, the tumor was p.L861Q/p.T790M mutated, was divided into 19 parts...",148,149,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...ient was naïve of EGFR-TKI, the tumor was p.L861Q/p.T790M mutated, was divided into 19 parts and bot...",148,157,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,P20	p.G719A	1	0	4	0	1	2	2,202,5,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,P21	p.G719A	5	0	2	0	 	6	1,203,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P28	p.L858R	4	0	2	0	 	6	 ,210,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P29	p.L858R	1£ + 1£	0	0	0	1	1	 ,211,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P30	p.L858R	2	0	0	0	 	2	 ,212,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P31	p.L858R	3	0	0	0	 	3	 ,213,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P32	p.L858R	0	3	0	1	2	2	 ,214,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P33	p.L858R	0	3	0	0	1	1	1,215,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P34	p.L858R	1£	1	0	1	1	 	2,216,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P35	p.L858R	4	0	2	0	 	6	 ,217,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P36	p.L858R	2	0	1	0	 	2	1,218,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P37	p.L858R	3	0	0	0	 	2	1,219,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P38	p.L858R	3	0	0	0	1	2	 ,220,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P39	p.L858R	3	0	0	0	 	2	1,221,5,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,P40	p.L861Q/p.T790M	19	0	0	0	 	18	1,222,5,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,P40	p.L861Q/p.T790M	19	0	0	0	 	18	1,222,13,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,[38]. The p.T790M resistance mutation was studied in all pat...,243,11,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...at were EGFR-TKI naïve. In untreated patient, the p.T790M mutation is usually described as a subclon...",243,135,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,"... the alteration was found once concomitantly to a p.L861Q mutation, both alleles were equally repres...",244,61,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...was homogeneous suggesting that in this case, the p.T790M alteration is a driver mutation altogether...",244,188,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,...teration is a driver mutation altogether with the p.L861Q. Routine EGFR testing gives a qualitative ...,244,248,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,...esistance. Issues are either the development of a p.T790M or a wild type subclon,314,213,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"[15,30,39]. In our series, there was no p.T790M heterogeneity. Considering that our detect...",315,41,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,...wild type this might not have been sufficient for p.T790M subclone detectio,315,234,J_Transl_Med_2014_May_16_12_131.txt
p.P660L,"...fied a novel TMC1 mutation in exon 20, c.1979C>T, p.P660L, which segregated with prelingual autosoma...",11,60,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,...hese data support the potential conserved role of p.P660L in human TMC1 function,14,157,J_Transl_Med_2016_Jan_28_14_29.txt
p.R34X,"...C1 reported to affect HL is the nonsense mutation p.R34X, which accounts for over 30 % of mutant all...",27,463,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,"...s mutation in TMC1 located in exon 20, c.1979C>T, p.P660L in a three-generation, 14-member family (S...",29,97,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,"...quencing and found a missense variant, c.1979C>T, p.P660L, in exon 20 of TMC1 [NM_138691, (MIM#60097...",66,128,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,"... position of c.1979C>T, a mutation in exon 20 and p.P660L in TM2 domai",66,937,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,"To determine the potential effects of the p.P660L missense mutation on TMC1 function, we fur...",71,43,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,138691	c.1979C>T	p.P660L	Hom	SIFT	Polyphen2	MutationTaster,76,19,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,"...vel TMC1 missense mutation in exon 20, c.1979C>T, p.P660L",81,1030,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,...acellular domains (Fig. 4).Fig. 4 Location of the p.P660L mutation and other reported exonic mutatio...,83,632,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,...n; and the green arrow/yellow star represents the p.P660L mutation located within a predicted third ...,83,852,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,"...r channel [16]. The mutation found in this study, p.P660L, was located within a predicted third extr...",87,395,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,"... to confer channel function [18]. TMC1 c.1979C>T, p.P660L is located in a predicted third extracellu...",91,739,J_Transl_Med_2016_Jan_28_14_29.txt
p.R34X,...Mustapha M  Delmaghani S    High frequency of the p.R34X mutation in the TMC1 gene associated with n...,123,98,J_Transl_Med_2016_Jan_28_14_29.txt
p.Asp231Ala,"...tin associated with a potentially novel mutation, p.Asp231Ala, in adiponectin itself. Cells studied ...",3,4104,JCI_Insight_1(17)_e88766.txt
p.Tyr657X,...n itself. Cells studied from one patient with the p.Tyr657X PIK3R1 mutation expressed abundant trunc...,3,4180,JCI_Insight_1(17)_e88766.txt
p.Asp231Ala,"...of whom had an additional rare missense mutation, p.Asp231Ala, in the ADIPOQ gene and severely suppr...",20,192,JCI_Insight_1(17)_e88766.txt
p.Tyr657X,"...latory subunits of PI3K, stood out. The mutation, p.Tyr657X (Y657X) when numbered according to the p...",33,160,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"... (P2–P4) all with the same rare missense variant, p.Arg649Trp (R649W), in the C-terminal SH2 domain ...",39,220,JCI_Insight_1(17)_e88766.txt
p.Tyr657X,"...orted C-terminal PIK3R1 mutations, including both p.Tyr657X and p.Arg649Trp, to be the cause of SHOR...",41,108,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...al PIK3R1 mutations, including both p.Tyr657X and p.Arg649Trp, to be the cause of SHORT syndrome (24...",41,122,JCI_Insight_1(17)_e88766.txt
p.Tyr657X,...ssion of WT p85α or one of two p85α mutants — the p.Tyr657X mutation studied in primary cells and th...,50,271,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...Tyr657X mutation studied in primary cells and the p.Arg649Trp mutation, which accounts for around 50...",50,323,JCI_Insight_1(17)_e88766.txt
p.Asp231Ala,"...eve to be a novel heterozygous missense mutation, p.Asp231Ala, within the globular domain of adipone...",53,442,JCI_Insight_1(17)_e88766.txt
p.Asp231Ala,"...n, which we suggest is attributable to the ADIPOQ p.Asp231Ala mutant identified here. Our findings s...",58,977,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...r1-null murine fibroblasts in which WT or mutant (p.Arg649Trp) PIK3R1 was stably overexpressed, a st...",64,541,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...2). However, previous studies have shown that the p.Arg649Trp variant found in the other patients we...",66,377,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...null murine fibroblasts stably overexpressing the p.Arg649Trp mutant PIK3R1 (24); however, recruitme...",66,871,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...ared, a knockin mouse heterozygous for the Pik3r1 p.Arg649Trp mutation was reported. While this exhi...",66,1882,JCI_Insight_1(17)_e88766.txt
p.Tyr657X,...atient 1 (P1) and her parents showing the de novo p.Tyr657X (Y657X) mutation in PIK3R1. (B) Domain s...,140,82,JCI_Insight_1(17)_e88766.txt
p.Asp231Ala,"... of adiponectin, with the approximate site of the p.Asp231Ala (D231A) substitution indicated. SP, si...",149,71,JCI_Insight_1(17)_e88766.txt
p.M40K,48 Bueno AC  et al  A novel ADIPOQ mutation (p.M40K) impairs assembly of high-molecular-weight ...,200,46,JCI_Insight_1(17)_e88766.txt
p.C436Y,...pound heterozygous missense mutations on SLC12A1 (p.C436Y and p.L560P) and atypical clinical and lab...,3,1894,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.L560P,...zygous missense mutations on SLC12A1 (p.C436Y and p.L560P) and atypical clinical and laboratory feat...,3,1906,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.F177Y,"...pound heterozygous mutations in the SLC12A1 gene (p.F177Y and p.D918fs), who were diagnosed as BS at...",30,1039,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.F177Y,... study of these two mutant proteins revealed that p.F177Y mutant had significant residual transport ...,30,1179,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.F177Y,...nificant residual transport activity of the NKCC2 p.F177Y mutant construct in contrast to no activit...,30,1548,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.F177Y,... intrinsic partial transport defect caused by the p.F177Y mutation. The partial function of NKCC2-F1...,30,1975,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.A555V,...patient with BS type I (compound heterozygous for p.A555V and p.G809V mutations) who presented with ...,30,2247,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.G809V,... BS type I (compound heterozygous for p.A555V and p.G809V mutations) who presented with asymptomatic...,30,2259,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.C436Y,...lso has compound heterozygous missense mutations (p.C436Y and p.L560P). These findings suggested tha...,30,2402,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.L560P,...ound heterozygous missense mutations (p.C436Y and p.L560P). These findings suggested that the phenot...,30,2414,Korean_J_Pediatr_2010_Aug_31_53(8)_809-813.txt
p.H186D,...nt our experience with a patient carrying a novel p.H186D heterozygous mutation in the KCNJ11 gene w...,3,2235,Korean_J_Pediatr_2015_Aug_21_58(8)_309-312.txt
p.H186D,We report a case of PNDM caused by a novel p.H186D heterozygous mutation in the KCNJ11 gene w...,12,44,Korean_J_Pediatr_2015_Aug_21_58(8)_309-312.txt
p.His186Asp,"...chromosome 11p15.1 and encoding Kir6.2, c.556C>G (p.His186Asp), was found (Fig. 1). Genetic study fo...",17,236,Korean_J_Pediatr_2015_Aug_21_58(8)_309-312.txt
p.H186D,...y. The patient in this case has a novel mutation (p.H186D) in the KCNJ11 gene and presented with a m...,30,202,Korean_J_Pediatr_2015_Aug_21_58(8)_309-312.txt
p.G13D,...nker DJ  Di Nicolantonio F   Association of KRAS  p.G13D mutation with outcome in patients with chem...,275,68,Lancet_2011_Jun_18_377(9783)_2103-2114.txt
p.Arg270His,"...ealed compound heterozygote mutations (c.809G > A p.Arg270His, c.1262G > A p.Trp421*) in the LPL gen...",44,513,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Trp421*,"...te mutations (c.809G > A p.Arg270His, c.1262G > A p.Trp421*) in the LPL gene. And a pedigree study s...",44,538,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Arg270His,"...t the proband’s father was carrier of c.809G > A (p.Arg270His) mutation, meanwhile his mother and br...",44,646,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Trp421*,"... mother and brother were carriers of c.1262G > A (p.Trp421*) mutation (Fig. 1a). For patient B, gene...",44,732,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Leu279Arg,... gene mutations: a missense mutation (c.836 T > G p.Leu279Arg) and a large fragment deletion (deleti...,44,888,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Leu279Arg,...a). Pedigree analysis shown that the c.836 T > G (p.Leu279Arg) mutation was from his father and the ...,44,1015,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Arg270His,... (proband A) was found compound heterozygosity of p.Arg270His and p.Trp421* mutations on LPL gene. L...,44,1362,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Trp421*,... found compound heterozygosity of p.Arg270His and p.Trp421* mutations on LPL gene. Left: Chromatogra...,44,1378,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Arg270His,"...ealed compound heterozygote mutations (c.809G > A p.Arg270His, c.1262G > A p.Trp421*) in the LPL gen...",53,242,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Trp421*,"...te mutations (c.809G > A p.Arg270His, c.1262G > A p.Trp421*) in the LPL gene (Fig. 1a). Both of the ...",53,267,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Trp421*,...r medium [13]. The nonsense mutation (c.1262G > A p.Trp421*) changes Tryptophan 421 to a stop codon ...,53,762,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Leu279Arg,...L gene mutations: a missense mutation (c.836T > G p.Leu279Arg) and a large fragment deletion (deleti...,53,1147,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Leu279Arg,...6]. Pedigree analysis showed that the c.836T > G (p.Leu279Arg) mutation was from his father and the ...,53,1570,Lipids_Health_Dis_2016_May_6_15_88.txt
p.Asn168Asn,...Traeger-Synodinos J  Giannatou E    The c.504T>C (p.Asn168Asn) polymorphism in the ABCB4 gene as a p...,176,71,Med_Sci_Monit_2011_May_1_17(5)_CR265-CR271.txt
p.G292R,"...ations and 3 cases were homozygous for the DFNB59 p.G292R variant. Mutations in the WFS1, GJB3, ESRR...",4,851,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G1151R,...edigrees (Figure 2B). Of the 2 missense variants (p.G1151R and p.R1604S) which predictably resulted ...,43,349,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.R1604S,...ure 2B). Of the 2 missense variants (p.G1151R and p.R1604S) which predictably resulted in amino acid...,43,362,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G1151R,"...ulted in amino acid changes, the pathogenicity of p.G1151R was supported by its low SIFT (0.01) and ...",43,443,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.R1604S,...no acid residue (Figure 2C). The pathogenicity of p.R1604S was less confirmable given its low PolyPh...,43,758,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.R1604S,"...nt alleles by chance. Therefore, we inferred that p.R1604S was causally related to SNHI in family DE...",43,1214,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.E49X,"...ations identified in the present study, including p.E49X, p.L1582fs, p.P1441_P1443dup, p.G1151R, p.S...",47,134,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G1151R,"...y, including p.E49X, p.L1582fs, p.P1441_P1443dup, p.G1151R, p.S622fs, and p.R1604S. Sequencing data ...",47,171,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.R1604S,"...1582fs, p.P1441_P1443dup, p.G1151R, p.S622fs, and p.R1604S. Sequencing data are shown on either the ...",47,195,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,Three cases were homozygous for the DFNB59 p.G292R (c.874G > A) variant. This variant was pre...,49,44,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...ism.32,33 However, the allele frequency of DFNB59 p.G292R in the 12 cases, which were recruited from...",49,194,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...mes in the present study, homozygosity for DFNB59 p.G292R has never been found in any of the >70 hea...",49,472,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...cordingly, from a statistical perspective, DFNB59 p.G292R might be associated with poor CI performan...",49,641,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.Q485X,"... 2). Two known autosomal dominant mutations, WFS1 p.Q485X35 and GJB3 p.V84I,36,37 were detected in 2...",51,210,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.V84I,"...somal dominant mutations, WFS1 p.Q485X35 and GJB3 p.V84I,36,37 were detected in 2 matched controls. ...",51,229,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...1). Similarly, the allele frequency of the DFNB59 p.G292R variant was significantly higher in cases ...",54,349,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...r of 1 patient (DE3039) homozygous for the DFNB59 p.G292R variant, whereas imaging findings were nor...",59,366,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...ients. One patient (DE3138) homozygous for DFNB59 p.G292R showed moderate speech perception scores, ...",59,544,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,...15 mutations and 3 were homozygous for the DFNB59 p.G292R variant. The allele frequencies of PCDH15 ...,64,179,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,...demonstrate poor performance with CIs. The DNFB59 p.G292R variant is of particular interest. Althoug...,68,431,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,...uld be consistent with the hypothesis that DNFB59 p.G292R is a pathogenic allele with incomplete pen...,68,987,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,.... Another possible explanation is that the DFNB59 p.G292R variant is not a causative mutation for de...,68,1094,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...ausative mutation in these 3 patients, the DFNB59 p.G292R variant still might serve as a predictor f...",68,1407,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G3658E,... amino acid change from glycine to glutamic acid (p.G3658E) at a highly conserved residue (Fig. 2) w...,40,676,Meta_Gene_2016_May_18_9_124-127.txt
p.G3658E,"3.3 In silico analysis of (c.10973G > A, p.G3658E) varian",42,42,Meta_Gene_2016_May_18_9_124-127.txt
p.Arg3527Gln,"...them being novel. 13 (8%) individuals carried the p.Arg3527Gln mutation in APOB, and overall the det...",12,122,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg3527Gln,"...LDLR gene, a fragment of exon 26 of APOB to cover p.Arg3527Gln and exon 7 of PCSK9 to cover p.Asp374...",33,110,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asp374Tyr,...o cover p.Arg3527Gln and exon 7 of PCSK9 to cover p.Asp374Tyr by high resolution melt and direct seq...,33,152,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg3527Gln,"...mutation. The most frequent mutation was in APOB (p.Arg3527Gln), found in 13 (8%) patients. No patie...",43,330,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asp374Tyr,...in 13 (8%) patients. No patient carried the PCSK9 p.Asp374Tyr mutation. Mutations in the LDLR gene w...,43,401,Metabolism_2016_Mar_65(3)_48-53.txt
p.Pro699Arg,...elC will also result in a frame shift in exon 14 (p.Pro699Argfs*10) and would be pathogenic. The mut...,48,297,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys255Tyr,"...9Argfs*10) and would be pathogenic. The mutations p.Cys255Tyr and p.Cys329Phe, would cause loss of c...",48,354,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys329Phe,"...ould be pathogenic. The mutations p.Cys255Tyr and p.Cys329Phe, would cause loss of cysteine in the l...",48,370,Metabolism_2016_Mar_65(3)_48-53.txt
p.Ser849*,... and cause aberrant protein folding. The mutation p.Ser849* causes a premature stop codon at positio...,48,510,Metabolism_2016_Mar_65(3)_48-53.txt
p.The621Arg,We predict that the novel mutation (p.The621Arg) would cause aberrant recycling of the...,50,37,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr621Arg,"...L) and LDL-C level (8.1 mmol/L) and inherited the p.Thr621Arg mutation. The index father, who had ra...",50,385,Metabolism_2016_Mar_65(3)_48-53.txt
p.Ala612Ser,"The other four novel mutations, p.Ala612Ser, p.Asp579Gly, p.Trp483Cys, and p.Val12...",52,33,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asp579Gly,"The other four novel mutations, p.Ala612Ser, p.Asp579Gly, p.Trp483Cys, and p.Val127Asp were als...",52,46,Metabolism_2016_Mar_65(3)_48-53.txt
p.Trp483Cys,"...r four novel mutations, p.Ala612Ser, p.Asp579Gly, p.Trp483Cys, and p.Val127Asp were also predicted t...",52,59,Metabolism_2016_Mar_65(3)_48-53.txt
p.Val127Asp,"...tions, p.Ala612Ser, p.Asp579Gly, p.Trp483Cys, and p.Val127Asp were also predicted to be pathogenic; ...",52,76,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg3527Gln,...most common APOB mutation in European populations p.Arg3527Gln usually accounts for 5–7% of FH patie...,60,472,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr621Arg,...demonstrated co-segregation of the novel mutation p.Thr621Arg with the FH phenotype. We also describ...,62,152,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys329Phe,...henotype. We also described the novel mutation of p.Cys329Phe in a previous report [17]. In our stud...,62,227,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr621Arg,...1 Family co-segregation of the novel c.1862C > G (p.Thr621Arg) LDLR mutation. (A) A family pedigree ...,92,56,Metabolism_2016_Mar_65(3)_48-53.txt
p.Gly396Ala, c.314-?_1186 + ?dup	p.Gly396Ala;Pro106_Val395dup	2	ex4-ex8 dup	n/a	n/a...,131,22,Metabolism_2016_Mar_65(3)_48-53.txt
p.Val233Ser, c.695-?_1586 + ?del	p.Val233Serfs*18	6	ex5-10 del	n/a	n/a	n/a	No,132,22,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys34Gly, c.100T > G	p.Cys34Gly	3	2	Probably damaging	Not tolerated	Dis...,137,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr62Met, c.185C > T	p.Thr62Met	1	2	Probably damaging	Tolerated	Disease...,138,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Val127Asp, c.380T > A	p.Val127Asp	1	41	Possibly damaging	Not tolerated	D...,139,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys167*, c.501C > A	p.Cys167*	1	4	n/a	n/a	n/a	No,140,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Ser177Leu, c.530C > T	p.Ser177Leu	1	4	Benign	Not tolerated	Disease causi...,141,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys222*, c.666C > A	p.Cys222*	1	4	n/a	n/a	n/a	No,143,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asp227Glu, c.681C > G	p.Asp227Glu	1	4	Probably damaging	Not tolerated	Di...,144,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys255Tyr, c.764G > A	p.Cys255Tyr	1	51	Probably damaging	Not tolerated	D...,145,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asp266Glu, c.798T > A	p.Asp266Glu	1	5	Probably damaging	Not tolerated	Di...,146,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys329Phe, c.986G > T	p.Cys329Phe	4	71	Probably damaging	Not tolerated	D...,147,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg350*, c.1048C > T	p.Arg350*	1	7	n/a	n/a	n/a	No,148,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asp362Ala, c.1085delA	p.Asp362Alafs*8	1	8	n/a	n/a	Disease causing	No,149,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg416Trp, c.1246C > T	p.Arg416Trp	2	9	Probably damaging	Not tolerated	Di...,150,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Trp483Cys, c.1449G > T	p.Trp483Cys	1	101	Possibly damaging	Not tolerated	...,151,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Val523Met, c.1567G > A	p.Val523Met	1	10	benign	Not tolerated	Disease caus...,152,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg574Cys, c.1720C > T	p.Arg574Cys	1	12	Probably damaging	Not tolerated	D...,153,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asp579Gly, c.1737C > G	p.Asp579Gly	3	121	probably damaging	Not tolerated	...,154,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Gly592Glu, c.1775G > A	p.Gly592Glu	4	12	probably damaging	Not tolerated	D...,155,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Ala612Ser, c.1834G > T	p.Ala612Ser	2	121	Possibly damaging	Not tolerated	...,156,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr621Arg, c.1862C > G	p.Thr621Arg	1	131	Probably damaging	Not tolerated	...,157,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Gly676Arg, c.2026G > C	p.Gly676Arg	1	14	Probably damaging	Not tolerated	D...,159,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Gln678*, c.2032C > T	p.Gln678*	2	14	n/a	n/a	n/a	No,160,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Pro685Leu, c.2054C > T	p.Pro685Leu	1	14	Probably damaging	Not tolerated	D...,161,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Pro699Leu, c.2096C > T	p.Pro699Leu	2	14	Probably damaging	Not tolerated	D...,162,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Pro699Arg, c.2096delC	p.Pro699Argfs*10	1	141	n/a	n/a	Disease causing	No,163,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Ser849*, c.2546C > A	p.Ser849*	1	171	n/a	n/a	n/a	No,164,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Ala391Thr, c.1171G > A	p.Ala391Thr	3	8	Benign	Tolerated	Polymorphism	No,177,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asn515Asn, c.1545C > T	p.Asn515Asn	1	10	n/a	Tolerated	Polymorphism	No,178,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asn640Asn, c.1920C > T	p.Asn640Asn	1	13	n/a	n/a	Polymorphism	No,179,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Val653Val, c.1959C > T	p.Val653Val	1	131	n/a	n/a	n/a	No,180,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Gly675Gly, c.2025C > T	p.Gly675Gly	1	141	n/a	n/a	Disease causing	No,181,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr726Ile, c.2177C > T	p.Thr726Ile	2	15	Benign	Tolerated	Polymorphism	No,182,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg744Gln, c.2231G > A	p.Arg744Gln	1	15	Benign	Tolerated	Polymorphism	No,183,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg3527Gln, c.10580G > A	p.Arg3527Gln	13	APOB ex26	Probably damaging	Not to...,189,15,Metabolism_2016_Mar_65(3)_48-53.txt
p.C89R,...howed that the proband has a homozygote c.265T>C (p.C89R) HJV mutation + a heterozygote c.884T>C (p....,43,304,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.V295A,... (p.C89R) HJV mutation + a heterozygote c.884T>C (p.V295A) mutation of HFE. The affected proband’s s...,43,352,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,"...nd’s sister presented with the same HJV c.265T>C (p.C89R) homozygote mutation. In addition, we found...",43,446,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.G320V,"...olaou et al. showed that 80% of HJV mutations are p.G320V, however until now more than 25 different ...",62,1012,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,...t cases III-9 and III-7 were homozygotes for HJV (p.C89R,180,118,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.V295A,"...5, III-9 were heterozygotes for the HFE mutation (p.V295A). Both parents (II-10 and II-11) were hete...",181,66,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,"for the HJV mutation (p.C89R). Additionally, the mother was a heterozygo...",182,23,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,"...he proband, case III-9 was a homozygote c.265T>C (p.C89R) HJV mutation + a heterozygote c.884T>C (p....",317,122,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.V295A,... (p.C89R) HJV mutation + a heterozygote c.884T>C (p.V295A) mutation for HFE. The latter mutation has...,317,170,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,"...V mutation found in the proband, namely c.265T>C (p.C89R). Also HJV c.98-6C>G (rs56025621) polymorph...",317,375,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.V295A,...I- 5 were also heterozygous for the HFE c.884T>C (p.V295A) mutation. Both parents (II-10 and II-11) ...,317,578,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,...nd II-11) were heterozygous for the HJV c.265T>C (p.C89R) mutation and the mother was also heterozyg...,317,668,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.V295A,...other was also heterozygous for the HFE c.884T>C (p.V295A) mutation (Figure 2),317,744,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,The HJV c.265T>C (p.C89R) mutation is a novel mutation and there is ...,336,19,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,...m Iran which is reported as a novel HJV mutation (p.C89R),340,447,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.R1645*,...n in the fourth homologous domain of the protein (p.R1645*). Neurons derived from these iPSCs were p...,7,182,Mol_Brain_2013_May_2_6_19.txt
p.R1645*,"...e Nav1.1 protein in the fourth homologous domain (p.R1645*, Additional file 1) [GenPept: NP_00115943...",23,936,Mol_Brain_2013_May_2_6_19.txt
p.Arg1715His,"...us system, including the cerebellum. The mutation p.Arg1715His, identified in this study, was found ...",8,589,Mol_Brain_2015_Dec_29_8_89.txt
p.Arg1715His,"...8694921G > A corresponded to CACNA1G:c.5144G > A, p.Arg1715His (NM_018896.4, MIM 604065) (Fig. 1d). ...",76,58,Mol_Brain_2015_Dec_29_8_89.txt
p.Arg1715His,...ocal images of HeLa cells expressing wild-type or p.Arg1715His mutant CaV3.1. HeLa cells were transi...,116,85,Mol_Brain_2015_Dec_29_8_89.txt
p.Arg1715His,...ls were transiently transfected with wild-type or p.Arg1715His mutant human CaV3.1 and immunostained...,116,171,Mol_Brain_2015_Dec_29_8_89.txt
p.D620N,...altered by the Parkinson’s disease VPS35 mutation p.D620N Hum Mol Genet 2015 24 6 1691 703 10.1093/h...,169,208,Mol_Brain_2015_Oct_31_8_70.txt
p.Ala92Val,(p.Ala92ValfsX15),82,2,Mol_Cancer_2014_Jan_24_13_11.txt
p.Ser577Ser,(p.Ser577Ser),84,2,Mol_Cancer_2014_Jan_24_13_11.txt
p.Arg226X,(p.Arg226X),86,2,Mol_Cancer_2014_Jan_24_13_11.txt
p.Lys195X,(p.Lys195X),88,2,Mol_Cancer_2014_Jan_24_13_11.txt
p.Glu470Gln,"We found a missense mutation (c.1408 G>C, p.Glu470Gln) in one patient and a nonsense mutatio...",12,43,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
p.Glu575*,"... nonsense mutation in another patient (c.1723G>T, p.Glu575*). None of these mutations were detected ...",12,126,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
p.Gly245Arg,"...d one single nucleotide polymorphismus (c.733G>A, p.Gly245Arg) homozygous in two and heterozygous in...",12,276,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
p.L1291F,"..., we found two novel MYO15A mutations, c.3871C>T (p.L1291F) and c.5835T>G (p.Y1945X) in an affected ...",11,594,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Y1945X,"...5A mutations, c.3871C>T (p.L1291F) and c.5835T>G (p.Y1945X) in an affected individual carrying conge...",11,619,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,"...uencing of 134 known deafness genes. The variant, p.L1291F and p.Y1945X, resided in the myosin motor...",11,790,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Y1945X,"...4 known deafness genes. The variant, p.L1291F and p.Y1945X, resided in the myosin motor and IQ2 doma...",11,803,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,"...e myosin motor and IQ2 domains, respectively. The p.L1291F variant was predicted to affect the struc...",11,876,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Y1945*,...re c.3871C>T (p.L 1291F) in exon 6 and c.5835T>G (p.Y1945*) in exon 24 (Fig. 1C). The mother of SB15...,47,692,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,...6-272 (SB156-328) was heterozygous for c.3871C>T (p.L1291F) and the father (SB156-327) was heterozyg...,47,792,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Y1945*,...ather (SB156-327) was heterozygous for c.5835T>G (p.Y1945*) (Figs. 1D and 1E). These two variants we...,47,861,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,"...ses consistently identified the MYO15A c.3871C>T (p.L1291F) SNP as “damaging.” Furthermore, p.L1291 ...",47,1087,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Y1945*,"...e myosin motor and IQ2 domains, respectively. The p.Y1945* was the second mutation detected in the I...",47,1462,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,The p.L1291F model was constructed from the wild-type ...,50,5,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,...oldX by replacing p.L1291 with phenylalanine. The p.L1291F mutation was evaluated by comparing that ...,50,128,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,"... region. As phenylalanine is larger than leucine, p.L1291F would push away the actin-binding region ...",50,641,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Y1945*,...he second mutation found was a nonsense mutation: p.Y1945* (c.5835T>G). It resides in the IQ2 domain...,64,52,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Y1945*,"...ormational changes (Bahler and Rhoads, 2002). The p.Y1945* (c.5835T>G) mutation is predicted to trun...",64,296,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Q2021*,"...s usual length. Several other nonsense mutations; p.Q2021*, p.S2661*, p.R2923* and p.Q3492*, located...",64,471,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.S2661*,"...ngth. Several other nonsense mutations; p.Q2021*, p.S2661*, p.R2923* and p.Q3492*, located downstrea...",64,481,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.R2923*,"...ral other nonsense mutations; p.Q2021*, p.S2661*, p.R2923* and p.Q3492*, located downstream to p.Y19...",64,491,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Q3492*,"...sense mutations; p.Q2021*, p.S2661*, p.R2923* and p.Q3492*, located downstream to p.Y1945*, have alr...",64,504,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Y1945*,"...61*, p.R2923* and p.Q3492*, located downstream to p.Y1945*, have already been reported to cause seve...",64,536,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Y1945*,"...et al., 2013). Therefore it seems likely that the p.Y1945* (c.5835T>G) mutation that results in a sh...",64,708,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.E396Rfs,... all patients with mutations in exon 2 of MYO15A (p.E396Rfs*36 homozygote) had residual hearing at l...,66,992,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.E1105*,"...ed in other studies in which mutations in exon 2 (p.E1105*, p.R1113Vfs*12 and p.Y289* homozygote), w...",66,1182,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.R1113Vfs,"...r studies in which mutations in exon 2 (p.E1105*, p.R1113Vfs*12 and p.Y289* homozygote), which encod...",66,1192,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Y289*,"... mutations in exon 2 (p.E1105*, p.R1113Vfs*12 and p.Y289* homozygote), which encodes the N-terminal ...",66,1210,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,.... (C) Sanger sequencing traces for the c.3871C>T (p.L1291F) + c.5835T>G (p.Y1945*) compound heterozy...,79,490,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Y1945*,... traces for the c.3871C>T (p.L1291F) + c.5835T>G (p.Y1945*) compound heterozygote (SB156-272). (D) S...,79,513,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,Fig. 3. The location of the p.L1291F mutation (blue) is close to two functiona...,83,29,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,Fig. 4. Pathogenicity of the p.L1291F mutation. The mutation p.L1291F would alt...,85,30,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,...hogenicity of the p.L1291F mutation. The mutation p.L1291F would alter the structure of the actin-bi...,85,62,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Leu1291Phe,B156-272	MYO15A	NM_016239:exon6:c.3871C> T:p.Leu1291Phe	AR	17	C	T	60	100.00%	60	5.01	Nonsynon...,90,44,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Tyr1945*,NM_016239:exon24:c.5835T> G:p.Tyr1945*	AR	17	T	G	81	100.00%	60		Nonsense,91,29,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Tyr289*,c.867C>G	p.Tyr289*	N-terminal	Homozygous	*Residual hearing ...,95,10,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Tyr289*,c.867C>G	p.Tyr289*	N-terminal	Homozygous	Profound	Cengiz et...,96,10,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Glu396Arg,c.1185dup	p.Glu396Argfs*36	N-terminal	Homozygous	*Residual h...,97,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Glu1105*,c.3313G>T	p.Glu1105*	N-terminal	Homozygous	Severe to profoun...,98,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Arg1113Val,c.3336del	p.Arg1113Valfs*12	N-terminal	Homozygous	*Residual ...,99,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Gln1229*,c.3685C>T	p.Gln1229*	Motor	Homozygous	Profound	Liburd et al....,100,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Thr1253Ile,c.3758C>T	p.Thr1253Ile	Motor	Homozygous	Severe to profound	N...,102,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Leu1291Phe,c.3871C>T	p.Leu1291Phe	Motor	Heterozygous	Profound	This stud...,104,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Tyr1392*,c.4176C>A	p.Tyr1392*	Motor	Homozygous	Severe to profound	Nal...,105,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Val1400Met,c.4198G>A	p.Val1400Met	Motor	Homozygous	Severe to profound	C...,106,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Glu1414Lys,c.4240G>A	p.Glu1414Lys		Homozygous	Profound	Brownstein et al...,107,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Asp1451Asn,c.4351G>A	p.Asp1451Asn	Motor	Homozygous	Severe to profound	N...,109,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Ser1481Pro,c.4441T>C	p.Ser1481Pro	Motor	Homozygous	Severe to profound	C...,110,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Lys1557Glu,c.4669A>G	p.Lys1557Glu	Motor	Homozygous	Severe to profound	N...,111,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Cys1666*,c.4998C>A	p.Cys1666*	Motor	Homozygous	Severe to profound	Bel...,112,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Gly1706Glu,c.5117_5118del	p.Gly1706Glufs*102	Motor	Homozygous	Severe to prof...,113,16,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Leu1730Pro,c.5189T>C	p.Leu1730Pro	Motor	Homozygous	Severe to profound	N...,114,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Gly1831Val,c.5492G>T	p.Gly1831Val	Motor	Homozygous	Profound	Kalay et al...,115,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Arg1937Thr,c.5808_5814del	p.Arg1937Thrfs*10	IQ 2	Homozygous	Severe to profou...,116,16,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Tyr1945*,c.5835T>G	p.Tyr1945*	IQ 2	Heterozygous	Profound	This study,117,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Gln2021*,"c.6061C>T	p.Gln2021*		?	Severe to profound	Nal et al., 2007",119,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Pro2073Ser,c.6217C>T	p.Pro2073Ser	MyTH4 1	Homozygous	Severe to profound...,120,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Ala2104Cys,c.6308dup	p.Ala2104Cysfs*19	MyTH4 1	Heterozygous	Severe to p...,121,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Val2114Met,c.6340G>A	p.Val2114Met	MyTH4 1	Heterozygous	Severe to profou...,122,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Arg2124Gln,c.6371G>A	p.Arg2124Gln	MyTH4 1	Homozygous	Severe to profound...,123,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Arg2146Gln,c.6437G>A	p.Arg2146Gln	MyTH4 1	Heterozygous	Severe to profou...,124,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Thr2205Ile,c.6614C>T	p.Thr2205Ile	MyTH4 1	Hemizygous	*Residual hearing ...,125,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Gly2244Glu,c.6731G>A	p.Gly2244Glu		Homozygous	Severe to profound	Nal et...,126,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Val2266Met,c.6796G>A	p.Val2266Met		Homozygous	Severe to profound	Nal et...,127,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Gln2716His,"c.8148G>T	p.Gln2716His		Homozygous	Profound	Liburd et al., 2...",131,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Asp2720His,c.8158G>C	p.Asp2720His		Homozygous	Severe to profound	Nal et...,132,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Arg2775His,c.8324G>A	p.Arg2775His		Heterozygous	Severe to profound	Yang...,133,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Val2792Ala,c.8375T>C	p.Val2792Ala		Heterozygous	Severe to profound	Gao ...,134,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Arg2923*,c.8767C>T	p.Arg2923*	SH3	Heterozygous	Severe to profound	Yan...,135,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Gly2941Val,c.8821_8822insTG	p.Gly2941Valfs*94	SH3	Homozygous	Severe to profoun...,136,18,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Leu3160Phe,c.9478C>T	p.Leu3160Phe	MyTH4 2	Homozygous	Severe to profound...,139,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Asp3320Thr,c.9958_9961del	p.Asp3320Thrfs*2	FERM	Heterozygous	Severe to profo...,140,16,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Ser3335Ala,c.9995_10002dup	p.Ser3335Alafs*121	FERM	Homozygous	Severe to profo...,141,17,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Gln3492*,c.10474C>T	p.Gln3492*	FERM	Homozygous	Severe to profound	Nal ...,143,12,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Ser3525Ala,c.10573del	p.Ser3525Alafs*29	FERM	Heterozygous	Severe to prof...,144,12,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Ser3525Ala,c.10573del	p.Ser3525Alafs*29	FERM	Homozygous	Severe to profou...,145,12,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Pro221Leu,...CG; p.Val19fs*24) and a point mutation (c.662C>T; p.Pro221Leu). The consanguineous parents carry the...,3,1465,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
p.Pro221Leu,... separate point mutation within exon 5 (c.662C>T; p.Pro221Leu). Neither mutation has been described ...,10,632,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
p.Pro221Leu,...es both the exon 1 (p.Val19fs*24) and the exon 5 (p.Pro221Leu) mutations (Fig. 1b). As the parents a...,16,130,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
p.Pro221Leu,...ble. It is difficult to predict the effect of the p.Pro221Leu change by itself: the pathogenicity pr...,38,258,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
p.Arg288Met,...s in the SMN1  gene in Chinese patients with SMA: p.Arg288Met mutations causing SMN1  transcript exc...,68,122,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
p.R49Efs,CCM1	6	c.143dupA	p.R49Efs*15	f	Cavé-Riant et al. (2002)	51,35,18,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.G105R,7	c.313G>C	p.G105R	f	Novel	12,36,12,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.Q136*,8	c.406C>T	p.Q136*	f	Novel	46,37,12,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.T188Nfs,9	c.557dupT	p.T188Nfs*2	f	Novel	1,38,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.Q201Rfs,IVS9	c.729+5G>A	p.Q201Rfs*23	f	Novel	44,39,17,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.D281Afs,10	c.842delA	p.D281Afs*7	f	Novel	28,41,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.H293Tfs,11	c.877delC	p.H293Tfs*12	f	Novel	15,44,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.G365*,12	c.1093G>T	p.G365*	f	Novel	1,45,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.G389Efs,13	c.1166delG	p.G389Efs*5	f	Novel	71,46,15,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.Y419Ffs,IVS13	c.1255-1G>A	p.Y419Ffs*153	f	Cavé-Riant et al. (2002)	31,48,19,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.E420Tfs,14	c.1255_1270delTATGAAAAAGTTCGAA	p.E420Tfs*12	f	Novel	78,49,35,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.R423*,"14	c.1267C>T4	p.R423*	i/f	Cavé-Riant et al. (2002)	23,63,79,44,3...",50,15,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.L436Afs,14	c.1306_1310delTTGAA	p.L436Afs*4	f	Battistini et al. (2007)	7,51,24,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.Y477*,15	c.1431T>A	p.Y477*	i	Novel	24,53,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.D511Mfs,15	c.1531delG	p.D511Mfs*2	i	Novel	23,54,15,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.L540*,16	c.1619T>A	p.L540*	f	Novel	10,56,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.L554Kfs,16	c.1660_1678delTTGGCAAGTCTGCTTTTGC	p.L554Kfs*2	i	Novel	14,57,38,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.Q560*,16	c.1678C>T	p.Q560*	f	Stahl et al. (2008)	8,58,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.I522*,"IVS16	c.1730+4_1730+7delAGTA4	p.I522*3	f	Cavé-Riant et al. (2002)	51,17",59,31,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.H603Ifs,17	c.1806_1807insAT	p.H603Ifs*59	i	Novel	31,60,21,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.S651Qfs,18	c.1950dupC	p.S651Qfs*4	f	Novel	13,61,15,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.K654Sfs,18	c.1961_1962delAA	p.K654Sfs*21	f	Novel	43,62,21,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.Y69Vfs,IVS2	c.205-2_205-1delAGinsT	p.Y69Vfs*33	f	Stahl et al. (2008)	43,68,29,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.E359Pfs,10	c.1071_1074dupCCCT	p.E359Pfs*2	f	Novel	47,69,23,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.D419Gfs,10	c.1255dupG	p.D419Gfs*2	f	Novel	33,70,15,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.L22Pfs,CCM3	4	c.63_64dupCC	p.L22Pfs*13	f	Novel	42,71,21,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.R35*,"5	c.103C>T4	p.R35*	i/f	Bergametti et al. (2005)	8,11,20,1",72,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.L38Rfs,5	c.113delT	p.L38Rfs*7	f	Novel	53,73,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.K106Rfs,7	c.317delA	p.K106Rfs*20	i	Novel	2,75,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.Q112Ffs,7	c.334_337delCAAA	p.Q112Ffs*13	f	Novel	20,76,20,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.I131Sfs,7	c.391delA	p.I131Sfs*4	f	Novel	1,77,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.A119Gfs,IVS8	c.475-2A>G	p.A119Gfs*423	i	Novel	22,78,17,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.R196*,10	c.586C>T	p.R196*	i	Bergametti et al. (2005)	17,81,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.Q200*,10	c.598C>T	p.Q200*	f	Schröder et al. (2014)	50,82,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.G105R,"...ant changes a conserved glycine into an arginine (p.G105R) and is probably damaging (Polyphen2, Muta...",116,262,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.W740S,"...his study, with two mutations in MFN2 (c.2219G>C, p.W740S; c.227T>C; p.L76P) comprising 8.7%. Other ...",82,1060,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.L76P,"... mutations in MFN2 (c.2219G>C, p.W740S; c.227T>C; p.L76P) comprising 8.7%. Other frequent mutations ...",82,1079,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.Arg954*,"...er frequent mutations included SH3TC2 (c.2860C>T; p.Arg954* [4.8%]), FIG4 (c.122T>C; p.Ile41Thr [4.3...",82,1157,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.Ile41Thr,"...C2 (c.2860C>T; p.Arg954* [4.8%]), FIG4 (c.122T>C; p.Ile41Thr [4.3%]), and GJB1 (c.305A>G; p.Glu102Gl...",82,1192,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.Glu102Gly,"...c.122T>C; p.Ile41Thr [4.3%]), and GJB1 (c.305A>G; p.Glu102Gly [2.5%]) (Table S6). The distribution o...",82,1232,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.Asp106Gly,"...ted as pathogenic for a given codon (i.e., PTPN11 p.Asp106Gly rather than p.Asp106Ala)",21,1250,Mol_Genet_Genomic_Med_2015_Mar_3_3(2)_99-110.txt
p.Asp106Ala,"...given codon (i.e., PTPN11 p.Asp106Gly rather than p.Asp106Ala)",21,1274,Mol_Genet_Genomic_Med_2015_Mar_3_3(2)_99-110.txt
p.R243Q,"...e in 2 patients with PKU, and previously reported p.R243Q, p.Y356X, p.V399V, p.A403V mutations were ...",10,628,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,"...tients with PKU, and previously reported p.R243Q, p.Y356X, p.V399V, p.A403V mutations were detected",10,637,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.V399V,"...th PKU, and previously reported p.R243Q, p.Y356X, p.V399V, p.A403V mutations were detected",10,646,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.A403V,"...nd previously reported p.R243Q, p.Y356X, p.V399V, p.A403V mutations were detected",10,655,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.R243Q,...patient was a compound heterozygote of a paternal p.R243Q (c.728 G to A transition) and a maternal p...,48,1272,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.V399V,... p.R243Q (c.728 G to A transition) and a maternal p.V399V (c.1197 A to T transversion) in PAH gene,48,1321,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,....5). The patient was a compound heterozygote of a p.Y356X (c.1068 C to A transversion) and a p.A403V...,50,766,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.A403V,...e of a p.Y356X (c.1068 C to A transversion) and a p.A403V (c.1208 C to T transition) in PAH gene. We...,50,809,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.A403V,"...nalysis in her mother, and detected a mutation of p.A403V. It was impossible to collect DNA sample f...",50,929,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.R243Q,"...on database). In this study, a total 4 mutations (p.R243Q, p.Y356X, p.V399V and A403V) from the 2 ca...",55,209,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,"...se). In this study, a total 4 mutations (p.R243Q, p.Y356X, p.V399V and A403V) from the 2 cases were ...",55,218,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.V399V,"...his study, a total 4 mutations (p.R243Q, p.Y356X, p.V399V and A403V) from the 2 cases were identifie...",55,227,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.R243Q,"...3V) from the 2 cases were identified in PAH gene. p.R243Q, p.Y356X, p.V399V mutations were previousl...",55,292,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,"...the 2 cases were identified in PAH gene. p.R243Q, p.Y356X, p.V399V mutations were previously reporte...",55,301,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.V399V,"...es were identified in PAH gene. p.R243Q, p.Y356X, p.V399V mutations were previously reported in Asia...",55,310,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.R243Q,Phe/Tyr - 22.6	p.R243,73,16,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.V399V,p.V399V,74,1,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,Phe/Tyr - 10.97	p.Y356,79,17,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.A403V,p.A403,80,1,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Asp816His,"...el, p.Lys558_Glu562del) and exon 17 (c.2446G > C, p.Asp816His) was used [26]. Xenografts were establ...",35,120,Mol_Imaging_Biol_2011_Dec_16_13(6)_1234-1240.txt
p.Met1093Ile,"... the identification of a novel missense mutation, p.Met1093Ile QIAO SHU-KAI 12REN HAN-YUN 1REN JIN-H...",3,241,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,"...he FVIII gene (F8) was found in this patient. The p.Val502Asp mutation, which has been reported prev...",3,1606,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"...domain function. A novel missense point mutation, p.Met1093Ile, was identified in the B domain. The ...",3,1725,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,"...omain. The compound heterozygote mutations in F8, p.Val502Asp and p.Met1093Ile, caused HA in this fe...",3,1814,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"...und heterozygote mutations in F8, p.Val502Asp and p.Met1093Ile, caused HA in this female patient, wi...",3,1830,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,"...e, F8 compound heterozygote mutations (c.1505T>A, p.Val502Asp and c.3279G>A, p.Met1093Ile) were iden...",12,210,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"... mutations (c.1505T>A, p.Val502Asp and c.3279G>A, p.Met1093Ile) were identified using multiplex PCR ...",12,237,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,"...d mutation (15) was detected (exon 10, c.1505T>A, p.Val502Asp), and a novel unreported missense poin...",31,107,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"...rted missense point mutation (exon 14, c.3279G>A, p.Met1093Ile) (Fig. 1)",31,189,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,...ting from F8 compound heterozygous mutations. The p.Val502Asp mutation located in A2 domains was fir...,44,169,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,...ing in altered stability and protein folding. The p.Met1093Ile mutation is located in the B domain o...,44,611,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"..., inactivation and clearance (30). Therefore, the p.Met1093Ile mutation in the B domain also affects...",44,1319,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"... have often been reported in HA patients (31,32). p.Met1093Ile is a novel missense mutation unreport...",44,1502,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,...timated that the compound heterozygous mutations (p.Val502Asp and p.Met1093Ile) are causative gene d...,44,1724,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"... compound heterozygous mutations (p.Val502Asp and p.Met1093Ile) are causative gene defects, which re...",44,1740,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,...ns 10 and 14. (A) Exon 10: NM_000132.3 c.1505T>A (p.Val502Asp). (B) Exon 14: NM_000132.3 c.3279G>A (...,51,94,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,...p.Val502Asp). (B) Exon 14: NM_000132.3 c.3279G>A (p.Met1093Ile),51,144,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,...domains are individually labeled and colored. The p.Val502Asp mutation located in the A2 domain is i...,53,193,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,...rrow. (B) Simple model of the FVIII B domain. The p.Met1093Ile mutation is located in the B domain a...,53,309,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,...tructure of the B domain. (C and D) Comparison of p.Val502Asp mutation structural images in A2 domai...,53,609,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Phe2127Ser,"...a A: Identification of a novel missense mutation, p.Phe2127Ser Thromb Haemost 104 718 723 2010 20664...",131,172,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.R603I,"... results identified two novel missense mutations, p.R603I and p.G749 V. These mutations were not ide...",3,1985,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,"...tion from glycine to valine and was designated as p.G749V. In family B, a heterozygous nucleotide ch...",24,394,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R603I,...from arginine to isoleucine acid at position 603 (p.R603I). No ATP2A2 variants were detected in the ...,24,616,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R603I,"... of the SIFT for each mutation were 0, therefore, p.R603I and p.G749V were considered deleterious mu...",24,1037,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,"... for each mutation were 0, therefore, p.R603I and p.G749V were considered deleterious mutations, aff...",24,1049,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R603I,The p.R603I and p.G749V mutations identified in the pr...,37,5,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,The p.R603I and p.G749V mutations identified in the present study ...,37,17,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R603I,"...nt study identified two novel missense mutations, p.R603I and p.G749V, in the ATP2A2 gene in two fam...",39,75,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,"...ntified two novel missense mutations, p.R603I and p.G749V, in the ATP2A2 gene in two families contai...",39,87,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,...roband of family A exhibited a missense mutation (p.G749V) in exon 15; whereas the (B) proband of fa...,46,131,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R603I,...roband of family B exhibited a missense mutation (p.R603I) in exon 14. Wild-type alleles of (C) exon...,46,219,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R541H,... protein function has revealed that the lamin A/C p.R541H mutation causes the highly conserved seque...,51,442,Mol_Med_Rep_2015_Oct_8_12(4)_5065-5071.txt
p.T528R,... 3. Chromatograms of the heterozygous c.1583 C→G (p.T528R) mutation in exon 9 of LMNA,65,100,Mol_Med_Rep_2015_Oct_8_12(4)_5065-5071.txt
p.H50Q,"...Rajput AH Jon Stoessl A Farrer MJ Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson’...",136,175,Mol_Neurodegener_2013_May_28_8_17.txt
p.H50Q,"...ut AH  Jon Stoessl A  Farrer MJ   Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson'...",205,195,Mol_Neurodegener_2014_Oct_29_9_43.txt
p.N410H,...W  Rademakers R   Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration Acta Neu...,223,229,Mol_Neurodegener_2014_Oct_29_9_43.txt
p.G51D,...t Parkinson’s disease with dementia carrying SNCA p.G51D mutation Parkinsonism Relat Disord 2014 20 ...,307,191,Mol_Neurodegener_2015_Aug_27_10_41.txt
p.H50Q,"...ion M  Sherman H  Yu I  Shah B    Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson’...",322,100,Mol_Neurodegener_2015_Aug_27_10_41.txt
p.K318E,"... located in PLXNB2 at 22q13 (rs28379706, c.A952G, p.K318E; PCC=1.31 × 10-5, beta=−0.04±0.009, odds r...",80,354,Mol_Psychiatry_2016_Aug_4_21(8)_1145-1151.txt
p.Asn74Lys,"frame-shift mutation in the Y0036 allele (p.Asn74Lysfs*2), potentiall",429,43,Mol_Syst_Biol_2014_Nov_28_10(11)_764.txt
p.Tyr402His,...n AMD-associated complement factor H polymorphism p.Tyr402His. Hum Mutat 2006 27 921 5 1686569,223,167,Mol_Vis_2007_Feb_7_13_196-205.txt
p.E402X,"...ly onset RP	Found in compound heterozygosity with p.E402X and with p.I459K	 [2,11]",45,95,Mol_Vis_2008_Apr_21_14_675-682.txt
p.I459K,"... in compound heterozygosity with p.E402X and with p.I459K	 [2,11]",45,112,Mol_Vis_2008_Apr_21_14_675-682.txt
p.G368W,Exon 11	c.1102G>T	p.G368W	LCA		 [2],51,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.F382S,Exon 11	c.1145T>C	p.F382S	Early onset RP		 [19],52,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.R400W,Exon 12	c.1198C>T	p.R400W	LCA		 [2],53,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.E402X,Exon 12	c.1204G>T	p.E402X	LCA	Found in compound heterozygosity with ...,54,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.R420P,Exon 13	c.1259G>C	p.R420P	Early onset RP	Found in compound heterozyg...,56,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.F491L,...ly onset RP	Found in compound heterozygosity with p.F491L	 [11],56,80,Mol_Vis_2008_Apr_21_14_675-682.txt
p.I459K,Exon 14	c.1376 T>A	p.I459K	Early onset RP	Found in compound heterozyg...,57,20,Mol_Vis_2008_Apr_21_14_675-682.txt
p.L461V,Exon 14	c.1381C>G	p.L461V	Juvenile RP		 [16],58,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.F491L,Exon 14	c.1472 T>C	p.F491L	Early onset RP	Found in compound heterozyg...,59,20,Mol_Vis_2008_Apr_21_14_675-682.txt
p.R420P,...ly onset RP	Found in compound heterozygosity with p.R420P	 [11],59,81,Mol_Vis_2008_Apr_21_14_675-682.txt
p.R482W,Exon 14	c.1444C>T	p.R482W	Early onset RP	Found in compound heterozyg...,60,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.K489R,Exon 14	c.1502G>A	p.K489R	RP		 [18],61,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.A496T,Exon 14	c.1522 G>A	p.A496T	RP	Found in heterozygosity; second mutant ...,62,20,Mol_Vis_2008_Apr_21_14_675-682.txt
p.R482W,...ly onset RP	Found in compound heterozygosity with p.R482W	 [17],66,103,Mol_Vis_2008_Apr_21_14_675-682.txt
p.Pro192Leu,"... known and one novel missense mutation (c.575C>T, p.Pro192Leu), one insertion mutation (c.579dupC, p...",15,1488,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Ile194His,"... p.Pro192Leu), one insertion mutation (c.579dupC, p.Ile194Hisfs29ext43), and one frameshift, causing...",15,1537,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Glu72Lys,c.214G>A	missense	p.Glu72Lys	exon 4	5	5	2	17.86,89,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Gly140Arg,c.418G>A	missense	p.Gly140Arg	exon 5	4	3	2	12.5%,90,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Arg141Cys,c.421C>T	missense	p.Arg141Cys	exon 5	6	6+1	3	21.42+1.79,91,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Arg141His,c.422G>A	missense	p.Arg141His	exon 5	5	4	1	16.07,92,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Pro192Ser,c.574C>T	missense	p.Pro192Ser	exon 6	3	2	2	8.93,93,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Pro192Leu,c.575C>T *	missense	p.Pro192Leu	exon 6	-	1	1	1.79,94,21,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Arg209Cys,c.625C>T	missense	p.Arg209Cys	exon 6	3	1	1	7.14,96,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Arg141Cys,...ommonly found mutation (23.21%) was the c.421C>T (p.Arg141Cys) missense mutation (exon 5). Molecular...,121,760,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Pro192Leu,"...ing revealed a novel missense mutation (c.575C>T, p.Pro192Leu) in exon 6 of family 7. In addition, t...",121,865,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.R733X,... A novel heterozygous nonsense mutation c.2197C>T(p.R733X)was detected in family F2,17,501,Mol_Vis_2008_Dec_29_14_2451-2457.txt
p.R733X,...G in family F1 and a nonsense mutation c.2197C>T (p.R733X) in family F2 (Figure 3). Using SSCP analy...,111,166,Mol_Vis_2008_Dec_29_14_2451-2457.txt
p.R733X,...a novel heterozygous nonsense mutation c.2197C>T (p.R733X). The 2 novel mutations cosegregated with ...,120,231,Mol_Vis_2008_Dec_29_14_2451-2457.txt
p.G401D,"... in Chinese patients. The 2 mutations, a missense p.G401D and a small deletion p. D950CfsX4, are ass...",122,166,Mol_Vis_2008_Dec_29_14_2451-2457.txt
p.R733X,The novel nonsense mutation c.2197C>T (p.R733X) detected in family F2 presumably caused p...,126,40,Mol_Vis_2008_Dec_29_14_2451-2457.txt
p.Glu150Lys,...sion 2712008MOLVIS307Research ArticleA homozygous p.Glu150Lys mutation in the opsin gene of two Paki...,3,97,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,...d a homozygous c.448G>A mutation resulting in the p.Glu150Lys amino acid change. This variant was fi...,13,290,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,"...tients, we identified a disease-causing mutation (p.Glu150Lys) in the RHO gene. Single nucleotide po...",16,129,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,...two Pakistani families studied here share the RHO p.Glu150Lys mutation due to a common ancestry,16,318,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,"...sanguineous Indian family, a homozygous c.448G>A (p.Glu150Lys) mutation in exon 2 was reported [15]....",23,807,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,...ed [15]. Here we report the identification of the p.Glu150Lys RHO mutation in affected individuals f...,23,899,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,...lacement of a lysine residue for a glutamic acid (p.Glu150Lys) [15]. All affected individuals in thi...,141,178,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu249Ter,...C3) loops [23]. The first reported null mutation (p.Glu249Ter) associated with arRP was shown to abo...,171,456,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,"...r, Zhu et al. [25] have shown that the homozygous p.Glu150Lys change does not affect binding of opsi...",173,330,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,...dopsin protein has been shown to be normal in the p.Glu150Lys heterozygotes [25],173,729,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.S138X,...tion in OTX2 was identified. A novel heterozygous p.S138X stop mutation was identified in a seven-ye...,13,64,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.S138X,A de novo heterozygous c.413C>G p.S138X stop mutation was identified in a seven-ye...,31,33,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Asn225Ser,c.674A>G	p.Asn225Ser	CPHD	[22],52,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Asn225Ser,c.674A>G	p.Asn225Ser	CPHD	[22],53,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Tyr31X,c.93C>G	p.Tyr31X	Microphthalmia	[20],56,9,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Arg36Pro,c.106dupC	p.Arg36ProfsX52	Microphthalmia OD/ normal OS	[20],57,11,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Arg36Pro,c.106dupC	p.Arg36ProfsX52	Anophthalmia OD/ Coloboma OS	[20],58,11,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Gln97X,c.289C>T	p.Gln97X	Extreme microphthalmia	[20],59,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Gln97X,c.289C>T	p.Gln97X	Inferior iris coloboma OD/ retinal colobo...,60,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Gly126Trp,c.373_374delAG	p.Gly126TrpfsX11	Anophthalmia	[20],61,16,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Ser136Leu,c.404_405dupCT	p.Ser136LeufsX43	Anophthalmia and CPHD	[21],62,16,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Ser135Leu,"c.402dupC	p.Ser135LeufsX2	Anophthalmia, GH deficiency; cleft...",63,11,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Ser156Leu,c.463_464dupGC	p.Ser156LeufsX23	bilateral anophthalmia; developme...,64,16,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Arg89Gly,c.265C>G	p.Arg89Gly	bilateral microphthalmia	[11],65,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Ser28Pro,c.81delC	p.Ser28ProfsX23	bilateral severe microphthalmia	[1...,66,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Tyr179X,"c.537T>A	p.Tyr179X	severe microphthalmia and colobomata, de...",67,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Tyr179X,"c.537T>A	p.Tyr179X	bilateral mild microphthalmia, retinal d...",68,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Arg40Gly,c.117_118delCC	p.Arg40GlyfsX47	bilateral anophthalmia	[11],69,16,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Gln99X,c.295C>T	p.Gln99X	bilateral anopthalmia	[11],70,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Pro133Thr,c.397C>A	p.Pro133Thr	bilateral microphthalmia	[11],71,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Pro134Ala,c.400C>G	p.Pro134Ala	anophthalmia OS/ OD normal	[11],72,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.R240X,... c.475delC [p.R159fs47]) and one known (c.718C>T [p.R240X]) PAX6 mutations in the affected members o...,13,430,Mol_Vis_2009_Oct_17_15_2074-2083.txt
p.R240X,...ost complete agenesis of the corpus callosum with p.R240X,13,912,Mol_Vis_2009_Oct_17_15_2074-2083.txt
p.R240X,".... In Family 3, the previously described c.718C>T (p.R240X) nonsense mutation in exon 9 [2,18,19] was...",86,799,Mol_Vis_2009_Oct_17_15_2074-2083.txt
p.R240X,The p.R240X mutation segregating in Family 3 has previ...,93,5,Mol_Vis_2009_Oct_17_15_2074-2083.txt
p.R240X,"... observation of MRI anomalies associated with the p.R240X mutation [10,14]. In contrast with both Si...",95,783,Mol_Vis_2009_Oct_17_15_2074-2083.txt
p.Glu181Glu,SNX5 (NM_152227)	c.543G>A	p.Glu181Glu	rs2273448	Y (hetero) Score=25	Y (heter...,80,27,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Ser15Cys,C20orf72 (NM_018152)	c.43A>T	p.Ser15Cys	rs11551768	Y (hetero) Score=18	N	Y (het...,82,30,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr265Ile, 	c.794C>T	p.Thr265Ile	-	N	Y (hetero) Score=2**	N	Y (hetero),83,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Asp282Asp, 	c.846T>C	p.Asp282Asp	rs28455091	Y (hetero) Score=2*	Y (hete...,84,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val116Gly,PTMAP3 (NG_001180)	c.347T>G	p.Val116Gly	-	N*	N*	Y (hetero)	Y (hetero),85,29,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val116Val, 	c.348C>G	p.Val116Val	-	N*	N*	Y (homo)	Y (homo),86,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr121Arg, 	c.362C>G	p.Thr121Arg	-	N*	N*	Y (homo)	Y (homo),87,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Leu139Leu, 	c.415T>C	p.Leu139Leu	-	N*	N*	Y (homo)	Y (homo),88,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Cys185Arg, 	c.553T>C	p.Cys185Arg	rs3748493	N*	N*	Y (hetero)	Y (homo),89,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Cys281Cys, 	c.843C>T	p.Cys281Cys	rs3748492	N*	Y (homo) Score=4**	Y (het...,90,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr109Thr,OVOL2 (NM_021220)	c.327C>A	p.Thr109Thr	rs6111803	Y (hetero) Score=17	N	Y (het...,92,28,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val400Gly,CSRP2BP (NM_020536)	c.1199T>G	p.Val400Gly	rs1205193	Y (homo) Score=23	Y (homo) S...,95,31,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro479Pro, 	c.1437C>T	p.Pro479Pro	rs1205194	N	N	N	N,96,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Ala500Val, 	c.1499C>T	p.Ala500Val	rs41276418	Y (hetero) Score=25	Y (hete...,97,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro741Pro, 	c.2223T>C	p.Pro741Pro	rs2747404	Y (homo) Score=25	Y (homo) S...,98,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Leu30Pro,MGC44328 (NM_001004344)	c.89T>C	p.Leu30Pro	rs1883938	Y (homo) Score=27	Y (homo) Sc...,101,33,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Leu14Leu,C20orf12 (NM_018152)	c.40T>C	p.Leu14Leu	rs6035051	Y (hetero) Score=25	Y (homo) ...,102,30,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Cys267Cys, 	c.801T>C	p.Cys267Cys	rs6035042	Y (homo) Score=29	Y (hetero)...,103,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Leu470Leu, 	c.1410G>C	p.Leu470Leu	rs6075337	Y (homo) Score=26	Y (homo)+ ...,104,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr280Thr,POLR3F (NM_006466)	c.840A>G	p.Thr280Thr	rs1055171	Y (homo) Score=26	Y (hetero)...,106,29,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg116Gly,RPL21P3 (NG_000976)	c.346delA	p.Arg116GlyfsX28	-	N*	N*	Y (hetero)	Y (hetero),107,31,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro46Ala,RPS19P1 (NG_001295)	c.136C>G	p.Pro46Ala	rs2009092	Y (hetero) Score=12	Y (hetero...,109,30,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg56Gln, 	c.167G>A	p.Arg56Gln	-	N*	N*	Y (hetero)	N,110,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val164Met,SEC23B (NM_032985)	c.490G>A	p.Val164Met	rs36023150	N	N	N	N,111,29,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Phe400Leu, 	c.1198T>C	p.Phe400Leu	-	N	Y (hetero) Score=8	N	Y(hetero),112,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val426Ile, 	c.1276G>A	p.Val426Ile	-	N	N	N	N,113,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.His489Gln, 	c.1467C>G	p.His489Gln	rs2273526	N	Y (hetero) Score=27	N	Y(he...,114,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg16Arg,LOC388789 (XM_939954)	c.48A>G	p.Arg16Arg	rs12624935	N*	N*	N	Y (hetero),115,31,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Gln149His,DUXAP7 (NG_004846)	c.447A>C	p.Gln149His	rs6132094	N*	N*	Y (hetero)	Y (hetero),117,29,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr222Ala, 	c.664A>G	p.Thr222Ala	rs6081271	N*	N*	Y (homo)	Y (homo),118,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr222Ile, 	c.665C>T	p.Thr222Ile	rs6081270	N*	N*	Y (hetero)	Y (hetero),119,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Ile239Lys, 	c.716T>A	p.Ile239Lys	-	N*	N*	Y (hetero)	Y (hetero),120,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Lys240Lys, 	c.719delA	p.Lys240LysfsX39	-	N*	N*	N	Y (hetero),121,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Lys240Lys, 	c.720delA	p.Lys240LysfsX39	-	N*	N*	Y (hetero)	Y (hetero),122,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Glu241Arg, 	c.721insA	p.Glu241ArgfsX25	-	N*	N*	Y (hetero)	Y (hetero),123,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg244Arg, 	c.726_730dupGAAAA	p.Arg244ArgfsX37	-	N*	N*	Y (hetero)	Y (hetero),124,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg244Arg, 	c.726_730dupGAAAA [3]	p.Arg244ArgfsX25	-	N*	N*	Y (hetero)	Y (hetero),125,25,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val315Leu, 	c.943G>C	p.Val315Leu	rs6132093	N*	N*	Y (hetero)	Y (hetero),126,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val375Ala, 	c.1124T>C	p.Val375Ala	rs6081268	N*	N*	Y (hetero)	Y (hetero),127,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro386Ser, 	c.1156C>T	p.Pro386Ser	rs6075382	N*	N*	Y (hetero)	Y (hetero),128,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Gln92X,LOC100132358 (NC_000020)	c.274C>T	p.Gln92X	rs6081369	Y (hetero) Score=24	Y (hetero) ...,129,35,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro58Ser,LOC100270804	172C>T	p.Pro58Ser	rs41309831	Y (hetero) Score=13	N	Y (het...,131,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Gly181Gly,c.543G>T	p.Gly181Gly	rs7262320	Y (hetero) Score=26	N	Y (het...,132,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg448Arg,1343G>A	p.Arg448Arg	rs80046336	Y (hetero) Score=22	Y (hete...,134,10,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Leu46Leu,LOC100128496 (XM_001725705)	c.138C>G	p.Leu46Leu	rs56743271	Y (hetero) Score=19	N	Y (het...,136,38,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Thr85Thr,C20orf79 (NM_178483)	c.255C>T	p.Thr85Thr	rs1053834	Y (hetero) Score=25	N	Y (hete...,137,31,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro99Ser,c.295C>T	p.Pro99Ser	rs1053839	Y (hetero) Score=20	N	Y (hete...,138,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val55Ile,c.163G>A	p.Val55Ile	rs1569767	N	Y (hetero) Score=17	N	Y (he...,140,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Ala123Ala,c.369G>A	p.Ala123Ala	rs3790261	Y (Hetero) Score=26	Y (homo)...,141,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Leu213Leu,c.639G>A	p.Leu213Leu	rs3790278	Y (homo) Score=30	Y (homo) S...,142,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Ile218Ile,c.654T>C	p.Ile218Ile	rs3790279	Y (homo) Score=26	Y (homo) S...,143,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg514Pro,"Two novel mutations, c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) in TGFBI were identifie...",13,46,Mol_Vis_2010_Feb_15_16_224-230.txt
p.His572Arg,"...utations, c. 531C>T (p. Arg124Cys) and c.1876A>G (p.His572Arg), were revealed in Family 2 and Family...",13,180,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,...ctural changes. Mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) and the c. 531C>T (p. A...,13,598,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"The novel mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu), c. 531C>T (p. Arg124Cy...",16,45,Mol_Vis_2010_Feb_15_16_224-230.txt
p.His572Arg,"... Phe515Leu), c. 531C>T (p. Arg124Cys), c.1876A>G (p.His572Arg) in TGFBI were responsible for LCD in ...",16,110,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,...he 3 families. Mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) and the c. 531C>T (p. A...,16,211,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"...ly 1, two novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu), in exon 11 of TGFBI (F...",61,148,Mol_Vis_2010_Feb_15_16_224-230.txt
p.His572Arg,"... 7). A recently reported mutation [8], c.1876A>G (p.His572Arg), in exon 13 was identified in the pro...",61,521,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"...of the two novel mutations c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu) of TGFBI in Family 1, a...",63,79,Mol_Vis_2010_Feb_15_16_224-230.txt
p.His572Arg,"... results of the heterozygote mutations c.1876A>G (p.His572Arg) of TGFBI in Family 3, and their corre...",67,70,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"...quences of TGFBI displayed a high conservation of p.Arg514Pro and Phe515Leu in the chimpanzee, cow, ...",69,475,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"...tion could be detected. In Family 1, the mutation p.Arg514Pro is predicted to shorten the helix and ...",74,257,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Phe515Leu,...ation of a downstream turn structure; whereas the p.Phe515Leu mutation could predictably elongate th...,74,372,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,...of these two mutations conformed to the result of p.Arg514Pro,74,502,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,...indicates that mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) and c. 531C>T (p. Arg12...,77,238,Mol_Vis_2010_Feb_15_16_224-230.txt
p.His572Arg,... more phenotypic effects. The mutation c.1876A>G (p.His572Arg) is also identified in Family 3. The p...,77,348,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg124Leu,...e. Dighiero and colleagues [10] suggest that both p.Arg124Leu and p.Thr125_Glu126del compound hetero...,79,769,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg124Cys,...al dystrophy. The compound heterozygous mutations p.Arg124Cys coupled with p.Gly470X (a nonsense mut...,79,953,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Gly470X,...d heterozygous mutations p.Arg124Cys coupled with p.Gly470X (a nonsense mutation) have been identifi...,79,978,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Gly470X,...’s daughter who carries the heterozygous mutation p.Gly470X alone was unaffected. This raises the qu...,79,1136,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Gly470X,...ected. This raises the question as to whether the p.Gly470X in the compound heterozygous mutations c...,79,1211,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Gly470X,...ld be pathogenic. The authors speculated that the p.Gly470X nonsense mutation might be nonpathogenic...,79,1313,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Ala546Asp,"...rance. The third compound heterozygous mutations, p.Ala546Asp and p.Pro551Gln, have been reported in...",79,1438,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Pro551Gln,"... compound heterozygous mutations, p.Ala546Asp and p.Pro551Gln, have been reported in two non-consang...",79,1454,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"... study, 2 novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu), are identified in Fami...",81,374,Mol_Vis_2010_Feb_15_16_224-230.txt
p.G113Afs,"...rate homozygous single-base deletions, c.337delG (p.G113AfsX1) and c.1459delG (p.G487GfsX20), which ...",13,215,Mol_Vis_2010_Jan_15_16_46-52.txt
p.G487Gfs,"...eletions, c.337delG (p.G113AfsX1) and c.1459delG (p.G487GfsX20), which were not detected in 282 cont...",13,244,Mol_Vis_2010_Jan_15_16_46-52.txt
p.G113Afs,"...ous single base deletion within exon 4, c.338delG p.G113AfsX1 (Figure 2A). The mutation segregated a...",42,240,Mol_Vis_2010_Jan_15_16_46-52.txt
p.G487Gfs,"...gous single-base deletion in exon 13, c.1459delG, p.G487GfsX20 (Figure 2B). This is predicted to lea...",46,216,Mol_Vis_2010_Jan_15_16_46-52.txt
p.K1370E,"...d only in the RP patients. Two missense variants (p.K1370E and p.R1652L), which are conserved in pri...",15,135,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"... RP patients. Two missense variants (p.K1370E and p.R1652L), which are conserved in primates, were p...",15,148,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,"...1 protein. The other three variants (c.787+34T>C, p.I408L and p.L2015L) were considered benign",15,308,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L2015L,"...he other three variants (c.787+34T>C, p.I408L and p.L2015L) were considered benign",15,320,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.T373I,"...ull length. Only a few missense variants, such as p.T373I [18], p.K663N [16], p.A669T [18], p.D984G ...",25,1220,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K663N,"...ly a few missense variants, such as p.T373I [18], p.K663N [16], p.A669T [18], p.D984G [21], and p.L1...",25,1234,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.A669T,"...nse variants, such as p.T373I [18], p.K663N [16], p.A669T [18], p.D984G [21], and p.L1808P [16], hav...",25,1248,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.D984G,"...such as p.T373I [18], p.K663N [16], p.A669T [18], p.D984G [21], and p.L1808P [16], have been found t...",25,1262,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L1808P,"...8], p.K663N [16], p.A669T [18], p.D984G [21], and p.L1808P [16], have been found to be disease causi...",25,1280,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R677X,...th mixed phenotypes. We found that RP1 mutations (p.R677X and p.D984G) accounted for about 1.2% of o...,27,163,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.D984G,...notypes. We found that RP1 mutations (p.R677X and p.D984G) accounted for about 1.2% of overall RP [2...,27,175,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R872H,"...iants were identified (Table 1). Among them, six (p.R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, an...",46,72,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.N985Y,"...e identified (Table 1). Among them, six (p.R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, and p.C2033...",46,81,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.A1670T,"...ied (Table 1). Among them, six (p.R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, and p.C2033Y) were c...",46,90,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.S1691P,"... 1). Among them, six (p.R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, and p.C2033Y) were common SNPs...",46,100,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1725Q,"... them, six (p.R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, and p.C2033Y) were common SNPs registere...",46,110,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.C2033Y,"...R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, and p.C2033Y) were common SNPs registered in the SNP d...",46,124,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,Exon 4	c.1222A>C	p.I408L	Novel	20090	0/190,54,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.G706R,Exon 4	c.2116G>C *	p.G706R	 [26]	20121	1/190,55,20,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R872H,Exon 4	c.2615G>A	p.R872H	rs444772	43/55	130/190,56,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.N985Y,Exon 4	c.2953A>T	p.N985Y	rs2293869	20149	27/190,57,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1008Q,Exon 4	c.3024G>A	p.Q1008Q	 [26]	20090	1/190,58,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,Exon 4	c.4108A>G	p.K1370E	Novel	20090	0/190,59,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,Exon 4	c.4955G>T	p.R1652L	Novel	20090	0/190,60,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.A1670T,Exon 4	c.5008G>A	p.A1670T	rs446227	44/55	106/190,61,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.S1691P,Exon 4	c.5071T>C	p.S1691P	rs414352	44/55	106/190,62,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1725Q,Exon 4	c.5175A>G	p.Q1725Q	rs441800	44/55	106/190,63,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L2015L,Exon 4	c.6045A>G	p.L2015L	Novel	20090	0/190,64,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.C2033Y,Exon 4	c.6098G>A	p.C2033Y	rs61739567	20149	27/190,65,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.G706R,*One patient was homozygous for the p.G706R variant while the other was heterozygous f...,67,37,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.G706R,"...o identified eight rare variants, three of which (p.G706R, p.Q1008Q, and c.6542C>T) occurred in both...",69,57,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1008Q,"...ied eight rare variants, three of which (p.G706R, p.Q1008Q, and c.6542C>T) occurred in both the case...",69,66,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L2015L,...jects from different areas of China. Two of them (p.L2015L and intronic c.787+34T>C) did not lead to...,69,258,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,"...lead to amino acid change, while the other three (p.I408L, p.K1370E, and p.R1652L) were missense cha...",69,351,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"...mino acid change, while the other three (p.I408L, p.K1370E, and p.R1652L) were missense changes",69,360,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...ge, while the other three (p.I408L, p.K1370E, and p.R1652L) were missense changes",69,374,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,The impact of variant p.I408L was predicted to be “Borderline” by PolyPh...,71,23,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,"...Grantham score was 5. Based on these assessments, p.I408L is less likely to be a disease-causing mut...",71,224,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...ely to be a disease-causing mutation. The variant p.K1370E was predicted as “Potentially damaging” a...,71,293,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"...was 56, being moderately conservative. Therefore, p.K1370E is potentially disease causing. For the p...",71,572,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"... p.K1370E is potentially disease causing. For the p.R1652L variant, the predictions were “Possibly d...",71,621,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...ndex of 7) by PMUT. With a Grantham score of 102, p.R1652L should be moderately radical and highly l...",71,810,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...r around these two residues. However, the variant p.R1652L was predicted to abolish one possible pro...",71,1025,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...Determination of the evolutionary conservation of p.K1370E and p.R1652L by multiple amino acid seque...,71,1190,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,... of the evolutionary conservation of p.K1370E and p.R1652L by multiple amino acid sequence alignment...,71,1203,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,Exon 4	c.1222A>C	p.I408L	adRP	F	56	0/552	Borderline	1.234	Tolerant	...,76,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,Exon 4	c.4108A>G	p.K1370E	sRP	F	61	0/552	Potentially damaging	1.477...,77,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,Exon 4	c.4955G>T	p.R1652L	sRP	F	50	0/552	Possibly damaging	1.63	Pot...,78,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"... RP1 wild type protein and the missense variants, p.K1370E and p.R1652L, were analyzed by web-based ...",81,134,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...e protein and the missense variants, p.K1370E and p.R1652L, were analyzed by web-based analysis prog...",81,147,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,A. Description	Wild type	p.K1370E,82,26,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,B. Description	Wild type	p.R1652L,85,26,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"Difference between wild type and the p.K1370E variant, at position around residue 1370....",90,38,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...due 1370. B. Difference between wild type and the p.R1652L variant, at position around residue 1652....",90,129,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"...ntosa 1 (RP1; partially), showing the location of p.K1370E and p.R1652L. The two residues are not co...",92,114,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"... partially), showing the location of p.K1370E and p.R1652L. The two residues are not conserved acros...",92,127,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.I408L,...ssment. By using these tools we would expect that p.I408L is less likely to be a functional mutation...,95,1047,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...-be-identified mutation. In contrast, the variant p.R1652L was likely to be a deleterious substituti...",95,1689,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"...PolyPhen, SIFT, PMUT, and Grantham score. Variant p.K1370E was also predicted to be deleterious by t...",95,1823,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...ypeptide where many mutations occur. Furthermore, p.R1652L was predicted to abolish one possible pro...",95,2109,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,...ur results are consistent for pathologic roles of p.R1652L and p.K1370E in RP. The patients with the...,95,2546,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...e consistent for pathologic roles of p.R1652L and p.K1370E in RP. The patients with these postulated...,95,2559,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...he truncation mutation carrier [29]. Notably, the p.R1652L and p.K1370E carriers were classified as ...",95,2784,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"... mutation carrier [29]. Notably, the p.R1652L and p.K1370E carriers were classified as sRP because t...",95,2797,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...sentations of the two putative missense mutation (p.K1370E and p.R1652L) carriers. They both appear ...,97,83,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,... the two putative missense mutation (p.K1370E and p.R1652L) carriers. They both appear to be less se...,97,96,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...m (ERG) and automated visual field reports of the p.K1370E carrier. B: Fundus photographs and automa...,97,283,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...ographs and automated visual field reports of the p.R1652L carrier, showing much milder clinical man...",97,365,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.S2Rfx,...l manifestation in comparison to the carrier with p.S2RfxX16 and p.P1648SfsX13 truncation mutations ...,97,460,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.P1648Sfs,... in comparison to the carrier with p.S2RfxX16 and p.P1648SfsX13 truncation mutations [29]. Abbreviat...,97,475,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R677X,"...revious studies, we identified two RP1 mutations, p.R677X and p.D984G, in two out of 173 Hong Kong C...",99,59,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.D984G,"...ies, we identified two RP1 mutations, p.R677X and p.D984G, in two out of 173 Hong Kong Chinese RP pa...",99,71,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.N985Y,"...mited. Recently, Sheng et al. [30] identified the p.N985Y variant as the disease-causing mutation fo...",99,596,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.N985Y,"...ee and absent in 105 controls. Interestingly, the p.N985Y variant was found to be very common in our...",99,754,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.P63I,"...eng et al., [30] another three missense variants (p.P63I, p.G79E, and p.P903L) were also found to oc...",99,1174,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.G79E,"...l., [30] another three missense variants (p.P63I, p.G79E, and p.P903L) were also found to occur at h...",99,1182,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.P903L,"...ther three missense variants (p.P63I, p.G79E, and p.P903L) were also found to occur at high frequenc...",99,1194,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R677X,"...her populations, with the most frequent mutation, p.R677X, presenting in approximately 3% of adRP pa...",101,475,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.T373I,p.T373I*	c.1118C>T	Pakistan	ARRP	[18],105,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K663N,p.K663N	c.1989G.>T	U.S.A.	ADRP	[16],106,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.A669T,p.A669T	c.2005G>A	Pakistan	ARRP	[18],107,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.D984G,p.D984G	c.2951A>G	Chinese	ADRP	[21],108,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.N985Y,p.N985Y	c.2954A>T	Chinese	ADRP	[39],109,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,p.K1370E	c.4108A>G	Chinese	SRP	Present Study,110,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,p.R1652L	c.4955G>T	Chinese	SRP	Present Study,111,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L1808P,p.L1808P	c.5423T>C	U.S.A.	ADRP	[16],112,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,... we have identified two novel missense mutations (p.R1652L and p.K1370E). These mutations were predi...,119,62,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...tified two novel missense mutations (p.R1652L and p.K1370E). These mutations were predicted to have ...,119,75,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.V107I,...ution of a highly conserved Valine by Isoleucine (p.V107I).The mutation was confirmed by DHPLC,15,423,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,"This study has identified a novel MIP mutation, p.V107I in a Chinese family with congenital catara...",18,49,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,...acement of highly conserved Valine by Isoleucine (p.V107I),46,260,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,"....1). We found that codon 107, where the mutation (p.V107I) occurred, was phylogenetically conserved ...",56,444,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,"...ecies reveals that codon 107, where the mutation (p.V107I) occurred, is highly conserved",58,166,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,"...n the substitution of a Valine for an Isoleucine (p.V107I), in loopC of AQP0 (Figure 5). The high co...",75,570,Mol_Vis_2010_Mar_25_16_534-539.txt
p.S110N,Allg	m.3635G>A (p.S110N)	MT-ND1	No	Yes	No	4/15859	1	0.797,43,17,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I278V,"Le329, Le337	m.5301A>G (p.I278V)	MT-ND2	Yes	Yes	Yes (M6, D5, H1e1a1)	125/1...",44,25,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I576T, 	m.14063T>C (p.I576T)	MT-ND5	Yes	Yes	No	12/15859	0.25	0.582,45,15,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.Y159H," 	m.12811T>C (p.Y159H)	MT-ND5	Yes	Yes	Yes (H3h, A2h1, M7b1’2’4–8...",46,15,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I164T, 	m.15237T>C (p.I164T)	MT-CYB	Yes	No	No	2/15859	1	0.508,47,15,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.F9L,EU807741.1	m.8551T>C (p.F9L)	MT-ATP6	Yes	Yes	No	10/15859	1	0.745,49,23,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.L95F,FJ969382.1	m.7868C>T (p.L95F)	MT-CO2	Yes	Yes	No	12/15859	0.15	0.539,50,23,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.S182L, 	m.9071C>T (p.S182L)	MT-ATP6	Yes	Yes	Yes (H16c)	5/15859	0.65	0...,51,14,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.T8A," 	m.12358A>G (p.T8A)	MT-ND5	Yes	Yes	Yes (B4e, P4a, N1a1b, M7d, N...",52,15,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.V39I,"FJ969383.1	m.3421G>A (p.V39I)	MT-ND1	Yes	Yes	Yes (D4n, HV1a3, W3a1a1, H8...",53,23,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I278V,...identified in Le329 and Le337 (m.5301A>G [MT-ND2: p.I278V]; m.14063T>C [MT-ND5: p.I576T]; m.12811T>C...,56,660,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I576T,...(m.5301A>G [MT-ND2: p.I278V]; m.14063T>C [MT-ND5: p.I576T]; m.12811T>C [MT-ND5: p.Y159H] and m.15237...,56,690,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.Y159H,"...m.14063T>C [MT-ND5: p.I576T]; m.12811T>C [MT-ND5: p.Y159H] and m.15237T>C [MT-CYB: p.I164T]), Le569 ...",56,720,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I164T,"...2811T>C [MT-ND5: p.Y159H] and m.15237T>C [MT-CYB: p.I164T]), Le569 (m.5773G>A, [MT-TC]), EU807741.1 ...",56,753,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.F9L,"...773G>A, [MT-TC]), EU807741.1 (m.8551T>C [MT-ATP6: p.F9L]), FJ969382.1 (m.7868C>T [MT-CO2: p.L95F]; m...",56,824,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.L95F,"...[MT-ATP6: p.F9L]), FJ969382.1 (m.7868C>T [MT-CO2: p.L95F]; m.9071C>T [MT-ATP6: p.S182L] and m.12358A...",56,864,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.S182L,"... (m.7868C>T [MT-CO2: p.L95F]; m.9071C>T [MT-ATP6: p.S182L] and m.12358A>G [MT-ND5: p.T8A]), and FJ96...",56,893,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.T8A,"...071C>T [MT-ATP6: p.S182L] and m.12358A>G [MT-ND5: p.T8A]), and FJ969383.1 (m.3421G>A [MT-ND1: p.V39I...",56,926,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.V39I,"...-ND5: p.T8A]), and FJ969383.1 (m.3421G>A [MT-ND1: p.V39I]; Table 1). Employing standard database and...",56,970,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.Y159H,...ed by the TMPRED program. A: Variants m.12811T>C (p.Y159H) and m.14063T>C (p.I576T) changed the stru...,58,205,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I576T,... A: Variants m.12811T>C (p.Y159H) and m.14063T>C (p.I576T) changed the structure of the membrane-spa...,58,230,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.I164T,...ion of the MT-ND5 protein. B: Variant m.15237T>C (p.I164T) changed the structure of the membrane-spa...,58,339,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.S182L,...gion of the MT-CYB protein. C: Variant m.9071C>T (p.S182L) changed the structure of the membrane-spa...,58,447,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.W157X,"... transcripts of this nonsense mutation (c.471G>A, p.W157X) may escape the NMD pathway and the aberra...",97,457,Mol_Vis_2012_Jul_11_18_1874-1880.txt
p.W157X,"...udy has identified a nonsense mutation (c.471G>A, p.W157X) in CRYGC associated with autosomal domina...",113,80,Mol_Vis_2012_Jul_11_18_1874-1880.txt
p.C271*,"...r in the MF2 family. Two novel mutations of FBN1, p.C271* and p.C637Y, were identified in the MF1 an...",12,539,Mol_Vis_2013_Apr_5_19_751-758.txt
p.C637Y,"... family. Two novel mutations of FBN1, p.C271* and p.C637Y, were identified in the MF1 and MF2 famili...",12,551,Mol_Vis_2013_Apr_5_19_751-758.txt
p.C271*,"...n (TGA) instead of a cysteine (TGC) at codon 271 (p.C271*). In the MF2 family, a heterozygous variat...",93,302,Mol_Vis_2013_Apr_5_19_751-758.txt
p.C637Y,...a cysteine substitution by tyrosine at codon 637 (p.C637Y). These two allelic variations were cosegr...,93,452,Mol_Vis_2013_Apr_5_19_751-758.txt
p.Val234Ile,CA4	p.Val234Ile	44	280	48	222	0*	-	0*	-	0*	-,81,5,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Cys214Tyr,PRPH2	p.Cys214Tyr	40	48	67	27	0*	-	0*	-	0*	-,86,7,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Asp338Gly,p.Asp338Gly	0*	-	0*	-	100	15	29	17	100	16,87,2,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Gln304Glu,p.Gln304Glu	0*	-	0*	-	96	27	28	25	100	32,88,2,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Arg310Lys,p.Arg310Lys	0*	-	48	40	100	25	92	24	96	28,89,2,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Cys2033Tyr,RP1	p.Cys2033Tyr	0*	-	0*	-	55	33	50	40	41	83,91,5,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Asn985Tyr,p.Asn985Tyr	0*	-	0*	-	60	20	53	17	46	55,92,2,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Ala1670Thr,p.Ala1670Thr	0*	-	71	119	0*	-	0*	-	30	54,93,2,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Ser1691Pro,p.Ser1691Pro	0*	-	100	122	0*	-	0*	-	49	53,94,2,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Arg310Lys,... 2). The sequences also revealed the polymorphism p.Arg310Lys in exon 3 of PRPH2 [20] in a heterozyg...,97,433,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Ala1670Thr,"...a heterozygous form and two polymorphisms in RP1, p.Ala1670Thr and p.Ser1691Pro [21], in a heterozyg...",97,522,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Ser1691Pro,"...rm and two polymorphisms in RP1, p.Ala1670Thr and p.Ser1691Pro [21], in a heterozygous and homozygos...",97,539,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Gln304Glu,"... or <30% total variation (i.e., the polymorphisms p.Gln304Glu and p.Asp338Gly in PRPH2) that proved ...",132,941,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Asp338Gly,"...ariation (i.e., the polymorphisms p.Gln304Glu and p.Asp338Gly in PRPH2) that proved to be positive v...",132,957,Mol_Vis_2013_Mar_21_19_654-664.txt
p.N105H,"... c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c.672_701dup...",12,114,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.R144W,"...4_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c.672_701dup30 (p.Ala224_Ala234dup10...",12,138,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.R144W,...he mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are two novel missense mutations,12,338,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.R144W,"..._Ala234dup10), c.313C>A (p. N105H), and c.430G>T (p.R144W; Figure 3). These mutations were also pres...",53,201,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.N105H,... (p.Ala224_Ala234dup10). B: Mutation of c.313C>A (p.N105H). C: Mutation of c.430G>T (p.R144W). The u...,55,186,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.R144W,...n of c.313C>A (p.N105H). C: Mutation of c.430G>T (p.R144W). The upper panel is the chromatogram of t...,55,221,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.R144W,...he mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are novel mutations in the FOXL2 gene,67,640,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.N105H,"...—c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the FOXL2 gene...",82,92,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.R144W,"...4_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the FOXL2 gene in four Han Chinese fam...",82,116,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.Cys134Trp,...losa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). PLoS ONE 2010 5 e8789 2009...,106,260,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.F1442S,"...SH2A) compound heterozygous mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), located in ex...",10,82,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.L5063R,"...s mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), located in exons 20 and 70, respectivel...",10,108,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,...nylalanine for a serine at protein position 1442 (p.F1442S) and a leucine for an arginine at protein...,77,106,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.L5063R,...leucine for an arginine at protein position 5063 (p.L5063R). The comparative amino acid sequence ana...,77,172,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,"...as found for these mutations. The missense mutant p.F1442S residue, buried in a fibronectin type III...",82,314,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.L5063R,"...imilarly, HOPE predictions showed that the mutant p.L5063R residue, located in a region annotated as...",82,533,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,"...e variants identified in this pedigree, the USH2A p.F1442S mutation is located in the extracellular ...",87,59,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.L5063R,"...cting protein(s). The second identified mutation, p.L5063R, represents the most downstream pathogeni...",87,495,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,"...ective USH2A membrane anchorage. Furthermore, the p.F1442S change affects long and short isoforms wh...",87,926,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.L5063R,... change affects long and short isoforms while the p.L5063R variant affects only the long isoform of ...,87,984,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.Tyr343Asp,"...ico analysis predicted that the missense variant, p.Tyr343Asp, disrupted the CYP4V2 surface electros...",10,724,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.G95R,"31	43/F	30	11	RE: —10.5	RE:20/200	c.283G>A, p.G95R+ c.1027T>G, p.Y343D﹡",46,45,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Y343D,"...	RE: —10.5	RE:20/200	c.283G>A, p.G95R+ c.1027T>G, p.Y343D﹡",46,64,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Q11X,"60	55/M	49	44	RE: —2.75	RE:20/200	c.31C>T, p.Q11X*+ c.31C>T, p.Q11X*",50,44,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Q11X,"...44	RE: —2.75	RE:20/200	c.31C>T, p.Q11X*+ c.31C>T, p.Q11X*",50,62,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Q11X,1	c.31C>T	p.Q11X	1/0	0/200	2/184	novel,66,11,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.L22V,1	c.64C>G	p.L22V	1/4	ND	6/184	Reported,67,11,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.F73L,2	c.219T>A	p.F73L	0/3	0/200	3/184	Reported,69,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.G95R,2	c.283G>A	p.G95R	0/5	ND	5/184	Reported,70,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.W244X,6	c.732G>A	p.W244X	0/1	ND	1/184	Reported,72,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.R320X,7	c.958C>T	p.R320X	0/1	ND	1/184	Reported,75,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.H331P,8	c.992A>C	p.H331P	0/22	ND	22/184	Reported,76,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Y343D,8	c.1027T>G	p.Y343D	0/1	0/200	1/184	novel,77,13,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.P396L,9	c.1187C>T	p.P396L	0/2	ND	2/184	Reported,80,13,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Tyr343Asp,"...h resulted in a tyrosine to aspartic acid change (p.Tyr343Asp). In patient 60, a nonsense mutation (...",84,502,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Gln11X,"...ermination codon (TAG) at amino acid position 11 (p.Gln11X) in exon 1 was identified (Figure 4C,D), ...",84,661,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Y343D,"...ozygous mutant single base-pair change (c.1027T>G,p.Y343D). B: Control (wild type, WT). C: The homoz...",88,137,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Tyr343Asp,Mutant molecular model showed that p.Tyr343Asp affected the alpha spiral structure on...,96,36,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Tyr343Asp,"...mbers confirming that these four novel mutations, p.Tyr343Asp, c.413+2T>G, c.791delT, and p.Gln11X, ...",103,169,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Gln11X,"...utations, p.Tyr343Asp, c.413+2T>G, c.791delT, and p.Gln11X, segregated with the BCD phenotypes and w...",103,209,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Gln11X,"...ion of CYP4V2. Second, a novel nonsense mutation (p.Gln11X) in exon 1 causes premature termination a...",103,657,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Q11X,"...a deleterious homozygous novel nonsense mutation (p.Q11X), did not exhibit earlier disorder symptom ...",105,493,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.R109Q,CAMK1D	NM_020397.2	c.326G>A (p.R109Q)	Probably damagin,57,30,Mol_Vis_2014_Jun_12_20_790-796.txt
p.V283I,PYROXD2	NM_032709.2	c.847G>A (p.V283I)	Probably damagin,61,31,Mol_Vis_2014_Jun_12_20_790-796.txt
p.E830K,SIPA1L3	NM_015073.1	c.2488G>A (p.E830K)	Possibly damagin,64,32,Mol_Vis_2014_Jun_12_20_790-796.txt
p.R109Q,"...nown significance in three other genes [c.326G>A (p.R109Q) in CAMK1D located on chromosome 10p13, c....",70,95,Mol_Vis_2014_Jun_12_20_790-796.txt
p.V283I,"... in CAMK1D located on chromosome 10p13, c.847G>A (p.V283I) in PYROXD2 located on chromosome 10q24.2 ...",70,153,Mol_Vis_2014_Jun_12_20_790-796.txt
p.E830K,...OXD2 located on chromosome 10q24.2 and c.2488G>A (p.E830K) in SIPA1L3 located on chromosome 19q13.13...,70,218,Mol_Vis_2014_Jun_12_20_790-796.txt
p.E820Gfs,"...fied three homozygous mutations [c.2458_2459insG (p.E820Gfs*23), c.1721+1G>A and c.760C>T (p.Q254*)]...",72,90,Mol_Vis_2014_Jun_12_20_790-796.txt
p.Q254*,"...459insG (p.E820Gfs*23), c.1721+1G>A and c.760C>T (p.Q254*)] in the ADAMTS17 gene in three Saudi Arab...",72,131,Mol_Vis_2014_Jun_12_20_790-796.txt
p.Asp218Thr,"...dentified a homozygous novel mutation, c.652delG (p.Asp218Thrfs*41), in a Saudi Arabian family. Inte...",72,299,Mol_Vis_2014_Jun_12_20_790-796.txt
p.E820Gfs,(p.E820Gfs*23)	Exon 18	Frameshift	Homozygous	Saudi ...,89,2,Mol_Vis_2014_Jun_12_20_790-796.txt
p.Q254*,(p.Q254*)	Exon 4	Nonsense	Homozygous	Saudi Arabian	...,92,2,Mol_Vis_2014_Jun_12_20_790-796.txt
p.Asp218Thr,(p.Asp218Thrfs*41)	Exon 4	Frameshift	Homozygous	Sau...,94,2,Mol_Vis_2014_Jun_12_20_790-796.txt
p.Arg116His,...t AM  Nagaoka Y  Jiang M  Bhat SP   HSF4 mutation p.Arg116His found in age-related cataracts and in ...,198,78,Mol_Vis_2015_Aug_28_21_955-973.txt
p.Asp122Gly,"...ation of the C-terminus of the expressed protein (p.Asp122Glyfs*12 and p.Leu143Alafs*55, respectivel...",26,485,Mol_Vis_2015_Feb_5_21_124-130.txt
p.Leu143Ala,"...us of the expressed protein (p.Asp122Glyfs*12 and p.Leu143Alafs*55, respectively), leading to mutate...",26,506,Mol_Vis_2015_Feb_5_21_124-130.txt
p.H395R,...he MKKS/BBS6 gene in both patients resulting in a p.H395R substitution in the MKKS/BBS6 protein. Thi...,10,287,Mol_Vis_2016_Jan_24_22_73-81.txt
p.H395R,...lts in the substitution of histidine by arginine (p.H395R) in a conserved amino acid position (Figur...,55,220,Mol_Vis_2016_Jan_24_22_73-81.txt
p.G2186E,... abnormal hydrogen bonds by the missense mutation p.G2186E (c.6557G>A) and elongation of its neighbo...,12,873,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G3083D,"... elongation of its neighboring β-sheet induced by p.G3083D (c.9248G>A), which could alter the tertia...",12,947,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,...of the wild-type and mutant eys proteins carrying p.G2186E were built based on template 3poy.1A as i...,45,1163,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,"ARRP07	RPSP	6: 64,791,763	c.6557G>A	p.G2186E	missense	Hom	E32	DA (0.03)	PD (0.68)	DE (...",68,37,Mol_Vis_2016_Jun_16_22_646-657.txt
p.I1698T,"ARRP08	RP	6: 65,300,667	c.5093T>C	p.I1698T	missense	Het	E26	DA (0)	B (0.082)	N (−0.8...",69,35,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G3083D,"6: 64,430,679	c.9248G>A	p.G3083D	missense	Het	E43	DA (0.02)	DA (0.979)	N (...",70,25,Mol_Vis_2016_Jun_16_22_646-657.txt
p.C2139Y,"6: 64,940,493	c.6416G>A	p.C2139Y	missense	Het	E31	DA (0)	PD (0.797)	DE (−4...",71,25,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,"ARRP09	RPSP	6: 64,791,763	c.6557G>A	p.G2186E	missense	Het	E32	DA (0.03)	PD (0.68)	DE (...",72,37,Mol_Vis_2016_Jun_16_22_646-657.txt
p.A2410Gfs,"6: 64,574,078	c.7228+1 G>A	p.A2410Gfs*4	splice site	Het	I36–37	NA	NA	NA	Novel...",73,28,Mol_Vis_2016_Jun_16_22_646-657.txt
p.A2410Gfs,"ARRP10	RP	6: 64,574,078	c.7228+1 G>A	p.A2410Gfs*4	splice site	Het	I36–37	NA	NA	NA	Novel...",74,38,Mol_Vis_2016_Jun_16_22_646-657.txt
p.S1653Kfs,"6: 65,300,802	c.4957dupA	p.S1653Kfs*2	frameshift	Het	E26	NA	NA	NA	Novel",75,26,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G3083D,"...cine to the acidic aspartic acid at residue 3083 (p.G3083D; Figure 1A,E and Figure 3). The crystal s...",78,455,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G3083D,... The crystal structure of the mutant protein with p.G3083D indicated shortening of the neighboring β...,78,541,Mol_Vis_2016_Jun_16_22_646-657.txt
p.C2139Y,...eine to the hydrophobic tyrosine at residue 2139 (p.C2139Y). Our previous work revealed the generati...,78,829,Mol_Vis_2016_Jun_16_22_646-657.txt
p.I1698T,...ine to the hydrophilic threonine at residue 1698 (p.I1698T),78,1097,Mol_Vis_2016_Jun_16_22_646-657.txt
p.A2410Gfs,...plice donor site and generate a truncated protein p.A2410Gfs*4 or cause nonsense-mediated mRNA decay...,80,351,Mol_Vis_2016_Jun_16_22_646-657.txt
p.S1653Kfs,...variation that might generate a truncated protein p.S1653Kfs*2 or cause NMD. The two novel variation...,80,626,Mol_Vis_2016_Jun_16_22_646-657.txt
p.E1836*,1*	-	p.E1836* (Hom)	II:1	RP	NA/F	20	20/400	HM	-	-	Dimin...,89,6,Mol_Vis_2016_Jun_16_22_646-657.txt
p.E1836*,1*	-	p.E1836* (Hom)	II:2	RP	40/M	15	20/400	20/400	Diffu...,90,6,Mol_Vis_2016_Jun_16_22_646-657.txt
p.E1836*,1*	-	p.E1836* (Hom)	II:5	RP	NA/F	20	20/400	HM	-	-	Dimin...,91,6,Mol_Vis_2016_Jun_16_22_646-657.txt
p.A2498P,3$	c.7492G>C (Hom)	p.A2498P (Hom)	W159–1	IRDs	34/M	20	20/40	20/50	-	-...,110,20,Mol_Vis_2016_Jun_16_22_646-657.txt
p.C2139Y,3$	c.6416G>A (Hom)	p.C2139Y (Hom)	W75–1	IRDs	31/M	20	20/100	20/100	-	...,113,20,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,"...thalmic examinations. The recurrent mutation, EYS p.G2186E, a mutational hotspot among multiple ethn...",116,261,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,"...studies, the RP age of onset of patients carrying p.G2186E range from 14- to 62 years-old, while one...",116,643,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,...e one patient in this study carrying a homozygous p.G2186E mutation claims to have had night blindne...,116,738,Mol_Vis_2016_Jun_16_22_646-657.txt
p.A2410Gfs,...ular splice site and generate a truncated protein p.A2410Gfs*4 or cause NMD. This variant was also f...,116,1410,Mol_Vis_2016_Jun_16_22_646-657.txt
p.C2139Y,"Another hotspot EYS mutation, p.C2139Y located in the EGF-like domain of the eys...",118,31,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G3083D,"...t also carries a novel heterozygous EYS mutation, p.G3083D, which has been found to induce the elong...",118,581,Mol_Vis_2016_Jun_16_22_646-657.txt
p.C2139Y,"...same allele with the reported pathogenic mutation p.C2139Y. Another recurrent mutation, the frameshi...",118,763,Mol_Vis_2016_Jun_16_22_646-657.txt
p.His4Arg,"Eight potentially pathogenic mutations (p.His4ArgfsX21, p.Asp23GlufsX9, p.Ile48ValfsX55, p...",10,41,Mol_Vis_2016_May_16_22_491-502.txt
p.Asp23Glu,"...potentially pathogenic mutations (p.His4ArgfsX21, p.Asp23GlufsX9, p.Ile48ValfsX55, p.His50Asp, p.Ser...",10,57,Mol_Vis_2016_May_16_22_491-502.txt
p.Ile48Val,"...ogenic mutations (p.His4ArgfsX21, p.Asp23GlufsX9, p.Ile48ValfsX55, p.His50Asp, p.Ser57*, p.Gly113Asp...",10,73,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,"...(p.His4ArgfsX21, p.Asp23GlufsX9, p.Ile48ValfsX55, p.His50Asp, p.Ser57*, p.Gly113Asp, p.Arg121Gln, an...",10,90,Mol_Vis_2016_May_16_22_491-502.txt
p.Ser57*,"...X21, p.Asp23GlufsX9, p.Ile48ValfsX55, p.His50Asp, p.Ser57*, p.Gly113Asp, p.Arg121Gln, and p.Cys126Ar...",10,102,Mol_Vis_2016_May_16_22_491-502.txt
p.Gly113Asp,"...23GlufsX9, p.Ile48ValfsX55, p.His50Asp, p.Ser57*, p.Gly113Asp, p.Arg121Gln, and p.Cys126Arg, includi...",10,112,Mol_Vis_2016_May_16_22_491-502.txt
p.Arg121Gln,"...Ile48ValfsX55, p.His50Asp, p.Ser57*, p.Gly113Asp, p.Arg121Gln, and p.Cys126Arg, including five novel...",10,125,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"...His50Asp, p.Ser57*, p.Gly113Asp, p.Arg121Gln, and p.Cys126Arg, including five novel ones), were obse...",10,142,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,"...ons were novel, including three missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) and two ...",68,456,Mol_Vis_2016_May_16_22_491-502.txt
p.Gly113Asp,"...el, including three missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) and two small base p...",68,468,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"...ee missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) and two small base pair frame shift d...",68,485,Mol_Vis_2016_May_16_22_491-502.txt
p.Asp23Glu,...g) and two small base pair frame shift deletions (p.Asp23GlufsX9 and p.Ile48ValfsX55). The p.His50As...,68,545,Mol_Vis_2016_May_16_22_491-502.txt
p.Ile48Val,...se pair frame shift deletions (p.Asp23GlufsX9 and p.Ile48ValfsX55). The p.His50Asp mutation was obse...,68,564,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,...letions (p.Asp23GlufsX9 and p.Ile48ValfsX55). The p.His50Asp mutation was observed in three familial...,68,586,Mol_Vis_2016_May_16_22_491-502.txt
p.Gly113Asp,"...s observed in three familial FEVR cases while the p.Gly113Asp, p.Cys126Arg, and p.Arg121Gln changes ...",68,658,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"... three familial FEVR cases while the p.Gly113Asp, p.Cys126Arg, and p.Arg121Gln changes were observed...",68,671,Mol_Vis_2016_May_16_22_491-502.txt
p.Arg121Gln,"...EVR cases while the p.Gly113Asp, p.Cys126Arg, and p.Arg121Gln changes were observed in three sporadi...",68,688,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,... in three sporadic cases (Figure 1). Although the p.His50Asp change segregated with the disease phen...,68,771,Mol_Vis_2016_May_16_22_491-502.txt
p.His4Arg,Exon 2	c.11_12delAT (p.His4ArgfsX21)	-	-	Reported [18]	OU:5	142 FR	0.00...,77,22,Mol_Vis_2016_May_16_22_491-502.txt
p.Asp23Glu,c.69delC (p.Asp23GlufsX9)	-	-	Novel	OD:4B OS: 5	21 FR	0.009/...,78,11,Mol_Vis_2016_May_16_22_491-502.txt
p.Ile48Val,c.142_145del ATCA (p.Ile48ValfsX55)	-	-	Novel	OU:5	97 FR	0.009/0.00,79,20,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,c.148C>G (p.His50Asp)	Damagin,80,11,Mol_Vis_2016_May_16_22_491-502.txt
p.Ser57*,c.170C>G (p.Ser57*)	-	-	Reported [59]	OU:5	108 FR	0.009/0.00...,85,11,Mol_Vis_2016_May_16_22_491-502.txt
p.Gly113Asp,Exon 3	c.338G>A (p.Gly113Asp)	Damaging 0	Probably damaging (1.000)	...,86,18,Mol_Vis_2016_May_16_22_491-502.txt
p.Arg121Gln,c.362G>A (p.Arg121Gln)	Damagin,87,11,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,c.376T>C (p.Cys126Arg)	Damaging 0	Probably damaging (0.997)	...,89,11,Mol_Vis_2016_May_16_22_491-502.txt
p.His4Arg,"...viously reported mutations comprising a deletion (p.His4ArgfsX21) [18], a nonsense change (p.Ser57*)...",92,74,Mol_Vis_2016_May_16_22_491-502.txt
p.Ser57*,"...eletion (p.His4ArgfsX21) [18], a nonsense change (p.Ser57*) [59], and a recurrent missense change (p...",92,115,Mol_Vis_2016_May_16_22_491-502.txt
p.Arg121Gln,"...(p.Ser57*) [59], and a recurrent missense change (p.Arg121Gln) [9,17,30] were observed in three spor...",92,164,Mol_Vis_2016_May_16_22_491-502.txt
p.His4Arg,"...re 1). In the present study, the three deletions (p.His4ArgfsX21, p.Asp23GlufsX9, and p.Ile48ValfsX5...",94,585,Mol_Vis_2016_May_16_22_491-502.txt
p.Asp23Glu,"...esent study, the three deletions (p.His4ArgfsX21, p.Asp23GlufsX9, and p.Ile48ValfsX55) and a reporte...",94,601,Mol_Vis_2016_May_16_22_491-502.txt
p.Ile48Val,"...ee deletions (p.His4ArgfsX21, p.Asp23GlufsX9, and p.Ile48ValfsX55) and a reported truncating mutatio...",94,621,Mol_Vis_2016_May_16_22_491-502.txt
p.Ser57*,...le48ValfsX55) and a reported truncating mutation (p.Ser57*) were found in exon 2. All three deletion...,94,674,Mol_Vis_2016_May_16_22_491-502.txt
p.His4Arg,...n of premature termination codons. In the case of p.His4ArgfsX21 (c.11_12delAT) and Asp23GlufsX9 (c....,94,813,Mol_Vis_2016_May_16_22_491-502.txt
p.Ile48Val,...gestive of nonsense-mediated mRNA decay [60]. The p.Ile48ValfsX55 (c.142_145delATCA) deletion led to...,94,1037,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...n at the positions of the novel missense changes (p.H50D, p.G113D, and p.C126R) demonstrates the evo...",96,129,Mol_Vis_2016_May_16_22_491-502.txt
p.G113D,"... positions of the novel missense changes (p.H50D, p.G113D, and p.C126R) demonstrates the evolutionar...",96,137,Mol_Vis_2016_May_16_22_491-502.txt
p.C126R,"... the novel missense changes (p.H50D, p.G113D, and p.C126R) demonstrates the evolutionarily conserved...",96,150,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...res of the patients with FEVR with novel changes (p.H50D, p.G113D, and p.D23EfsX9) identified in the...",101,110,Mol_Vis_2016_May_16_22_491-502.txt
p.G113D,"...he patients with FEVR with novel changes (p.H50D, p.G113D, and p.D23EfsX9) identified in the NDP gen...",101,118,Mol_Vis_2016_May_16_22_491-502.txt
p.D23Efs,"...ith FEVR with novel changes (p.H50D, p.G113D, and p.D23EfsX9) identified in the NDP gene. A: Patient...",101,131,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,...d in the NDP gene. A: Patient ID: family 33-II:2 (p.H50D); the right eye of the patient shows straig...,101,202,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,...ovascular traction. B: Patient ID: family 33-I:2 (p.H50D; affected mother of the proband); the left ...,101,394,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...cular dragging. C, D: Patient ID: family 72-IV:1 (p.H50D); the right (C) and left (D) eyes show drag...",101,549,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,...n ectopic macula. E: Patient ID: family 139-II:2 (p.H50D); the right eye of the patient shows an ava...,101,687,Mol_Vis_2016_May_16_22_491-502.txt
p.G113D,...ter the treatment. F: Patient ID: family 85-II:1 (p.G113D); fundus fluorescein angiogram of the left...,101,854,Mol_Vis_2016_May_16_22_491-502.txt
p.D23Efs,"...ular junction. G, H: Patient ID: family 21-III:2 (p.D23EfsX9; affected mother of the proband); the r...",101,1077,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,...observed in the women who harbor the heterozygous p.His50Asp and p.Asp23GlufsX9 mutations (Figure 1)...,103,435,Mol_Vis_2016_May_16_22_491-502.txt
p.Asp23Glu,... women who harbor the heterozygous p.His50Asp and p.Asp23GlufsX9 mutations (Figure 1) but with a les...,103,450,Mol_Vis_2016_May_16_22_491-502.txt
p.Ile48Val,"...The female carriers who harbored the heterozygous p.Ile48ValfsX55, p.Ser57*, p.Gly113Asp, and p.Arg1...",103,604,Mol_Vis_2016_May_16_22_491-502.txt
p.Ser57*,"...rs who harbored the heterozygous p.Ile48ValfsX55, p.Ser57*, p.Gly113Asp, and p.Arg121Gln changes wer...",103,621,Mol_Vis_2016_May_16_22_491-502.txt
p.Gly113Asp,"...bored the heterozygous p.Ile48ValfsX55, p.Ser57*, p.Gly113Asp, and p.Arg121Gln changes were phenotyp...",103,631,Mol_Vis_2016_May_16_22_491-502.txt
p.Arg121Gln,"...ygous p.Ile48ValfsX55, p.Ser57*, p.Gly113Asp, and p.Arg121Gln changes were phenotypically normal on ...",103,648,Mol_Vis_2016_May_16_22_491-502.txt
p.His4Arg,...irect ophthalmoscopic examination (Figure 1). The p.His4ArgfsX21 and p.Cys126Arg mutations were dete...,103,751,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,...ic examination (Figure 1). The p.His4ArgfsX21 and p.Cys126Arg mutations were detected only in the pr...,103,770,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,"... present study, the three novel missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) were loc...",110,57,Mol_Vis_2016_May_16_22_491-502.txt
p.Gly113Asp,"...dy, the three novel missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) were located in the ...",110,69,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"...el missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) were located in the highly conserved ...",110,86,Mol_Vis_2016_May_16_22_491-502.txt
p.Asp23Glu,"...isease [7]. In this study, we observed two novel (p.Asp23GlufsX9 and p.Ile48ValfsX55) mutations, a r...",114,251,Mol_Vis_2016_May_16_22_491-502.txt
p.Ile48Val,"... study, we observed two novel (p.Asp23GlufsX9 and p.Ile48ValfsX55) mutations, a reported frame shift...",114,270,Mol_Vis_2016_May_16_22_491-502.txt
p.His4Arg,"...Ile48ValfsX55) mutations, a reported frame shift (p.His4ArgfsX21) mutation, and a missense change at...",114,322,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"..., and a missense change at cysteine 126 position (p.Cys126Arg) in four unrelated patients with FEVR....",114,396,Mol_Vis_2016_May_16_22_491-502.txt
p.Q36X,"... A heterozygous CTR9 nonsense mutation, c.106C>T; p.Q36X, was present in each half-sister (Fig. 1b)....",19,151,Nat_Commun_2014_Aug_7_5_4398.txt
p.R1163X,"...ntified a somatic truncating mutation, c.3487A>T; p.R1163X (Fig. 1b). While the phase of this mutati...",25,340,Nat_Commun_2014_Aug_7_5_4398.txt
p.Lys101Asn,c.303G>C; p.Lys101Asn	 	Possibly damaging	Tolerated	No effec...,168,11,Nat_Commun_2014_Aug_7_5_4398.txt
p.Asn102Asp,c.304A>G; p.Asn102Asp	 	Benign	Tolerated	No effect	1	 ,169,11,Nat_Commun_2014_Aug_7_5_4398.txt
p.Glu443Asp,c.1329G>T; p.Glu443Asp	 	Benign	Tolerated	No effect	2	 ,173,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Arg839Gln,c.2516G>A; p.Arg839Gln	 	Benign	Tolerated	No effect	 	1,183,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Gly966Ala,c.2897G>C; p.Gly966Ala	rs192522878	Benign	Tolerated	No effect...,186,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Arg985Cys,c.2953C>T; p.Arg985Cys	 	Possibly damaging	Affect protein fun...,187,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Lys1050Arg,c.3149A>G; p.Lys1050Arg	rs141131642	Benign	Tolerated	No effec...,189,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Cys1052Arg,c.3154T>C; p.Cys1052Arg	rs35696189	Benign	Tolerated	No effect...,190,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Gly1071Ser,c.3211G>A; p.Gly1071Ser	rs35766432	Benign	Tolerated	No effect...,192,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Asp1082Asn,c.3244G>A; p.Asp1082Asn	rs138871050	Benign	Tolerated	No effec...,193,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Arg1095Lys,c.3284G>A; p.Arg1095Lys	rs141434094	Possibly damaging	Tolerat...,194,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Gly1098Ser,c.3292G>A; p.Gly1098Ser	rs376210239	Benign	Tolerated	No effec...,195,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Glu1150Gly,c.3449A>G; p.Glu1150Gly	rs35023148	Benign	Tolerated	No effect...,197,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Asp1171Gly,c.3512A>G; p.Asp1171Gly	 	Benign	Deleterious	No effect	1	 ,198,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.V1184A,"...me sequencing we here identify a missense change (p.V1184A) in NaV1.9, which leads to cold-aggravate...",3,2514,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...umans. Electrophysiological analysis reveals that p.V1184A shifts the voltage dependence of channel ...,3,2636,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...ing NaV1.9, was the heterozygous de novo mutation p.L811P, which confers gain-of-function properties...",12,227,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,We here describe a NaV1.9 mutation (p.V1184A) that causes early onset cold-aggravated ...,14,37,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...mperature sensitivity of the patients' phenotype, p.V1184A-dependent nociceptor excitability is less...",14,387,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...ividuals, a missense change in SCN11A, c.3551T>C, p.V1184A (chr3:38913144A>G, hg19), was the most li...",20,1199,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,Assessment of p.V1184A in voltage-clamp experiment,22,15,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"To analyse the consequences of mutation p.V1184A for the function of NaV1.9, we performed ...",23,41,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...rger current densities of cells expressing mutant p.V1184A were accompanied by three major effects: ...,25,627,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...aV1.9 at 30 and 20 °C; 9.8±1.0 and 9.8±0.7 mV for p.V1184A at 30 and 20 °C, respectively; both P>0.0...",25,1612,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"... for NaV1.9 between −57 and −17 mV; 1.45±0.06 for p.V1184A between −67 and −27 mV), and the closing ...",25,2095,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...for NaV1.9 between −117 and −77 mV; 1.31±0.04 for p.V1184A between −117 and −87 mV), were not marked...",25,2219,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"At either temperature, mutation p.V1184A did not affect the kinetics of fast chann...",27,33,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,... for NaV1.9 between −57 and −17 mV; 1.81±0.25 for p.V1184A between −67 and −27 mV). The half-maximal...,27,329,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"In summary, the mutation p.V1184A confers gain-of-function properties to Na...",29,26,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,Influence of p.V1184A on DRG neuron excitabilit,31,14,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...ing their RMP3. To analyse the impact of mutation p.V1184A on the excitability of primary nociceptiv...,32,181,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"When overexpressed in DRG neurons, p.V1184A mutant channels depolarized the cell memb...",34,36,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...f 1.6±0.1 (P<0.001, two-tailed t-test) for mutant p.V1184A (Fig. 5b,d). Thus, attenuation of DRG neu...",36,837,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,Comparison of mutation p.V1184A with p.L811,38,24,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,Comparison of mutation p.V1184A with p.L811,38,38,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,The phenotypes associated with mutation p.V1184A in NaV1.9 as well as those with mutations...,39,41,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...t to that of the NaV1.9 gain-of-function mutation p.L811P, which results in pain insensitivity1516. ...",39,215,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...ned elusive. Therefore, we analysed the impact of p.L811P on excitability of DRG neurons under ident...",39,385,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...der identical experimental conditions as used for p.V1184A. As illustrated in Supplementary Fig. 1, ...",39,476,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...pplementary Fig. 1, the RMP of neurons expressing p.L811P was increased by 5.9±1.4 mV (P<0.01, two-t...",39,556,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...ction potentials were only marginally affected by p.L811P (Supplementary Fig. 1c). Analysis of repet...,39,839,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...ed with current injections for 2 s, revealed that p.L811P rendered neurons hyperexcitable at both te...",39,957,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"... between excitability of neurons transfected with p.L811P or p.V1184A. However, longer trains of act...",39,1141,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...citability of neurons transfected with p.L811P or p.V1184A. However, longer trains of action potenti...",39,1152,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...shable firing patterns between neurons expressing p.L811P or p.V1184A (Fig. 6). As illustrated in Fi...,39,1282,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...ng patterns between neurons expressing p.L811P or p.V1184A (Fig. 6). As illustrated in Fig. 6a,b, 76...",39,1293,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...and 81% of repetitively firing neurons expressing p.V1184A maintained stable action potential amplit...,39,1460,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"... was fulfilled for only 35% of neurons expressing p.L811P (P<0.01, Z-test). Thus, p.L811P channels i...",39,1682,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...eurons expressing p.L811P (P<0.01, Z-test). Thus, p.L811P channels increase the probability of cumul...",39,1714,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...tudy identified a heterozygous missense mutation (p.V1184A) in NaV1.9 as a cause for early onset col...,42,56,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,We demonstrated that mutation p.V1184A confers gain-of-function attributes to Na...,44,31,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...f KV and NaV channel structures26272829, mutation p.V1184A is located within a conserved sequence at...",44,550,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...e can trigger painful episodes in carriers of the p.V1184A mutation, we analysed the effect of tempe...",46,482,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,... temperature. We further showed that the mutation p.V1184A did not affect the Q10 values of the gati...,46,906,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...nario would be in line with our data showing that p.V1184A does not affect the intrinsic temperature...,48,1083,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,The clinical symptoms caused by mutation p.V1184A in NaV1.9 are reminiscent of primary eryt...,50,42,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...ture sensitivity of pain sensation. Specifically, p.V1184A-related pain is mostly aggravated by cool...",50,372,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1316A,...algia phenotype caused by the homologous mutation p.V1316A in NaV1.7 (ref. 10): p.V1316A in NaV1.7 c...,50,700,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1316A,...homologous mutation p.V1316A in NaV1.7 (ref. 10): p.V1316A in NaV1.7 causes warmth-aggravated severe...,50,730,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1316A,...tions linked to primary erythromelalgia—including p.V1316A—is a hyperpolarizing shift in the voltage...,50,961,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...n5. As demonstrated here, the homologous mutation p.V1184A alters the properties of NaV1.9 channels ...",50,1144,Nat_Commun_2015_Dec_8_6_10049.txt
p.I381T,"...odic peripheral pain phenotype caused by mutation p.I381T in NaV1.9. Likewise, Zhang et al.19 report...",50,1562,Nat_Commun_2015_Dec_8_6_10049.txt
p.R225C,"...d body areas in patients carrying NaV1.9 mutation p.R225C or p.A808G. Notably, Han et al.36 describe...",50,1704,Nat_Commun_2015_Dec_8_6_10049.txt
p.A808G,"...s in patients carrying NaV1.9 mutation p.R225C or p.A808G. Notably, Han et al.36 described mutation ...",50,1715,Nat_Commun_2015_Dec_8_6_10049.txt
p.G699R,"...p.A808G. Notably, Han et al.36 described mutation p.G699R, located in the S4/S5 linker in domain II ...",50,1765,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...viously171819, as well as this report on mutation p.V1184A are in marked contrast to the NaV1.9 gain...",52,104,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,... contrast to the NaV1.9 gain-of-function mutation p.L811P that results in pain insensitivity1516. Th...,52,176,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...d elusive. To infer potential differences between p.V1184A and p.L811P we assessed the functions of ...,52,346,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,... infer potential differences between p.V1184A and p.L811P we assessed the functions of both mutation...,52,359,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...m inactivation of the wild type, whereas mutation p.L811P causes profound slowing of channel inactiv...",52,1130,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...tage dependence of channel inactivation. However, p.L811P shifts the voltage dependence of opening o...",52,1343,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"... of opening of NaV1.9 by −29 mV, whereas mutation p.V1184A shifts the same parameter by only −20 mV,...",52,1430,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"... only −20 mV, clearly demonstrating that mutation p.L811P facilitates opening of NaV1.9 more strongl...",52,1517,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...tes opening of NaV1.9 more strongly than mutation p.V1184A (Fig. 7b). As a result, the window curren...",52,1583,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...cator of channel activity—is largest for mutation p.L811P followed by p.V1184A and wild-type NaV1.9 ...,52,1773,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...ivity—is largest for mutation p.L811P followed by p.V1184A and wild-type NaV1.9 (Fig. 7b). These dat...,52,1793,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...ntary Fig. 1d–g). Thus, neurons expressing either p.V1184A or p.L811P must be considered hyperexcita...",54,282,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...d–g). Thus, neurons expressing either p.V1184A or p.L811P must be considered hyperexcitable under th...",54,294,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...f repetitive firing revealed that, in contrast to p.V1184A, mutation p.L811P leads to a substantial ...",54,467,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"... revealed that, in contrast to p.V1184A, mutation p.L811P leads to a substantial instability of DRG ...",54,486,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...ed in a substantial portion of neurons expressing p.L811P mutant channels (Fig. 6). This instability...,54,692,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,... may be caused by increased influx of Na+ through p.L811P as it is predicted by the larger window cu...,54,792,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...(Fig. 7b) and the slower inactivation kinetics of p.L811P compared with p.V1184A or wild-type NaV1.9...,54,898,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...er inactivation kinetics of p.L811P compared with p.V1184A or wild-type NaV1.9 (Fig. 7a). Excessive ...,54,920,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...aptic plasticity. In summary, the missense change p.V1184A, which causes cold-aggravated peripheral ...",54,1300,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...wever, differs from the gain-of-function mutation p.L811P; the latter only transiently results in DR...",54,1698,Nat_Commun_2015_Dec_8_6_10049.txt
p.Val1184Ala,...n pcDNA3.1 was used as template15. The c.3551T>C (p.Val1184Ala) mutation was introduced by PCR-based...,67,84,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...of the family with episodic pain. Genotype of the p.V1184A mutation is indicated. V/A=heterozygous m...,130,64,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...ins (DI-DIV) are indicated; position of mutations p.L811P (blue) causing pain insensitivity and p.V1...,130,437,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...ons p.L811P (blue) causing pain insensitivity and p.V1184A (red) causing cold-aggravated peripheral ...,130,483,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,Figure 2 Mutation p.V1184A enhances activation of NaV1.9,132,19,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,Figure 3 Effects of mutation p.V1184A on inactivation properties of NaV1.9 chan...,135,30,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...nactivation of NaV1.9 is not affected by mutation p.V1184A while mutation p.L811P slows down channel...,148,222,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"... not affected by mutation p.V1184A while mutation p.L811P slows down channel inactivation, thus prol...",148,246,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...rent; this window current is largest for mutation p.L811P followed by p.V1184A and wild-type NaV1.9....,148,681,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...rrent is largest for mutation p.L811P followed by p.V1184A and wild-type NaV1.9. (c) Current traces ...,148,701,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...ltage steps. Notably, fast inactivation of mutant p.L811P (n=11) is impaired in the entire voltage r...",148,953,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...paired in the entire voltage range while mutation p.V1184A (n=9) does not affect fast inactivation (...,148,1023,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...al insensitivity to pain due to the Na1.9 variant p.L811P . Eur. J. Hum. Genet.,236,76,Nat_Commun_2015_Dec_8_6_10049.txt
p.Leu117Val,...a point mutation causing the predicted amino acid p.Leu117Val substitution. This missense mutation o...,20,521,Nat_Commun_2015_Jun_16_6_7092.txt
p.Trp124Ter,"...A and R03-303A were nonsense mutations in exon 6 (p.Trp124Ter) and 13 (p.Glu334Ter), respectively. W...",20,1181,Nat_Commun_2015_Jun_16_6_7092.txt
p.Glu334Ter,"...onsense mutations in exon 6 (p.Trp124Ter) and 13 (p.Glu334Ter), respectively. Western blot analyses ...",20,1202,Nat_Commun_2015_Jun_16_6_7092.txt
p.Leu117Val,...2LI1 is markedly reduced in R01-013A (c.993+1G>A; p.Leu117Val) and R07-628A (p.Trp124Ter; p.Leu117Va...,20,1348,Nat_Commun_2015_Jun_16_6_7092.txt
p.Trp124Ter,"... R01-013A (c.993+1G>A; p.Leu117Val) and R07-628A (p.Trp124Ter; p.Leu117Val), indicating that these m...",20,1375,Nat_Commun_2015_Jun_16_6_7092.txt
p.Leu117Val,"...993+1G>A; p.Leu117Val) and R07-628A (p.Trp124Ter; p.Leu117Val), indicating that these mutations like...",20,1388,Nat_Commun_2015_Jun_16_6_7092.txt
p.Leu117Val,p.Leu117Val	Exon 6	3.63	deleterious	probably damag...,150,1,Nat_Commun_2015_Jun_16_6_7092.txt
p.Leu117Val,p.Leu117Val	Exon 6	3.63	deleterious	probably damag...,152,1,Nat_Commun_2015_Jun_16_6_7092.txt
p.Trp124Ter,p.Trp124Ter	Exon 6	4.46			26.5,154,1,Nat_Commun_2015_Jun_16_6_7092.txt
p.Glu334Ter,p.Glu334Ter	Exon 13	4.55			38.0,156,1,Nat_Commun_2015_Jun_16_6_7092.txt
p.Thr468Met,Medulloblastoma in a patient with the PTPN11 p.Thr468Met mutation . Am. J. Med. Genet. A,303,46,Nat_Commun_2015_Nov_30_6_8859.txt
p.S621G,...e with glycine at codon 621 at the protein level (p.S621G). Sanger sequencing of 29 family members d...,17,1234,Nat_Commun_2016_Apr_15_7_11253.txt
p.S621G,"...re transfected with wild-type or mutant cyclin F (p.S621G) expression constructs, and cells were col...",116,79,Nat_Commun_2016_Apr_15_7_11253.txt
p.S621G,"... h. (a,b) Cells transfected with mutant cyclin F (p.S621G) show increased levels (normalized to tran...",116,194,Nat_Commun_2016_Apr_15_7_11253.txt
p.S621G,...ed Neuro-2a cells (wild-type and mutant cyclin F (p.S621G)) show elevated levels of ubiquitinated RR...,116,615,Nat_Commun_2016_Apr_15_7_11253.txt
p.S3G, p.S3G	7A>G	1	1/99 US FTLD-ALS	0/1038 US controls0/...,121,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.K97R, p.K97R	290A>G	4	1/159 UK FALS	0/897 UK controls0/9...,122,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.S195R, p.S195R	585T>G	6	1/30 SP FALS	0/967 AU control exo...,123,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.S509P, p.S509P	1525T>C	13	1/99 IT FALS1/168 CA SALS	0/361...,124,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.S621G, p.S621G	1861A>G	16	1/75 AU FALS	0/864 AU Sanger co...,125,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.I772T, p.I772T	2315T>C	17	1/159 UK FALS	0/897 UK controls...,126,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.T181I, p.T181I	542C>T	6	1/283 JA SALS	0/514 JA controls0/...,129,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.R392T, p.R392T	1175G>C	11	1/99 US FTLD	0/1038 US controls...,130,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.T543I, p.T543I	1628C>T	15	1/283 JA SALS	0/514 JA controls...,131,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.E624K, p.E624K	1870G>A	16	1/49 US SALS trios	0/801 AU San...,132,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.R179X,"...predicted protein-truncating variant (rs36095412, p.R179X, genotyped in 11,148 ulcerative colitis pa...",5,1017,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,"...ion genotyping and imputation of a PTV in RNF186 (p.R179X) in 11,148 UC patients and 295,446 control...",12,361,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,... (P=0.02); and (3) a premature stop gain variant (p.R179X) in RNF186 with signal of association (P=0...,16,1407,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,"...rong support that the premature stop-gain allele, p.R179X, confers protection against UC (P=0.0028, ...",19,238,Nat_Commun_2016_Aug_9_7_12342.txt
p.A64T,"...w-frequency coding variant in RNF186 (rs41264113, p.A64T, MAF=0.8%) was found to confer increased ri...",27,390,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,...discovery and replication component of this study p.R179X was found to lie on the haplotype backgrou...,27,531,Nat_Commun_2016_Aug_9_7_12342.txt
p.A64T,"...ith rs3806308 or the low-frequency coding variant p.A64T (Supplementary Fig. 3). Naturally, the prot...",27,719,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,"...tary Fig. 3). Naturally, the protective signal at p.R179X remains unchanged when corrected for the b...",27,786,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,...920. To understand the functional consequences of p.R179X we integrated transcriptome and protein ex...,30,266,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,... expression (ASE) data for individual carriers of p.R179X in the GTEx project. Within GTEx we identi...,33,80,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,...d two individual carriers containing ASE data for p.R179X in transverse colon and sigmoid colon. The...,33,183,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,...be necessary to determine the molecular impact of p.R179X on RNF186 function (ref. 5). The gene cont...,33,527,Nat_Commun_2016_Aug_9_7_12342.txt
p.A64T,...ing common non-coding alleles and risk increasing p.A64T is available for further experimentation. F...,42,177,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,"..., the same rare allele of the same variant coding p.R179X has been reported in Iceland to have a gen...",42,343,Nat_Commun_2016_Aug_9_7_12342.txt
p.V362I,"...ants in IBD, including the coding IL23R variants (p.V362I, MAF=1.27%, OR=0.72 (0.63–0.83); p.G149R, ...",42,677,Nat_Commun_2016_Aug_9_7_12342.txt
p.G149R,"...ariants (p.V362I, MAF=1.27%, OR=0.72 (0.63–0.83); p.G149R, MAF=0.45%, OR=0.60 (0.45–.0.79)) and the ...",42,718,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,RNF186 p.R179X was assayed using Sequenom MassARRAY iPLEX...,86,8,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,Table 1 Association of p.R179X in RNF186 with ulcerative colitis,147,24,Nat_Commun_2016_Aug_9_7_12342.txt
p.Trp977X,"...Table 1) revealed a nonsense mutation, c.2931G>A (p.Trp977X), also in IGSF1 (Fig. 1c). B-III.7 and B...",42,1226,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Glu750Lys,"...d the same single nucleotide deletion [c.2248del (p.Glu750LysfsX28)]. In families E and F, we observ...",54,129,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Trp977X,c.2931G>A	p.Trp977X	UK	4 wks	+	+	10.52	1.1/1.0 [0.55-1.87],184,12,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Glu750Lys,c.2248del	p.Glu750LysfsX28	NL	3 wks	+	+	16.60	18/18 [7.8-16....,200,12,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Glu750Lys,c.2248del	p.Glu750LysfsX28	NL	3 wks	++	+	10.46	1/1 [0.55-1.8...,203,12,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Ser863Phe,c.2588C>T	p.Ser863Phe	NL	5 wks	+	+	27.52	11.8/38 [8.5-18.3],233,12,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Cys947Arg,c.2839T>C	p.Cys947Arg	NL	6.5 yrs	+	+	18.36	22.7/22.7 [8.5-18...,242,12,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Trp1173X,c.3518G>A	p.Trp1173X	NL	14.1 yrs	+	+	16.69	19/17 [8-16.5],248,12,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Ser770Asn,c.2309G>A	p.Ser770Asn	IT	10.6 yrs	+	+	26.54	21.5/21.4 [8.5-1...,257,12,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Phe91Ser,"...milies, we found a homozygous mutation (c.272T>C; p.Phe91Ser) of CIB2 (Figs. 1 and 2a; Supplementary...",24,435,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Cys99Trp,"...wo DFNB48 families (DEM4025, DEM4225) a c.297C>G (p.Cys99Trp) CIB2 mutation co-segregated with deafn...",24,555,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Ile123Thr,"... 2). In addition, a transition mutation c.368T>C (p.Ile123Thr) of CIB2 co-segregated with ARNSHI in ...",24,785,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Glu64Asp,...ig. 1c) were found to be homozygous for c.192G>C (p.Glu64Asp) in CIB2. This new locus is designated ...,26,329,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Glu64Asp,"...e to a conformational change (Fig. 2c). Possibly, p.Glu64Asp alters the energetic cost of accommodat...",28,1160,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Phe91Ser,"...p.Phe91 lines the effector-binding pocket, and so p.Phe91Ser may disrupt effector-binding. Similarly...",28,1333,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Ile123Thr,"...inding by the second EF hand domain. In contrast, p.Ile123Thr is located within the second CIB2 EF-h...",28,1524,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Ile123Thr,...ing residue. Our molecular modeling predicts that p.Ile123Thr increases Ca2+-binding affinity (Fig. ...,28,1666,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Cys99Trp,"...B2 interacting with IP receptors.10-13 3 However, p.Cys99Trp abolished the ability of CIB2 to decrea...",30,572,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Ile123Thr,"...e ability of CIB2 to decrease Ca2+ release, while p.Ile123Thr enhanced this inhibition (Fig. 2d). Th...",30,645,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Phe91Ser,"...5SA975 (78.56 Mb). CIB2 mutant alleles [c.272T>C (p.Phe91Ser), c.297C>G (p.Cys99Trp) and c.297C>G (p...",118,609,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Cys99Trp,"... mutant alleles [c.272T>C (p.Phe91Ser), c.297C>G (p.Cys99Trp) and c.297C>G (p.Ile123Thr)] co-segrega...",118,632,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Ile123Thr,"...(p.Phe91Ser), c.297C>G (p.Cys99Trp) and c.297C>G (p.Ile123Thr)] co-segregate with NSHI phenotype in ...",118,658,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Glu64Asp,...pe of family PKDF117 co-segregates with c.192G>C (p.Glu64Asp) mutation of CIB2. These four recessive...,118,830,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Cys99Trp,...iceable changes of CIB2 distribution (not shown). p.Cys99Trp abolished CIB2’s ability to decrease se...,120,885,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Ile123Thr,"...agonist-induced Ca2+ release from the cell, while p.Ile123Thr enhanced this ability",120,1001,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Asp575Asn,".... Additionally, two SNPs in ERAP1, encoding ERAP1 p.Asp575Asn and p.Arg725Gln, recessively conferred...",7,710,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,"...two SNPs in ERAP1, encoding ERAP1 p.Asp575Asn and p.Arg725Gln, recessively conferred disease risk. T...",7,726,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Asn104Ser,"...mous SNPs rs2617170 and rs1841958, encoding KLRC4 p.Asn104Ser and p.Ile129Ser. In a meta-analysis, w...",15,788,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Ile129Ser,"...170 and rs1841958, encoding KLRC4 p.Asn104Ser and p.Ile129Ser. In a meta-analysis, we combined the T...",15,804,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Asp575Asn,"...ntified rs10050860 and rs17482078, encoding ERAP1 p.Asp575Asn and p.Arg725Gln, which conferred risk ...",17,609,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,"...60 and rs17482078, encoding ERAP1 p.Asp575Asn and p.Arg725Gln, which conferred risk for BD with uvei...",17,625,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...a recessive model (Figure 2d). A meta-analysis of p.Arg725Gln combining the Turkish discovery collec...,17,732,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...nd revealed a large effect size of the homozygous p.Arg725Gln genotype on BD with uveitis (odds rati...,17,991,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...hether the recessive model would reveal the ERAP1 p.Arg725Gln association with BD susceptibility in ...,19,162,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...s found significant association of the homozygous p.Arg725Gln genotype with BD susceptibility (p=4.3...,19,362,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...ariant in strong linkage disequilibrium [LD] with p.Arg725Gln) was too low in the Japanese populatio...,19,540,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Asp575Asn,"...ERAP1 variants in psoriasis21, 22 and AS12. ERAP1 p.Asp575Asn and p.Arg725Gln, which are in strong L...",21,223,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,"...n psoriasis21, 22 and AS12. ERAP1 p.Asp575Asn and p.Arg725Gln, which are in strong LD, confer protec...",21,239,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,"...n-uveitis) samples (Figure 3). Furthermore, ERAP1 p.Arg725Gln homozygosity was associated with an od...",23,471,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...ides are altered in ERAP1 deficient mice25. ERAP1 p.Arg725Gln-related alterations might affect the r...,25,443,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Ile29Ser,"...in KLRC4, rs1841958 and rs2617170, encoding KLRC4 p.Ile29Ser and Asn104Ser, are found on the BD-prot...",27,231,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...asis between HLA-B*51 and ERAP1 rs17482078 (ERAP1 p.Arg725Gln) coding variant in B,70,65,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Asn104Ser,KLRC4 rs2617170 (KLRC4p.Asn104Ser)	Turkish Discovery	TOF-MS	BD	1144	734	...,101,23,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,ERAP1 rs17482078 (ERAP1 p.Arg725Gln)	Turkish Discovery	TOF-MS	Uveitis BD	4...,121,25,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Met187Ile,"...ly inherited variant. The paternal carrier of the p.Met187Ilefs*19 variant also had DD, including wa...",36,1401,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Gln587Del,"...gs. We also detected a de novo in-frame deletion (p.Gln587Del) in the MYND domain (Gln87), which rep...",36,1603,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Ile822Tyr,DNA03-00335	14 yrs	M	p.Ile822Tyrfs*13	de novo	Normal IQ			+	+	+	+,252,22,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Leu411Gly,DNA-008897	73 yrs	M	p.Leu411Glyfs*6		Profound ID		+	+	+	+	+,253,21,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Trp532*,Troina 1274	19 yrs	M	p.Trp532*	de novo	Severe ID			+	+	+	+	-,254,22,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Ser1011*,Troina 1512	17 yrs	M	p.Ser1011*	de novo	Mild ID	+ (3y8m)	+		+	+	+	-,255,22,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Arg143Val,Troina 3097	34 yrs	F	p.Arg143Valfs*64		Severe ID				+	+	+	+,256,22,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Arg625*,DNA11-21308Z	36 years	F	p.Arg625*		Mild to Moderate ID	+	+	+	+	+	+,257,25,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Arg626*,DNA11-19324Z	9 yrs	F	p.Arg626*		2 to 2.5 year delay at 9 yr				+	-	+	-,258,22,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Gly15Arg,DNA08-08272	9 yrs	M	p.Gly15Argfs*47		Mild ID	+		+	+	+	+	+,259,21,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Lys592*,Rauch et al	13 yrs	F	p.Lys592*		Mild ID	+	+		+	-	+,260,22,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Asn152Thr,Adelaide3553	22y	M	p.Asn152Thrfs*26		Global DD	+		+,270,20,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Thr70Asn,DNA-017151	17 y	F	p.Thr70Asnfs*12	de novo	Normal IQ	+	+	+	+,271,19,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Gln326*,DNA04-02424	41 y	M	p.Gln326*		Mild ID	+	+	+	+,272,20,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Glu416Ser,DNA05-04370		M	p.Glu416Serfs*5		Severe ID	+	+		+,273,16,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Met187Ile,DNA-013587	25 y	M	p.Met187Ilefs*19	inherited	Global DD	+	+	+	+,274,19,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Met187Ile,Fa of DNA-013587		M	p.Met187Ilefs*19	carrier	DD,275,21,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Asn279Ser,"...9, coding for an amino-acid substitution in EXO1 (p.Asn279Ser; CADD score 3331), suggesting that thi...",29,561,Nat_Genet_2015_Apr_9_47(4)_373-380.txt
p.Q185X,... heterozygous for the paternally derived nonsense p.Q185X (c.553C>T) mutation in exon 5 of HOIL1 (Fi...,14,1549,Nat_Immunol_2012_Dec_28_13(12)_1178-1186.txt
p.Q185X,"...sing TRIB3 and HOIL1, and the nonsense c.553 C>T, p.Q185X mutant allele in HOIL1. Pedigree of kindre...",103,189,Nat_Immunol_2012_Dec_28_13(12)_1178-1186.txt
p.T232P,"...Supplementary Methods). Three missense mutations (p.T232P, p.A597D and p.H1204P) could be scored wit...",17,1536,Nature_2011_Jan_27_469(7331)_539-542.txt
p.A597D,"...tary Methods). Three missense mutations (p.T232P, p.A597D and p.H1204P) could be scored with these a...",17,1545,Nature_2011_Jan_27_469(7331)_539-542.txt
p.H1204P,"...). Three missense mutations (p.T232P, p.A597D and p.H1204P) could be scored with these alignments. T...",17,1557,Nature_2011_Jan_27_469(7331)_539-542.txt
p.R1020K,"...und to have two heterozygous missense mutations - p.R1020K,c.3059G>A and p.L1872P,c.5615T>C. Both ca...",29,198,Nature_2011_Jan_27_469(7331)_539-542.txt
p.L1872P,"...ygous missense mutations - p.R1020K,c.3059G>A and p.L1872P,c.5615T>C. Both cases (PD2126, PD2127) ha...",29,221,Nature_2011_Jan_27_469(7331)_539-542.txt
p.V600E,...ng LH  Zheng G  Dudley J  Illei P  Gocke CD   Non-p.V600E BRAF mutations are common using a more sen...,131,67,Neoplasia_2016_Sep_20_18(9)_577-583.txt
p.S13F,...s: the cardiac phenotype of DES founder mutations p.S13F and p.N342D van Spaendonck-Zwarts K. Y. +31...,3,245,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...iac phenotype of DES founder mutations p.S13F and p.N342D van Spaendonck-Zwarts K. Y. +31-50-3617229...,3,256,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...gene (DES). We describe new families carrying the p.S13F or p.N342D DES mutations, the cardiac pheno...",4,190,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,".... We describe new families carrying the p.S13F or p.N342D DES mutations, the cardiac phenotype of al...",4,200,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...collected the clinical details of all carriers of p.S13F or p.N342D. The founder effects were studie...,7,54,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...the clinical details of all carriers of p.S13F or p.N342D. The founder effects were studied using ge...,7,64,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,... identified three new index patients carrying the p.S13F mutation and two new families carrying the ...,10,53,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...p.S13F mutation and two new families carrying the p.N342D mutation. In total, we summarised the clin...",10,103,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...n total, we summarised the clinical details of 39 p.S13F carriers (eight index patients) and of 21 p...",10,172,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... p.S13F carriers (eight index patients) and of 21 p.N342D carriers (three index patients). The cardi...,10,221,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"... (three index patients). The cardiac phenotype of p.S13F carriers is fully penetrant and severe, cha...",10,287,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...weakness is a prominent and presenting symptom in p.N342D carriers, their cardiac phenotype is simil...",10,506,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...rs, their cardiac phenotype is similar to that of p.S13F carriers. The founder effects of p.S13F and...",10,570,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...o that of p.S13F carriers. The founder effects of p.S13F and p.N342D were demonstrated by genealogy ...,10,610,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,....S13F carriers. The founder effects of p.S13F and p.N342D were demonstrated by genealogy and haploty...,10,621,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...e cardiac phenotypes of the DES founder mutations p.S13F and p.N342D are characterised by cardiac co...,13,117,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...henotypes of the DES founder mutations p.S13F and p.N342D are characterised by cardiac conduction di...,13,128,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...ematic representation of desmin with locations of p.S13F (‘head’ structure) and p. N342D (2B domain)...,22,997,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"In the Netherlands, two DES mutations (p.S13F and p.N342D) have been identified in severa...",28,40,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"In the Netherlands, two DES mutations (p.S13F and p.N342D) have been identified in several index pat...",28,51,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...ms were (1) to describe new families carrying the p.S13F or p.N342D DES mutations, (2) to investigat...",28,394,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...) to describe new families carrying the p.S13F or p.N342D DES mutations, (2) to investigate the card...",28,404,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...luated known and obligate Dutch carriers (35 with p.S13F and 19 with p.N342D). Some of these data ha...,35,192,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ligate Dutch carriers (35 with p.S13F and 19 with p.N342D). Some of these data have been described p...,35,211,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...so summarised the published cardiological data on p.S13F and p.N342D carriers of other origin,35,669,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ed the published cardiological data on p.S13F and p.N342D carriers of other origin,35,680,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...ikely carriers (n = 2 and n = 13 respectively) of p.S13F or p.N342D in the Netherlands by collecting...,44,148,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...iers (n = 2 and n = 13 respectively) of p.S13F or p.N342D in the Netherlands by collecting the posta...,44,158,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...ng in the following changes at the protein level: p.S13F, p.N342D, p.R454W, p.T442I, and p.T453I (Ta...",48,142,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...e following changes at the protein level: p.S13F, p.N342D, p.R454W, p.T442I, and p.T453I (Table 1). ...",48,150,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R454W,"...ng changes at the protein level: p.S13F, p.N342D, p.R454W, p.T442I, and p.T453I (Table 1). Previousl...",48,159,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.T442I,"...s at the protein level: p.S13F, p.N342D, p.R454W, p.T442I, and p.T453I (Table 1). Previously, we pub...",48,168,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.T453I,"...ein level: p.S13F, p.N342D, p.R454W, p.T442I, and p.T453I (Table 1). Previously, we published on p.S...",48,181,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...nd p.T453I (Table 1). Previously, we published on p.S13F, p.N342D, and p.R454W [6–8]. The two other ...",48,228,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...3I (Table 1). Previously, we published on p.S13F, p.N342D, and p.R454W [6–8]. The two other mutation...",48,236,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R454W,"... Previously, we published on p.S13F, p.N342D, and p.R454W [6–8]. The two other mutations (p.T442I an...",48,249,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.T442I,"...342D, and p.R454W [6–8]. The two other mutations (p.T442I and p.T453I) have been newly identified in...",48,289,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.T453I,...R454W [6–8]. The two other mutations (p.T442I and p.T453I) have been newly identified in the Netherl...,48,301,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.G27S,"...ng in the following changes at the protein level: p.G27S, p.L136L, p.A213V, p.A285V, p.R315H, p.N342...",48,617,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.L136L,"...e following changes at the protein level: p.G27S, p.L136L, p.A213V, p.A285V, p.R315H, p.N342N. In ad...",48,625,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.A213V,"...ng changes at the protein level: p.G27S, p.L136L, p.A213V, p.A285V, p.R315H, p.N342N. In addition, t...",48,634,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.A285V,"...s at the protein level: p.G27S, p.L136L, p.A213V, p.A285V, p.R315H, p.N342N. In addition, the follow...",48,643,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R315H,"...protein level: p.G27S, p.L136L, p.A213V, p.A285V, p.R315H, p.N342N. In addition, the following intro...",48,652,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342N,"...evel: p.G27S, p.L136L, p.A213V, p.A285V, p.R315H, p.N342N. In addition, the following intronic and 3...",48,661,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"p.S13F	6,8	5 families	Dutch	Founder",51,1,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,p.N342D	This article	2 families	Dutch	Founder,54,1,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R454W,p.R454W	7	1 family	Dutch,57,1,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.T442I,p.T442I	11	1 family	French,59,1,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.T453I,p.T453I	10	1 patient	Italian?	De novo,61,1,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...dy we focused on the two Dutch founder mutations (p.S13F and p.N342D). Mutation p.S13F (c.38 C > T) ...,65,62,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ed on the two Dutch founder mutations (p.S13F and p.N342D). Mutation p.S13F (c.38 C > T) is a missen...,65,73,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,... founder mutations (p.S13F and p.N342D). Mutation p.S13F (c.38 C > T) is a missense mutation in the ...,65,92,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...se mutation in the head domain (Fig. 1). Mutation p.N342D (c.1024A > G) is a missense mutation in th...,65,173,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...l alleles. Twenty-seven proven and eight obligate p.S13F carriers were identified by family cascade ...,65,493,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... index patients. Twelve proven and seven obligate p.N342D carriers were identified by family cascade...,65,611,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,Cardiac phenotype of p.S13,67,22,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...leading to death. In total, 35 known and obligate p.S13F carriers (including eight index patients) h...",68,762,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...s (June 2011).Table 2 Clinical characteristics of p.S13F carriers, patient ID of new index patients ...",68,928,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"D-II-7 8	F	p.S13F	collapse (55)	RBBB, cAVB, LAHB (55)	normal ...",71,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"D-III-3 8	M	p.S13F	screening (37)	PVCs, IVCD (37)	normal (37)	...",72,13,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,D-III-4 8	F	p.S13F	screening (32)	IVCD (32)	normal (32)	normal...,73,13,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"E-I-2 8	F	p.S13F	MW (54)	incomplete RBBB (62), incomplete RB...",74,11,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"F-III-1	M	p.S13F (index)	arrhythmias (32)	PACs, AVNRT, AVB, ...",75,11,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,G-III-1	M	p.S13F (index)	Effort-related chest discomfort (37...,76,11,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,H-III-1	F	p.S13F (index)	collapse (36)	cAVB (36)	normal (36)...,77,11,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,H-III-2	F	p.S13F	screening (33)	IVCD (33)	normal (33)	no wea...,78,11,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"H-IV-2	M	p.S13F	screening (9)	PVCs, LBBB (9)	NA (pending)	n...",79,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,P-I-2 12	F	p.S13F	screening	NA	NA	very mild proximal and dist...,80,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,P-II-2 12	F	p.S13F	screening	NA	NA	very mild proximal and dist...,81,13,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,P-II-3 12	M	p.S13F (index)	collapse (39)	cAVB (39)	normal (39)...,82,13,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,P-II-4 12	M	p.S13F	screening	NA	NA	mild proximal and distal li...,83,13,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"... recently identified index patients with mutation p.S13F. Square symbols indicate men, circles women...",86,76,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...CM = dilated cardiomyopathy, E: S13F = carrier of p.S13F mutation, E: - = not a carrier of p.S13F mu...",86,508,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...rrier of p.S13F mutation, E: - = not a carrier of p.S13F mutation, ICD = implantable cardioverter de...",86,549,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...with the data published on four Singapore-Chinese p.S13F carriers [12] (Table 2). Many patients show...,90,94,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,Genealogy and haplotype analysis of families with p.S13,92,51,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...aled a different haplotype in a Singapore-Chinese p.S13F carrier (individual Pica II-3) [12] (see on...,93,440,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,Cardiac phenotype of p.N342,95,22,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"... cardiopathy” were reported [13]. We identified a p.N342D mutation in these families, thereby provin...",96,149,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...r these families. In total, 19 known and obligate p.N342D and 10 probable carriers (including three ...",96,315,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...ade atrioventricular block (b) from patients with p.S13,96,781,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... 3 Clinical characteristics of known and obligate p.N342D carriers and relatives likely to be carrie...,98,56,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,O-III-12	F	p.N342D	MW (37)	Repolarisation abnormality (63)	LV...,106,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,O-III-14	M	p.N342D	MW (23)	repolarisation abnormality (24); a...,108,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"O-III-15	F	p.N342D	MW (38)	atrial rhythm, repolarisation abno...",109,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,O-IV-2	F	p.N342D (index)	MW (27)	RBBB (45)	normal (45)	bulb...,110,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"O-IV-9	F	p.N342D	MW (23)	normal (35)	normal (35)	bulbar, ne...",111,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,U-III-14	F	p.N342D	NA	LAHB	NA	peroneal (29)	D (44),118,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,U-III-15	F	p.N342D	NA	Repolarisation abnormality (45)	NA	scap...,119,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"U-III-17	F	p.N342D	MW (16)	PACs, PVCs, ventricular bigeminy, ...",120,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,U-IV-5	M	p.N342D (index)	painful calves (23)	NA	NA	ilio-per...,123,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,U-IV-9	F	p.N342D	MW (27)	normal (29)	normal (29)	scapulo-il...,125,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"A-II-1 7	M	p.N342D (index)	MW, palpitations (36)	AF (39); sin...",126,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,A-II-2 7	M	p.N342D	MW (41)	first-degree AVB (46)	LV dysfuncti...,127,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"D-I-3 1,14	F	p.N342D (index)	MW (30)	normal	NA	distal, CK 364 (...",128,14,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"D-I-4 1,14	M	p.N342D	MW (23)	normal	NA	mild distal (23), CK 963...",129,14,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...ised our data together with that published on two p.N342D carriers of Irish-German decent [1, 14]. D...",134,60,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,Genealogy and haplotype analysis of families with p.N342,136,51,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,Geographical distribution of carriers of p.S13F or p.N342,139,42,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...eographical distribution of carriers of p.S13F or p.N342,139,52,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...ibution of known, obligate and likely carriers of p.S13F (n = 26) or p.N342D (n = 25) in the Netherl...",140,88,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...bligate and likely carriers of p.S13F (n = 26) or p.N342D (n = 25) in the Netherlands (Fig. 5a, b), ...",140,107,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ig. 4 Pedigrees of families O and U with mutation p.N342D. Updated pedigrees of the two families (O ...,140,555,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...ekens et al. [13] in which we identified mutation p.N342D. Square symbols indicate men, circles wome...",140,690,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,Fig. 5 Geographical distribution of carriers of p.S13F (A) and p.N342D (B). The geographical distr...,142,49,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...phical distribution of carriers of p.S13F (A) and p.N342D (B). The geographical distribution of know...,142,64,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...ibution of known, obligate and likely carriers of p.S13F (n = 26) and p.N342D (n = 25), respectively...",142,149,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...ligate and likely carriers of p.S13F (n = 26) and p.N342D (n = 25), respectively, in the Netherlands...",142,169,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"... all carriers of two Dutch DES founder mutations (p.S13F and p.N342D), including three new index pat...",147,89,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...rs of two Dutch DES founder mutations (p.S13F and p.N342D), including three new index patients with ...",147,100,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...p.N342D), including three new index patients with p.S13F and two new large families with p.N342D. Th...",147,150,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ients with p.S13F and two new large families with p.N342D. This is the largest series to date of car...,147,189,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,The cardiac phenotype of p.S13F seems to be fully penetrant and is characte...,149,26,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,The cardiac phenotype of p.N342D is in accordance with the phenotype of p.S...,151,26,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...of p.N342D is in accordance with the phenotype of p.S13F. However, the neuromuscular phenotype is mo...",151,73,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...ular phenotype is more prominent in carriers with p.N342D than in those with p.S13F, because all p.N...",151,153,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...inent in carriers with p.N342D than in those with p.S13F, because all p.N342D carriers presented wit...",151,180,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...th p.N342D than in those with p.S13F, because all p.N342D carriers presented with a neuromuscular ph...",151,200,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...eart failure or the exact causes of death of some p.N342D carriers. The type of rhythm and conductio...,151,377,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...oblems seem to have been the cause of death. Five p.N342D carriers (5/18, aged between 21-30 years) ...",151,620,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...dependent) penetrance of the cardiac phenotype of p.N342D cannot be excluded,151,867,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... the mutation. Mutations in the 2B domain such as p.N342D are predominantly involved when patients h...,153,168,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...r phenotype in carriers of the 2B domain mutation p.N342D is more prominent compared with carriers o...,153,451,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...inent compared with carriers of the head mutation p.S13F, these mutations both cause cardiological a...",153,521,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,... our analysis revealed a different haplotype in a p.S13F carrier of the Singapore-Chinese family to ...,157,234,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...nced that there are many unidentified carriers of p.S13F and p.N342D founder mutations in the Nether...,159,63,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...here are many unidentified carriers of p.S13F and p.N342D founder mutations in the Netherlands. Our ...,159,74,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...nds. Our estimation of the number of unidentified p.S13F carriers is several hundreds, taking into a...",159,165,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.Asp620Asn,...the identification of the same missense mutation (p.Asp620Asn) in the vacuolar protein sorting 35 (V...,100,80,Neurogenetics_2015_May_16_16_245-263.txt
p.S115S,...ome sequencing analysis [114]. A silent mutation (p.S115S) in the ATP6AP2 gene has been identified i...,289,187,Neurogenetics_2015_May_16_16_245-263.txt
p.Asp3Glu,"...ce site in intron 2 of the GYG1 gene (c.143+3G>C, p.Asp3Glufs*4), either in homozygous (in the 2 sib...",542,531,Neurol_Genet_2015_Sep_24_1(3)_e21.txt
p.N370S,"...84dupG (84GG), c.115+1G>A (IVS2+1G>A), c.1226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (p.D409H)...",342,638,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.V394L,"...1G>A (IVS2+1G>A), c.1226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P)...",342,659,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.D409H,"...226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>T (p.R463C)...",342,680,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.L444P,"...297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>T (p.R463C), and c.1604G>A (p.R4...",342,701,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.R463C,"...342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>T (p.R463C), and c.1604G>A (p.R496H)) and 2 recombina...",342,722,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.R496H,"...>C (p.L444P), c.1504C>T (p.R463C), and c.1604G>A (p.R496H)) and 2 recombinant alleles (RecNci-l and ...",342,747,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.Ile349Ser,...ver and 1000 Genomes Project. The c.1039_1043dup (p.Ile349Serfs*) mutation is inherently pathogenic ...,1220,328,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
p.Arg155His,"...due to a frameshift, and the mutations, c.464G>A (p.Arg155His) and c.902C>G (p.Ser301Cys), affect hi...",1220,428,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
p.Ser301Cys,"...e mutations, c.464G>A (p.Arg155His) and c.902C>G (p.Ser301Cys), affect highly conserved sites and ar...",1220,455,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
p.Ala239Thr,...LD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant . Acta Neuropathol,1577,94,Neuropathol_Appl_Neurobiol_2015_Aug_30_41(5)_601-612.txt
p.Met694Val,"...he most frequent eight missense mutations: M694V (p.Met694Val, c.2080A>G, rs61752717), M694I (p.Met6...",22,563,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Met694Ile,"...694V (p.Met694Val, c.2080A>G, rs61752717), M694I (p.Met694Ile, c.2082G>A, rs28940578), M680I (p.Met6...",22,607,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Met680Ile,"...694I (p.Met694Ile, c.2082G>A, rs28940578), M680I (p.Met680Ile, c.2040G>C, rs28940580), V726A (p.Val7...",22,651,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Val726Ala,"...680I (p.Met680Ile, c.2040G>C, rs28940580), V726A (p.Val726Ala, c.2177T>C, rs28940579), R761H (p.Arg7...",22,695,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Arg761His,"...726A (p.Val726Ala, c.2177T>C, rs28940579), R761H (p.Arg761His, c.2282G>A, rs104895097), and K695R (p...",22,739,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Lys695Arg,"...(p.Arg761His, c.2282G>A, rs104895097), and K695R (p.Lys695Arg, c.2084A>G, rs104895094) in exon 10; P...",22,788,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Pro369Ser,"...95Arg, c.2084A>G, rs104895094) in exon 10; P369S (p.Pro369Ser, c.1105C>T, rs11466023) in exon 3; and...",22,844,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Glu148Gln,"...Ser, c.1105C>T, rs11466023) in exon 3; and E148Q (p.Glu148Gln, c.442G>C, rs3743930) in exon 2 of the...",22,902,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.N478D,The homozygous p.N478D missense mutation in MTPAP causes spastic ...,16,16,Nucleic_Acids_Res_2015_Oct_15_43(18)_9065-9075.txt
p.Gly129Arg,"...kely pathogenic variant in exon 7 (EYA4:c.385G>C, p.Gly129Arg) of sample H23 that converts a Gly cod...",27,521,Oncogene_2014_Sep_4_33(36)_4464-4473.txt
p.Gly129Arg,"...mutation in exon 7 was identified (EYA4:c.385G>C, p.Gly129Arg), which is shown along with wild-type ...",93,244,Oncogene_2014_Sep_4_33(36)_4464-4473.txt
p.G12S,"1	63	M	R (asc)	5,0 cm	T3	Not tested	KRAS c.34G>A (p.G12S)	Reg Ascending LN & metachr Liver: KRAS c.3...",36,51,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12S,...)	Reg Ascending LN & metachr Liver: KRAS c.34G>A (p.G12S)	None,36,107,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"L (desc)	2,5 cm	T3	Not tested	KRAS c.35G>A (p.G12D)",37,45,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"2	74	M	NS	5,8 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Paraaortic LN & metachr Brain & metachr Lu...",38,43,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12V,"...3	M	R (cecum)	10,0 cm	T3	MLH-1/PMS2	KRAS c.35G>T (p.G12V)	Reg LN WT	Multiple CBC, RCC",42,54,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"5	79	M	L (desc)	3,5 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Synchr lung WT	Prostate Cancer",44,49,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G13D,"R (transv)	1,6 cm	T1	MSH2/MSH6	KRAS c.38G>A (p.G13D)",47,46,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12V,7	63	F	R (asc)	Biopsy	NA	NA	KRAS c.35G>T (p.G12V)	liver (clinicaly)	None,48,43,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12V,R (transv)	Biopsy	NA	NA	KRAS c.35G>T (p.G12V),49,39,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.Q61L,"8	69	M	L (desc)	5,5 cm	T3	NA	NRAS c.182A>T (p.Q61L)	Reg LN & synchr liver WT	None",50,45,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"... were noted: 3 cases of c.35G>A in KRAS codon 12 (p.G12D), 3 cases of c.35G>T (p.G12V) in KRAS codon...",57,312,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12V,"...>A in KRAS codon 12 (p.G12D), 3 cases of c.35G>T (p.G12V) in KRAS codon 12, and 1 case of c.34G>A (p...",57,341,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12S,"...(p.G12V) in KRAS codon 12, and 1 case of c.34G>A (p.G12S). A KRAS mutation in codon 13 (c.38G>A [p.G...",57,390,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G13D,"...A (p.G12S). A KRAS mutation in codon 13 (c.38G>A [p.G13D]) was observed in 1 patient, and a NRAS mut...",57,437,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.Q61L,"...tient, and a NRAS mutation in codon 61 (c.182A>T [p.Q61L]) detected in 1 patient. There were no muta...",57,516,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"... 1) harbored a mutation in KRAS codon 12 c.35G>A (p.G12D) and c.34G>A (p.G12S), respectively. Of the...",59,430,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12S,"...on in KRAS codon 12 c.35G>A (p.G12D) and c.34G>A (p.G12S), respectively. Of the 2 cases that showed ...",59,451,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12S,...N and liver metastases had the same KRAS c.34G>A (p.G12S) mutation. See Table 1 for RAS mutational d...,61,520,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G13D,"...ations respond to EGFR inhibitors [24], specially p.G13D, RAS-mutated tumors generally fail to respo...",66,207,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.V600E,... for BRAF mutation status between paired lesions (p.V600E and WT status) and MSI status in 1 patient...,72,475,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.Q61L,...tumor model carrying an activating NRAS mutation (p.Q61L). SiRNA-based knockdown of hnRNP K induced ...,7,307,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.Q61L,"... cellular tumor model carrying an activating NRAS p.Q61L mutation (IPC-298). Finally, we examined th...",19,1690,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.Q61L,"...osequencing. The CAA to CTA transition leads to a p.Q61L amino acid substitution, comprising constit...",69,793,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.Q61L,"...sition in codon 61 of the NRAS gene, leading to a p.Q61L amino acid substitution (Fig. 1C). After in...",72,229,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.Q61L,"...or model. We could confirm a previously described p.Q61L mutation of the NRAS gene in IPC-298 cells,...",100,210,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.Q61L,"... activated MAPK-signaling upon an activating NRAS p.Q61L mutation, MEK inhibition significantly decr...",104,423,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.Q61L,"...es as well as mature melanosomes and carry a NRAS p.Q61L mutation [42, 43]. Cells were cultivated un...",120,333,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.V600E,† 4 p.V600E and 2 p.D594G mutations,65,5,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.D594G,† 4 p.V600E and 2 p.D594G mutations,65,19,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.Y177Ter, 131	p.Y177Ter (c.531T > G)		6,74,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.R233Ter, 133	p.R233Ter (c.697C > T)		7,75,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.A126T, 181	p.A126T (c.376G > A)		5,76,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.T319Ter, 48	p.T319Ter (c.954_957del)	delTACT of (TACT)2	8,78,5,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.N323Mfs, 143	p.N323Mfs*21 (c.968delA)	delA of (A)6	8,79,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.L325R, 218	p.L325R (c.974T > G)		8,80,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.K267Rfs, 218	p.K267Rfs*9 (c.800delA)	delA of (A)6	7,81,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.R234W, 240	p.R234W (c.700C > T)		7,82,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.I122N, 264	p.I122N (c.365T > A)		5,83,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.R130Q, 264	p.R130Q (c.359G > A),84,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.N323Mfs, 264	p.N323Mfs*21 (c.968delA)	delA of (A)6	8,85,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.S10I, 273	p.S10I (c.29G > T)		1,86,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.Y178Ffs,MSIH22	p.Y178Ffs*6 (c.531_532dupTT)	dupTT	6,87,8,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.K267Rfs,MSIH22	p.K267Rfs*9 (c.800delA)	delA of (A)6	7,88,8,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.K267Rfs,MSIH24	p.K267Rfs*9 (c.800delA)	delA of (A)6	7,89,8,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.N323Mfs,MSIH24	p.N323Mfs*21 (c.968delA)	delA of (A)6	8,90,8,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.V600E,...y J  Illei P  Gocke CD  Eshleman JR  Lin MT   Non-p.V600E BRAF mutations are common using a more sen...,211,81,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.G13D,... JR  Simes J  Karapetis CS    Association of KRAS p.G13D mutation with outcome in patients with chem...,95,229,Oncotarget_2015_Oct_26_6(38)_40815-40821.txt
p.G13D,...ng YF  Yang ZY  Zheng DY  Chen JZ  Tang JL   KRAS p.G13D mutation and codon 12 mutations are not cre...,96,64,Oncotarget_2015_Oct_26_6(38)_40815-40821.txt
p.E322K,"...to have therapeutic value [13, 14]. Recently, the p.E322K mutation in MAPK1 was reported to confer e...",12,343,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.G13C,"...p = 0.7). Patient 5 had somatic mutations in HRAS p.G13C, CASP8 p.R127* and PDGFRA p.R764H at all su...",25,287,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.R127*,"...ent 5 had somatic mutations in HRAS p.G13C, CASP8 p.R127* and PDGFRA p.R764H at all sub-sites in pri...",25,301,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.R764H,"...utations in HRAS p.G13C, CASP8 p.R127* and PDGFRA p.R764H at all sub-sites in primary and metastatic...",25,320,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.R127*,...consistent with these being driver mutations. The p.R127* substitution in CASP8 a protein critical i...,25,560,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.R764H,"...ns in CASP8 have been reported [16, 17]. Finally, p.R764H substitution in PDGFRA has not been previo...",25,778,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.R282W,...rs had somatic point mutations identified in TP53 p.R282W in patient 6 and p.S241F in patient 2 in p...,30,71,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.S241F,...tions identified in TP53 p.R282W in patient 6 and p.S241F in patient 2 in primary sub-sites and meta...,30,96,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,"...geal tumor), a substitution at amino acid residue p.I251N in the TP53 gene was observed in two sub-s...",30,276,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,"...(Figure 2). Interestingly, another TP53 mutation, p.Y236C separated by 45 bases from p.I251N, was un...",30,444,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,"...TP53 mutation, p.Y236C separated by 45 bases from p.I251N, was unique to sub-site A. Further examina...",30,479,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,...m TP53 fragments spanning the amino acid residues p.I251N and p.Y236C were carried out. We observed ...,30,611,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,...ents spanning the amino acid residues p.I251N and p.Y236C were carried out. We observed 21.86% alter...,30,623,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,...lteration (T replaced by C) at amino acid residue p.Y236C and 6.87% alteration (A replaced by T) at ...,30,719,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,"...p.Y236C and 6.87% alteration (A replaced by T) at p.I251N in the sub-site A. Further, at the tumor s...",30,769,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,"... the tumor sub-site B, there was no alteration at p.Y236C and 59.23% alteration (A replaced by T) at...",30,857,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,....Y236C and 59.23% alteration (A replaced by T) at p.I251N. Thus the p.I251N alteration at sub-site A...,30,908,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,...alteration (A replaced by T) at p.I251N. Thus the p.I251N alteration at sub-site A developed indepen...,30,926,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,...tion at sub-site A developed independently of the p.Y236C alteration at tumor sub-site B. The number...,30,990,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,Figure 2 TP53 mutations p.I251N and p.Y236C within the primary laryngeal t...,32,25,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,Figure 2 TP53 mutations p.I251N and p.Y236C within the primary laryngeal tumor sub-sit...,32,37,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,...A had 6.87% alterations in the amino acid residue p.I251N and 21.86% alterations in p.Y236C. Tumor B...,33,312,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,...no acid residue p.I251N and 21.86% alterations in p.Y236C. Tumor B had 59.23% alterations in the p.I...,33,346,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,...in p.Y236C. Tumor B had 59.23% alterations in the p.I251N residue and no alteration in p.Y236C. Thus...,33,393,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,"...tions in the p.I251N residue and no alteration in p.Y236C. Thus, mutations in p.I251N and p.Y236C re...",33,430,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,"... and no alteration in p.Y236C. Thus, mutations in p.I251N and p.Y236C residues emerged independently...",33,458,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,"...ration in p.Y236C. Thus, mutations in p.I251N and p.Y236C residues emerged independently at differen...",33,470,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.A934P,"...tinguishable from acrocallosal syndrome who has a p.A934P GLI3 mutation [21]. Second, patients with ...",57,949,Orphanet_J_Rare_Dis_2008_Apr_24_3_10.txt
p.E191K,Genotype	c.571>A (p.E191K,165,19,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.H454R,c.1361A>G (p.H454R)	c.571>A (p.E191K,166,12,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.E191K,c.1361A>G (p.H454R)	c.571>A (p.E191K,166,30,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.R184W,c.550C>T (p.R184W)	c.526G>A (p.A176T,167,11,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.A176T,c.550C>T (p.R184W)	c.526G>A (p.A176T,167,30,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.N417S,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,23,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.R71H,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,43,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.Ser298Pro,... A Steglich C Muhlhausen C Ullrich K The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is ass...,125,71,Orphanet_J_Rare_Dis_2011_Jun_20_6_43.txt
p.Lys62X,...lly always double heterozygous mutations) and the p.Lys62X/p.Cys84fs mutation is present in two-thir...,260,453,Orphanet_J_Rare_Dis_2011_May_19_6_26.txt
p.E2496E,"...and XhoI/BamHI restriction sites for the variants p.E2496E and p.V382M, respectively, using T4 DNA l...",60,353,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V382M,"...I restriction sites for the variants p.E2496E and p.V382M, respectively, using T4 DNA ligase (Invitr...",60,366,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V382M,"...igase (Invitrogen Corporation, Carlsbad, CA). The p.V382M mutation was generated by site-directed mu...",60,453,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R274X,c.820C > T	5	p.R274X	+	2	Present study,70,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y506X,"c.1518T > A	8	p.Y506X	+	1	Bernal et al., 2005",72,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R1295X,"c.3883C > T	18	p.R1295X	+	1	Dreyer et al., 2000",74,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E1492X,"c.4474G > T	21	p.E1492X	+	2	Bernal et al., 2005",76,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R1549X,"c.4645C > T	22	p.R1549X	+	1	Baux et al., 2007",78,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.W2618X,c.7854G > C	41	p.W2618X	+	1	Present study,80,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3251X,c.9753T > A	50	p.C3251X	+	2	Present study,82,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3368X,c.10102C > T	51	p.Q3368Xa	+	1	Present study,84,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3587X,"c.10759C > T	55	p.Q3587X	+	2	Baux et al., 2007",86,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3716X,c.11146C > T	57	p.Q3716X	+	1	Present study,88,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S307Afs,c.918_919insGCTG	6	p.S307AfsX17	+	1	Present study,94,20,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N405Ifs,"c.1214delA	7	p.N405IfsX3	+	5	Bernal et al., 2005",96,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.F543Lfs,c.1629_1645del	10	p.F543LfsX2	+	1	Present study,98,19,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E767Sfs,"c.2299delG	13	p.E767SfsX21	+	8	Eudy et al., 1998",100,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.D1760Mfs,c.5278delG	26	p.D1760MfsX10a	+	1	Present study,102,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N1848X,c.5540_5541dup	27	p.N1848X	+	1	Present study,104,19,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V2107X,c.6319_6324delinsTAAA	32	p.V2107X	+	1	Present study,106,26,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.W2964Lfs,c.8890dupT	45	p.W2964LfsX89	+	1	Present study,108,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G2985Afs,c.8954delG	45	p.G2985AfsX3	+	1	Present study,110,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E3088Kfs,c.9261delT	47	p.E3088KfsX9	+	1	Present study,112,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3425Ffs,"c.10272_10273dupTT	52	p.C3425FfsX4	+	1	Aller et al., 2006",114,23,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S3856Vfs,c.11566delA	60	p.S3856VfsX28	+	1	Present study,116,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y4031X,c.12093delC	62	p.Y4031X	+	1	Present study,118,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V4381Cfs,c.13140delA	63	p.V4381CfsX10	+	1	Present study,120,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.A125T,"c.373G > A	2	p.A125T	-	81	Dreyer et al., 2000",144,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,c.130G > A	2	p.G44R	+	1	Present Study,146,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V230M,"c.688G > A	4	p.V230M	-	3	Dreyer et al., 2000",148,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R303H,"c.908G > A	6	p.R303He	UV3	1	Yan et al., 2009",150,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V382M,c.1144G > A	7	p.V382Mb	UV3	1	Present Study,152,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E478D,"c.1434G > C	8	p.E478D	-	4	Seyedahmadi et al., 2004",154,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.L555V,"c.1663C > G	10	p.L555V	-	2	Bernal et al., 2003",156,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.D644V,"c.1931A > T	11	p.D644V	-	6	Weston et al., 2000",158,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C759F,"c.2276G > T	13	p.C759F	+	3	Dreyer et al., 2000",162,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S841Y,"c.2522C > A	13	p.S841Y	UV2	1	Jaijo et al., 2009",164,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R1486K,"c.4457G > A	21	p.R1486K	-	75	Dreyer et al., 2000",166,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.L1572F,"c.4714C > T	22	p.L1572F	-	7	Dreyer et al., 2008",168,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.I1665T,"c.4994T > C	25	p.I1665T	-	31	Kaiserman et al., 2007",170,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y1992C,"c.5975A > G	30	p.Y1992Ce	UV3	1	McGee et al., 2010",172,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.I2106T,"c.6317T > C	32	p.I2106T	-	117	Aller et al., 2006",174,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.I2169T,"c.6506T > C	34	p.I2169T	-	85	Aller et al., 2006",176,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S2196T,"c.6587G > C	34	p.S2196T	UV2	2	Jaijo et al., 2009",178,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2238A,"c.6713A > C	35	p.E2238A	-	1	Aller et al., 2006",180,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R2292H,"c.6875G > A	36	p.R2292H	-	2	Dreyer et al., 2008",182,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2377S,c.7130A > G	38	p.N2377S	UV2	1	Present Study,184,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2394K,c.7182C > A	38	p.N2394K	UV2	1	Present Study,186,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P2502P,"c.7506G > A	40	p.P2502P	-	11	Baux et al., 2008",188,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V2562A,"c.7685T > C	41	p.V2562A	-	1	Dreyer et al., 2008",190,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S2639P,"c.7915T > C	41	p.S2639P	UV2	3	McGee et al., 2010",192,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R2875Q,"c.8624G > A	43	p.R2875Q	-	9	Aller et al., 2006",194,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.L2886F,"c.8656C > T	43	p.L2886F	-	9	Aller et al., 2006",196,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E3088K,"c.9262G > A	47	p.E3088K	-	1	Dreyer et al., 2008",198,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N3099S,"c.9296A > G	47	p.N3099S	-	12	Aller et al., 2006",200,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T3115A,"c.9343A > G	47	p.T3115A	-	9	Dreyer et al., 2008",202,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.D3144N,"c.9430G > A	48	p.D3144N	-	8	Aller et al., 2006",204,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N3199D,"c.9595A > G	49	p.N3199D	-	9	Baux et al., 2007",206,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,"c.9799T > C	50	p.C3267R	+	5	Aller et al., 2006",208,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"c.10073G > A	51	p.C3358Y	+	1	McGee et al., 2010",210,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E3411A,"c.10232A > C	52	p.E3411A	-	94	Aller et al., 2006",212,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,c.10636G > A	54	p.G3546R	+	4	Present Study,214,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T3835I,c.11504C > T	59	p.T3835I	-	30	Present Study,216,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.M3868V,"c.11602A > G	60	p.M3868V	-	34	Aller et al., 2006",218,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P3893T,"c.11677C > A	60	p.P3893T	-	2	Dreyer et al., 2008",220,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N3894D,c.11680A > G	60	p.N3894D	UV3	1	Present Study,222,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R4115C,"c.12343C > T	63	p.R4115C	-	2	van Wijk et al., 2004",224,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G4692R,"c.14074G > A	64	p.G4692Rc	UV2	1	McGee et al., 2010",226,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P4818L,"c.14453C > T	66	p.P4818L	+	1	Aller et al., 2006",228,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G4838E,"c.14513G > A	66	p.G4838E	-	1	McGee et al., 2010",230,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R4848Q,"c.14543G > A	66	p.R4848Q	-	1	McGee et al., 2010",232,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4921K,c.14761G > A	67	p.E4921K	UV2	1	Present Study,234,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.K5026E,"c.15076A > G	70	p.K5026E	UV2	1	McGee et al., 2010",236,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R5031W,"c.15091C > T	70	p.R5031W	-	2	Dreyer et al., 2008",238,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R303H,e p.R303H and p.Y1992C were initially described as b...,247,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y1992C,e p.R303H and p.Y1992C were initially described as being pathoge...,247,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T168T,"c.504A > G	3	p.T168T	-	75	Baux et al., 2008",254,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q393Q,"c.1179A > G	7	p.Q393Q	-	1	Aller, 2008",256,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T473T,"c.1419C > T	8	p.T473T	-	36	Dreyer et al., 2000",258,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.D703D,"c.2109T > C	12	p.D703D	-	7	Weston et al., 2000",260,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.H752H,"c.2256T > C	13	p.H752H	-	3	Dreyer et al., 2008",262,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N1315N,c.3945T > C	18	p.N1315N	UV2	3	Present Study,264,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S1457S,"c.4371G > A	20	p.S1457S	-	1	Dreyer et al., 2000",266,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G1671G,"c.5031C > A	25	p.G1671G	-	22	Aller et al., 2006",268,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y1917Y,"c.5751C > T	28	p.Y1917Y	UV2	1	McGee et al., 2010",270,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2496E,c.7488A > G	40	p.E2496Eb	+	1	Present Study,272,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P2502P,"c.7506G > A	40	p.P2502P	-	11	McGee et al., 2010",274,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E3912E,"c.11736G > A	61	p.E3912E	-	2	Dreyer et al., 2008",276,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P3969P,"c.11907A > T	61	p.P3969P	-	2	Dreyer et al., 2008",278,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.L3982L,"c.11946A > T	61	p.L3982L	-	29	Dreyer et al., 2008",280,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y4031Y,"c.12093C > T	62	p.Y4031Y	-	1	Dreyer et al., 2008",282,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T4204T,"c.12612A > G	63	p.T4204T	-	129	Dreyer et al., 2008",284,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T4222T,"c.12666A > G	63	p.T4222T	-	58	Dreyer et al., 2008",286,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4397E,"c.13191G > A	63	p.E4397E	-	23	Dreyer et al., 2008",288,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.A4827A,"c.14481C > T	66	p.A4827A	-	1	McGee et al., 2010",290,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T4888T,c.14664G > A	67	p.T4888T	UV2	1	Present Study,292,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E1492X,RP1274*	p.E1492X/p.E1492X	1969	USH2		Moderate-severe and s...,308,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E1492X,RP1274*	p.E1492X/p.E1492X	1969	USH2		Moderate-severe and stable	Nor...,308,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E1492X,RP1633	p.E1492X/p.E1492X	1962	USH2	25	Since infancy	Norma...,310,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E1492X,RP1633	p.E1492X/p.E1492X	1962	USH2	25	Since infancy	NormalA	25	25	...,310,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,RP1607	p.G3546R/p.G3546R	1925	USH2	33	Mild-moderate	Norma...,312,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,RP1607	p.G3546R/p.G3546R	1925	USH2	33	Mild-moderate	NormalA	16	25	...,312,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,RP259	c.1214delA/p.C3267R	1974	USHA	19	Profound since 6 years	Vesti...,316,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R303H,RP1775	c.2299delG/p.R303H#	1961	USHA	30	Moderate since 7 years and p...,326,19,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,RP1618	p.C3267R/c.6319_6324delinsTAAA	1964	USH2		Severe-p...,328,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,"RP1442*	p.C3267R/c.12093delC	1962	USH2	20	Congenital, mode...",330,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,RP1703*	p.C3267R/p.C3358Y	1936	USHA	50	Since 64 years		50	...,332,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,RP1703*	p.C3267R/p.C3358Y	1936	USHA	50	Since 64 years		50	55	Reduce...,332,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,"RP1759	p.C3267R/p.Y1992C#	1945	USH2	62	Congenital, modera...",334,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y1992C,"RP1759	p.C3267R/p.Y1992C#	1945	USH2	62	Congenital, moderate and st...",334,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R274X,RP1625*	c.12067-2A > G/p.R274X	1976	USH2	25	Since infancy	NormalA	19	24	C...,336,24,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R274X,RP1631	c.1841-2A > G/p.R274X	1976	USH2		Since infancy	NormalA	28	28	Con...,338,22,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3251X,"RP951	c.1214delA/p.C3251X	1969	USH2	25	Congenital, severe and stabl...",340,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R1549X,RP1558	p.R1549X/c.1328 + 1G > T	1933	USH2	43	Severe and p...,342,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R1295X,"RP1539*	p.R1295X/p.N3894D#	1987	USH2	20	Congenital, modera...",344,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N3894D,"RP1539*	p.R1295X/p.N3894D#	1987	USH2	20	Congenital, moderate and st...",344,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.W2618X,RP1172*	c.10272_10273dupTT/p.W2618X	1964	USH2	23	Moderate and stable since 7 ...,346,28,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C759F,RP1641*	p.C759F/p.W4725X	1967	USHA		Moderate and progressi...,348,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.W4725X,RP1641*	p.C759F/p.W4725X	1967	USHA		Moderate and progressive	Centr...,348,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C759F,RP1667*	p.C759F/c.11548 + 2T > G	1954	USH2	15	Mild and sli...,350,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P4818L,RP690M*	p.P4818L/p.Q3368X + c.5278delG	1972	USH2	22	Congen...,352,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3368X,"RP690M*	p.P4818L/p.Q3368X + c.5278delG	1972	USH2	22	Congenital, mod...",352,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y506X,RP532	p.Y506X/p.Q3587X	1968	USH2		Profound	NormalA	15	20...,354,7,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3587X,RP532	p.Y506X/p.Q3587X	1968	USH2		Profound	NormalA	15	20	Marked ...,354,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3587X,RP946*	p.Q3587X/p.E2496E	1982	USHNC	17,356,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2496E,RP946*	p.Q3587X/p.E2496E	1982	USHNC	17,356,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,RP1613	c.9260delT/p.G44R	1971	USH2	30	Severe	NormalA	20	20	Marked co...,358,19,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G713R,"...were classified as possibly non-pathologic (UV2). p.G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and...",426,75,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S841Y,"...sified as possibly non-pathologic (UV2). p.G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E...",426,84,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S2196T,"... possibly non-pathologic (UV2). p.G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E have alr...",426,93,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S2639P,"...non-pathologic (UV2). p.G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E have already been ...",426,103,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G4692R,"...ogic (UV2). p.G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E have already been reported i...",426,113,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.K5026E,"....G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E have already been reported in other works...",426,126,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2377S,"...umc.nl/LOVD2/Usher_montpellier, [35]]. Meanwhile, p.N2377S, p.N2394K and p.E4921K have not been desc...",426,317,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2394K,"...D2/Usher_montpellier, [35]]. Meanwhile, p.N2377S, p.N2394K and p.E4921K have not been described prev...",426,327,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4921K,"...pellier, [35]]. Meanwhile, p.N2377S, p.N2394K and p.E4921K have not been described previously, so th...",426,340,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,p.G44R	Affect (Score 0.01)	Probably damaging	Patho...,431,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2377S,p.N2377S	Tolerated (Score 0.44)	Possibly damaging	...,433,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2394K,p.N2394K	Tolerated (Score 0.23)	Possibly damaging	...,435,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,p.G3546R	Affect (Score 0.01)	Probably damaging	Pat...,437,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N3894D,p.N3894D	Tolerated (Score 0.05)	Probably damaging	...,439,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4921K,p.E4921K	Tolerated (Score 0.85)	Benign	Neutral (NN...,441,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R303H,...sified as possibly-pathogenic (UV3). The variants p.R303H and p.Y1992C were described previously [ht...,448,83,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y1992C,...ssibly-pathogenic (UV3). The variants p.R303H and p.Y1992C were described previously [https://grenad...,448,95,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N3894D,".../LOVD2/Usher_montpellier, [35]]. The novel change p.N3894D was not found in 200 control alleles and ...",448,204,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V382M,"...d it as clearly pathogenic (See Table 6). The new p.V382M change, which affects the first base of ex...",448,411,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2496E,Figure 1 In vitro splicing assays for p.E2496E and p.V382M mutations. Gel electrophoresi...,450,39,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V382M,...igure 1 In vitro splicing assays for p.E2496E and p.V382M mutations. Gel electrophoresis shows the d...,450,52,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2496E,"...s compared to the full-length transcript. For the p.E2496E mutation, an evident increase of band b (...",450,371,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V382M,...rd to the WT minigene expression product. For the p.V382M variant a small increase of the exon 7 ski...,450,577,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C759F,...missense mutations were considered as pathogenic. p.C759F and p.C3267R were already described by oth...,452,64,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,...ations were considered as pathogenic. p.C759F and p.C3267R were already described by others authors ...,452,76,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"...//grenada.lumc.nl/LOVD2/Usher_montpellier, [35]]. p.C3358Y and p.P4818L were classified by McGee et ...",452,195,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P4818L,"...c.nl/LOVD2/Usher_montpellier, [35]]. p.C3358Y and p.P4818L were classified by McGee et al. (2010) [3...",452,208,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"...-pathogenic (UV3). However, in the present study, p.C3358Y was detected in a patient together with a...",452,346,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,... patient together with another nucleotide change (p.C3267R) and the segregation analysis confirmed t...,452,422,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P4818L,...d that the mutations were not in the same allele. p.P4818L was detected in a patient together with t...,452,519,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3368X,...directly or indirectly cause a truncated protein (p.Q3368X and c.5278delG). The segregation analysis...,452,643,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"...gregation analyses support the damaging effect of p.C3358Y and p.P4818L, so we have considered them ...",452,900,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P4818L,"...lyses support the damaging effect of p.C3358Y and p.P4818L, so we have considered them as pathogenic...",452,913,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,"...P4818L, so we have considered them as pathogenic. p.G44R and p.G3546R were novel; none of them was d...",452,965,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,...we have considered them as pathogenic. p.G44R and p.G3546R were novel; none of them was detected in ...,452,976,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,... was detected in 200 control alleles. The variant p.G44R was detected in a single patient and p.G354...,452,1059,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,...riant p.G44R was detected in a single patient and p.G3546R in three cases (one homozygous and two co...,452,1103,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2496E,... three were novel (See Table 3). Only the variant p.E2496E was categorized as pathogenic. It was not...,455,195,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2496E,...ites which were predicted to affect the splicing (p.E2496E and p.V382M) showed that p.E2496E creates...,465,578,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V382M,...re predicted to affect the splicing (p.E2496E and p.V382M) showed that p.E2496E creates a de novo do...,465,591,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2496E,...t the splicing (p.E2496E and p.V382M) showed that p.E2496E creates a de novo donor splice site stron...,465,612,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V382M,"...as pathogenic. On the other hand, the presence of p.V382M revealed a mild increase of the transcript...",465,831,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.D27Afs,"V.1, V.2, V.4	He	c.80_81delAT	p.D27Afs*18	2	N-terminal	Not described",70,31,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.G162D,I.1	He	c.485 G > A	p.G162D	4	SRCR	Le Quintrec M. et al. 2008 [17],71,20,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.R187X,"IV.1, IV.3, IV4, V.1, V.3	He	c.559 C > T	p.R187X	4	SRCR	Not described",72,42,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.A258T,"II.1, II.2, II.3	Ho He	c.772 G > A	p.A258T	5	LDLRA2	Vyse et al. 1996 [18]",73,36,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.W393Yfs,"I.1, I.2	He	c.1176_1177dupAT	p.W393Yfs*5	11	SP	Baracho et al. 2003 [19]",74,30,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.R474X,"III.1, III.3, III.4	He	c.1420 C > T	p.R474X	11	SP	Fremaux-Bacchi et al. 2004 [20]",75,37,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.V537Vfs,"IV.1, IV.2, IV.4	He	c.1610_1611insAT	p.V537Vfs*2	13	SP	Not described",76,38,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.N177I,"...reported molecular change in exon 4, c.738 A > T; p.N177I. Taking into account that patient III.2’s ...",79,721,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.D27Afs,...ing situation that causes a premature stop codon (p.D27Afs*18),87,337,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.Gly162Ser,...se variants in exon 4 (rs56098093; g.30100401C>T; p.Gly162Ser) and exon 6 (rs201231713; g.30099890C>...,83,177,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Arg272Gln,...ly162Ser) and exon 6 (rs201231713; g.30099890C>T; p.Arg272Gln) were found in a higher frequency in p...,83,230,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Gly162Ser,p.Gly162Ser	 	 	GA: 12 (10.7%)	GA: 8 (4%),96,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Arg272Gln,p.Arg272Gln	 	 	GA: 9 (8.0%)	GA: 2 (1%),102,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Cys4Ser,"...ne patient had a missense variant (g.35295505G>C; p.Cys4Ser) in exon 1, three patients had the same ...",124,209,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Pro312His,...the same missense variant in ex 5 (g.35300142C>A; p.Pro312His) and one patient had another missense ...,124,300,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Arg332Pro,... another missense variant in ex 5 (g.35300202C>G; p.Arg332Pro) (Table 3). None of the variants are r...,124,382,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Cys4Ser,"... found in five MA patients. A) The g.35295505G>C (p.Cys4Ser) variant in control and patient 223, B) ...",126,147,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Pro312His,"...in control and patient 223, B) the g.35300142C>A (p.Pro312His) in control and patients 162, 237, and...",126,216,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Arg332Pro,"...tients 162, 237, and 97 and C) the g.35300202C>G (p.Arg332Pro) in control and patient 110. The varia...",126,296,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Cys4Ser,p.Cys4Ser	 	 	GC: 1 (0.9%)	GC: 0 (0%),133,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Pro312His,p.Pro312His	 	 	CA: 3 (2.7%)	CA: 0 (0%),136,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Arg332Pro,p.Arg332Pro	 	 	CG: 1 (0.9%)	CG: 0 (0%),139,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.I1061T,"...ngs presented the c.3182T>C (P.I1061T)/c.3182T>C (p.I1061T) genotype, while the third unrelated NPC ...",44,367,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
p.V1165M,... NPC patient presented the c.2795+1G>C/c.3493G>A (p.V1165M) genotype. This study was approved by the...,44,462,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
p.Arg192Gln,"...ations (c.468_469delTC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A and c.752-2A>G) were iden...",12,940,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
p.Leu105X,...g mutation in our cohort was c.312_321del10insAT (p.Leu105X) (16 homozygous and 11 compound heterozy...,160,450,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
p.Leu105X,...lian cohort had at least one c.312_321del10insAT (p.Leu105X) mutation. No specific genotype phenotyp...,160,1345,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
p.Arg192Gln,"...ations (c.468_469delTC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G)",163,156,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
p.Arg192Gln,"...rs of age. The novel missense mutation (c.575G>A, p.Arg192Gln) was found in a 12 year old female (ca...",167,848,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
p.R206H,...us for a recurrent activating mutation (c.617G>A; p.R206H) in the cytoplasmic GS (glycine-serine ric...,21,94,Orphanet_J_Rare_Dis_2013_Sep_18_8_145.txt
p.Arg371Cys,...nt. A missense mutation [NM_006517.4:c.1111C > T; p.Arg371Cys] in exon 4 of the SLC16A2 gene was ide...,62,672,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.G334Pfs,...mature stop codon [NM_006517.4:c.990_991insGCTGC; p.G334PfsX11] and segregated with the clinical phe...,101,154,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.G833R,...ation t(X;12) (q24;q15)	Deletion	Missense variant p.G833R	Missense variant p.R631S	Missense variant ...,118,74,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.R631S,...eletion	Missense variant p.G833R	Missense variant p.R631S	Missense variant p.M706T	Missense variant ...,118,99,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.M706T,...p.G833R	Missense variant p.R631S	Missense variant p.M706T	Missense variant p.R450Q	Partial duplicati...,118,124,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.R450Q,...p.R631S	Missense variant p.M706T	Missense variant p.R450Q	Partial duplication of GRIA3	Partial dupli...,118,149,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.G630R,...IA3	Partial duplication of GRIA3	Missense variant p.G630R	Missense variant p.G630R	Missense variant ...,118,232,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.G630R,...f GRIA3	Missense variant p.G630R	Missense variant p.G630R	Missense variant p.G630R,118,257,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.G630R,...p.G630R	Missense variant p.G630R	Missense variant p.G630R,118,282,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gly630Arg,...novel missense mutation [NM_000828.4:c.1888G > C; p.Gly630Arg] in exon 12 of the GRIA3 gene that seg...,146,108,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gly630Arg,The wild type residue glycine of the p.Gly630Arg is neutral and the mutant residue argi...,149,38,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg441Trp,...novel missense mutation [NM_201599.2:c.1321C > T; p.Arg441Trp] in exon 7 of the ZMYM3 gene was prese...,219,202,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg441Trp,...ution of the amino acid arginine with tryptophan (p.Arg441Trp) and was absent in 100 Finnish anonymo...,219,462,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gly293Ser,...n exon 6 of the SYP gene [NM_003179.2:c.877G > A; p.Gly293Ser]. This missense variant was found in a...,231,139,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.G334Pfs,[30]. The novel frameshift mutation p.G334PfsX11 identified in family D299 is located ...,243,37,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg371Cys,...9 is located in the seventh TMD and the recurrent p.Arg371Cys amino acid substitution present in fam...,243,124,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg445Cys,"...ied in a sporadic case (annotated as c.1333C > T, p.Arg445Cys using a different SLC16A2 isofor",243,311,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg445Cys,...uld speak some words. Based on the available data p.Arg445Cys mutation seems to be associated with v...,246,333,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gly630Arg,We identified a missense mutation c.1888G > C (p.Gly630Arg) (RefSeq NM_000828.4) in the glutamate...,248,48,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg631Ser,...d in GRIA3[34-38]. One of the missense mutations (p.Arg631Ser,252,161,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Met706Thr,"...bled, whereas one patient with a missense change (p.Met706Thr) had mild I",253,553,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg441Trp,The missense mutation c.1321C > T (p.Arg441Trp) (RefSeq NM_201599.2) is the first var...,264,36,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gln119Arg,...ense variant of unknown significance (c.356A > G (p.Gln119Arg)) in ZMYM3 was reported in the index p...,265,189,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gly293Ser,...features. The missense benign variant c.877G > A (p.Gly293Ser) (RefSeq NM_003179.2) has been reporte...,271,151,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg2900*,"...matic father was found to be heterozygous for the p.Arg2900* mutation, the asymptomatic mother heter...",268,631,Orphanet_J_Rare_Dis_2014_Jan_22_9_11.txt
p.Arg1834Gly,... PCD (confirmed on nasal biopsy) only carried the p.Arg1834Gly mutation. The p.Arg2068His and p.Trp3...,268,1001,Orphanet_J_Rare_Dis_2014_Jan_22_9_11.txt
p.Arg2068His,...opsy) only carried the p.Arg1834Gly mutation. The p.Arg2068His and p.Trp3238Arg mutations have been ...,268,1028,Orphanet_J_Rare_Dis_2014_Jan_22_9_11.txt
p.Trp3238Arg,...d the p.Arg1834Gly mutation. The p.Arg2068His and p.Trp3238Arg mutations have been found in 3 patien...,268,1045,Orphanet_J_Rare_Dis_2014_Jan_22_9_11.txt
p.Arg2068His,...tions have been found in 3 patients with PCD. The p.Arg2068His and p.Trp3238Arg mutations are theref...,268,1112,Orphanet_J_Rare_Dis_2014_Jan_22_9_11.txt
p.Trp3238Arg,...ound in 3 patients with PCD. The p.Arg2068His and p.Trp3238Arg mutations are therefore very likely t...,268,1129,Orphanet_J_Rare_Dis_2014_Jan_22_9_11.txt
p.E191K,"...homozygous DHCR24 mutation (NM_014762.3:c.571G>A; p.E191K), a recognized cause of desmosterolosis (A...",26,121,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
p.E191K,...her were heterozygous for NM_014762.3:c.571G > A (p.E191K) mutation. The propositae have the mutatio...,101,360,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
p.G205S,"1	CHILD syndrome	NSDHL: c.613G>A, p.G205S (heterozygous)	Yes",34,35,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
p.Q210X,"2	CHILD syndrome	NSDHL: c.628C>T, p.Q210X (heterozygous)	Yes",37,35,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
p.R88X,"3	CHILD syndrome	NSDHL: c.262C>T, p.R88X (heterozygous)	Yes",40,35,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
p.A176D,...recessive congenital ichthyosis	NIPAL4: c.527C>A; p.A176D (homozygous)	No,46,63,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
p.A176D,"...due to the homozygous NIPAL4 mutation c.527C > A; p.A176D was treated. Ichthyin, the polypeptide enc...",64,690,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
p.Arg50Ala,"...heterozygous frameshift mutation, c.141_142delTG (p.Arg50Alafs*103), in OSBPL2, encoding a protein k...",10,389,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg50Ala,"...after birth of children, stress; CI around 50 ys.	p.Arg50Alafs*103",84,73,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg50Ala,III:9	61	yes	30	CI at 50 ys.	p.Arg50Alafs*103,86,30,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg50Ala,IV:7	50	yes	10	CI at 36 ys.	p.Arg50Alafs*103,89,29,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg50Ala,IV:9	49	yes	12	CI at 39 ys.	p.Arg50Alafs*103,91,29,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg50Ala,IV:10	45	yes	22	hearing aids at 34 ys.	p.Arg50Alafs*103,92,40,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg50Ala,...om investigations; hearing worse under stress	?	?	p.Arg50Alafs*103,94,70,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg50Ala,...5	worsening after birth of children; CI at 27 ys.	p.Arg50Alafs*103,96,63,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg50Ala,V:3	26	yes	11	hearing aids at 12 ys.	p.Arg50Alafs*103,97,38,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg50Ala,V:6	20	yes	10	hearing aids at 15 ys.	p.Arg50Alafs*103,100,38,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg50Ala,...ewer (IGV) for patient IV:10. The c.141_142delTG (p.Arg50Alafs*103) mutation in OSBPL2 was present i...,110,442,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg506Gly,...he chromosome 12 candidate region: The c.1516C>G (p.Arg506Gly) variant in SLC11A2 has been annotated...,115,243,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg18His,"...ations cause ADNSHL. A missense variant, c.53G>A (p.Arg18His), was identified in CELA1 (chymotrypsin...",115,609,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg18His,"...ned essentiality of this gene [36]. Moreover, the p.Arg18His variant has an MAF of 0.28% which is no...",115,890,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg401Pro,...e region on chromosome 20: The variant c.1202G>C (p.Arg401Pro) in GTPBP5 affects an evolutionarily n...,117,131,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Thr580Pro,"...h an MAF of 0.04%. A variant in DIDO1 (c.1738A>C; p.Thr580Pro), also affects a non-conserved residue...",117,310,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Ser96*,"A nonsense mutation, c.287C>G (p.Ser96*), was found in both patients in SLC17A9, ...",119,32,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Ser96*,"...ls of the family (II:5, III:10, IV:13). Moreover, p.Ser96*SLC17A9 was also present in heterozygous s...",119,445,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg50Ala,"...s carried the frameshift mutation c.141_142delTG (p.Arg50Alafs*103) in OSBPL2 (Figure 3B,C), a gene ...",121,155,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Arg50Ala,...80 residues) including 102 unrelated amino acids (p.Arg50Alafs*103) or in an unstable mRNA undergoin...,137,759,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Ser96*,"... candidate locus, a nonsense mutation in SLC17A9, p.Ser96*, is unlikely to cause hearing loss becaus...",141,119,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Ser96*,...ndividuals from our DFNA67 family who carried the p.Ser96*SLC17A9 mutation had any skin abnormalitie...,141,568,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Val50Met,...g fluorescent PCR primers designed to amplify the p.Val50Met in exon 2 of the TTR gene and is curren...,9,138,Orphanet_J_Rare_Dis_2015_Nov_2_10(Suppl_1)_I5.txt
p.Trp41Gly,"1		16,9	4	2	c.120delG heterozygous	p.Trp41GlyfsX17	Frameshift",35,36,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Pro97Ser,...9C>T heterozygous de novo (both parents wildtype)	p.Pro97Ser	Missense,36,66,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Trp155*,p.Trp155,38,2,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Glu321*,"4		31,8	2	0	c.961G>T heterozygous	p.Glu321",40,35,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gln363*,"7		17,1	4	1	c.1087C>T heterozygous	p.Gln363",44,36,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gly452Arg,"8		41,4	2	0	c.1351_1352insAG heterozygous	p.Gly452ArgfsX47	Frameshift",46,43,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Arg527Pro,...			c.1580_1581insCAGAAGGACCTGGGGGATG heterozygous	p.Arg527ProfsX100	Frameshift,47,58,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Tyr731*,"11	II/1	3,4	4	0	c.2192dupA heterozygous maternal	p.Tyr731",49,50,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Tyr731*,p.Tyr731,52,2,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Asp871Glu,p.Asp871GlufsX4	Frameshift,56,2,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Ser995Gly,"...	33,3			c.2983_2987delTCAAA heterozygous maternal	p.Ser995GlyfsX31	Frameshift",59,58,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Ser995Gly,"I/1	55,4			c.2983_2987delTCAAA heterozygous	p.Ser995GlyfsX31	Frameshift",60,46,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Leu1059Trp,"16		17,2	2	2	c.3174delT heterozygous	p.Leu1059TrpfsX12	Frameshift",61,38,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gln1248*,"17		16,6	2	1	c.3742C>T heterozygous	p.Gln1248",62,37,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gln1432*,"18		37,3	3	1	c.4294C>T heterozygous	p.Gln1432",64,37,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gly1526*,"21		18,0			c.4576G>T heterozygous	p.Gly1526",68,35,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Asp1574Thr,p.Asp1574ThrfsX39	Frameshift,71,2,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Ile1666Asp,"23	II/1	33,0	2	0	c.4994dupA heterozygous maternal	p.Ile1666AspfsX12	Frameshift",72,51,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Ile1666Asp,"I/1	65,8			c.4994dupA heterozygous	p.Ile1666AspfsX12	Frameshift",73,37,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gly1896Arg,"30,7	1	0	c.5686G>A heterozygous paternal	p.Gly1896Arg/Splice	Splice site mutation",76,43,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gly1896Arg,"28,9	3	1	c.5686G>A heterozygous paternal	p.Gly1896Arg/Splice	Splice site mutation",78,43,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gly1896Arg,"62,2	2	0	c.5686G>A mosaicism	p.Gly1896Arg/Splice	Splicesitemutation",80,31,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Cys2107*,"25		47,0	2	1	c.6321C>A heterozygous	p.Cys2107",81,37,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gln2300*,"26		17,8			c.6898C>T heterozygous	p.Gln2300",83,35,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Leu2335Arg,"28		2,5	4	2	c.6994_7003dupGCCCGCCGCC heterozygous	p.Leu2335ArgfsX8	Frameshift",86,51,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Ser2352*,"...38,2	2	3	c.7055_7070delCTTTTGCAGTCAGCCT mosaicism	p.Ser2352",87,59,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gly2359Cys,"30		44,0	2	2	c.7075_7077delinsT heterozygous	p.Gly2359CysfsX25	Frameshift",89,46,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Ser2372*,"31		21,7			c.7115C>G heterozygous	p.Ser2372",90,35,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gly2408Ala,p.Gly2408AlafsX45	Frameshift,96,2,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Arg2419*,"34		1,0	4	2	c.7255C>T heterozygous	p.Arg2419",97,36,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Phe2512Ser,"35		42,2	2	0	c.7533delC heterozygous	p.Phe2512SerfsX24	Frameshift",100,38,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Val2572Ile,...	4	1	c.7714G>A heterozygous; unclassified variant	p.Val2572Ile - VUS3	Missense/splice site mutation?...,101,58,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Tyr2614Leu,"37		8,2	1	8	c.7840dupT heterozygous	p.Tyr2614LeufsX136	Frameshift",102,37,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Pro97Ser,... patients. For one of these two missense variants p.Pro97Ser (c.289C>T) the absence in both parental...,149,271,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Glu82Val,...vicinity additional pathogenic missense mutations p.Glu82Val and p.Met102Val have been described pre...,149,585,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Met102Val,"...onal pathogenic missense mutations p.Glu82Val and p.Met102Val have been described previously [21, 22...",149,600,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Val2572Ile,.... For the other patient with the missense variant p.Val2572Ile no parental samples were available. I...,149,701,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Ser2352*,...on of a stop codon directly at the mutation site (p.Ser2352*; Fig. 2a). Based on the available chrom...,151,217,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Ser2352*,"...ryotype 46,XY, resulting in the nonsense mutation p.Ser2352*, novel stop codon boxed. Wildtype seque...",152,205,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Val455Met,... caused by a spontaneous GCK activating mutation (p.Val455Met) suffered from epilepsy and showed neu...,8,97,Orphanet_J_Rare_Dis_2015_Sep_24_10_120.txt
p.Val455Met,"...as referred to our hospital, and the heterozygous p.Val455Met mutation was found at GCK gene sequenc...",23,888,Orphanet_J_Rare_Dis_2015_Sep_24_10_120.txt
p.Arg329His,(NM_001605.2)	3	c.986G>A	p.Arg329His,141,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Thr994Ile,(NM_000052.6)	1	c.2981C>T	p.Thr994Ile,144,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Asn88Ser,(NM_032667.6)	2	c.263 A>G	p.Asn88Ser,147,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Leu90Ser,(NM_032667.6)	1	c.269 C>T	p.Leu90Ser,150,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg598Cys,(NM_001376.4)	2	c.1792 C>T	p.Arg598Cys,156,29,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Asp411Asn,(NM_000399.3)	1	c.1231G>A	p.Asp411Asn,159,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg373Cys,(NM_006329.3)	1	c.1117C>T	p.Arg373Cys,162,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Leu239Phe,(NM_018972.2)	1	c.715C>T	p.Leu239Phe,171,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Ile30Phe,(NM_000166.5)	1	c.88A>T	p.Ile30Phe,174,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg215Pro,(NM_000166.5)	1	c.641dup	p.Arg215Profs*28,177,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Glu208Lys,(NM_000166.5)	1	c.622G>A	p.Glu208Lys,180,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Ile71Thr,(NM_000166.5)	1	c.212T>C	p.Ile71Thr,183,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Met169Ile,(NM_001540.3)	1	c.505_506dup	p.Met169Ilefs*5,192,31,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg7Ser,(NM_006308.2)	1	c.21G>T	p.Arg7Ser,195,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Leu128Pro,(NM_022489.3)	1	c.383T>C	p.Leu128Pro,198,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Leu78Pro,(NM_022489.3)	1	c.233T>C	p.Leu78Pro,201,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Gly112Ser,(NM_001136472.1)	1	c.334G>A	p.Gly112Ser,207,30,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg94Trp,(NM_014874.3)	1	c.280 C>T	p.Arg94Trp,210,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Leu146Phe,(NM_014874.3)	1	c.436 C>T	p.Leu146Phe,213,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.His165Tyr,(NM_014874.3)	1	c.493 C>T	p.His165Tyr,216,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Met234Lys,(NM_014874.3)	1	c.701T>A	p.Met234Lys,219,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg280His,(NM_014874.3)	1	c.839G>A	p.Arg280His,222,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg294*,(NM_014874.3)	1	c.880C>T	p.Arg294*,225,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.His361Tyr,(NM_014874.3)	1	c.1081C>T	p.His361Tyr,228,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg364Trp,(NM_014874.3)	1	c.1090 C>T	p.Arg364Trp,231,29,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Asn525Ser,(NM_014874.3)	1	c.1574A>G	p.Asn525Ser,234,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg148*,(NM_001135242.1)	1	c.442 C>T	p.Arg148*,237,31,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Phe104Val,(NM_006158.4)	1	c.310T>G	p.Phe104Val,240,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Glu396Lys,(NM_006158.4)	1	c.1186G>A	p.Glu396Lys,243,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Cys42Arg,(NM_153322.1)	1	c.124T>C	p.Cys42Arg,246,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Val141Pro,(NM_153322.1)	1	c.421_436del	p.Val141Profs*9,249,31,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Gly382Arg,(NM_004863.3)	1	c.1144G>C	p.Gly382Arg,270,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg186Gln,(NM_021625.4)	1	c.557G>A	p.Arg186Gln,273,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg329His,Mutation p.Arg329His (c.986G>A) was found in three families...,290,10,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg598Cys,A mutation p.Arg598Cys (c.1792 C>T) in DYNC1H1 gene was found...,297,12,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg148*,A homozygous mutation p.Arg148* in the NDRG1 gene was surprisingly detec...,303,23,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg113*,...nt is also a heterozygous carrier of the mutation p.Arg113* in the REEP1 gene (NM_022912.2). This mu...,305,90,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Pro168Leu,(NM_001605.2)	c.503 C>T	p.Pro168Leu	SIFT:,320,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Gly514Ser,(NM_001003800.1)	c.1540G>A	p.Gly514Ser	SIFT:,326,29,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Ala163Thr,(NM_004082.4)	c.487G>A	p.Ala163Thr	SIFT:,332,25,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg297Leu,(NM_001005360)	c.890G>T	p.Arg297Leu	SIFT:,338,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg266Trp,(NM_001005360)	c.796C>T	p.Arg266Trp	SIFT:,344,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg42Gln,(NM_021629.3)	c.125G>A	p.Arg42Gln	SIFT:,350,25,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Met1064Val,(NM_002224.3)	c.3190A>G	p.Met1064Val	SIFT:,356,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Ser433Leu,(NM_138361.5)	c.1298C>T	p.Ser433Leu	SIFT:,361,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Asn73Ser,(NM_001142386.2)	c.218A>G	p.Asn73Ser	SIFT:,366,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Ile1942Thr,(NM_015046.5)	c.5825T>C	p.Ile1942Thr	SIFT:,371,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Cys438Leu,(NM_004863.3)	c.1313del	p.Cys438Leu fs*5	frameshift		No,377,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Glu208Lys,...representative example is a patient with mutation p.Glu208Lys in the GJB1 gene. This patient was pre...,424,121,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Gly694Glu,"...s study c.1822_1824del; p.Asp608del, c.2081G > A; p.Gly694Glu and c.989_991delCAA; p.Thr330del are i...",26,230,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.Gly694Glu,...A5: c.989_991delCAA; p.Thr330del and c.2081G > A; p.Gly694Glu was identified based on their compound...,33,979,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.Gly694Glu,...r was heterozygous for the p.Thr330 deletion. The p.Gly694Glu variant was not present in the mother;...,33,1125,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.Gly608Glu,...loured according to their atom type. p.Asp608 and p.Gly608Glu are located at the subunit interface a...,37,873,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.Gly694Glu,...to a lesser extent compared to the p.Asp608del or p.Gly694Glu variants. The p.Thr330del variant was ...,43,364,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.Gly694Glu,...wo of the variants reported here (p.Asp608del and p.Gly694Glu) are located at the subunit interface ...,49,400,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.R150C,...cci syndrome) is not caused by the PTHR1 mutation p.R150C Hum Mutat 2004 24 466 73 15523647,55,141,Orthop_Rev_(Pavia)_2012_May_29_4(2)_e16.txt
p.Gly230Val,... Italian families. All had the ELOVL5 c.689G > T (p.Gly230Val) missense mutation,10,142,Parkinsonism_Relat_Disord_2016_Jul_28_80-86.txt
p.Gly230Val,...m twenty-one SCA38 cases carrying the c.689G > T (p.Gly230Val) mutation in ELOVL5. All patients belo...,51,110,Parkinsonism_Relat_Disord_2016_Jul_28_80-86.txt
p.Gly230Val,We screened the c.689G > T (p.Gly230Val) mutation in exon 7 of ELOVL5 by Sange...,58,29,Parkinsonism_Relat_Disord_2016_Jul_28_80-86.txt
p.Gly230Val,...inical data from 21 patients with the c.689G > T (p.Gly230Val) mutation in the ELOVL5 gene from thre...,67,66,Parkinsonism_Relat_Disord_2016_Jul_28_80-86.txt
p.Gly230Val,...er 21 cases. All have the same ELOVL5 c.689G > T (p.Gly230Val) mutation: two of the families were re...,98,336,Parkinsonism_Relat_Disord_2016_Jul_28_80-86.txt
p.C78W,...date variants that remained for consideration are p.C78W (TNFRSF9; CD137; 4-1BB) and p.L227X (TNFAIP...,15,536,Pediatr_Rheumatol_Online_J_2013_Nov_8_11(Suppl_1)_A184.txt
p.L227X,...sideration are p.C78W (TNFRSF9; CD137; 4-1BB) and p.L227X (TNFAIP3;A20). Haplotype analysis showed t...,15,571,Pediatr_Rheumatol_Online_J_2013_Nov_8_11(Suppl_1)_A184.txt
p.C78W,...27X (TNFAIP3;A20). Haplotype analysis showed that p.C78W occurred de novo on the haplotype inherited...,15,625,Pediatr_Rheumatol_Online_J_2013_Nov_8_11(Suppl_1)_A184.txt
p.L227X,...the haplotype inherited from the grandmother. The p.L227X mutation-associated haplotype was found on...,15,702,Pediatr_Rheumatol_Online_J_2013_Nov_8_11(Suppl_1)_A184.txt
p.L149R,"..., leading to the missense amino acid substitution p.L149R. The presence of this variant was validate...",15,312,Pediatr_Rheumatol_Online_J_2015_Sep_28_13(Suppl_1)_P57.txt
p.Cys130Arg,"...e‐nucleotide polymorphisms, NM_000041.2:c.388T>C (p.Cys130Arg; rs429358) and c.526C>T (p.Arg176Cys; ...",170,747,Physiol_Rep_2016_Apr_25_4(8)_e12733.txt
p.Arg176Cys,....2:c.388T>C (p.Cys130Arg; rs429358) and c.526C>T (p.Arg176Cys; rs7414) as follows: at nucleotides 38...,170,784,Physiol_Rep_2016_Apr_25_4(8)_e12733.txt
p.V1316A,...iophysical Basis Underlying Gating Changes in the p.V1316A Mutant Nav1.7 Channel and the Molecular P...,3,1950,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...ort a case of a severe phenotype of IEM caused by p.V1316A mutation in the Nav1.7 channel. Mechanist...,35,671,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...f recovery from inactivation. In this regard, the p.V1316A mutation makes hyperpolarization shift in...",35,1273,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...eration, the most important changes caused by the p.V1316A mutation are both acceleration of the tra...",35,1528,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,The gain-of-function mutation (p.V1316A) of the Nav1.7 channel causes inherited e...,40,32,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...at results in neuropathic pain. We found that the p.V1316A mutation alters the basic gating properti...,40,238,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...e genesis of resurgent currents. We show that the p.V1316A mutation chiefly accelerates the I to O t...,40,708,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...3020) [6–13]. Recently, two sporadic cases of the p.V1316A (located in the DIII/S4–5 linker) mutatio...",46,725,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.I234T,"...cated in the S4–S5 linker in each domain, such as p.I234T, p.I848T, p.G856D, p.L858F, p.L858H, p.P13...",48,889,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.I848T,"...the S4–S5 linker in each domain, such as p.I234T, p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and ...",48,898,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.G856D,"... linker in each domain, such as p.I234T, p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A ...",48,907,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.L858F,"...n each domain, such as p.I234T, p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations...",48,916,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.L858H,"...main, such as p.I234T, p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations [11]. Ac...",48,925,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.P1308L,"...h as p.I234T, p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations [11]. Accordingly...",48,934,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations [11]. Accordingly, these mutati...",48,948,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.A1632E,"... D3–D4 linker), M1627K (in S4–S5 linker /D4), and p.A1632E (in S4–S5 linker/D4) mutant channels show...",48,1317,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...stigated the changes in molecular behavior of the p.V1316A mutant channel which causes the severe cl...,48,2012,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...istent only in the presence of Navβ4 peptide. The p.V1316A mutation markedly increases both the sust...,48,2377,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...15]. Genetic analysis showed a missense mutation (p.V1316A) of human Nav1.7 (SCN9A) gene. The excruc...,52,203,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...vestigate the molecular functional changes of the p.V1316A mutant Nav1.7 channel, we first character...",58,56,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,Larger Sustained Na+ Currents in the p.V1316A Mutant than in the WT Channe,66,38,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,Fig 4 compares the basic gating behaviors of the p.V1316A mutant with the WT Nav1.7 channel. The ac...,67,50,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...hannel. The activation and inactivation curves of p.V1316A mutant channel are negatively and positiv...,67,136,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...he mutation (Fig 4B). These results indicate that p.V1316A mutant channel can be more activated but ...,67,391,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...tently, the increase in sustained currents in the p.V1316A mutant channel could be demonstrated with...",67,738,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...the open state) or both. Fig 4E shows that in the p.V1316A mutant channel, the decay of transient cu...",67,1228,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...oscopic inactivation rates are ~50% slowed by the p.V1316A mutation. In other words, the Navβ4 pepti...",67,1518,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...an accelerates decay of transient currents in the p.V1316A mutant channel, and the p.V1316A mutation...",67,1636,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"... currents in the p.V1316A mutant channel, and the p.V1316A mutation slows the macroscopic inactivati...",67,1669,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... substantiate that both the Navβ4 peptide and the p.V1316A mutation are gating modifiers of the Nav1...,67,1998,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...n are gating modifiers of the Nav1.7 channel, and p.V1316A mutation may at least decrease the inacti...",67,2064,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...g 4 The activation and inactivation curves of the p.V1316A mutant channel in the presence of the Nav...,69,86,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...10 mV pulse following the prepulse) curves of the p.V1316A mutant channel in the presence of the Nav...,70,212,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"... significant difference versus WT channel) in the p.V1316A mutant channel, respectively. Single Bolt...",70,819,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...gle Boltzmann fits to the mean values are for the p.V1316A mutant channel: Vh and k are ~–30.7 mV an...,70,911,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...same protocols described in part A for the WT and p.V1316A mutant channels (n = 15 for the WT channe...,70,1303,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...nnels (n = 15 for the WT channels; n = 12 for the p.V1316A mutant channels). The ratio between the s...,70,1372,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...in the same sweep) is significantly larger in the p.V1316A mutant channel with depolarization potent...,70,1510,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...ctivation) phase of transient Na+ currents in the p.V1316A mutant channel are normalized to the aver...,70,1751,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...zation voltage is significantly lengthened by the p.V1316A mutation only in the presence but not in ...,70,2160,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...olarization of +40 mV but not 0 mV in both WT and p.V1316A mutant channels, again demonstrating the ...",73,422,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...t currents indeed are significantly larger in the p.V1316A mutant channel than in the WT channel in ...,73,871,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...hese results suggest that DIII/S4–5 linker, where p.V1316A mutation is located, may play a critical ...",73,1007,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...irections. These altered gating properties by the p.V1316A mutation could be in turn responsible for...,73,1270,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...61.g005Fig 5 Larger resurgent Na+ currents in the p.V1316A mutant than that in the WT channels,75,77,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...e of the Navβ4 peptide. (B) Sample sweeps for the p.V1316A mutant channel in the presence of 0.1 mM ...,76,281,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...om experiments described in part A for the WT and p.V1316A mutant channels (each n = 10). The ratio ...,76,473,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...in the same sweep) is significantly larger in the p.V1316A mutant than WT channels at repolarization...,76,623,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...ion curve of resurgent Na+ currents in the WT and p.V1316A mutant channels,78,101,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...activation curve of resurgent Na+ currents in the p.V1316A mutant channel is obtained with the same ...,79,1215,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...n curves of transient Na+ currents for the WT and p.V1316A mutant channels and the activation curves...,79,1384,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...for comparison. The resurgent activation curve of p.V1316A mutant channels for each cells are also o...,79,1608,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...the activation curve of transient currents in the p.V1316A mutant channels) and 21.70±1.14 (n = 10; ...,79,1831,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...the activation curve of transient currents in the p.V1316A mutant channels), respectively. Single Bo...",79,1947,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... Single Boltzmann fits to the mean values are for p.V1316A mutant channel: Vh = ~59.5 mV and k = ~21...,79,2037,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...n curves of resurgent Na+ currents in both WT and p.V1316A mutant channels are markedly shifted to t...,79,2165,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...the activation curve of resurgent currents in the p.V1316A mutant channel is very similar to or even...,82,1343,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...e of both sustained and resurgent currents by the p.V1316A mutation (Figs 4D and 5C), this finding i...",82,1530,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...d Decay Kinetics of the Resurgent Currents in the p.V1316A Mutant Channe,84,83,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... the kinetics of resurgent currents caused by the p.V1316A mutation (Fig 7A and 7B). The kinetics of...,85,112,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...resurgent currents is significantly longer in the p.V1316A mutant than in the WT channel (Fig 7B and...,85,360,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...increased sustained and resurgent currents in the p.V1316A mutant channel, which may be chiefly and ...",85,500,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ated by membrane hyperpolarization in both WT and p.V1316A mutant channels. Interestingly, the kinet...",85,1042,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...currents (<~1 ms in the WT channel, <~2 ms in the p.V1316A mutant channel, Fig 7C), this finding is ...",85,1348,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...or the resurgent currents remain unchanged by the p.V1316A mutation (see Discussion),85,1733,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...rents by membrane hyperpolarization in the WT and p.V1316A mutant channels,87,141,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...~+160 mV for ~10 ms in 20 mV increment for WT and p.V1316A mutant channels. Note that the inverse de...,88,259,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...e decay time constants are very similar in WT and p.V1316A mutant channels. (B) Cumulative results w...,88,355,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...time to peak of the resurgent Na+ currents in the p.V1316A mutant channel is always slower than that...,88,538,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... the voltage of the resurgent pulse in the WT and p.V1316A mutant channels (each n = 10). Note trend...,88,933,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...gent Na+ currents peak is evidently larger in the p.V1316A mutant than that of the WT channels with ...,88,1088,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...voltage in semi-logarithmic scales for the WT and p.V1316A mutant channels. The lines are linear reg...,88,1405,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...annel and 1/tau(V) = 0.04×exp(–0.97V/25) ms-1 for p.V1316A mutant channel, respectively, where V is ...",88,1576,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...resurgent currents are very similar in the WT and p.V1316A mutant channels. (E) The cells were held ...,88,1762,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...for ~20 ms (the deactivation pulse) in the WT and p.V1316A mutant channels. The tail currents show f...,88,2002,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...r different deactivating potentials in the WT and p.V1316A mutant channels. The inverses of time con...,88,2258,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...nst voltage in semi-logarithmic scales for WT and p.V1316A mutant channels (n = 10). The lines are l...,88,2416,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...nnel, and 1/tau(V) = 1.25×exp(–0.71V/25) ms-1 for p.V1316A mutant channel, respectively, where V is ...",88,2599,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... the tail currents are very similar in the WT and p.V1316A mutant channels. Individual data is shown...,88,2796,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...ning of the depolarization prepulse in the WT and p.V1316A mutant channels (Fig 8A and 8B). These fi...,91,344,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...epolarization prepulse 3 ms in length, the WT and p.V1316A mutant channels have not yet reached a st...",91,471,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...surgent currents are quite the same in the WT and p.V1316A mutant channels, although the absolute sp...",91,993,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...bsolute speed of decay is ~2–3-fold slower in the p.V1316A mutant than in the WT channel (Fig 8C and...,91,1083,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...er with lengthening of the prepulse in the WT and p.V1316A mutant channels. Sample resurgent Na+ cur...,94,286,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...nd 0.31 for +60 mV prepulse, respectively, in the p.V1316A mutant channel (each n = 7). (C) The inve...",94,1083,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...l, and 1/tau(V) = 0.07×exp(–0.8V/25) ms–1 for the p.V1316A mutant channel, respectively, where V is ...",94,1384,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ntials (e.g., +20, +40, and +60 mV) in the WT and p.V1316A mutant channels. Note that there is no si...",94,1622,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...e is no significant difference between the WT and p.V1316A mutant channels at each voltage (n = 7; N...,94,1712,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...addition of Navβ4 peptide (Fig 2B and 2C). In the p.V1316A mutant channel, the addition of Navβ4 pep...",98,622,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...and 7F). In addition, the major findings with the p.V1316A mutation, such as the concomitant increas...",98,2308,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...II and IV) of the homology model of WT Nav1.7 and p.V1316A mutant channels are shown in the ribbon p...,101,3777,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ue distances (from side chain tip to tip) between p.V1316A and L1610, and p.V1316A and R1611 are ~11...",101,4310,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...chain tip to tip) between p.V1316A and L1610, and p.V1316A and R1611 are ~11.3 Å, ~8.1 Å, respective...",101,4334,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...d R1611 are ~11.3 Å, ~8.1 Å, respectively, in the p.V1316A mutant channel. (F) A summary plot of the...",101,4395,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...(tip to tip) distances between residues V1316 (or p.V1316A) and L1610, R1611, V1722, and G1723 in th...",101,4505,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...evidently increased distances in all cases in the p.V1316A mutant than in the WT channels (see also ...,101,4635,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...mulations of resurgent Na+ currents in the WT and p.V1316A mutant channels,103,107,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...he gating scheme and simulated currents of WT and p.V1316A mutant channels with the same stimulation...,104,56,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...T channels, the main gating changes caused by the p.V1316A mutation include larger rate constants fo...",104,706,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...nd 0.54 for +60 mV prepulse, respectively, in the p.V1316A mutant channel. (E) The inverses of time ...",104,1605,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"..., and 1/tau(V) = 0.17×exp(–1.03V/25) ms–1 for the p.V1316A mutant channel, respectively, where V is ...",104,1894,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...e 1 Kinetic parameters for the wild type (WT) and p.V1316A mutant Nav1.7 channels with and without N...,106,88,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...thout Navβ4 peptide	WT channel with Navβ4 peptide	p.V1316A mutant channel with Navβ4 peptide,107,65,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...se in Sustained and Resurgent Na+ Currents by the p.V1316A Mutatio,128,60,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,The p.V1316A mutant Nav1.7 channel is characterized by...,129,5,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...n effective promotion of repetitive discharges by p.V1316A mutation in different firing patterns (e....,129,457,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...upling between activation and inactivation by the p.V1316A mutation. These findings would provide im...,129,1030,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...omology modeling of Nav1.7 channel shows that the p.V1316A mutation may increase the inter-residue d...,129,2334,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...rease the inter-residue distances between residue p.V1316A of the S4–S5 linker/D3 and the nearby res...,129,2409,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...y that the conformational changes associated with p.V1316A mutation may well involve the pivotal poi...,129,2748,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"... [40–42]. In this study, we demonstrated that the p.V1316A mutation, which causes very prominent and...",132,671,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...r fluorescent microscope (Nikon, Inc. Japan). The p.V1316A mutation was made using Quikchange site-d...",139,263,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...ls were transfected with either wild-type (WT) or p.V1316A mutant cDNA constructs of the human Nav1....,142,638,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...tch recordings from CHO–K1 cells expressing WT or p.V1316A mutant channels were conducted at room te...,145,64,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"... in presence or absence of the Navβ4 peptide, and p.V1316A mutant channels in presence of Navβ4 pept...",154,285,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...vation curve of resurgent currents of both WT and p.V1316A mutant channels. The ionic currents are a...,154,546,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...een the sustained and peak currents in the WT and p.V1316A mutant channels are obtained with the sam...,166,70,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...gs, simulated sustained currents are increased in p.V1316A mutant channels. (B) The kinetics of the ...",166,239,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...etics of the resurgent Na+ currents in the WT and p.V1316A mutant channels are obtained with same pu...,166,326,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...nnel, and 1/tau(V) = 0.003×exp(–2.0V/25) ms-1 for p.V1316A mutant channel, respectively, where V is ...",166,548,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...nt sodium currents are similar between the WT and p.V1316A mutant channels. These findings are compa...,166,732,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...(D) The activation and inactivation curves in the p.V1316A mutant channels are simulated with the sa...,166,1617,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ack symbols and line), and ~62.1 mV and ~17.2 for p.V1316A mutant resurgent currents (red symbols an...",166,2434,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,S2 Fig The homology modeling for the WT and p.V1316A mutant Nav1.7 channels based on the X-ray...,172,46,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...II and IV) of the homology model of WT Nav1.7 and p.V1316A mutant channels are in the ribbon present...,173,87,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ue distances (from side chain tip to tip) between p.V1316A and V1722, and p.V1316A and G1723 are ~6....",173,609,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...chain tip to tip) between p.V1316A and V1722, and p.V1316A and G1723 are ~6.4 Å, and ~6.9 Å, respect...",173,633,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...G1723 are ~6.4 Å, and ~6.9 Å, respectively in the p.V1316A mutant channel. Individual data is shown ...",173,696,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.Arg760*,"...ing a truncated protein at position arginine 760 (p.Arg760*) (Figure S3). However, no mutational cha...",157,554,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.R760*,...n (10–20% WT levels) in CV1720 cells suggest that p.R760* ATRIP is unstable (given that the mRNA lev...,173,159,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.R760*,...l of this allele is normal). To substantiate that p.R760* expression impairs the ATR–dependent respo...,173,260,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.R760*,... defect of CV1720 cells. We also examined whether p.R760* might exert a dominant negative impact (si...,173,450,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.R760*,... affect G2/M checkpoint arrest demonstrating that p.R760* ATRIP does not exert a dominant negative i...,173,1611,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.R760*,"...t negative impact. Collectively, we conclude that p.R760* ATRIP impacts upon ATRIP function",173,1699,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Arg760*,....g003Figure 3 WT ATRIP cDNA but not cDNA encoding p.Arg760* ATRIP complements the G2/M checkpoint de...,175,79,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Arg760*,"...s the G2/M checkpoint defect in CV1720 cells, and p.Arg760*ATRIP impairs ATR–ATRIP protein interacti...",175,155,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Arg760*,"... (lane2), or R760* ATRIP cDNA (lane3) (generating p.Arg760* ATRIP protein) together with ATR cDNA. T...",176,999,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.R760*,"...0 lies close to these regions. To examine whether p.R760* ATRIP can interact with ATR, HA-tagged WT ...",180,171,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Met1159Ile,"...). This change causes an amino acid substitution, p.Met1159Ile, which lies within a conserved UME (N...",184,916,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Val2300Gly,"... second ATR mutation identified was c.6897+464C>G;p.Val2300Gly fs75*, which, surprisingly, was also ...",189,54,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Arg760*,"...f the ATRIP–c.2278C (normal) and ATRIP–c.2278C>T (p.Arg760*) alleles in LBLs from patient CV1720, an...",234,70,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.R760*,"...ing a truncated protein at position arginine 760 (p.R760*). WT sequence shown in blue, the mutation ...",263,391,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Met1159Ile,"...both patients causing an amino acid substitution, p.Met1159Ile, which lies within a conserved UME (N...",275,261,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Val2300Gly,...insertion causes a frameshift and a stop codon at p.Val2300Glyfs*75. D) Diagram showing the likely o...,275,709,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Ser1012Pro,"...und to carry a de novo USP9X mutation (c.3034T>C, p.Ser1012Pro) at a highly conserved residue (GERP ...",131,286,PLoS_Genet_2015_Mar_12_11(3)_e1005022.txt
p.Gly1890Glu,"...es unavailable) harbored variant (T2587c.5669G>A, p.Gly1890Glu) a rare missense variant. Both mutati...",131,511,PLoS_Genet_2015_Mar_12_11(3)_e1005022.txt
p.G28Qfs,...3 allele includes a frameshift in the 28th codon (p.G28QfsX83) and a premature stop in the 110th cod...,40,596,PLoS_Genet_2016_Jun_13_12(6)_e1006099.txt
p.R216H,...d haplotypes observed. The non-synonymous variant p.R216H was associated with the occurrence of schi...,11,478,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.Gly204Ser,... syndrome [32]. Two affected individuals with the p.Gly204Ser amino acid substitution in CRD of COLE...,27,920,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,"...276C>T), and the non-synonymous (ns) substitution p.R216H in exon8 were genotyped in the entire stud...",47,282,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...he promoter region and the non-synonymous variant p.R216H in exon8 were chosen for further genotypin...,57,530,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,"...C>G, −276C>T, and the non-synonymous substitution p.R216H in exon8 were genotyped. LDs of the five C...",60,120,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,The non-synonymous COLEC11 variant rs7567833G/A (p.R216H) in exon8 was observed more frequently amo...,65,50,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...t001Table 1 Distribution of COLEC11—rs7567833G/A (p.R216H) genotypes and allele(s),67,80,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,Exon8 rs7567833 G/A (p.R216H)	GG	114 (68.2)	81 (68)	32 (47.8)	113 (60.7...,75,22,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,"..., 95%CI = 1.15–2.70, Pcorr = 0.007). COLEC11*TCCA-p.R216H, was observed more frequently among SELN c...",99,508,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,The minor allele of exon8 variant rs7567833A (p.R216H) was significantly associated with increas...,140,47,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...s (median values) with investigated rs7567833G/A (p.R216H) variant,142,123,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...study suggests that a non-synonymous substitution p.R216H in the exon8 of COLEC11 contributes to sus...,154,315,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...tic models for the contribution of the respective p.R216H genotypes. It has been hypothesized that t...,154,603,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...216H genotypes. It has been hypothesized that the p.R216H substitution increases the alpha helical p...,154,656,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...tability and protein folding properties [41]. The p.R216H substitution is located in the carbohydrat...,154,799,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,"...n addition, this particular variant rs7567833G/A (p.R216H) was reported to be under selective pressu...",154,1015,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...ficantly elevated [44]. The COLEC11 rs7567833G/A (p.R216H) variant was observed to correlate with in...,158,660,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,"...ed by S. haematobium. Furthermore, the variant in p.R216H in exon8 of the COLEC11 gene is a host gen...",162,194,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.Phe31Ile,...sense substitutions in STK15 and MMP3 (rs2273535 (p.Phe31Ile) and rs679620 (p.K45E) respectively) we...,15,1777,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.K45E,...15 and MMP3 (rs2273535 (p.Phe31Ile) and rs679620 (p.K45E) respectively) were also analysed,15,1803,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.K45E,The rs679620 A MMP3 p.K45E polymorphism in the matrix metalloproteinas...,93,21,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.Phe31Ile,"...sformation [46]. Previously the STK15 (rs2273535, p.Phe31Ile) variant was found to alter the potency...",95,1070,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.Phe31Ile,"... not detect a significant association between the p.Phe31Ile variant and RCC, the patient and contro...",95,1387,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.Phe31Ile,...ing evidence for an association between the STK15 p.Phe31Ile variant and RCC was less secure a lower...,97,459,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.A145S,"... have been identified, the benign and polymorphic p.A145S variant (rs29281) and the p.I304N mutation...",81,100,PLoS_One_2010_Mar_5_5(3)_e9476.txt
p.I304N,...and polymorphic p.A145S variant (rs29281) and the p.I304N mutation previously detected in a severely...,81,134,PLoS_One_2010_Mar_5_5(3)_e9476.txt
p.T348M,3 p.T348M allele specific primer,97,3,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.S52N,"MVK (N = 19)	p.S52N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S...",110,16,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.S135L,"MVK (N = 19)	p.S52N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),c.632−18A>G ...",110,47,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.S135S,"... = 19)	p.S52N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),c.632−18A>G (1)(2), c.76...",110,59,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.D170D,"...N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),c.632−18A>G (1)(2), c.769-7_769-6dup...",110,71,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.G309S,"... (1)(2), c.769-7_769-6dupT(1)*,c.885+24G>A(1)(2), p.G309S(1), p.S329N(1), p.V377I(1)(2), p.R388X(1),...",110,146,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.S329N,"...69-7_769-6dupT(1)*,c.885+24G>A(1)(2), p.G309S(1), p.S329N(1), p.V377I(1)(2), p.R388X(1), p.E296GfsX1...",110,158,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.V377I,"...pT(1)*,c.885+24G>A(1)(2), p.G309S(1), p.S329N(1), p.V377I(1)(2), p.R388X(1), p.E296GfsX14(1)		MVK (N...",110,170,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.R388X,"...G>A(1)(2), p.G309S(1), p.S329N(1), p.V377I(1)(2), p.R388X(1), p.E296GfsX14(1)		MVK (N = 1)	Chr12q24....",110,185,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.E296Gfs,"....G309S(1), p.S329N(1), p.V377I(1)(2), p.R388X(1), p.E296GfsX14(1)		MVK (N = 1)	Chr12q24.1del		MVK (N...",110,197,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.Y141Y,"NLRP3 (N = 23)	c.278−45T>C(1), p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T219T(1), p...",111,34,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.R168Q,"NLRP3 (N = 23)	c.278−45T>C(1), p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*...",111,47,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.V198M,"...(N = 23)	c.278−45T>C(1), p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)...",111,59,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T219T,"...78−45T>C(1), p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L...",111,71,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.A242A,"... p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A4...",111,83,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.P340P,"...R168Q(3), p.V198M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(...",111,99,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.L344L,"...8M(1), p.T219T(1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(1), p.T587I(1),...",111,114,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.A439P,"...1), p.A242A(1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(1), p.T587I(1), p.Q703K(1)(2),...",111,129,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.H463H,"...1)(2)*, p.P340P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),...",111,141,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T587I,"...40P(1)(3), p.L344L(1)(3), p.A439P(1), p.H463H(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T...",111,153,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.Q703K,"....L344L(1)(3), p.A439P(1), p.H463H(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M...",111,165,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.Y859C,"....A439P(1), p.H463H(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3)...",111,180,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,"...7I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1)(2), p.T436P(3)	...",111,208,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.L411L,"...3K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1)(2), p.T436P(3)		NLRP3 (N = ...",111,220,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.S434S,"...Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1)(2), p.T436P(3)		NLRP3 (N = 1)	p.T348M a...",111,232,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T436P,"...+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1)(2), p.T436P(3)		NLRP3 (N = 1)	p.T348M artificial delet...",111,247,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,"...411L(3), p.S434S(1)(2), p.T436P(3)		NLRP3 (N = 1)	p.T348M artificial deletion (allele specific prime...",111,273,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.C30R,"TNFRSF1A (N = 7)	p.C30R(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54...",112,20,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.C30F,"TNFRSF1A (N = 7)	p.C30R(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54E(1), p.P46...",112,31,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.C73W,"TNFRSF1A (N = 7)	p.C30R(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54E(1), p.P46L(1), p.R92...",112,42,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.E54E,"...= 7)	p.C30R(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54E(1), p.P46L(1), p.R92Q(1)		ITGB5 (N = 1)	Chr...",112,65,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.P46L,"...(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54E(1), p.P46L(1), p.R92Q(1)		ITGB5 (N = 1)	Chr3q21.2dup		...",112,76,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.R92Q,"...(1), p.C73W(1), p.H69fs(1), p.E54E(1), p.P46L(1), p.R92Q(1)		ITGB5 (N = 1)	Chr3q21.2dup",112,87,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.A242A,"...nly 3 polymorphisms (c.769-7_769-6dupT in MVK and p.A242A, p.Y141Y in NLRP3) went undetected (not sh...",144,376,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.Y141Y,"...ymorphisms (c.769-7_769-6dupT in MVK and p.A242A, p.Y141Y in NLRP3) went undetected (not shown)",144,385,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,...ng for mental retardation); 2) One patient with a p.T348M (c.1043C>T) mutation in NLRP3 in whom we p...,146,335,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,"...ontrols, 10 patients, and the artificial positive p.T348M patient and (iii) exons 2–4 of the TNFRSF1...",149,226,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,"...I]+[G226S], and p.[T237S]+[T237S]; one with CAPS, p.T348M; and two with TRAPS, p.C70R and p.R92Q. Re...",152,414,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.C70R,"...37S]; one with CAPS, p.T348M; and two with TRAPS, p.C70R and p.R92Q. Representative HRM difference p...",152,443,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.R92Q,"...ith CAPS, p.T348M; and two with TRAPS, p.C70R and p.R92Q. Representative HRM difference plots are sh...",152,454,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.Arg554X,"...n recorded in CAPS. However, a nonsense mutation (p.Arg554X) was identified in NLRP3 putatively resu...",164,1045,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.Q2980X,p.Q2980X	p.S1142X	p.S1142X	p.K722X+D3771fsX3790,28,2,PLoS_One_2011_Apr_26_6(4)_e19081.txt
p.S1142X,p.Q2980X	p.S1142X	p.S1142X	p.K722X+D3771fsX3790,28,11,PLoS_One_2011_Apr_26_6(4)_e19081.txt
p.S1142X,p.Q2980X	p.S1142X	p.S1142X	p.K722X+D3771fsX3790,28,20,PLoS_One_2011_Apr_26_6(4)_e19081.txt
p.K722X,p.Q2980X	p.S1142X	p.S1142X	p.K722X+D3771fsX3790,28,29,PLoS_One_2011_Apr_26_6(4)_e19081.txt
p.Arg274Trp,...ather (P1) [6]. The same STAT1 variant (c.820C>T; p.Arg274Trp) was detected in all three individuals...,20,221,PLoS_One_2011_Dec_14_6(12)_e29248.txt
p.G1069R,A. Mutation c.3293A>G (p.G1069R) in homozygous state in our proband and i...,24,24,PLoS_One_2011_Jun_9_6(6)_e20854.txt
p.Q1069R,"...bols, unaffected individuals; Mut/Mut, homozygous p.Q1069R mutation; Mut/WT, heterozygous Q1069R mut...",24,387,PLoS_One_2011_Jun_9_6(6)_e20854.txt
p.R2065S,"... of the protein containing the missense mutation, p.R2065S, was identified as highly conserved in va...",56,505,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.G308Afs,1	Typical	c.921–922delAG	p.G308AfsX9	Frameshift			(20),60,26,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.L2444X,2	Atypical	c.7331T>A	p.L2444X	Nonsense			Novel,61,22,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.R2065S,3	Atypical	c.6193C>A	p.R2065S	Missense			Novel,62,22,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.T2278Hfs,4	Atypical	c.6832insC	p.T2278HfsX3	Frameshift			Novel,63,23,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.Q74Hfs,6	Typical	c.222delG	p.Q74HfsX9	Frameshift			Novel,65,21,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.Q489X,9	Atypical	c.1465C>T	p.Q489X	Nonsense			(20),68,22,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.R2065S,"...he region containing the novel missense mutation, p.R2065S (indicated as an asterisk), is highly con...",164,263,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.Thr7Ile,"...non-synonymous amino acid change in cytochrome b (p.Thr7Ile). On the other hand, the m. 10398G allel...",138,431,PLoS_One_2012_Aug_28_7(8)_e44128.txt
p.Thr114Ile,"...mino acid change in NADH dehydrogenase subunit 3 (p.Thr114Ile) which is observed in haplogroups K, J...",138,735,PLoS_One_2012_Aug_28_7(8)_e44128.txt
p.Tyr304His,...mino acid change in NADH dehydrogenase subunit 1 (p.Tyr304His),138,923,PLoS_One_2012_Aug_28_7(8)_e44128.txt
p.Ser86Asn,...haplogroup N9b specific polymorphisms m.11016G>A (p.Ser86Asn in NADH dehydrogenase 4) and m.13183A>G...,147,1288,PLoS_One_2012_Aug_28_7(8)_e44128.txt
p.Ile283Val,...Ser86Asn in NADH dehydrogenase 4) and m.13183A>G (p.Ile283Val in NADH dehydrogenase 5) confer resist...,147,1340,PLoS_One_2012_Aug_28_7(8)_e44128.txt
p.Ser252Trp,"...o different mutations of FGFR2 (c.755C>G encoding p.Ser252Trp and c.758C>G encoding p.Pro253Arg, bot...",26,416,PLoS_One_2012_Aug_6_7(8)_e42382.txt
p.Pro253Arg,"...755C>G encoding p.Ser252Trp and c.758C>G encoding p.Pro253Arg, both causing Apert syndrome) and a mu...",26,450,PLoS_One_2012_Aug_6_7(8)_e42382.txt
p.Met918Thr,"...drome) and a mutation in RET (c.2943T>C, encoding p.Met918Thr and causing multiple endocrine neoplas...",26,535,PLoS_One_2012_Aug_6_7(8)_e42382.txt
p.Gly380Arg,"...FGFR3 c.1138G>A achondroplasia mutation (encoding p.Gly380Arg) obtained broadly comparable results, ...",26,1690,PLoS_One_2012_Aug_6_7(8)_e42382.txt
p.E542K,(a) The heterozygous p.E542K (c.G1624A) PIK3CA hotspot mutation was det...,109,22,PLoS_One_2012_Feb_17_7(2)_e31255.txt
p.E545Q,...ildtype and mutated alleles. (b) The heterozygous p.E545Q (c.G1633C) PIK3CA hotspot mutation was det...,109,732,PLoS_One_2012_Feb_17_7(2)_e31255.txt
p.Val63Glu,... 3D structure studies of its amino acid sequence (p.Val63Glufs*78) predicted the removal of the thre...,40,818,PLoS_One_2012_Jan_3_7(1)_e29205.txt
p.G299R,...sense mutations for our experimental design: DYSF p.G299R and DYSF p.L1341P. The consequences of the...,18,83,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...or our experimental design: DYSF p.G299R and DYSF p.L1341P. The consequences of these mutations at t...,18,100,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...rlin cDNA or missense-mutated dysferlin cDNA DYSF p.G299R or p.L1341P. Transfected cells were treate...,21,123,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...r missense-mutated dysferlin cDNA DYSF p.G299R or p.L1341P. Transfected cells were treated with TAT-...,21,134,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...using an anti-dysferlin ab. (C) merge. (D–F) DYSF p.G299R-GFP tagged. Experiment performed 14×. (D) ...,21,415,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...) Peptide A2 (10-mer) added corresponding to DYSF p.G299R. GFP-dysferlin relocalizes to sarcolemmal ...,21,591,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...r but not expressed at the sarcolemma. (G–I) DYSF p.L1341P-GFP tagged. Experiment performed 12×. (G)...,21,786,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...ed. (H) Peptide B2 (10-mer) corresponding to DYSF p.L1341P supports reallocation of dysferlin to the...,21,902,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...ma. (I) Peptide B4 (15-mer) corresponding to DYSF p.L1341P. 10mer peptides carrying the correspondin...,21,1011,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...y human myotubes obtained from patients with DYSF p.G299R and DYSF p.L1341P. Missense mutated dysfer...,39,144,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...obtained from patients with DYSF p.G299R and DYSF p.L1341P. Missense mutated dysferlin accumulates w...,39,161,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ect. (A–C) Primary human myotubes expressing DYSF p.G299R. Experiment performed 9x. (A) No peptides ...,42,506,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...) Peptide A2 (10-mer) added corresponding to DYSF p.G299R. (C) Nonsense peptide added (control). (D–...,42,615,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...y human myotubes harboring the dysferlin mutation p.L1341P. Experiment performed 7x. (D) No peptides...,42,724,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...) Peptide B2 (10-mer) added corresponding to DYSF p.L1341P. (F) Sarcolemmal dysferlin localization i...,42,834,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... influx (FM1-43) in human myotubes harboring DYSF p.G299R or in normal human myotubes is shown at th...,48,66,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"...µm boundary area of the plasma membrane. (A) DYSF p.G299R, no peptide. (B) DYSF p.G299R, nonsense pe...",48,289,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"... membrane. (A) DYSF p.G299R, no peptide. (B) DYSF p.G299R, nonsense peptide added. (C) DYSF p.G299R,...",48,319,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"...B) DYSF p.G299R, nonsense peptide added. (C) DYSF p.G299R, corresponding mutant peptide A2 added. (D...",48,361,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...eptide FM1-43 dye rapidly spreads within the DYSF p.G299R human myotubes. After treatment with speci...,48,551,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"... normal and dysferlin-mutant human myotubes. DYSF p.L1341P myotubes, untreated and treated with TAT-...",50,209,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"... hardly detectable and closes rapidly. (D–F) DYSF p.L1341P primary human myotube 6, 20 and 90 sec af...",53,355,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...lesion continuously increases in size. (G–I) DYSF p.L1341P primary human myotube treated with corres...,53,473,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"...otubes. Peptide B2, which corresponds to the DYSF p.L1341P mutation, was fluorescently labeled with ...",56,174,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...t C2E domain of dysferlin that contained the DYSF p.L1341P mutation and the corresponding wildtype o...,56,845,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,Peptide B2 corresponding to DYSF p.L1341P was labeled with ATTO-495-ME fluorescent ...,59,34,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...TO-495-ME fluorescent dye (red) and added to DYSF p.L1341P human myotubes. (A) DYSF p.L1341P human m...,59,112,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...d added to DYSF p.L1341P human myotubes. (A) DYSF p.L1341P human myotube immediately after addition ...,59,146,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"... after addition of ATTO-495-ME-peptide B2 to DYSF p.L1341P human myotubes, (B) after 8 minutes and (...",59,230,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,ER Stress is Reduced by Treating DYSF p.G299R Expressing myotubes with TAT-Labeled Mutan...,61,39,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... stress sensor BiP in myotubes harboring the DYSF p.G299R mutation compared to normal controls (Fig....,62,229,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,(A) In DYSF p.G299R human myotubes HSPA5 gene expression is si...,65,13,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...t peptides decrease HSPA5 gene expression in DYSF p.G299R human myotubes most effectively (RT-PCR). ...,65,196,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ients with LGMD2B: DYSF c.855+1delG and c.895G>A; p.G299R; homozygosity for DYSF c.4022T>C; p.L1341P...,91,464,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...895G>A; p.G299R; homozygosity for DYSF c.4022T>C; p.L1341P. Muscle specimens were placed in 30.2 mM ...,91,506,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...man muscle cells endogenously expressing the DYSF p.L1341P mutation [52],91,1354,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...o wildtype dysferlin and dysferlin mutations DYSF p.G299R and DYSF p.L1341P 10 and 15mer peptides we...,94,66,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...lin and dysferlin mutations DYSF p.G299R and DYSF p.L1341P 10 and 15mer peptides were synthesized an...,94,83,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"...tle Upon Tyne, UK). DYSF c.895G>A leading to DYSF p.G299R and DYSF c.4022T>C leading to DYSF p.L1431...",97,218,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1431P,...o DYSF p.G299R and DYSF c.4022T>C leading to DYSF p.L1431P were cloned into the vector by site-direc...,97,261,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,The sequence encoding for the C2E domain of DYSF p.L1341P was amplified by PCR using primers to gen...,114,50,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ent the amino-acid sequence corresponding to DYSF p.G299R in the C2B (red) and p.L1431P in the C2E d...,125,300,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1431P,...orresponding to DYSF p.G299R in the C2B (red) and p.L1431P in the C2E domain (green) [53],125,329,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... with either missense-mutated dysferlin cDNA DYSF p.G299R (upper lane) or p.L1341P (lower lane). Tra...,131,183,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...tated dysferlin cDNA DYSF p.G299R (upper lane) or p.L1341P (lower lane). Transfected cells were trea...,131,207,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...bes carrying the dysferlin missense mutation DYSF p.G299R in (A) and immortalized human myotubes car...,137,128,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...and immortalized human myotubes carrying the DYSF p.L1341P mutation in (B) were treated with the dys...,137,193,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,Figure S4 DYSF p.L1341P does not stably bind corresponding dysfer...,143,17,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...analyte the recombinant C2E domain harboring DYSF p.L1341P expressed in E.coli was used. The kinetic...,143,212,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...eptides. (A) In human myotubes harboring the DYSF p.G299R mutation specific peptides reduce the rela...,149,109,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...e peptide) is compared to untreated controls DYSF p.G299R. Median ± SEM for each condition is listed...,149,791,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... FM1-43 uptake after laser induced damage in DYSF p.G299R primary human myotubes. No peptides added,161,60,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... FM1-43 uptake after laser induced damage in DYSF p.G299R primary human myotubes. Nonsense peptide a...,167,60,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... FM1-43 uptake after laser induced damage in DYSF p.G299R primary human myotubes. Corresponding pept...,173,60,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,Video S6 Sarcolemmal injury in DYSF p.L1341P primary human myotubes induced by atomic ...,191,38,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,Video S7 Sarcolemmal injury in DYSF p.L1341P primary human myotubes induced by atomic ...,197,38,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...d and TAT conjugated dysferlin-peptide B2 in DYSF p.L1341P primary human myotubes. Time lapse is ind...,203,98,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.Arg25Cys,"..., Ucar T , Atalay S , et al (2008 ) The effect of p.Arg25Cys alteration in NKX2-5 on conotruncal hea...",187,90,PLoS_One_2012_Nov_30_7(11)_e49532.txt
p.A350V,"...ogyMedicineNeurologyParkinson DiseaseSubstitution p.A350V in Na+/Mg2+ Exchanger SLC41A1, Potentially...",3,481,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...s Disease, Is a Gain-of-Function Mutation SLC41A1 p.A350V Is a Gain-of-Function MutationKolisek Mart...",3,608,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...tasis. Here, we demonstrate that the substitution p.A350V potentially associated with PD is a gain-o...",7,894,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...tion and leads to a reduced proliferation rate in p.A350V compared with wt cells. We hypothesize tha...,7,1345,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...enhanced Mg2+-efflux conducted by SLC41A1 variant p.A350V might result, in the long-term, in chronic...",7,1447,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.K146E,...-specific SLC41A1 variants (c.436A>G resulting in p.K146E; c.1440A>G resulting in p.P480P; and c.552...,19,159,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.P480P,...6A>G resulting in p.K146E; c.1440A>G resulting in p.P480P; and c.552+50G>A) in the Chinese populatio...,19,191,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...t of SLC41A1 carrying the amino acid substitution p.A350V (c.1049C>T) in one PD patient of Caucasian...,19,315,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...ve mainly examined the effect of the substitution p.A350V potentially related to PD on the performan...,23,71,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... SLC41A1. Our findings show that the substitution p.A350V in SLC41A1 is a gain-of-function mutation ...,23,199,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...3-(HA-strep-SLC41A1) and HEK293-(HA-strep-SLC41A1-p.A350V) were constructed in co-operation with Dua...,27,79,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...-terminal HA-strep tag. Point mutation c.1049C>T (p.A350V) was introduced by PCR-site-directed mutag...,27,347,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...or tet-inducible expression of the wt or mutated (p.A350V) HA-strep-tagged SLC41A1. Protein expressi...,27,782,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...3-(HA-strep-SLC41A1) and HEK293-(HA-strep-SLC41A1-p.A350V) cells were cultured in Dulbecco's modifie...,29,56,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,HEK293 cells inducibly over-expressing wt or the p.A350V variant were grown to approximately 80% co...,34,50,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...s, over-expressing flag- or HA-strep-tagged wt or p.A350V, and the respective uninduced controls wer...",40,62,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...for the HA-strep-tagged wild-type variant and the p.A350V mutant, 30 µg total protein were run on a ...",40,452,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...eins from HEK293 cell lines over-expressing wt or p.A350V according to the manufacturer's protocol. ...,43,167,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...he Qproteome cell compartment kit (Qiagen). Wt or p.A350V cells were induced or left untreated. Cell...,46,135,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...rmination of the phosphorylation status of wt and p.A350V varian,48,55,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... strep- or flag-tagged wt or strep-tagged variant p.A350V (HA-Strep-tagged) were used as starting ma...,49,219,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...and Western blot analysis of SLC41A1- and SLC41A1 p.A350V-protein complexe,51,79,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...teins were transferred to a PVDF membrane. Wt and p.A350V protein complexes were immuno-detected as ...,52,299,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... goat serum. For detection of strep-tagged wt and p.A350V, we used a primary anti-strep antibody (di...",55,224,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"The -tet and +tet wt and p.A350V cells were rinsed twice with ice-cold, com...",58,26,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...dent Mg2+ extrusion from induced SLC41A1 (wt) and p.A350V cells was determined from the [Mg2+]i chan...,60,401,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"..., or dB-cAMP. Subsequently, per well, 5×105 wt or p.A350V cells were plated in a final volume of 100...",67,220,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... of tet-induced over-expression of SLC41A1 wt and p.A350V variants in HEK293 cell,70,67,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...to further only as wt cells) and HA-strep-SLC41A1-p.A350V (HEK293-(HA-strep-SLC41A1-p.A350V); referr...,71,252,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...A-strep-SLC41A1-p.A350V (HEK293-(HA-strep-SLC41A1-p.A350V); referred to further only as p.A350V cell...,71,286,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...rep-SLC41A1-p.A350V); referred to further only as p.A350V cells). Thus, the basic characteristics of...",71,324,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...the potentially PD-associated variant of SLC41A1, p.A350V, was performed",71,499,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...ssion of SLC41A1 wt (further only wt) and SLC41A1 p.A350V (further only p.A350V) variants would be t...,73,258,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...urther only wt) and SLC41A1 p.A350V (further only p.A350V) variants would be tolerated, or whether i...",73,280,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...ability of the cells over-expressing either wt or p.A350V. Viability of uninduced (-tet) wt or -tet ...,73,482,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...p.A350V. Viability of uninduced (-tet) wt or -tet p.A350V cells ranged after 24 h between 95% and 10...,73,532,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...t a 24-h tet-induced over-expression of the wt or p.A350V variant had no significant effect on cell ...,73,667,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...ct on cell viability. Weaker expression of wt and p.A350V was also demonstrated by the finding that ...,73,756,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...mbinant HA-strep-SLC41A1(wt) and HA-strep-SLC41A1-p.A350V in total protein isolate from -tet and +te...,75,665,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...m -tet and +tet (24 h) cells. Strep-tagged wt and p.A350V were detected only in tet-induced cells. P...,75,751,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...mbinant HA-strep-SLC41A1(wt) and HA-strep-SLC41A1-p.A350V in soluble and membrane-protein-enriched f...,75,1064,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...m -tet and +tet (24 h) cells. Strep-tagged wt and p.A350V were detected almost exclusively in tet-in...,75,1185,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...mbinant HA-strep-SLC41A1(wt) and HA-strep-SLC41A1-p.A350V in subcellular protein fractions isolated ...,75,1623,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...fractions isolated from +tet (24 h) cells. Wt and p.A350V were predominantly detected in membrane (M...,75,1704,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...s in cytosolic (C) protein fractions and also for p.A350V in traces in the nuclear (N) protein fract...,75,1849,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...and 1B). Therefore, we concluded that both wt and p.A350V cells produced similar amounts of transcri...",76,557,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...of SLC41A2 and/or SLC41A3 in +tet and -tet wt and p.A350V cells, respectively. Indeed, we did not de...",76,805,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...did not detect any significant influence of wt or p.A350V over-expression on the expression of SLC41...,76,895,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...s [27], [37]. Therefore, we tested whether wt and p.A350V over-expressing cell lines exhibited consi...",78,130,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...iderable levels of leaky expression of the wt and p.A350V variants. As a control, we used clone 17 o...",78,229,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...t analysis revealed bands specific for the wt and p.A350V variants (both ∼56 kDa) almost exclusively...,78,428,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...perimentation. Next, we determined whether wt and p.A350V cells expressed comparable amounts of SLC4...",78,725,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...ith equal amounts of protein isolates from wt and p.A350V cells, we calculated that the density of p...",78,892,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... p.A350V cells, we calculated that the density of p.A350V-specific bands was ∼1% lower compared with...",78,941,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...c bands. Therefore, we concluded that both wt and p.A350V cells produced nearly identical amounts of...",78,1060,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,SLC41A1 p.A350V localizes within the cytoplasmic membran,80,9,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...ned whether the potentially PD-associated variant p.A350V of SLC41A1 was properly targeted into the ...,81,270,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...s of MF and SF isolated from -tet and +tet wt and p.A350V cells. The ∼56 kDa bands corresponding to ...,81,473,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... cells. The ∼56 kDa bands corresponding to wt and p.A350V were predominantly detected in the MF, wit...",81,530,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...tionation with HEK293 cells over-expressing wt or p.A350V (Fig. 1E). Probing of the electroseparated...,81,936,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...almost exclusive detection of both the wt and the p.A350V variants in the fraction enriched in plasm...,81,1106,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... microscopy data, which revealed that both wt and p.A350V SLC41A1 variants were predominantly locali...",81,1552,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...exa-488- and Alexa-647-specific signals in wt and p.A350V variants revealed a 94.5±1.8% (N = 6) and ...,81,1945,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... red pixels, respectively. In contrast, no wt- or p.A350V-specific fluorescence was seen in -tet cel...",81,2085,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...mbrane localization of the potentially PD-related p.A350V variant of SLC41A1. Thus, we conclude that...",81,2255,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...t of SLC41A1. Thus, we conclude that the mutation p.A350V does not affect the intracellular localiza...",81,2319,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,(wt) and HA-strep-SLC41A1-p.A350V in +tet (2,84,27,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,h) cells. Strep-tagged wt and p.A350V were immunolabeled with primary mouse anti...,85,31,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,p.A350V exhibits identical complex-forming abiliti...,87,1,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"[27]. Therefore, we wondered whether the mutation p.A350V could affect the complex-forming character...",89,51,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...th blue native electrophoresis [27], [33]. Wt and p.A350V variants showed identical separation patte...",89,282,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...This leads us to the assumption that the mutation p.A350V has no obvious effect on the complex-formi...,89,480,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...18%) and Western blot analysis of SLC41A1(wt) and p.A350V (M) complexes. Both wt and p.A350V variant...,92,54,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...LC41A1(wt) and p.A350V (M) complexes. Both wt and p.A350V variants form identical complexes (two; la...,92,89,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,Amino acid substitution p.A350V in human SLC41A1 induces increased Mg2+ ef...,94,25,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... in our previous study [20], -tet and +tet wt and p.A350V cells were Mg2+-loaded by a 20-min pre-inc...",95,53,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...riod are shown in Table 1. Uninduced wt cells and p.A350V cells regulate their [Mg2+]i at stable lev...,95,385,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... of +tet cells was increased by 25% (wt) and 33% (p.A350V) when incubated in 10 mM Mg2+ solution. Af...,95,546,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...-(HA-strep-SLC41A1), and HEK293-(HA-strep-SLC41A1-p.A350V) cells",97,150,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...-strep-SLC41A1) (control)	HEK293-(HA-strep-SLC41A1p.A350V),98,72,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...93-(HA-strep-SLC41A1) or HEK293-(HA-strep-SLC41A1-p.A350V) cells,102,362,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...g2+ efflux [20]. The results for +tet wt and +tet p.A350V cells are summarized in figure 4 showing a...,104,150,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...y stronger Mg2+ extrusion of 81.2±4.7 µM/10 min (Np.A350V  = 113) in p.A350V cells compared with 48....,104,263,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...rusion of 81.2±4.7 µM/10 min (Np.A350V  = 113) in p.A350V cells compared with 48.2±7.0 µM/10 min (Nw...,104,282,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...early demonstrate an increased efflux capacity of p.A350V cells,104,437,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...71096.g004Figure 4 SLC41A1-related Mg2+ efflux in p.A350V cells compared with wt cells,106,74,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...wing conditions: (1) completely Mg2+-free media (Np.A350V  = 113 & Nwt  = 82); (2) media supplemente...,107,255,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...t  = 82); (2) media supplemented with 5 mM Mg2+ (Np.A350V  = 13 & Nwt  = 14); and (3) media suppleme...,107,324,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...14); and (3) media supplemented with 10 mM Mg2+ (Np.A350V  = 13 & Nwt  = 14). Values have been corre...,107,397,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...rusion occurred from Mg2+-loaded +tet wt and +tet p.A350V cells. Instead, as can be seen in figure 4...",109,194,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...y 73.6±16.4 µM/10 min and 103.2±21.5 µM/10 min in p.A350V cells (Np.A350V; [Mg2+]e (5 mM)  = 13 & Np...,109,439,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...0 min and 103.2±21.5 µM/10 min in p.A350V cells (Np.A350V; [Mg2+]e (5 mM)  = 13 & Np.A350V; [Mg2+]e ...,109,455,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... p.A350V cells (Np.A350V; [Mg2+]e (5 mM)  = 13 & Np.A350V; [Mg2+]e (10 mM)  = 13) incubated in 5 or ...,109,488,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...P on SLC41A1-related Mg2+ efflux from +tet wt and p.A350V cell,111,86,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"In both wt- and p.A350V-over-expressing cells, the observed [Mg2+]...",112,17,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...2 µM/10 min, Nwt  = 21; and 101.7±9.2 µM/10 min, Np.A350V  = 26) was nearly completely abolished (−0...",112,137,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...3.5 µM/10 min, Nwt  = 21; and 8.7±9.1 µM/10 min, Np.A350V  = 26) by the tricyclic antidepressant imi...",112,241,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...es, cell adhesion, and cell proliferation in +tet p.A350V cells and wt cells",114,188,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...]i changes after resuspension of Mg2+-loaded +tet p.A350V cells and wt cells in completely Mg2+-free...,115,70,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...i changes in -tet cells and given as means ± SE; Np.A350V  = 26 & Nwt  = 21 single experiments per c...,115,313,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...]i changes after resuspension of Mg2+-loaded +tet p.A350V cells and wt cells in completely Mg2+-free...,115,464,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...Mg2+]i changes in -tet cells and are means ± SE; Np.A350V  = 15 & Nwt  = 15 single experiments per c...,115,695,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...on; **P = 0.01. C: Original growth curves of +tet p.A350V cells and wt cells under control condition...,115,801,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...ates of induced +tet flag-wt, strep-wt, and strep-p.A350V. Figure 6 demonstrates that the ∼56 kDa ba...",117,385,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...es that the ∼56 kDa bands corresponding to wt and p.A350V were detected in the P fractions. The spec...,117,463,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"(wt), HA-strep-SLC41A1 (wt), and HA-strep-SLC41A1-p.A350V with the PhosphoProtein purification kit (...",120,51,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...g-tag. A signal specific for phosphorylated wt or p.A350V was detected in all three cell lines. The ...,120,337,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...he SLC41A1-dependent Mg2+ efflux from +tet wt and p.A350V cells could be further stimulated by the a...,122,75,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...20]. No additional effects on Mg2+ extrusion from p.A350V cells were observed after the application ...,122,312,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...bserved after the application of 100 µM dB-cAMP (Np.A350V  = 15; Fig. 5B). However, as shown in figu...",122,382,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,Amino acid substitution p.A350V in human SLC41A1 effects cell growt,124,25,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,The 48-h growth curves of +tet p.A350V cells and wt cells obtained under control ...,125,32,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...th +tet wt cells, the normalized CI (nCI) of +tet p.A350V cells was reduced (2.03±0.03 vs. 2.26±0.08...",125,235,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...creases and increases the 48-h nCI of +tet wt and p.A350V cells compared with control values (Fig. 5...,125,486,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...I amounted to 0.18±0.17 in wt and to 0.26±0.40 in p.A350V cells, thus showing a strong reduction in ...",125,631,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...much stronger in +tet wt cells compared with +tet p.A350V cells (2.81±0.08 vs. 2.55±0.08; P<0.001),125,802,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... coding variant of SLC41A1, carrying substitution p.A350V. Here, we have investigated if this potent...",132,118,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...ylation status, or complex-forming ability of the p.A350V variant when compared with the wt protein....",132,396,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... protein. However, we have demonstrated that +tet p.A350V cells are able to perform Mg2+-efflux more...",132,487,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...reased by 69±10% (P<0.001) after the induction of p.A350V over-expression compared with cells over-e...,132,693,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...ctivity, we found a reduced proliferation rate in p.A350V compared to wt cells. As the growth experi...",132,854,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... media containing 1.2 mM Mg2+, the effects of the p.A350V mutation seem to be of relevance also unde...",132,1043,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...+tet wt cells, whereas no effect has been seen in p.A350V cells. This insensitivity of mutant NME to...",137,266,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... growth-promoting effect of dB-cAMP is reduced in p.A350V-over-expressing cells compared with wt cel...,137,753,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... with wt cells. The inability further to increase p.A350V-related NME function via cAMP also suggest...,137,841,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...ty [53], is similar (0.44±0.01 mM) between wt and p.A350V cells. Therefore, one can speculate that t...",137,1143,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...350V cells. Therefore, one can speculate that the p.A350V mutation augments the affinity of the tran...",137,1196,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... block SLC41A1-related Mg2+ efflux in both wt and p.A350V cells. Increasing the extracellular Mg2+ c...,140,139,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... PD-associated coding variant of the NME SLC41A1, p.A350V. We have demonstrated that p.A350V is able...",145,423,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...e NME SLC41A1, p.A350V. We have demonstrated that p.A350V is able to perform Mg2+-extrusion more eff...",145,458,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...on and have found a reduced proliferation rate in p.A350V compared with wt cells. Our data therefore...,145,620,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... indicate that the rare conservative substitution p.A350V is a gain-of-function mutation leading to ...,145,720,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...ion of HA-strep-SLC41A1 (wt) and HA-strep-SLC41A1-p.A350V in -tet (24 h) cells. Strep-tagged wt and ...,148,85,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...p.A350V in -tet (24 h) cells. Strep-tagged wt and p.A350V were immunolabeled with primary mouse anti...,148,135,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.Tyr1957Ter,...ordersIdentification of a Novel Nonsense Mutation p.Tyr1957Ter of CACNA1A in a Chinese Family with E...,3,475,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"...to identify a novel nonsense mutation of CACNA1A (p.Tyr1957Ter, NP_001120693.1) resulting in truncat...",7,849,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"... This mutation introduced a premature stop codon (p.Tyr1957Ter, NP_001120693.1 ) and caused either l...",56,492,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,...ure 2 Identification of novel premature mutation (p.Tyr1957Ter) in the c-tail of CACNA1A in a Chines...,58,87,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"...eration sequencing to identify nonsense mutation (p.Tyr1957Ter) in CACNA1A. SNP, single nucleotide p...",59,125,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"...s mutation in CACNA1A (c.6107C>A, NM_001127221.1, p.Tyr1957Ter, NP_001120693.1) by Sanger sequencing...",59,373,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"... technology, we identified a nonsense mutation of p.Tyr1957Ter in CACNA1A. Sanger sequence confirmed...",62,590,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"...mutations to cause EA2, the truncated mutation of p.Tyr1957Ter in this study becomes interesting bec...",66,124,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"...in is caused by “dominant negative effect” of the p.Tyr1957Ter. However, abdominal pain and episodic...",66,1403,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"In summary, a novel nonsense mutation of p.Tyr1957Ter in CACNA1A was identified in a four-g...",68,42,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Lys2950Asn,... (DSS1) or pGEX-4T1 (BRCA2). The BRCA2 c.8850G>T (p.Lys2950Asn) variant was inserted by direct mutag...,38,272,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Ser127Thr,...n 7	r.[380_441del]	mono-allelic	stop at codon 137	p.Ser127ThrfsX11	5,61,111,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Gln148Asp,...n 8	r.[442_547del]	mono-allelic	stop at codon 198	p.Gln148AspfsX51	5,62,90,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Val1665Ser,...	r.[4987_5074del]	mono-allelic	stop at codon 1672	p.Val1665SerfsX8	5,64,95,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Phe1761Asn,"...ono-allelic	stop at codon 1774,stop at codon 1826	p.Phe1761AsnfsX14,p.Ile1760GlyfsX67	5",65,171,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Ile1760Gly,"...t codon 1774,stop at codon 1826	p.Phe1761AsnfsX14,p.Ile1760GlyfsX67	5",65,189,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Phe1761Asn,...	r.[5278_5332del]	mono-allelic	stop at codon 1774	p.Phe1761AsnfsX14	5,66,95,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Pro143Gly,...n 5	r.[426_475del]	mono-allelic	stop at codon 165	p.Pro143GlyfsX23	5,68,89,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Val159Gly,"...l]	bi-allelic	stop at codon 168,stop at codon 154	p.Val159GlyfsX10,p.Ser142ArgfsX13	4",69,159,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Ser142Arg,"...p at codon 168,stop at codon 154	p.Val159GlyfsX10,p.Ser142ArgfsX13	4",69,176,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Thr2337Phe,"... codon 2353,stop at codon 2363,stop at codon 3337	p.Thr2337PhefsX17,p.Thr2337AsnfsX27,p.Thr2337Valfs...",70,240,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Thr2337Asn,"...t codon 2363,stop at codon 3337	p.Thr2337PhefsX17,p.Thr2337AsnfsX27,p.Thr2337ValfsX1001	5",70,258,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Thr2337Val,"...at codon 3337	p.Thr2337PhefsX17,p.Thr2337AsnfsX27,p.Thr2337ValfsX1001	5",70,276,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Gly2919Leu,"...	bi-allelic	stop at codon 2921,stop at codon 2944	p.Gly2919LeufsX3,p.Gly2919LysfsX26	4",71,183,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Gly2919Lys,"...at codon 2921,stop at codon 2944	p.Gly2919LeufsX3,p.Gly2919LysfsX26	4",71,200,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Val2985Gly,"...n of 17aa,stop at codon 2988	p.Val2985_Thr3001del,p.Val2985GlyfsX4	5",72,221,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Cys27X,...orm	r.[81_134del]	not assessable	stop at codon 27	p.Cys27X	4 or 5,91,117,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Cys64X,...form	r.[191_212del]	mono-allelic	stop at codon 64	p.Cys64X	5,92,98,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Arg71Ser,...9_213-1; 213-11u>g]	mono-allelic	stop at codon 81	p.Arg71SerfsX11	5,93,139,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Gly1366Asp,...ne	r.[4097g>a]	bi-allelic	aa change at codon 1366	p.Gly1366Asp	2,96,73,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Ala1453Gly,...	r.[4358_4484del]	mono-allelic	stop at codon 1462	p.Ala1453GlyfsX10	5,97,91,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Asp1778Gly,...ne	r.[5333a>g]	bi-allelic	aa change at codon 1778	p.Asp1778Gly	2,99,74,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Gly173Ser,...n 7	r.[517_631del]	mono-allelic	stop at codon 191	p.Gly173SerfsX19	5,101,86,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Gly2919Val,...54+46; 8754+4a>g]	mono-allelic	stop at codon 2922	p.Gly2919ValfsX4	5,102,147,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Pro3039Leu,...ne	r.[9116c>u]	bi-allelic	aa change at codon 3039	p.Pro3039Leu	2,103,75,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Val2985Gly,...	r.[8954_9117del]	mono-allelic	stop at codon 2988	p.Val2985GlyfsX4	5,104,91,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Lys2950Asn,...2 DBD wild-type and BRCA2 DBD carrying a variant (p.Lys2950Asn) classified as clinically neutral [7]...,144,505,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Lys2950Asn,...ained with Coomassie dye. The BRCA2 wild-type and p.Lys2950Asn polypeptides were both recovered in t...,149,490,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Gly1366Asp,... were intronic and 3 introduced missense changes (p.Gly1366Asp and p.Asp1778Gly in BRCA1 and p.Pro30...,183,88,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Asp1778Gly,...d 3 introduced missense changes (p.Gly1366Asp and p.Asp1778Gly in BRCA1 and p.Pro3039Leu in BRCA2). ...,183,105,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Pro3039Leu,...anges (p.Gly1366Asp and p.Asp1778Gly in BRCA1 and p.Pro3039Leu in BRCA2). For all the latter substit...,183,131,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Asp1778Gly,"...dence from previous studies. In particular, BRCA1 p.Asp1778Gly located in the C-terminus transcripti...",183,549,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Pro3039Leu,"...the proband’s affected mother. Finally, the BRCA2 p.Pro3039Leu has been classified as neutral using ...",183,1085,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.I2285V,...led by a comprehensive analysis of the c.6853A>G (p.I2285V) variant . Hum Mutat 30 : 1543 –50 197954...,293,169,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Val145Phe,"...fferent mutations including four novel mutations (p.Val145Phe, p.Glu388X, p.Thr498Ser and p.Gly837X)...",7,1326,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Glu388X,"...ions including four novel mutations (p.Val145Phe, p.Glu388X, p.Thr498Ser and p.Gly837X) in the ATP7B...",7,1339,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr498Ser,"...ing four novel mutations (p.Val145Phe, p.Glu388X, p.Thr498Ser and p.Gly837X) in the ATP7B gene were ...",7,1350,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly837X,"...utations (p.Val145Phe, p.Glu388X, p.Thr498Ser and p.Gly837X) in the ATP7B gene were identified in ou...",7,1366,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg778Leu,"...revealed that founder effects for four mutations (p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala12...",7,1497,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro992Leu,"... founder effects for four mutations (p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala1295Val) existe...",7,1510,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ile1148Thr,"...cts for four mutations (p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala1295Val) existed in these fa...",7,1523,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...tions (p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala1295Val) existed in these families. Transfect...",7,1540,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ser137Ser,"...6 polymorphisms (7 novel polymorphisms: c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (...",73,92,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Phe763Phe,"...polymorphisms: c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), c.3973C>T (...",73,117,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Val834Val,"...p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), c.3973C>T (p.Leu1325Leu), c.3999G>T ...",73,142,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Leu1325Leu,"...p.Phe763Phe), c.2502C>G (p.Val834Val), c.3973C>T (p.Leu1325Leu), c.3999G>T (p.Leu1333Leu), IVS8+26A>...",73,167,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Leu1333Leu,"....Val834Val), c.3973C>T (p.Leu1325Leu), c.3999G>T (p.Leu1333Leu), IVS8+26A>G, and IVS8+27G>A), in the...",73,193,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ser105X,"...Twenty mutations, including 3 nonsense mutations (p.Ser105X, p.Gln388X and p.Gly837X), one deletion ...",73,400,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gln388X,"...tions, including 3 nonsense mutations (p.Ser105X, p.Gln388X and p.Gly837X), one deletion mutation (c...",73,411,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly837X,"...ng 3 nonsense mutations (p.Ser105X, p.Gln388X and p.Gly837X), one deletion mutation (c.2659delG), on...",73,425,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Val145Phe,"...mutation (c.1708-1G>C) and 15 missense mutations (p.Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu...",73,534,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr498Ser,"...708-1G>C) and 15 missense mutations (p.Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu...",73,547,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Asp765Gly,"... 15 missense mutations (p.Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu, p.Gly869Arg...",73,560,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg778Leu,"...mutations (p.Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu, p.Gly869Arg, p.Ala874Pro...",73,573,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro840Leu,"...Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro...",73,586,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly869Arg,"...Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro, p.Thr935Met...",73,599,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala874Pro,"...Asp765Gly, p.Arg778Leu, p.Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro, p.Thr935Met, p.Pro992Leu...",73,612,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr888Pro,"...Arg778Leu, p.Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Va...",73,625,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr935Met,"...Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Val, p.Ile1148T...",73,638,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro992Leu,"...Gly869Arg, p.Ala874Pro, p.Thr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Val, p.Ile1148Thr, p.Glu1173...",73,651,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Asp1047Val,"...Ala874Pro, p.Thr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala129...",73,664,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ile1148Thr,"...hr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala1295Val and p.Arg...",73,678,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Glu1173Lys,"...r935Met, p.Pro992Leu, p.Asp1047Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala1295Val and p.Arg1320Ser) were ...",73,692,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...992Leu, p.Asp1047Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala1295Val and p.Arg1320Ser) were identified by ...",73,706,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg1320Ser,"...Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala1295Val and p.Arg1320Ser) were identified by further analysis ...",73,723,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Val145Phe,"...o NCBI, Table S2–4). Among these mutations, Four (p.Val145Phe, p.Gln388X, p.Thr498Ser and p.Gly837X)...",73,942,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gln388X,"... S2–4). Among these mutations, Four (p.Val145Phe, p.Gln388X, p.Thr498Ser and p.Gly837X) of them are ...",73,955,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr498Ser,"...ng these mutations, Four (p.Val145Phe, p.Gln388X, p.Thr498Ser and p.Gly837X) of them are novel ATP7B...",73,966,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly837X,"...ns, Four (p.Val145Phe, p.Gln388X, p.Thr498Ser and p.Gly837X) of them are novel ATP7B gene mutations ...",73,982,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg778Leu,"... mutation revealed that clear founder effects for p.Arg778Leu (Families M1279, M1524, M1841, M2621 a...",76,105,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro992Leu,"... (Families M1279, M1524, M1841, M2621 and M4056), p.Pro992Leu (Families M1031, M1038, M1623, M1841, ...",76,166,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ile1148Thr,"...38, M1623, M1841, M1856, M4061, M4062 and M4174), p.Ile1148Thr (Families M1807 and M1856) and p.Ala1...",76,248,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...174), p.Ile1148Thr (Families M1807 and M1856) and p.Ala1295Val (Families M41 and M1407) mutations ex...",76,292,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Val145Phe,"...ong the novel mutations identified in this study, p.Val145Phe was present in two compound heterozygo...",101,1591,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr498Ser,...fected mother was in heterozygous status (M1279). p.Thr498Ser was found in a 20-year female WD patie...,101,1723,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr498Ser,"...1038, II:1) with compound heterozygous mutations (p.Thr498Ser and p.Pro992Leu), and the age at the o...",101,1828,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro992Leu,"... compound heterozygous mutations (p.Thr498Ser and p.Pro992Leu), and the age at the onset was 12 year...",101,1844,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly837X,...sentation. Compound heterozygous ATP7B mutations (p.Gly837X/p.Pro992Leu) were found in an 18-year WD...,101,1967,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro992Leu,... Compound heterozygous ATP7B mutations (p.Gly837X/p.Pro992Leu) were found in an 18-year WD female (M...,101,1977,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...may be inherited from a same ancestor. Homozygous p.Ala1295Val mutation, located in the conserved ad...",101,3509,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro992Leu,"...TP7B and hepatic phenotype [20]. p. Arg778Leu and p.Pro992Leu mutations, was found with high allele ...",101,3801,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro992Leu,...e frequencies (15% for p. Arg778Leu and 22.5% for p.Pro992Leu) were found in our study. Interestingl...,101,3958,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg778Leu,"...e different pedigrees existed founder effects for p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala12...",101,4097,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro992Leu,"...edigrees existed founder effects for p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala1295Val mutatio...",101,4110,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ile1148Thr,"...ted founder effects for p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala1295Val mutations, suggestin...",101,4123,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...ts for p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala1295Val mutations, suggesting these mutations...",101,4140,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Y83Y,"... of the family (Table 1). These SNPs, rs73415876 (p.Y83Y) and rs139884 (p.H309H) have a global Minor...",67,255,PLoS_One_2013_Jun_26_8(6)_e66631.txt
p.H309H,"...1). These SNPs, rs73415876 (p.Y83Y) and rs139884 (p.H309H) have a global Minor Allele Frequency of 0...",67,277,PLoS_One_2013_Jun_26_8(6)_e66631.txt
p.G1481E,"...V linker (Figure 6), leading to either LQTS (e.g. p.G1481E, p.M1498T, p.1500delK, p.L1501V, p.1505–1...",158,864,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.M1498T,"...Figure 6), leading to either LQTS (e.g. p.G1481E, p.M1498T, p.1500delK, p.L1501V, p.1505–1507delKPQ,...",158,874,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.L1501V,"...either LQTS (e.g. p.G1481E, p.M1498T, p.1500delK, p.L1501V, p.1505–1507delKPQ, p.1507–1509delQKP) [4...",158,896,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.Q1476X,"...a result of residual current [33] or to BrS (e.g. p.Q1476X, p.K1493X, p.Y1494N, p.1500delK, p.L1501V...",158,1044,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.K1493X,"...f residual current [33] or to BrS (e.g. p.Q1476X, p.K1493X, p.Y1494N, p.1500delK, p.L1501V, p.G1502S...",158,1054,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.Y1494N,"... current [33] or to BrS (e.g. p.Q1476X, p.K1493X, p.Y1494N, p.1500delK, p.L1501V, p.G1502S, p.R1512W...",158,1064,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.L1501V,"...S (e.g. p.Q1476X, p.K1493X, p.Y1494N, p.1500delK, p.L1501V, p.G1502S, p.R1512W, p.I1521K) [23], [44]...",158,1086,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.G1502S,"...Q1476X, p.K1493X, p.Y1494N, p.1500delK, p.L1501V, p.G1502S, p.R1512W, p.I1521K) [23], [44], [45], [4...",158,1096,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.R1512W,"...K1493X, p.Y1494N, p.1500delK, p.L1501V, p.G1502S, p.R1512W, p.I1521K) [23], [44], [45], [46], [47] a...",158,1106,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.I1521K,"...Y1494N, p.1500delK, p.L1501V, p.G1502S, p.R1512W, p.I1521K) [23], [44], [45], [46], [47] as a result...",158,1116,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.E338X,ESCO1	T79	Serous	Stable	c.G1012T	p.E338X	Nonsense	n/a	n/a	n/a,95,34,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.D359N,T113	Clear cell	Stable	c.G1075A	p.D359N	Missense	Low	Tolerated	Benign,96,34,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.S532L,T77	Clear cell	Unstable	c.C1595T	p.S532L	Missense	Low	Tolerated	Probably damaging,97,35,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.R786C,T88	Endometrioid	Unstable	c.C2356T	p.R786C	Missense	Medium	Affects function	Probably ...,98,37,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.D679N,CHTF18	T79	Serous	Stable	c.G2035A	p.D679N	Missense	Low	Tolerated	Probably damaging,99,35,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.R854W,T88	Endometrioid	Unstable	c.C2560T	p.R854W	Missense	Medium	Tolerated	Possibly damagin...,100,37,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.D692Y,MRE11A	T68	Serous	Stable	c.G2074T	p.D692Y	Missense	Low	Affects function	Probably dam...,101,35,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.R483Q,T3†	Serous	Stable	c.G1448A	p.R483Q	Missense	Low	Tolerated	Benign,102,29,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.D131N,T3†	Serous	Stable	c.G391A	p.D131N	Missense	Medium	Affects function	Possibly ...,103,28,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.G49S,rs3750823	10	88707134	MMRN2	NM_024756	c.G145A	p.G49S	0.15	borderline	0.27	neutral,121,47,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.H731D,rs4934281	10	88692330	MMRN2	NM_024756	c.C2191G	p.H731D	0.62	neutral	NA	NA,122,48,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.V910L,rs34587013	10	88686602	MMRN2	NM_024756	c.G2728C	p.V910L	0.91	neutral	NA	NA,123,49,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.E110V,rs9864	10	88712378	SNCG	NM_003087	c.A329T	p.E110V	0.15	borderline	0.36	neutral,124,43,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.I82V,rs2641563	10	88758233	AGAP11	NM_133447	c.A244G	p.I82V	1.00	neutral	NA	NA,125,48,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.W151C,...tion of a highly conserved Tryptophan to Cystine (p.W151C). The mutation was confirmed by restrictio...,9,1176,PLoS_One_2013_Nov_28_8(11)_e81290.txt
p.D107D,"...ients a sysnonimous variant of ATP6AP2, c.321C>T (p.D107D) and a resultant markedly increased exon 4...",119,152,PLoS_One_2013_Nov_4_8(11)_e78603.txt
p.S115S,"...r synonymous mutation in the same exon, c.345C>T (p.S115S), which also affects RNA splicing, was rep...",119,298,PLoS_One_2013_Nov_4_8(11)_e78603.txt
p.S3588P,Pathogenicity of the bfb p.S3588P mutation was estimated using Polyphen (ht...,34,26,PLoS_One_2013_Oct_15_8(10)_e76342.txt
p.S3588P,.../) was also used to predict the effect of the bfb p.S3588P amino acid substitution on protein functi...,34,515,PLoS_One_2013_Oct_15_8(10)_e76342.txt
p.S3588P,...ediction output from PolyPhen-2 for the bfb Fras1 p.S3588P mutation indicates a ‘probably damaging’ ...,69,316,PLoS_One_2013_Oct_15_8(10)_e76342.txt
p.S3588P,...99. SIFT prediction output denotes that bfb Fras1 p.S3588P amino acid change is ‘not tolerated’. A t...,69,484,PLoS_One_2013_Oct_15_8(10)_e76342.txt
p.Val13Leu,"...were heterozygous for a variant in RGS6: c.37del; p.Val13LeufsX11, c.217C>T; p.Leu73Phe, c.808G>T; p...",99,367,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Leu73Phe,"...iant in RGS6: c.37del; p.Val13LeufsX11, c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c.1382C>T; p...",99,394,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Ala270Ser,"... p.Val13LeufsX11, c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c.1382C>T; p.Ala461Val were evalua...",99,416,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Ala461Val,"... p.Leu73Phe, c.808G>T; p.Ala270Ser, or c.1382C>T; p.Ala461Val were evaluated in parallel with 11 age...",99,443,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Val13Leu,...ubject (black) and a subject heterozygous for the p.Val13LeufsX11 variant in the RGS6 gene (red) det...,102,407,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Val13Leu,"... these criteria, only the individual carrying the p.Val13LeufsX11 RGS6 variant exhibited increased i...",104,321,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Val13Leu,...sed in this individual (Table S4 in File S1). The p.Val13LeufsX11 variant is a single nucleotide del...,104,618,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Ala461Val,"...st, variants in RGS6 predicting missense changes (p.Ala461Val, p.Ala270Ser and p.Leu73Phe) did not s...",104,789,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Ala270Ser,"...in RGS6 predicting missense changes (p.Ala461Val, p.Ala270Ser and p.Leu73Phe) did not significantly ...",104,802,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Leu73Phe,"...ng missense changes (p.Ala461Val, p.Ala270Ser and p.Leu73Phe) did not significantly affect HRV (Fig....",104,818,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Ala461Val,"... atropine. Consistent with the clinical data, the p.Ala461Val, p.Ala270Ser and p.Leu73Phe variants d...",106,474,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Ala270Ser,"...nsistent with the clinical data, the p.Ala461Val, p.Ala270Ser and p.Leu73Phe variants did not affect...",106,487,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Leu73Phe,"...e clinical data, the p.Ala461Val, p.Ala270Ser and p.Leu73Phe variants did not affect the ability of ...",106,503,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Val13Leu,"...ing (Fig. 5C,D). In contrast, introduction of the p.Val13LeufsX11 variant severely disrupted the abi...",106,630,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.L90P,"...34	IV, mild, Hy	FLG R501X/wt; GJB2−/− (p.G11fsX59/p.L90P)",40,64,PLoS_One_2013_Oct_9_8(10)_e75355.txt
p.Cys356Gly,p.Cys356Gly mutant	57±9	52±10,97,1,PLoS_One_2014_Apr_10_9(4)_e94697.txt
p.Cys356Gly,I-2	57	M	5.20	0.93	1.09	3.10	p.Cys356Gly (c.1129T>G),107,30,PLoS_One_2014_Apr_10_9(4)_e94697.txt
p.Cys356Gly,II-1	28	F	4.47	1.47	1.26	4.02	p.Cys356Gly (c.1129T>G),109,31,PLoS_One_2014_Apr_10_9(4)_e94697.txt
p.Arg52Cys,"...in the exon1 of the human MBL2 gene at codons 52 (p.Arg52Cys, MBL2*D), 54 (p.Dly54Asp, MBL2*B), and ...",30,160,PLoS_One_2014_Apr_21_9(4)_e95519.txt
p.Dly54Asp,"... MBL2 gene at codons 52 (p.Arg52Cys, MBL2*D), 54 (p.Dly54Asp, MBL2*B), and 57 (p.Gly57Glu, MBL2*C), ...",30,185,PLoS_One_2014_Apr_21_9(4)_e95519.txt
p.Gly57Glu,"...g52Cys, MBL2*D), 54 (p.Dly54Asp, MBL2*B), and 57 (p.Gly57Glu, MBL2*C), interfere with the formation ...",30,214,PLoS_One_2014_Apr_21_9(4)_e95519.txt
p.N247S,"... , Ainsworth JR , Shah S , et al (2007 ) Study of p.N247S KERA mutation in a British family with cor...",145,86,PLoS_One_2014_Apr_23_9(4)_e95037.txt
p.V600E,"...reditary origin, the mutation hotspot (c.1779T>A, p.V600E) of BRAF was scanned via HRM followed by d...",55,122,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Met35Ile,MLH1/Exon 1	c.104-105insAA	p.Met35IlefsX6	Chinese	1	1	Pathogenic	Dis causing	...,77,28,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Asp154Asp,MLH1/Exon 6	c.462delC	p.Asp154AspfsX5	Chinese	1	1	No record	No record	No...,78,23,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Ala202Leu,MLH1/Exon 8	c.604delG	p.Ala202LeufsX27	Chinese	1	2	No record	No record	N...,79,23,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Lys546Lys,MLH1/Exon 14	c.1636-1640insAAGTT	p.Lys546LysfsX46	Chinese	1	3	No record	No record	N...,82,34,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Thr553X,MLH1/Exon 14	c.1657delACCAAGCTTAG	p.Thr553X	Malay	1	1	No record	No record	Novel path...,83,35,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Pro648Prp,MLH1/Exon 17	c.1944delCCinsG	p.Pro648PrpfsX12	Chinese	1	1	No record	No record	N...,84,30,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Ala681Thr,MLH1/Exon 18	c.2041G>A	p.Ala681Thr	Chinese	1	1	Pathogenic	Dis causing	Yes...,85,24,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Gln170X,"MSH2/Exon 3	c.508C>T	p.Gln170X	Chinese	1	1	Pathogenic	Dis causing	Yes, ...",87,22,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Gln681X,MSH2/Exon 13	c.2041C>T	p.Gln681X	Eurasian	1	1	No record	No record	Novel p...,90,24,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Ala202Leu,"45	MLH1/Exon 8, c.604delG, p.Ala202LeufsX27	Novel Pathogenic	Lost	Normal	Norm...",107,28,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Ala202Leu,"39	MLH1/Exon 8, c.604delG, p.Ala202LeufsX27	Novel Pathogenic	Lost	Normal	Norm...",108,28,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Arg265Cys,"32	MLH1/Exon 10, c.793C>T, p.Arg265Cys	Pathogenic	Lost	Normal	Normal	Lost	Yes...",110,28,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Lys546Lys,"36	MLH1/Exon 14, c.1636-1640insAAGTT, p.Lys546LysfsX46	Novel Pathogenic	Lost	Normal	Lost...",111,39,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Lys546Lys,"26	MLH1/Exon 14, c.1636-1640insAAGTT, p.Lys546LysfsX46	Novel Pathogenic	Lost	Normal	Norm...",112,39,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Thr553X,"136	MLH1/Exon 14, c.1657delACCAAGCTTAG, p.Thr553X	Novel Pathogenic	Lost	Normal	Normal	Lost...",113,41,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Pro648Prp,"29	MLH1/Exon 17,c.1944delCCinsG, p.Pro648PrpfsX12	Novel Pathogenic	Lost	Normal	Norm...",114,34,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Gln170X,"21	MSH2/Exon 3, c.508C>T, p.Gln170X	Pathogenic	Normal	Lost	Equivocal	Equivoc...",116,27,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Gln681X,"52	MSH2/Exon 13, c.2041C>T, p.Gln681X	Novel Pathogenic	Normal	Lost	Lost	Normal...",117,29,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Ala681Thr,"393	MLH1/Exon 18, c.2041G>A, p.Ala681Thr	Pathogenic	Normal	Normal	Normal	Lost	N...",125,30,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Ala681Val,"81	MLH1/Exon 18, c.2042 C>T, p.Ala681Val	Discrepancy by InSiGHT † and HGMD ‡ cl...",127,30,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Glu34Val,"448	MLH1/Exon 1, c.101–102delAGinsTT, p.Glu34Val	Inframe indel, novel VUS	Normal	Normal	...",128,39,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Leu390Phe,"68	MSH2/Exon 7, c.1168C>T, p.Leu390Phe	Probably dis causing by HGMD criteria ...",131,28,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Gly749Ala,"8	MSH6/Exon 4, c.2246G>C, p.Gly749Ala	Novel VUS	Normal	Normal	Normal	Normal	...",132,27,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Ile240Phe,"409	PMS2/Exon 7, C.718 A>T, p.Ile240Phe	Novel VUS	Normal	Normal	Normal	Normal	...",133,29,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.R93H,"...ther one carrying a missense variation in PLCXD3 (p.R93H), both supporting a role of the phosphatidy...",7,1508,PLoS_One_2014_Aug_11_9(8)_e104326.txt
p.R93H,"...n 2, in order to determine the specificity of the p.R93H mutation",28,714,PLoS_One_2014_Aug_11_9(8)_e104326.txt
p.R93H,"...und in these patients, and one amino acid change (p.R93H) was identified in one subject with early-o...",94,1127,PLoS_One_2014_Aug_11_9(8)_e104326.txt
p.R93H,"...to change the amino acid sequence of the protein (p.R93H) and transmitted from his father, who had a...",102,1180,PLoS_One_2014_Aug_11_9(8)_e104326.txt
p.R268Q,"...e identified a novel missense mutation (c.803G>A, p.R268Q) in the plasma membrane calcium ATPase (PM...",7,589,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,"... identified a novel causative mutation, c.803G>A, p.R268Q in the PMCA4 gene",15,222,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,"...d in an amino acid substitution at the same site, p.R268Q, of both protein isoforms, NP_001001396.1 ...",63,479,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,"... evaluated the impact of the mutation, c. 803G>A (p.R268Q), on PMCA4 protein structure (Fig. 2a,b). ...",78,53,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,"... mutation on the protein. According to AGGRESCAN, p.R268Q is located in protein aggregation-prone se...",78,370,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,...m 1% to 3%. All the other variants were rare. The p.R268Q variant that was identified in the symptom...,84,743,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,...database. There was perfect co-segregation of the p.R268Q mutation with disease status in our family...,84,935,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,"...death [23]. Taken together, we postulate that the p.R268Q mutation in PMCA4 identified in this famil...",86,1035,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.G13D,"...nchi A , Tu D , et al (2010 ) Association of KRAS p.G13D mutation with outcome in patients with chem...",169,109,PLoS_One_2014_Aug_4_9(8)_e103551.txt
p.P297S,"...ransactivation in in vitro reporter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P...",11,513,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,"...in in vitro reporter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPR...",11,528,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.S113T,"...orter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPRYDPCAAAAPGAPGP....",11,543,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,exon 3	c.280G>C	p.A94P	28	M	—	—	—	rs201350646,53,18,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I189F,c.565A>T	p.I189F	40	P	—	—	—	—,54,12,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A291V,c.872C>T	p.A291V	73	P	0.2	—	—	rs200459003,55,12,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,c.1334A>G	p.Y445C	35	—	—	—	—	—,56,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P297S,c.889C>T	p.P297S	66	M	—	—	1.7	rs79691946,59,12,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P195A,FOXC2	exon 1	c.583C>G	p.P195A	78	P	0.2	—	—	rs200751941,62,23,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,c.1331A>G	p.Q444R	34	—	0.2	0.14	—	rs147258453,63,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.S113T,exon 3	c.338G>C	p.S113T	500	—	0.8	0.66	0.2	rs144830740,69,18,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.T233T,GATA4	exon 2	c.699G>A	p.T233T	323	—	—	0.3	0.1	rs55788387,70,23,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A346V,exon 5	c.1037C>T	p.A346V	59	—	0.4	0.31	0.13	rs115372595,74,19,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A388A,exon 6	c.1164G>A	p.A388A	315	M	—	0.03	—-	rs55968178,76,19,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.G27G,TBX20	exon 1	c.81C>T	p.G27G	325	M	—	0.01	—	rs113390069,89,22,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I122V,exon 2	c.364A>G	p.I122V	31	M	0.2	—	—	—,90,18,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.G39S,TBX1	exon 3	c.115G>A	p.G39S	31	M	—	—	—	—,91,22,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A346V,...t in a single patient apart from GATA4 c.1037C>T (p.A346V) and c.*1012G>C; and FOXH1 c.-333T>C that ...,98,228,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,"...CC, p.A25_A26insAA (maternal) and FOXA2 c.280G>C, p.A94P (maternal). The second patient carried GATA...",98,1197,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A291V,"...arried GATA4 c.*979G>C (maternal) FOXA2 c.872C>T, p.A291V (paternal) and TBX1 c.*11C>T (maternal). A...",98,1286,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P297S,"...ransactivation in in vitro reporter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P...",101,124,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,"...in in vitro reporter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPR...",101,139,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.S113T,"...orter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPRYDPCAAAAPGAPGP....",101,154,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,"...PGAPGP. Six variants (HAND2 p.A25_A26insAA, FOXA2 p.A94P, p.I189F and p.Y445C, and FOXC1 p.G378_G380...",101,247,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I189F,"...Six variants (HAND2 p.A25_A26insAA, FOXA2 p.A94P, p.I189F and p.Y445C, and FOXC1 p.G378_G380delGGG a...",101,255,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,"... (HAND2 p.A25_A26insAA, FOXA2 p.A94P, p.I189F and p.Y445C, and FOXC1 p.G378_G380delGGG and p.A488_49...",101,267,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,"...missense changes, in silico tools predicted FOXA2 p.A94P, p.I189F and p.Y445C to be damaging (with P...",101,478,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I189F,"... changes, in silico tools predicted FOXA2 p.A94P, p.I189F and p.Y445C to be damaging (with PolyPhen ...",101,486,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,"... silico tools predicted FOXA2 p.A94P, p.I189F and p.Y445C to be damaging (with PolyPhen scores of 0....",101,498,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,"...ptional activities of HAND2 p.A25_A26insAA, FOXA2 p.A94P, p.I189F and p.Y445C, and the compound FOXC...",101,653,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I189F,"...activities of HAND2 p.A25_A26insAA, FOXA2 p.A94P, p.I189F and p.Y445C, and the compound FOXC1 p.G378...",101,661,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,"...f HAND2 p.A25_A26insAA, FOXA2 p.A94P, p.I189F and p.Y445C, and the compound FOXC1 p.G378_G380delGGG ...",101,673,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I122V,... we studied the transcriptional activity of TBX20 p.I122V as variation of the neighbouring amino aci...,101,892,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,"...three non-synonymous FOXA2 variants investigated (p.A94P, p.I189F, and p.Y445C) affected transcripti...",110,173,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I189F,"...n-synonymous FOXA2 variants investigated (p.A94P, p.I189F, and p.Y445C) affected transcriptional act...",110,181,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,"...FOXA2 variants investigated (p.A94P, p.I189F, and p.Y445C) affected transcriptional activity as meas...",110,194,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I122V,...gulation observed between wild-type TBX20 and the p.I122V variant (data not shown),113,222,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.T233T,...constructs for ISL1 c.219-3C>T and GATA4 c.699G>A p.T233T produced an RNA profile identical to the w...,119,71,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A346V,"...runcating variants were found. All bar one, GATA4 p.A346V, was found in a single patient and each pa...",122,460,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P297S,"...nd found to alter transactivation capacity: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P...",124,388,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,"...er transactivation capacity: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPR...",124,403,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.S113T,"...ion capacity: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPRYDPCAAAAPGAPGP ...",124,418,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I122V,"[14]. Finally, TBX20 p.I122V was also studied as a change in the adjace...",125,22,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I121M,"...ied as a change in the adjacent amino acid (TBX20 p.I121M), identified in a patient with an ostium s...",125,93,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P11R,... [28]. This study detected one missense mutation (p.P11R) in two TOF patients that was not present i...,127,1219,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,34	FOXC2	p.Q444R	Tetralogy of Fallot with moderate valvar p...,133,10,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P297S,66	FOXC1	p.P297S	Tetralogy of Fallot with moderate to sever...,134,10,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.S113T,500	FOXH1	p.S113T	Tetralogy of Fallot with severe valvar and...,136,11,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P297S,"...n three of the controls, a missense change, FOXC1 p.P297S, and non-contiguous deletion of three glyc...",137,174,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P297S,...in Axenfeld Rieger syndrome (ARS) patients. FOXC1 p.P297S has been reported in two patients with thi...,137,392,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I122V,"...e readout of the functional assays, nor for TBX20 p.I122V. More detailed phenotypic information for ...",139,909,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.G149V,"...oding region of NOTCH3, a novel missense mutation p.G149V (c.446G>T) was found. This mutation was no...",7,1451,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149V,"...main and its high conservation through evolution, p.G149V mutation could be a potential pathogenic c...",7,1663,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149V,...utation at the nucleotide position 446 (c.446G>T; p.G149V) in a Chinese family with CADASIL,15,111,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149V,...e reported a novel NOTCH3 gene missense mutation (p.G149V) in a Chinese CADASIL family. The clinical...,89,67,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149V,"...By genetic testing, we revealed a novel c.446G>T (p.G149V) mutation located in exon 4 of the NOTCH3 ...",91,871,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149C,"...ype of CADASIL. Similarly, the mutation c.445G>T (p.G149C) was reported in 5 individuals with CADASI...",91,1506,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149V,"... of glycine within the C-loop of EGF-like domain, p.G149V mutation could be a potential pathogenic c...",95,178,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.V44A,... MedicineClinical PathologyA Novel GJA8 Mutation (p.V44A) Causing Autosomal Dominant Congenital Cata...,3,398,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,"...fied a novel heterozygous mutation, the c.131T>C (p.V44A) mutation, in exon2 of GJA8 in a Chinese fa...",28,75,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,...(c.131T>C) in exon 2. E: Conservation analysis of p.V44A of the Cx50 gene,73,617,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,"...e residue for alanine at codon 44 of connexin 50 (p.V44A), which is located in the first extracellul...",76,412,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44Amu,Our data indicated that the p.V44Amutation in the GJA8 gene was the causative ...,103,29,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,"...ary, we identified a novel heterozygous c.131T>C (p.V44A) mutation in GJA8 in a family of Chinese or...",116,58,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.Arg355Gln,...heterozygote of c.615+5G>A and a novel c.1064G>A (p.Arg355Gln) mutation. An aberrant transcript with...,11,158,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.R355Q,...AAAACTCAAATGCAGAACC	Site-directed mutagenesis for p.R355Q,54,62,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Arg355Gln,"...615+5G>A and a novel missense mutation c.1064G>A (p.Arg355Gln), which was inherited from his father ...",103,189,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Arg355Gln,"...lix of citrin protein (Fig. 4B), and the mutation p.Arg355Gln shortened the distance of the H-bond b...",109,291,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Arg355Gln,"...Furthermore, functional prediction of the variant p.Arg355Gln by Polyphen-2 produced a value of 1.00...",109,701,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Ala206Val,"...don 212, thus forming a truncated citrin molecule p.Ala206Valfs212X",115,906,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Arg355Gln,...g. 6B). These results indicated that the mutation p.Arg355Gln caused complete loss of the AGC functi...,124,687,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Arg355Gln,...ompound heterozygote of c.615+5G>A and c.1064G>A (p.Arg355Gln). The former was a common SLC25A13 mut...,130,794,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.G56R,"...have a recessive mode of inheritance, a c.166G>A (p.G56R) mutation in the NR2E3 gene is associated w...",14,1343,PLoS_One_2014_Jan_31_9(1)_e87942.txt
p.Pro15Ser,...829	G	G/A	0.093**	0.089	0.85	0.113	0.48	C	c.43C>T	p.Pro15Ser	missense	1	NH2-terminal region,92,70,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Thr296Thr,...s144891994	C	C/T	0 ∧	0.005	NA	0.008	NA	G	c.888G>A	p.Thr296Thr	synonymous	2	CCD,95,65,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Ala404Val,...3	G	G/A	0.135**	0.165	0.24	0.156	0.52	C	c.1211C>T	p.Ala404Val	missense	4	linker region between CCD &...,97,73,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Asn561Asn,...4	A	A/G	0.250**	0.292	0.20	0.347	0.02	T	c.1683T>C	p.Asn561Asn	synonymous	6	linker region between TMD...,98,73,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Tyr705Tyr,...044	G	G/A	0.020	0.020	1.00	0.024	0.75	C	c.2115C>T	p.Tyr705Tyr	synonymous	8	linker region between TMD...,99,71,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Thr714Thr,...4891994	C	C/A	0.008	0.005	0.66	0	0.32	G	c.2142G>T	p.Thr714Thr	synonymous	8	TMD 6,100,68,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Phe843Phe,...209	G	G/A	0.077	0.054	0.28	0.081	0.87	C	c.2529C>T	p.Phe843Phe	synonymous	11,102,71,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Gln904Gln,...8	C	C/T	0.140**	0.158	0.49	0.153	0.69	G	c.2712G>A	p.Gln904Gln	synonymous	13,103,73,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.I148M,"Genotyping of PNPLA3 variant p.I148M (rs738409, allele C/G) was performed accor...",61,30,PLoS_One_2014_Mar_17_9(3)_e91987.txt
p.I148M,"...and J , et al (2012 ) A common variant of PNPLA3 (p.I148M) is not associated with alcoholic chronic ...",275,109,PLoS_One_2014_Mar_17_9(3)_e91987.txt
p.T41A,"...nd in about 64–85% of all sporadic desmoids, with p.T41A (threonine to alanine), p.S45F (serine to p...",14,799,PLoS_One_2014_May_1_9(5)_e96391.txt
p.S45F,"...dic desmoids, with p.T41A (threonine to alanine), p.S45F (serine to phenylalanine), and p.S45P (seri...",14,830,PLoS_One_2014_May_1_9(5)_e96391.txt
p.S45P,"...o alanine), p.S45F (serine to phenylalanine), and p.S45P (serine to proline) being the most frequent...",14,868,PLoS_One_2014_May_1_9(5)_e96391.txt
p.P140S,"...e found five potential disease-causing mutations, p.P140S, p.S183L, p.S196G, p.Ser161delAGC and p. S...",7,784,PLoS_One_2014_May_21_9(5)_e98157.txt
p.S183L,"...ive potential disease-causing mutations, p.P140S, p.S183L, p.S196G, p.Ser161delAGC and p. Ser192_Gly...",7,793,PLoS_One_2014_May_21_9(5)_e98157.txt
p.S196G,"...tial disease-causing mutations, p.P140S, p.S183L, p.S196G, p.Ser161delAGC and p. Ser192_Gly193delAGC...",7,802,PLoS_One_2014_May_21_9(5)_e98157.txt
p.P140S,...). All other mutations were located in SRJ except p.P140S,119,444,PLoS_One_2014_May_21_9(5)_e98157.txt
p.S183L,"...cotransfection of VP16-P300 and the four mutants (p.S183L, p.S196G, p.Ser161delAGC, p.Ser192_Gly193d...",122,521,PLoS_One_2014_May_21_9(5)_e98157.txt
p.S196G,"...ction of VP16-P300 and the four mutants (p.S183L, p.S196G, p.Ser161delAGC, p.Ser192_Gly193delAGCGGC)...",122,530,PLoS_One_2014_May_21_9(5)_e98157.txt
p.P140S,"...ein interactions between p300 and CITED2, but the p.P140S mutant didn't alter the interactions",122,803,PLoS_One_2014_May_21_9(5)_e98157.txt
p.P140S,"...ctivity of mutants increased obviously except the p.P140S mutant. In conclusion, CITED2 mutations we...",127,371,PLoS_One_2014_May_21_9(5)_e98157.txt
p.P140S,"...tants were decreased obviously compared with wt. (p.P140S vs. wt-type 80% (t test, p<0.01), p.S183L ...",132,498,PLoS_One_2014_May_21_9(5)_e98157.txt
p.S183L,"...th wt. (p.P140S vs. wt-type 80% (t test, p<0.01), p.S183L vs. wt-type 85% (t test, p<0.01), p.Ser192...",132,540,PLoS_One_2014_May_21_9(5)_e98157.txt
p.I94X,"...ation of four novel cytochrome P4501B1 mutations (p.I94X, p.H279D, p.Q340H, and p.K433K) in primary ...",152,110,PLoS_One_2014_Oct_16_9(10)_e110473.txt
p.H279D,"... four novel cytochrome P4501B1 mutations (p.I94X, p.H279D, p.Q340H, and p.K433K) in primary congenit...",152,118,PLoS_One_2014_Oct_16_9(10)_e110473.txt
p.Q340H,"...el cytochrome P4501B1 mutations (p.I94X, p.H279D, p.Q340H, and p.K433K) in primary congenital glauco...",152,127,PLoS_One_2014_Oct_16_9(10)_e110473.txt
p.K433K,"... P4501B1 mutations (p.I94X, p.H279D, p.Q340H, and p.K433K) in primary congenital glaucoma patients ....",152,140,PLoS_One_2014_Oct_16_9(10)_e110473.txt
p.R534Q,"... the genetic factors, factor V Leiden (c.1601G>A, p.R534Q) and prothrombin G20210A mutations are wel...",17,157,PLoS_One_2015_Jul_17_10(7)_e0133196.txt
p.K196E,"...archers identified a missense mutation (c.586A>G, p.K196E) in the PS gene as a genetic risk factor f...",17,391,PLoS_One_2015_Jul_17_10(7)_e0133196.txt
p.L160H,"...with other CYP2A6 SNPs, e.g., rs1801272 (c.479T>A/p.L160H), with effect size of 0.68 CPD (N = 66,380...",176,516,PLoS_One_2015_Jul_1_10(7)_e0126113.txt
p.Ser163Arg,...responsible for X-linked retinitis pigmentosa and p.Ser163Arg in C1QTNF5 associated with Late-Onset ...,7,1304,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Asp186Asn,... a missense change in PRPH2 (NM_000322.4:c556G>A; p.Asp186Asn) [30] and the complete segregation in ...,97,74,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Phe162Tyr,"...ft deletion in RPGR (NM_000328.2: c.485_486delTT; p.Phe162Tyrfs*4) [31], a gene associated with xlRP...",97,308,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Ser163Arg,"...45.3: c.489C>A), leading to the missense mutation p.Ser163Arg previously associated with Late-Onset ...",97,691,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Ser163Arg,"...index case. Validation and segregation of C1QTNF5 p.Ser163Arg in the family revealed that, along wit...",97,855,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Asp186Asn,RP-0107	adRP	adCRD	PRPH2 c556G>A; p.Asp186Asn (NM_000322.4)	Kohl et al. 2012 [33],103,35,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Phe162Tyr,...0858	adRP + high myopia	xlRP	RPGR c.485_486delTT; p.Phe162Tyrfs*4 (NM_000328.2)	Sharon et al. 2000 [...,105,54,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Ser163Arg,RP-0911	adRP + AMD	LORD	C1QTNF5 c. 489C>A; p.Ser163Arg (NM_015645.3)	Hayward C et al. 2003 [3...,106,44,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Ser163Arg,"Family RP-0911 carried the mutation p.Ser163Arg C1QTNF5 responsible for LORD, a very r...",125,37,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.P174T,"c.521C>G, p.P174T	c.949_950insC	-",18,11,PLoS_One_2015_Jul_29_10(7)_e0134748.txt
p.R132H,"6	39	F	+++	p.R132H	WT	3,5",130,12,PLoS_One_2015_Jul_9_10(7)_e0130596.txt
p.D150H,"...served aspartic acid with histidine at codon 150 (p.D150H). By linkage and haplotype analysis, we ob...",7,1097,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...results of PolyPhen-2 and SIFT indicated that the p.D150H mutation was likely to damage to the struc...,7,1410,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...structure and function of AQP0. The wild type and p.D150H mutant AQP0 were expressed in HeLa cells s...,7,1505,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,"...ndividually. Taken together, our data suggest the p.D150H mutation is a novel disease-causing mutati...",7,2046,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,"...P, which substituted histidine for aspartic acid (p.D150H). The mutant would damage the trafficking ...",19,232,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...served aspartic acid with histidine at codon 150 (p.D150H) (Fig 3). This change was cosegregated wit...,60,203,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...tic acid (GAC) with histidine (CAC) at codon 150 (p.D150H),63,300,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,"MIP: c.448G>C, p.D150H		1.628	1.718	1.797	1.806",77,16,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,In order to evaluate the impact of p.D150H mutation on the structure and function of ...,82,36,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...on was damaging. These results together indicated p.D150H mutation is likely to be deleterious to th...,82,535,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,....0126679.g005Fig 5 Bioinformatics analysis of the p.D150H mutation and multiple sequence alignment,84,71,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,To investigate whether the p.D150H mutation impacts the normal trafficking of...,91,28,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...ids individually. These data demonstrate that the p.D150H mutation would damage the trafficking mech...,91,852,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...e bar = 10μm. (B) The quantities of wild type and p.D150H mutant AQP0 in membrane-enriched lysates o...,94,518,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...ace the conserved aspartic acid with a histidine (p.D150H) in AQP0. This mutation was cosegregated w...,97,382,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,"...esult, we identified this novel mutation of AQP0 (p.D150H) as the genetic defect of this congenital ...",97,915,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.M1T,"...autosomal dominant congenital cataract in humans (p.M1T [14], p.R33C [15], p.R113X [13], p.E134G [16...",97,1235,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.R33C,"...minant congenital cataract in humans (p.M1T [14], p.R33C [15], p.R113X [13], p.E134G [16], p.T138R [...",97,1247,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.R113X,"...ital cataract in humans (p.M1T [14], p.R33C [15], p.R113X [13], p.E134G [16], p.T138R [16], p.G165D ...",97,1260,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.E134G,"...in humans (p.M1T [14], p.R33C [15], p.R113X [13], p.E134G [16], p.T138R [16], p.G165D [12], p.Y177C ...",97,1274,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.T138R,"...1T [14], p.R33C [15], p.R113X [13], p.E134G [16], p.T138R [16], p.G165D [12], p.Y177C [17], p.R187C ...",97,1288,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.G165D,"...C [15], p.R113X [13], p.E134G [16], p.T138R [16], p.G165D [12], p.Y177C [17], p.R187C [18], p.V203fs...",97,1302,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.Y177C,"...X [13], p.E134G [16], p.T138R [16], p.G165D [12], p.Y177C [17], p.R187C [18], p.V203fs [19], p.G213V...",97,1316,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.R187C,"...G [16], p.T138R [16], p.G165D [12], p.Y177C [17], p.R187C [18], p.V203fs [19], p.G213VfsX46 [20], p....",97,1330,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.G213Vfs,"... [12], p.Y177C [17], p.R187C [18], p.V203fs [19], p.G213VfsX46 [20], p.G215D [21] and p.R233K [22])....",97,1359,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.G215D,"..., p.R187C [18], p.V203fs [19], p.G213VfsX46 [20], p.G215D [21] and p.R233K [22]). As the presence of...",97,1378,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.R233K,"....V203fs [19], p.G213VfsX46 [20], p.G215D [21] and p.R233K [22]). As the presence of clinical heterog...",97,1395,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.E134G,".... The mutations in transmembrane domains, such as p.E134G, p.T138R, p.G165D and p.G215D, show loss o...",99,791,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.T138R,"...ations in transmembrane domains, such as p.E134G, p.T138R, p.G165D and p.G215D, show loss of water p...",99,800,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.G165D,"... transmembrane domains, such as p.E134G, p.T138R, p.G165D and p.G215D, show loss of water permeabili...",99,809,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.G215D,"...ne domains, such as p.E134G, p.T138R, p.G165D and p.G215D, show loss of water permeability due to im...",99,821,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.G213Vfs,...otein in the endoplasmic reticulum (ER) caused by p.G213VfsX46 mutation increases the ER stress and ...,99,1056,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.R33C,"...rafficking [26]. In contrast, the cataract-linked p.R33C mutation, which locates at the extracellula...",99,1512,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,"...s in AQP0 function, we first tested the impact of p.D150H on protein location in HeLa cells. Intrigu...",101,134,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...positively charged) near the C terminus [29]. The p.D150H mutation results in the replacement of asp...,103,282,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...gressive cortical punctate cataract caused by the p.D150H mutation of MIP. It is a new missense muta...,105,99,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,"... Moreover, this study presented the evidence that p.D150H damages the trafficking of AQP0 and causes...",105,361,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...dies focusing on the biological changes caused by p.D150H are needed,105,570,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.P2328S,"...ter called as exon 3 deletion) or point mutations p.P2328S (c.6982C>T), p.T2538R (c.7613C>G), p.L411...",31,346,PLoS_One_2015_May_8_10(5)_e0125366.txt
p.T2538R,"...eletion) or point mutations p.P2328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q42...",31,368,PLoS_One_2015_May_8_10(5)_e0125366.txt
p.L4115F,"...tions p.P2328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p....",31,390,PLoS_One_2015_May_8_10(5)_e0125366.txt
p.Q4201R,"...>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c.13957G>T). Mu...",31,413,PLoS_One_2015_May_8_10(5)_e0125366.txt
p.V4653F,"..., p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c.13957G>T). Mutation nomenclature was b...",31,438,PLoS_One_2015_May_8_10(5)_e0125366.txt
p.Leu412Phe,...prising 1116 matching donors and recipients. TLR3 p.Leu412Phe and SIGIRR p.Gln312Arg significantly d...,7,921,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln312Arg,...onors and recipients. TLR3 p.Leu412Phe and SIGIRR p.Gln312Arg significantly deviated from Hardy-Wein...,7,944,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,"... Carrier frequencies of the minor alleles of TLR1 p.His305Leu (OR = 4.79, 95% CI = 2.35–9.75, P = 0....",7,1521,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,"...(OR = 4.79, 95% CI = 2.35–9.75, P = 0.0002), TLR1 p.Asn248Ser (OR = 1.26, 95% CI = 1.07–1.47, P = 0....",7,1583,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"...OR = 1.26, 95% CI = 1.07–1.47, P = 0.04) and TLR8 p.Met1Val (OR = 1.37, 95% CI = 1.14–1.64, P = 0.00...",7,1646,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...on single nucleotide polymorphisms (SNPs) such as p.Asp299Gly allele A/G and p.Thr399Ile allele C/T,...",13,1609,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,"...rphisms (SNPs) such as p.Asp299Gly allele A/G and p.Thr399Ile allele C/T, recipients were less likel...",13,1636,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...e (Illumina). Of the chosen SNPs, rs4986790 (TLR4 p.Asp299Gly) and rs4986791 (TLR4 p.Thr399Ile) are ...",20,937,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,... rs4986790 (TLR4 p.Asp299Gly) and rs4986791 (TLR4 p.Thr399Ile) are in linkage disequilibrium (LD) (r...,20,970,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Leu412Phe,"... Bonferroni correction for multiple testing, TLR3 p.Leu412Phe (P = 0.046) and SIGIRR p.Gln312Arg (P ...",33,599,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln312Arg,"... testing, TLR3 p.Leu412Phe (P = 0.046) and SIGIRR p.Gln312Arg (P < 0.0001) appeared in Hardy-Weinber...",33,634,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,"TLR1	4	p.His305Leu (rs3923647)	GOF [24,25] LOF [26]	T/a	9...",71,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,TLR1	4	p.Asn248Ser (rs4833095)	LOF [25–27]	C/t	53.7	36.6	...,72,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	4	p.Arg753Gln (rs5743708)	LOF [28–30]	G/a	95.2	4.8	0...,73,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Leu412Phe,"TLR3	4	p.Leu412Phe (rs3775291)	LOF [31,32] GOF [33]	C/t	4...",74,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"TLR4	9	p.Asp299Gly (rs4986790)	LOF [34,35]	A/g	89.3	10.1	...",75,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,"TLR4	9	p.Thr399Ile (rs4986791)	LOF [34,35]	C/t	89.1	10.3	...",76,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	1	p.Arg392Ter (rs5744168)	LOF [36–38]	G/a	88.1	11.7	...,77,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	1	p.Phe616Leu (rs5744174)	GOF [39–41]	A/g	34.8	48.5	...,78,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	4	p.Ser249Pro (rs5743810)	GOF [24]	G/a	35.8	46.7	17....,79,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,"TLR7	X	p.Gln11Leu (rs17900)	LOF [42,43]	A/t	71.7	23.3	5.0...",80,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"TLR8	X	p.Met1Val(rs3764880)	GOF [44,45]	A/g	66.4	15.0	18....",81,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln312Arg,SIGIRR	11	p.Gln312Arg (rs3210908)	ND	C/t	60.8	34.2	5.0	22.1	...,82,11,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,"...he carrier frequency of the minor allele for TLR1 p.His305Leu (OR = 4.79, 95% CI = 2.35–9.75, P = 0....",86,366,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,"...(OR = 4.79, 95% CI = 2.35–9.75, P = 0.0002), TLR1 p.Asn248Ser (OR = 1.26, 95% CI = 1.07–1.47, P = 0....",86,428,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"...OR = 1.26, 95% CI = 1.07–1.47, P = 0.04) and TLR8 p.Met1Val (OR = 1.37, 95% CI = 1.14–1.64, P = 0.00...",86,491,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,...lying disease entities. The minor allele for TLR1 p.His305Leu showed the strongest association with ...,86,877,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,"...(OR = 4.37, 95% CI = 1.83–10.43, P = 0.003). TLR1 p.Asn248Ser and TLR8 p.Met1Val showed some specifi...",86,1280,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"...1.83–10.43, P = 0.003). TLR1 p.Asn248Ser and TLR8 p.Met1Val showed some specificity for immunecomple...",86,1301,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	9.5	2.6	4.79	2.35–9.75	0.0002	0%,90,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,TLR1	p.Asn248Ser	30.0	25.9	1.26	1.07–1.47	0.04	6%,91,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	p.Arg753Gln	9.6	5.1	0.73	0.22–2.43	1,92,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,TLR4	p.Asp299Gly	5.8	5.4	1.27	0.52–3.12	1,93,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,TLR4	p.Thr399Ile	6.0	5.5	1.77	0.57–5.51	1,94,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	p.Arg392Ter	8.2	7.1	2.93	1.03–8.33	0.4,95,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	p.Phe616Leu	44.6	42.6	0.92	0.82–1.04	1,96,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	38.6	41.0	0.92	0.81–1.04	1,97,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,TLR7	p.Gln11Leu	21.7	21.1	1.05	0.85–1.30	1,98,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,TLR8	p.Met1Val	27.9	22.6	1.37	1.14–1.64	0.008	1%,99,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	Congenital	216	10.4	2.6	4.94	2.26–10.8...,108,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,TLR1	p.Asn248Ser	Congenital	216	25.9	25.9	1.02	0.76–1.3...,112,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,TLR8	p.Met1Val	Congenital	216	24.6	22.6	1.18	0.86–1.64	...,116,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	T/a	0.69	0.34–1.30	1	1.12	0.75–1.67	1,132,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,TLR1	p.Asn248Ser	C/t	0.86	0.65–1.13	1	0.85	0.64–1.12	1,134,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	p.Arg753Gln	G/a	0.71	0.44–1.11	1	0.74	0.52–1.04	1,136,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,TLR4	p.Asp299Gly	A/g	1.30	0.86–1.94	1	0.82	0.53–1.24	1,138,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,TLR4	p.Thr399Ile	C/t	1.28	0.85–1.90	1	0.85	0.56–1.28	1,140,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	p.Arg392Ter	G/a	1.35	0.94–1.93	1	1.08	0.75–1.54	1,142,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	p.Phe616Leu	A/g	0.92	0.69–1.24	1	0.78	0.59–1.05	1,144,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	G/a	1.00	0.75–1.33	1	0.91	0.68–1.20	1,146,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,TLR7	p.Gln11Leu	A/t	0.88	0.63–1.23	1	0.83	0.57–1.19	1,148,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,TLR8	p.Met1Val	A/g	0.96	0.68–1.34	1	1.09	0.77–1.55	1,150,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	T/a	0.68	0.39–1.18	1	1.60	1.20–2.12	0....,164,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,TLR1	p.Asn248Ser	C/t	0.97	0.78–1.20	1	1.09	0.88–1.35	1,166,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	p.Arg753Gln	G/a	0.84	0.59–1.20	1	1.32	1.04–1.68	0....,168,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,TLR4	p.Asp299Gly	A/g	0.85	0.60–1.20	1	0.90	0.65–1.25	1,170,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,TLR4	p.Thr399Ile	C/t	0.91	0.65–1.27	1	0.94	0.68–1.30	1,172,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	p.Arg392Ter	G/a	1.00	0.75–1.34	0.3	0.80	0.59–1.09	...,174,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	p.Phe616Leu	A/g	1.08	0.85–1.36	1	0.92	0.74–1.16	1,176,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	G/a	0.89	0.72–1.12	1	0.73	0.59–0.92	0....,178,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,TLR7	p.Gln11Leu	A/t	0.99	0.76–1.28	1	0.91	0.68–1.22	1,180,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,TLR8	p.Met1Val	A/g	1.25	0.98–1.61	1	1.07	0.81–1.41	1,182,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	T/a	1.02	0.52–2.00	1	1.01	0.65–1.56	1,196,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,TLR1	p.Asn248Ser	C/t	1.13	0.84–1.52	1	1.11	0.82–1.50	1,198,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	p.Arg753Gln	G/a	1.13	0.72–1.77	1	1.29	0.93–1.80	1,200,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,TLR4	p.Asp299Gly	A/g	1.15	0.74–1.80	1	0.80	0.50–1.29	1,202,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,TLR4	p.Thr399Ile	C/t	1.17	0.76–1.81	1	0.74	0.45–1.20	1,204,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	p.Arg392Ter	G/a	1.31	0.90–1.90	1	0.84	0.55–1.27	1,206,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	p.Phe616Leu	A/g	1.03	0.75–1.43	1	1.20	0.87–1.64	1,208,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	G/a	1.19	0.87–1.64	1	0.85	0.62–1.17	1,210,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,TLR7	p.Gln11Leu	A/t	0.83	0.57–1.19	1	0.89	0.59–1.35	1,212,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,TLR8	p.Met1Val	A/g	0.99	0.68–1.44	1	1.05	0.71–1.56	1,214,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,"...l transplant recipients, we observed that 1) TLR1 p.His305Leu, TLR1 p.Asn248Ser and TLR8 p.Met1Val s...",223,495,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,"...ients, we observed that 1) TLR1 p.His305Leu, TLR1 p.Asn248Ser and TLR8 p.Met1Val significantly assoc...",223,513,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"...at 1) TLR1 p.His305Leu, TLR1 p.Asn248Ser and TLR8 p.Met1Val significantly associated with the preval...",223,534,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,...d a higher frequency of the minor allele for TLR1 p.Asn248Ser in pediatric patients with IgA nephrop...,225,455,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,"... in our cohort. Unfortunately, in this study TLR1 p.His305Leu, the variant that showed a robust and ...",225,741,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...disease in our cohort, was not investigated. TLR4 p.Asp299Gly and p.Thr399Ile are by far the most st...",225,888,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,"...ohort, was not investigated. TLR4 p.Asp299Gly and p.Thr399Ile are by far the most studied TLR varian...",225,904,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...tion, which is in line with our study and because p.Asp299Gly and p.Thr399Ile are in high linkage di...",225,1277,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,"...n line with our study and because p.Asp299Gly and p.Thr399Ile are in high linkage disequilibrium, on...",225,1293,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,...f the minor allele frequency for the TLR4 variant p.Asp299Gly with pyelonephritis (both with and wit...,225,1531,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,...n association of the minor allele of TLR5 variant p.Arg392Ter with native kidney diseases [57]. The ...,225,1797,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"...]. The residual TLR variants, which includes TLR8 p.Met1Val that showed an association with end-stag...",225,1890,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	-	-	-	-	-	-	-,229,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,"TLR1	p.Asn248Ser	Lee, 2011	[56]	Korean	Native	GN	Health...",230,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,"TLR2	p.Arg753Gln	Mutlubas, 2009	[58]	Turkey	Native	CKD	...",232,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"TLR4	p.Asp299Gly	Nogueira, 2007	[12]	Brazil	Native	CKD	...",238,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,"TLR4	p.Thr399Ile	Nogueira, 2007	[12]	Brazil	Native	CKD	...",258,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,"TLR5	p.Arg392Ter	Cheng, 2013	[57]	Taiwan	Native	PN	no P...",272,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	p.Phe616Leu	-	-	-	-	-	-	-,276,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	-	-	-	-	-	-	-,277,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,TLR7	p.Gln11Leu	-	-	-	-	-	-	-,278,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,TLR8	p.Met1Val	-	-	-	-	-	-	-,279,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,... al. [58] did not identify an association of TLR2 p.Arg753Gln with renal transplant outcomes. In the...,286,519,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...es. In the context of renal transplantation, TLR4 p.Asp299Gly and p.Thr399Ile are also among the mos...",286,609,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,"...xt of renal transplantation, TLR4 p.Asp299Gly and p.Thr399Ile are also among the most studied TLR SN...",286,625,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,"...th our study, did not find an association of TLR5 p.Arg392Ter with renal transplant outcomes. Even t...",286,2198,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.A1066V,"M1040I, p.A1066V	3120G>A, 3197C>T	1	0.1",79,9,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
p.Gly1752Arg,.... A novel homozygous missense mutation c.5254G>A (p.Gly1752Arg) in gene RAI1 (retinoic acid induced ...,44,194,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,"...; a novel homozygous missense mutation c.1111C>G (p.Gly371Arg) in gene OTOF (otoferlin, MIM 603681) ...",44,373,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,"...sly known homozygous missense mutation c.2168A>G (p.His723Arg) was found in gene SLC26A4 (pendrin, M...",44,537,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,Nucleotide change (Amino acid change)	c.5254G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg) *	c.2168A>...,63,50,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,...cid change)	c.5254G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg) *	c.2168A>G (p.His723Arg),63,77,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,...ly1752Arg) *	c.1111C>G (p.Gly371Arg) *	c.2168A>G (p.His723Arg),63,103,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,Variant c.5254G>A (p.Gly1752Arg) in the RAI1 gen,78,20,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,...153841.g001Fig 1 Identification of the c.5254G>A (p.Gly1752Arg) mutation in the RAI1 gene in Altaian...,81,73,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,"...s F18, F37, F42, and F43 with mutation c.5254G>A (p.Gly1752Arg) in the RAI1 gene. (B) Validation of ...",82,130,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,"... is marked by grey symbols. M—mutation c.5254G>A (p.Gly1752Arg), wt—wild type",82,428,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,Variant c.1111C>G (p.Gly371Arg) in the OTOF gen,92,20,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,We found a novel mutation c.1111C>G (p.Gly371Arg) in the OTOF gene in two siblings (54-...,93,38,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,...153841.g002Fig 2 Identification of the c.1111C>G (p.Gly371Arg) mutation in the OTOF gene and the c.2...,95,73,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,...Arg) mutation in the OTOF gene and the c.2168A>G (p.His723Arg) mutation in the SLC26A4 gene in Altai...,95,131,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,...with related family F24) with mutation c.1111C>G (p.Gly371Arg) in the OTOF gene denoted as M. (B) Va...,96,105,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,...ee of the WES family F53 with mutation c.2168A>G (p.His723Arg) in the SLC26A4 gene which is denoted ...,96,259,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,Variant c.2168A>G (p.His723Arg) in gene SLC26A,100,20,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,Homozygous mutation c.2168A>G (p.His723Arg) in gene SLC26A4 was found in the only...,101,32,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,...hanging nonpolar glycine to basic polar arginine (p.Gly1752Arg) at amino acid position 1752 in the C...,114,389,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.R1217Q,"...ted forms of RAI1 protein with missense mutations p.R1217Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q156...",116,1304,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Q1389R,"...ein with missense mutations p.R1217Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S...",116,1326,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Q1562R,"...tions p.R1217Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) (all...",116,1348,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.S1808N,"...), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) (all are in C-terminal half o...",116,1373,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,"...actor activity [47]. Mutation found in our study, p.Gly1752Arg, locates in RAI1 amino acid sequence ...",116,2101,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Q1562R,...tes in RAI1 amino acid sequence between mutations p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) stud...,116,2169,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.S1808N,...quence between mutations p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) studied by Carmona-Mora et al...,116,2194,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,...le explanations [47] might also be applicable for p.Gly1752Arg,116,2348,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,...s meet main genetic criteria [48] for classifying p.Gly1752Arg variant as pathogenic rather than ben...,118,62,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,...enign: (i) strong segregation of homozygosity for p.Gly1752Arg with recessive HL in multiple affecte...,118,160,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,...ation prediction tools used in this study defined p.Gly1752Arg as possibly damaging or deleterious. ...,118,576,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,...se issues and prove presumed pathogenicity of the p.Gly1752Arg variant in further experimental studi...,118,1342,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,...evolutionarily conserved amino acid position 371 (p.Gly371Arg) in the region between domains C2B and...,124,195,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.G368Afs,"... (S3 Fig). Notably, mutations c.1103_1104delinsC (p.G368AfsX2), c.1180dupG (p.E394GfsX6), c.1194T>A ...",124,307,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.E394Gfs,"...ons c.1103_1104delinsC (p.G368AfsX2), c.1180dupG (p.E394GfsX6), c.1194T>A (p.D398E), and c.1236delC ...",124,333,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.D398E,"....G368AfsX2), c.1180dupG (p.E394GfsX6), c.1194T>A (p.D398E), and c.1236delC (p.E413NfsX90) located in...",124,358,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.E413Nfs,"....E394GfsX6), c.1194T>A (p.D398E), and c.1236delC (p.E413NfsX90) located in the same region of the OT...",124,384,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,...s differs across populations. Mutation c.2168A>G (p.His723Arg) found in Altaian family F53 is one of...,128,421,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.R152W,...ardiac phenotype associated with homozygosity for p.R152W mutation in the ARSB gene . Am J Med Genet...,196,197,PLoS_One_2016_Apr_19_11(4)_e0153543.txt
p.Asn98Ser,...estive of a possible underlying CPVT phenotype. A p.Asn98Ser mutation in CALM2 was detected in both ...,17,252,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,Human calmodulin 2 mutation p.Asn98Ser is associated with sudden cardiac death...,20,29,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,... pathogenic variant found in probands A and B was p.Asn98Ser in CALM2 (protein code: NP_001734.1:p.A...,37,1845,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,...as p.Asn98Ser in CALM2 (protein code: NP_001734.1:p.Asn98Ser; genomic code: NC_000002.11:g.47388990T...,37,1892,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,...0.1371/journal.pone.0153851.g002Fig 2 View of the p.Asn98Ser mutation,45,52,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,... pathogenic variant found in probands A and B was p.Asn98Ser in CALM2. p.Asn98Ser is not listed in p...,54,98,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,...ound in probands A and B was p.Asn98Ser in CALM2. p.Asn98Ser is not listed in public databases nor h...,54,119,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,"...ow frequency, that pAsn98Ser is a mutation. CALM2 p.Asn98Ser has been described recently by Makita e...",54,415,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,"...t the EF-hand 3 domain, a calcium binding region. p.Asn98Ser affects a highly conserved amino acid a...",54,651,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,"...ry small, this study provide novel information on p.Asn98Ser mutation in CALM2 as a cause of UCA in ...",57,900,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,Despite CALM2 p.Asn98Ser not being previously associated to CPVT...,61,15,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asp96Val,...a variant affecting the immediate upstream codon (p.Asp96Val) to our case was also described in a ch...,63,66,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,...ive early manifestations in children carrying the p.Asn98Ser mutation on CALM2. The evidence is more...,67,97,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.G110Efs,"...YP21A2 deletion, large gene conversion, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M23...",57,364,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.I236N,"... conversion, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p...",57,391,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.V237E,"...on, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p.Q318X, p...",57,400,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.M239K,"...A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p.Q318X, p.G424S, p...",57,409,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.R356W,"... cluster (p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p.Q318X, p.G424S, p.Arg483fs or the IVS2-...",57,431,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.Q318X,"...(p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p.Q318X, p.G424S, p.Arg483fs or the IVS2-13 A/C>G ...",57,440,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.G424S,"... p.V237E, p.M239K), p.Leu307fs, p.R356W, p.Q318X, p.G424S, p.Arg483fs or the IVS2-13 A/C>G (I2 splic...",57,449,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.I172N,"... A/C>G (I2 splice) mutations. B alleles carry the p.I172N mutation, resulting in 3 ± 7% residual enz...",57,533,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.P30L,"...idual enzymatic activity, and C alleles carry the p.P30L, p.V281L or p.P453S mutations, resulting in...",57,624,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.V281L,"...zymatic activity, and C alleles carry the p.P30L, p.V281L or p.P453S mutations, resulting in 20 ± 60...",57,632,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.P453S,"...ivity, and C alleles carry the p.P30L, p.V281L or p.P453S mutations, resulting in 20 ± 60% residual ...",57,643,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.A467T,...cleotide position (np) 1399 in exon 7 (c.1399G>A; p.A467T) in all four individuals,93,543,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
p.Ala467Thr,...f the common homozygous polymerase-gamma mutation p.Ala467Thr?,226,86,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
p.A467T,...resis (SANDO) in a sibling pair with a homozygous p.A467T POLG mutation . Muscle Nerve . 2010 ;41 (2...,239,103,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
p.Tyr75*,...ed previously. A novel de novo variant (c.225C>A; p.Tyr75*) was identified in the PAX6 gene in two u...,14,157,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Arg217*,"...aniridia. In addition, a known variant (c.649C>T; p.Arg217*) in PAX6 segregated in a family with ani...",14,280,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,"...XC1 gene, a novel heterozygous variant (c.454T>C; p.Trp152Arg) segregated with the disease in a Mexi...",14,396,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Tyr75*,...A novel heterozygous nonsense mutation (c.225C>A; p.Tyr75*) in the PAX6 gene was identified in the p...,41,369,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Tyr75*,...ee and segregation of a novel mutation (c.225C>A; p.Tyr75*) in the PAX6 gene. (B). Clinical presenta...,44,61,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Tyr75*,The same variation (c.225C>A; p.Tyr75*) was identified in another unrelated 2-ye...,46,31,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Arg217*,... eye. A heterozygous nonsense mutation (c.649C>T; p.Arg217*) in the PAX6 gene was detected in the pr...,48,475,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Arg217*,...ion of a previously described mutation (c.649C>T; p.Arg217*) in the PAX6 gene. (b). DNA sequence chr...,51,76,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,...racteristics. A novel missense variant (c.454T>C; p.Trp152Arg) was identified in the FOXC1 gene (Fig...,54,464,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,...gregation of a novel missense mutation (c.454T>C; p.Trp152Arg) in the FOXC1 gene. (B). Systemic and ...,57,70,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,...region of the FOXC1 protein surrounding the novel p.Trp152Arg mutation in various species. The trypt...,57,632,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Tyr75*,...ith aniridia. A novel de novo mutation (c.225C>A; p.Tyr75*) was identified in the PAX6 gene in one f...,69,141,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Arg217*,"...dition, a previously reported mutation (c.649C>T; p.Arg217*) was identified in the PAX6 gene [17] in...",69,337,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,"... ARS: a heterozygous missense mutation (c.454T>C; p.Trp152Arg), and a homozygous in-frame deletion (...",73,142,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,...amino-acid FHD [27]. The novel missense mutation (p.Trp152Arg) identified in this study affects a co...,75,620,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Gly,...ts the same amino acid as the previously reported p.Trp152Gly mutation in a patient with aniridia [2...,75,807,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Try152Gly,...Gly mutation in a patient with aniridia [28]. The p.Try152Gly mutation has a severe effect on FOXC1 ...,75,865,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,"...nding ability, and nuclear localization [28]. The p.Trp152Arg mutation may have a similar consequenc...",75,1029,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,"...phenotypes of the patients with these mutation as p.Trp152Arg mutation leads to ARS, while the previ...",75,1226,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Gly,"...ds to ARS, while the previously reported mutation p.Trp152Gly causes aniridia. Another FOXC1 mutatio...",75,1300,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Met161Lys,...rp152Gly causes aniridia. Another FOXC1 mutation (p.Met161Lys) has been reported to cause both aniri...,75,1353,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.L22F,1 p.L22F,220,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.D61N,2 p.D61N,222,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.A142T,3 p.A142T,224,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.M63X,1 p.M63X,260,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.A99T,2 p.A99T,262,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.T115A,1 p.T115A,310,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.L139X,2 p.L139X,312,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.Gly316Ser,... severe diseases of infancy. The patient’s ATP1A3 p.Gly316Ser mutation was validated in the laborato...,7,802,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...nalyzed with the Swiss PDV Viewer, SPDBV 4.1. The p.Gly316Ser mutation was introduced into human ATP...",25,258,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"ATP1A3	19	NM_152296.3	[c.946G>A, p.Gly316Ser]	A/G	G/G	G/G	G/G	G/G",60,34,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Glu482Lys,"UBQLN4	1	NM_020131.3	[c.1444G>A, p.Glu482Lys]	A/G	G/G	G/G	G/G	G/G",61,34,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Thr458Asn,"SRPK3	X	NM_014370.2	[c.1373C>A, p.Thr458Asn]	hemiA	A/C	hemi C	hemi C	C/C",63,33,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...in binding pockets in the middle of the membrane. p.Gly316Ser mutation is novel, and is in the highl...",67,216,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...e crystal structure in the K+-bound conformation, p.Gly316Ser is directly apposed to a residue in th...",67,367,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Phe780Leu,"...he 5th transmembrane span that is mutated in RDP (p.Phe780Leu) (Fig 2, top) [8]. The glycine is <3.7...",67,466,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,...ession studies were performed to test whether the p.Gly316Ser ATP1A3 mutation impairs the activity o...,73,64,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,...ed to be viable (not shown). Cells expressing the p.Gly316Ser mutation survived for 2–3 weeks in sta...,73,839,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,...le those with pGly316Ser were more rounded. Other p.Gly316Ser-transfected wells were trypsinized at ...,73,1125,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...aces were flattened (white arrowheads). In C, the p.Gly316Ser mutation was transfected. Many cells s...",76,462,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...nd no detectable division of the remaining living p.Gly316Ser cells. (D) Na,K-ATPase α3 western blot...",76,697,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...her lanes show transient expression of WT ATP1A3, p.Gly316Ser, and p.Glu815Lys, an inactive mutation...",76,1284,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Glu815Lys,"...ansient expression of WT ATP1A3, p.Gly316Ser, and p.Glu815Lys, an inactive mutation found in AHC [28...",76,1301,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Ile758Ser,...dy of four brains from aged RDP siblings with the p.Ile758Ser mutation demonstrated neuron losses in...,82,205,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly358Val,...[17]. In an infant with catastrophic epilepsy and p.Gly358Val ATP1A3 mutation that severely inhibite...,82,422,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...e critical role of the Na,K-ATPase, our patient’s p.Gly316Ser ATP1A3 mutation may be sufficient to c...",84,635,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Thr467Ile,"...quilins, is a homozygous UBQLN2 missense variant, p.Thr467Ile, found in a female FTD patient [41]. I...",87,1227,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Glu482Lys,"...quence. The functional consequences of the UBQLN4 p.Glu482Lys variant are not known, but substitutio...",87,1564,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.R47H,TREM2 variant p.R47H as a risk factor for sporadic amyotrophic l...,127,15,PLoS_One_2016_Mar_7_11(3)_e0150211.txt
p.His558Arg,"... RYR2 (rs3765097). Of these, the SCN5A rs1805124 (p.His558Arg) was the only non-synonymous variant. ...",77,205,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.N120Lfs,"...Fig 4). These results identified LMNA c.357-2A>G (p.N120Lfs*5) (NM_170707.3), a novel heterozygous s...",119,610,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,...anger sequencing. Two examples are provided: TMPO p.Arg690Cys variant (C>T) for a confirmed variant ...,122,113,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.N120Lfs,...0155421.g005Fig 5 Novel LMNA mutation c.357-2A>G (p.N120Lfs*5),127,72,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg225X,"...ected) identified a novel LMNA nonsense mutation (p.Arg225X) in a Japanese family [16], and WES of f...",142,384,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Lys219Thr,...unaffected) found a known LMNA missense mutation (p.Lys219Thr) in an Italian family [17]. WES of fiv...,142,520,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Gly232Val,...ected) identified a novel LMNA missense mutation (p.Gly232Val) in a Chinese family [18]. In these th...,142,659,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,"...orts, our study does not support the role of TMPO p.Arg690Cys [22], MYBPC3 p.Val895Met [23,24], and ...",148,78,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Val895Met,"...support the role of TMPO p.Arg690Cys [22], MYBPC3 p.Val895Met [23,24], and HCN4 p.Met1113Val [25] as...",148,103,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Met1113Val,"...690Cys [22], MYBPC3 p.Val895Met [23,24], and HCN4 p.Met1113Val [25] as highly penetrant, primary mut...",148,133,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,"...ly penetrant, primary mutations. We excluded TMPO p.Arg690Cys as the primary mutation in our family ...",148,208,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,... cohort was screened for TMPO mutations. The TMPO p.Arg690Cys variant was found in two brothers with...,148,494,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,...y that showed reduced lamin A binding of the TMPO p.Arg690Cys protein in vitro [22]. Our family stud...,148,648,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,"...ad the variant; therefore, we concluded that TMPO p.Arg690Cys variant was not the primary mutation i...",148,884,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Val895Met,"...ur study also does not support the role of MYBPC3 p.Val895Met as a highly penetrant, primary mutatio...",150,52,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Val895Met,"...iomyopathy (HCM); however, the role of the MYBPC3 p.Val895Met variant is not clear. As evidence for ...",150,219,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Val895Met,"...his 69-year-old unaffected brother had the MYBPC3 p.Val895Met variant, we concluded that the variant...",150,752,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Met1113Val,"Finally, HCN4 p.Met1113Val was another interesting candidate sin...",152,15,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.M1113V,...th preliminary evidence for an association of HCN p.M1113V and post-partum sinus bradycardia [25]. A...,152,180,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.M1113V,"...lished HCN4 mutation and two subjects had the HCN p.M1113V variant [25]. In our family, we found the...",152,336,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.M1113V,"...ily, we found the lack of segregation for the HCN p.M1113V and heart disease; only one affected sibl...",152,419,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Thr6018Ser,"... further analysis (Table 2) including a novel TTN p.Thr6018Ser variant, the rare variants reported a...",174,118,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,"...nts reported as putative mutations including TMPO p.Arg690Cys [22] and p.MYBPC3 Val895Met [23,24,26]...",174,204,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg795Lys,"...k for arrhythmia [52]. In addition, we found PKP4 p.Arg795Lys in all four affected members and in on...",174,383,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg321Ter,"...li A , Hansen J , et al (2013 ) The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy...",277,114,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.L811P,"...in sensation, a de novo missense SCN11A mutation (p.L811P; we have abbreviated the prefix “p” in thi...",15,584,PLoS_One_2016_May_25_11(5)_e0154827.txt
p.R222H,"...sis performed individuals. The genotype of SCN11A p.R222H (Family 1, 2, 4, 5 and 6) or SCN11A p.R222...",35,484,PLoS_One_2016_May_25_11(5)_e0154827.txt
p.R222S,"...CN11A p.R222H (Family 1, 2, 4, 5 and 6) or SCN11A p.R222S (Family 3) for each individual is illustra...",35,528,PLoS_One_2016_May_25_11(5)_e0154827.txt
p.W57C,"p.W57C[44, 45],[4]	Homo	-			221.71±16.19	337.84 ± ...",89,1,PLoS_One_2016_May_31_11(5)_e0156252.txt
p.Y81N,Comp. Het.	Comp. Het		p.Y81N* in POAG			0 for both	5for Y81N; 0 for fs	J...,93,23,PLoS_One_2016_May_31_11(5)_e0156252.txt
p.T325Sfs,Comp. Het.			p.T325SfsX104			0	0,106,14,PLoS_One_2016_May_31_11(5)_e0156252.txt
p.R444Q,"p.R444Q[69, 76, 78, 79]	Homo	-	-		274.15 ± 5.80	25...",113,1,PLoS_One_2016_May_31_11(5)_e0156252.txt
p.Glu22Glu,ER23/23EK	c.66G>A (p.Glu22Glu)	rs6189	2.19%	2.98% (ss1317539291)	2.93...,129,20,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
p.Arg23Lys,c.68G>A (p.Arg23Lys)	rs6190		2.98% (ss1317539290)	2.85%	2.4...,130,10,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
p.Asn363Ser,N363S	c.1088A>G (p.Asn363Ser)	rs56149945 (former rs6195 or rs356601...,131,18,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
p.F352C,.../heterozygous variants for [rs2229291; c.1055T>G (p.F352C)] and [rs1799821; c.1102G>A (p.V368I)] of ...,56,937,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2015_Oct_9_91(8)_351-368.txt
p.V368I,...; c.1055T>G (p.F352C)] and [rs1799821; c.1102G>A (p.V368I)] of CPT II and mitochondrial energy crisi...,56,974,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2015_Oct_9_91(8)_351-368.txt
p.Val213Ala,"...leles are PI*M1 (rs6647; NM_000295.4:c.710 T > C; p.Val213Ala, mature protein), PI*M2 (rs709932; c.3...",28,392,Respir_Res_2014_Oct_7_15(1)_125.txt
p.Arg101His,"...la, mature protein), PI*M2 (rs709932; c.374G > A; p.Arg101His) and PI*M3 (rs1303; c.1200A > C; p.Glu...",28,451,Respir_Res_2014_Oct_7_15(1)_125.txt
p.Glu376Asp,...> A; p.Arg101His) and PI*M3 (rs1303; c.1200A > C; p.Glu376Asp). The allelic frequency of these polym...,28,496,Respir_Res_2014_Oct_7_15(1)_125.txt
p.Glu342Lys,"... p. Glu264Val) and PI*Z (rs28929474; c.1096G > A; p.Glu342Lys), with a PI*S prevalence in Caucasians...",28,923,Respir_Res_2014_Oct_7_15(1)_125.txt
p.Leu79Arg,"...on 79, resulting in a missense amino acid variant p.Leu79Arg. This p.Leu79Arg variant is listed in t...",44,464,SAGE_Open_Med_Case_Rep_2014_Oct_6_2_2050313X14553520.txt
p.Leu79Arg,...in a missense amino acid variant p.Leu79Arg. This p.Leu79Arg variant is listed in the Leiden Open Va...,44,481,SAGE_Open_Med_Case_Rep_2014_Oct_6_2_2050313X14553520.txt
p.Leu79Arg,... at the Leiden Open Variation Database. Since the p.Leu79Arg variant had been identified in only one...,44,1341,SAGE_Open_Med_Case_Rep_2014_Oct_6_2_2050313X14553520.txt
p.R161Q,... for a mutation in the GCDH-coding gene (c.482G>A;p.R161Q). This case alerts pediatricians to consid...,26,390,Saudi_Med_J_2015_Nov_36(11)_1269.txt
p.Y110C,...g detected a homozygous novel mutation (c.329A>G; p.Y110C) in the MUT gene in patient 1 and a hetero...,3,1725,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
p.Q734X,... a novel homozygous nonsense mutation (c.2200C>T; p.Q734X) and a heterozygous in parents. This mutat...,3,1961,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
p.Y110C,"...nt 1, we detected a homozygous mutation (c.329A>G;p.Y110C) and heterozygous in both his parents. Thi...",23,59,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
p.Q734X,...etected a homozygous nonsense mutation (c.2200C>T;p.Q734X) in the patient and heterozygous in both h...,25,69,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
p.Y110C,"...nted in both patients. In patient 1, the c.329A>G;p.Y110C mutation is located in the alpha/beta chai...",30,804,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
p.Q734X,"...the protein, whereas in patient 2, the (c.2200C>T;p.Q734X) is located in the cobalamin binding domai...",30,926,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
p.P753S," 	EGFR c.2257C > T, p.P753S	Yes	98%	Yes	99%",170,21,Sci_Rep_2013_Dec_13_3_3494.txt
p.D3590A,"MAP3K5	c.3951T > G, p.D3590A (HT144)",188,21,Sci_Rep_2013_Dec_13_3_3494.txt
p.L1270F," 	c.4169 G > A, p.L1270F (MeWo)",189,17,Sci_Rep_2013_Dec_13_3_3494.txt
p.E376G,"MAP3K9	c.1127T > C, p.E376G (MeWo)",190,21,Sci_Rep_2013_Dec_13_3_3494.txt
p.P388S," 	c.1162 G > A, p.P388S (MeWo)",191,17,Sci_Rep_2013_Dec_13_3_3494.txt
p.R560X," 	c.1678G > A, p.R560X (MeWo",192,16,Sci_Rep_2013_Dec_13_3_3494.txt
p.W450*,"... a TULP1 homozygous nonsense mutation (c.1349G>A, p.W450*) which cosegregated with LCA in branch A o...",25,379,Sci_Rep_2015_Aug_26_5_13187.txt
p.D498E,"...ied a novel missense sequence variant (c.1494C>A, p.D498E) in the CNNM4 gene which is located in the...",25,777,Sci_Rep_2015_Aug_26_5_13187.txt
p.W450*,"Following the identification of the p.W450* nonsense mutation in MOL0367, we screened ...",27,37,Sci_Rep_2015_Aug_26_5_13187.txt
p.W450*,"...of 33 families of Druze origin. We identified the p.W450* mutation in one of these families, MOL1145...",27,159,Sci_Rep_2015_Aug_26_5_13187.txt
p.W450*,"...rly onset RP, were found to be homozygous for the p.W450* mutation. Three siblings (III:3, III:4, II...",27,391,Sci_Rep_2015_Aug_26_5_13187.txt
p.V734M,...nd identified a novel homozygous missense change (p.V734M) in the CDH3 gene. The p.V734M change was ...,27,675,Sci_Rep_2015_Aug_26_5_13187.txt
p.V734M,"...s missense change (p.V734M) in the CDH3 gene. The p.V734M change was absent in WES databases, fully ...",27,706,Sci_Rep_2015_Aug_26_5_13187.txt
p.C363S,ADAM9	c.1087T>A	p.C363S	0	arRP	Iraqi Jew	MOL0827 MOL0838	—	Homozyg...,85,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.V71F,AIPL1	c.211G>T	p.V71F	8*10−6	arLCA	Mix Jew	MOL0113	—	Homozygous	 ...,86,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.R160Q,BBS1	c.479G>A	p.R160Q	4*10−5	arRP	Arab Muslim	MOL0745	—	Homozygo...,87,15,Sci_Rep_2015_Aug_26_5_13187.txt
p.D696Afs,CDHR1	c.2087_2090delACAA	p.D696Afs	0	arRD	Arab Muslim	MOL0835	—	Homozygous	...,88,26,Sci_Rep_2015_Aug_26_5_13187.txt
p.R32*,CNGA1	c.94C>T	p.R32*	0	arRP	Moroccan Jew	MOL0927	—	Heterozygous	...,89,15,Sci_Rep_2015_Aug_26_5_13187.txt
p.R514*,CNGA1	c.1540C>T	p.R514*	0	arRP	Moroccan Jew	MOL0927	—	Heterozygous...,90,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.R762C,CNGB1	c.2284C>T	p.R762C	0	arRP	Buchara Jew	MOL0990	4	Homozygous	 ,91,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.W920*,CNGB1	c.2760G>A	p.W920*	8*10−6	arRP	Ashkenazi Jew	CHRD	—	Homozygou...,92,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.D498E,CNNM4	c.1494C>A	p.D498E	0	ar Jalili syndrome	Druze	MOL0367	—	Homoz...,93,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.L375*,CYP4V2	c.1123delC	p.L375*	0	arRP	Yemenite Jew	MOL0816	1	Homozygous	3...,94,19,Sci_Rep_2015_Aug_26_5_13187.txt
p.R984*,"C2ORF71	c.2950C>T	p.R984*	2*10−5	arRP	Jew (Iran, Turkey)	MOL0425	—	H...",95,19,Sci_Rep_2015_Aug_26_5_13187.txt
p.Q1097*,"C2ORF71	c.3289C>T	p.Q1097*	4*10−5	arRP	Jew (Iran, Turkey)	MOL0425	—	...",96,19,Sci_Rep_2015_Aug_26_5_13187.txt
p.T452Sfs,FAM161A	c.1355_6delCA	p.T452Sfs	4*10−5	arRP	Moroccan Jew	MOL0228	26	Homo...,97,23,Sci_Rep_2015_Aug_26_5_13187.txt
p.Q654*,PDE6A	c.1960C>T	p.Q654*	0	arRP	Arab Muslim	MOL0271	—	Homozygous	33...,101,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.T494M,PRPF3	c.1481C>T	p.T494M	0	adRP	Yemenite Jew	MOL0108	—	Heterozygous...,102,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.L99I,RDH12	c.295C>A	p.L99I	7*10−5	arRP	Moroccan Jew Moroccan Jew Turki...,105,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.A126V,RDH12	c.377C>T	p.A126V	8*10−6	arRP	Arab Muslim	MOL1389	—	Homozygo...,106,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.H241L,RPE65	c.722A>T	p.H241L	0	arRP	Ashkenazi Jew	MOL0942	—	Homozygous	...,107,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.G230*,RP1	c.688G>T	p.G230*	0	arRP	Yemenite Jew	MOL0181	1	Homozygous	2...,108,14,Sci_Rep_2015_Aug_26_5_13187.txt
p.C96*,SPATA7	c.288T>A	p.C96*	3*10−5	arLCA	Arab Muslim	MOL0758	—	Homozygo...,109,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.C181F,TSPAN12	c.542G>T	p.C181F	0	arFEVR	Beduin	MOL0513	—	Homozygous	 ,110,18,Sci_Rep_2015_Aug_26_5_13187.txt
p.G2313C,USH2A	c.6937G>T	p.G2313C	1*10−4	arRP	Arab Muslim	MOL1234	—	Heteroz...,113,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.V734M,CDH3	c.2200G>A	p.V734M	3*10−5	arRP	Druze	MOL1145	—	Homozygous	 ,122,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.M1L,CDHR1	c.1T>G	p.M1L	0	arRP	Druze	MOL1275	—	Homozygous	 ,123,14,Sci_Rep_2015_Aug_26_5_13187.txt
p.H76P,RPE65	c.227A>C	p.H76P	0	arRP	Arab Muslim	MOL1026	—	Homozygous	 ,124,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.D110G,RPE65	c.329A>G	p.D110G	0	arLCA	Arab Muslim	MOL0093	—	Homozygous	3...,125,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.C363S,ADAM9	c.1087T>A	p.C363S	Disease causing	1	0.00 Damaging	0	0	0,131,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.V734M,CDH3	c.2200G>A	p.V734M	Disease causing	1	0.06 Tolerated	0	0	3*10−...,132,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.M1L,CDHR1	c.1T>G	p.M1L	Disease causing	0	0.54 Tolerated	0	0	0,133,14,Sci_Rep_2015_Aug_26_5_13187.txt
p.D498E,CNNM4	c.1494C>A	p.D498E	Disease causing	1	0.00 Damaging	0	0	0,134,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.H76P,RPE65	c.227A>C	p.H76P	Disease causing	0.059	0.11 Tolerated	0	0	0,135,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.D110G,RPE65	c.329A>G	p.D110G	Disease causing	0.998	0.31 Tolerated	0	0	0...,136,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.G2313C,USH2A	c.6937G>T	p.G2313C	Disease causing	1	0.00 Damaging	1*10−3	8*...,137,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.V200M,"...e is the NLRP3 variant V198M (or, more precisely, p.V200M, rs121908147), detected in the control pop...",11,1017,Sci_Rep_2015_May_19_5_10200.txt
p.I591T,"...gous state with unknown function for patients O1 (p.I591T, rs11466045, MAF 0.07) and R1 (p.F425Y, rs...",27,381,Sci_Rep_2015_May_19_5_10200.txt
p.F425Y,"...tients O1 (p.I591T, rs11466045, MAF 0.07) and R1 (p.F425Y, rs11466045, MAF 0.001). None of these wer...",27,420,Sci_Rep_2015_May_19_5_10200.txt
p.E148Q,"...Conversely, in family A, we identified a variant (p.E148Q, rs3732930, MAF 0.06) shared among the two...",27,575,Sci_Rep_2015_May_19_5_10200.txt
p.Q703K,"...d a heterozygous change in NLRP3 related to CAPS (p.Q703K, rs35829419, MAF 0.04). In family B, we id...",27,750,Sci_Rep_2015_May_19_5_10200.txt
p.R121Q,"...A, usually associated with milder forms of TRAPS (p.R121Q, rs4149584, MAF 0.018). This change cosegr...",27,893,Sci_Rep_2015_May_19_5_10200.txt
p.R211C,"... cold autoinflammatory syndrome-2, in patient R1 (p.R211C). This change, located in a well-conserved...",27,1096,Sci_Rep_2015_May_19_5_10200.txt
p.V198M,The NLRP3 variant p.V198M associated with CAPS does not cosegregate ...,29,19,Sci_Rep_2015_May_19_5_10200.txt
p.V200M,"...ily O revealed the presence of the variant V198M (p.V200M, rs12908147, MAF 0.01), often associated w...",30,75,Sci_Rep_2015_May_19_5_10200.txt
p.R274Q,"...tated changes in NLRP5, for patients 2940 and F1 (p.R274Q, and p.N255S, respectively). Again, patien...",33,423,Sci_Rep_2015_May_19_5_10200.txt
p.N255S,"... in NLRP5, for patients 2940 and F1 (p.R274Q, and p.N255S, respectively). Again, patient 2940 presen...",33,436,Sci_Rep_2015_May_19_5_10200.txt
p.L607P,"...presented another rare variant in the gene NLRP2, p.L607P (rs182098487, MAF 0.001). A novel change, ...",33,530,Sci_Rep_2015_May_19_5_10200.txt
p.G504D,"...p.L607P (rs182098487, MAF 0.001). A novel change, p.G504D, was found in this same gene in patient B7...",33,580,Sci_Rep_2015_May_19_5_10200.txt
p.S4L,"...her common in the control CoLaus Lausanne cohort (p.S4L, rs142463014, for 2492, MAF 0.09; p.I331V, r...",33,857,Sci_Rep_2015_May_19_5_10200.txt
p.I331V,"...e cohort (p.S4L, rs142463014, for 2492, MAF 0.09; p.I331V, rs61735077, for R1 and R2, MAF 0.05). Ano...",33,897,Sci_Rep_2015_May_19_5_10200.txt
p.T162M,"...2, MAF 0.05). Another common variant in NLRP4 was p.T162M (rs117212164, MAF 0.03), co-segregating wi...",33,980,Sci_Rep_2015_May_19_5_10200.txt
p.I384T,"...R families we identified a rare change in NLRP10, p.I384T (rs150112481, MAF 0.01) although only in p...",33,1214,Sci_Rep_2015_May_19_5_10200.txt
p.S1025L,"...0.01) although only in patient O1, and the change p.S1025L (rs11671248, MAF 0.08) in NLRP11 in patie...",33,1290,Sci_Rep_2015_May_19_5_10200.txt
p.V939M,"... of the NLRP1 gene, with the only exception being p.V939M (rs61754791, MAF 0.01), found only in pati...",33,1458,Sci_Rep_2015_May_19_5_10200.txt
p.C10X,"...the inflammatory system. These polymorphisms were p.C10X (rs2043211, MAF 0.30) found in patients A1,...",33,1995,Sci_Rep_2015_May_19_5_10200.txt
p.G786V,"...s missense change in NLRC4, better known as IPAF, p.G786V (rs149451729, MAF 0.03) in patient 2941; a...",33,2231,Sci_Rep_2015_May_19_5_10200.txt
p.C241G,"...AF 0.03) in patient 2941; a novel change in NOD1 (p.C241G) in patient 2942, again in the NACHT domai...",33,2304,Sci_Rep_2015_May_19_5_10200.txt
p.V200M,...for example observed for the NLRP3 variant V198M (p.V200M). This change has been reported in several...,42,1052,Sci_Rep_2015_May_19_5_10200.txt
p.V200M,"...gues. Altogether, these data indicate that V198M (p.V200M) is likely a neutral human polymorphism an...",42,2350,Sci_Rep_2015_May_19_5_10200.txt
p.R211C,"... the novel change found in patient R1, the NLRP12 p.R211C, which is present in a well-conserved doma...",44,69,Sci_Rep_2015_May_19_5_10200.txt
p.R352C,...n function. Recently a similar missense mutation (p.R352C) in the same NACHT domain of this gene was...,44,215,Sci_Rep_2015_May_19_5_10200.txt
p.F425Y,...arried another very rare change in the gene MEFV (p.F425Y) with function unknown. The intriguing hyp...,44,701,Sci_Rep_2015_May_19_5_10200.txt
p.E148Q,"...fically, we identified a change in the MEFV gene (p.E148Q) and in NLRP3 (p.Q703K), both common polym...",44,1011,Sci_Rep_2015_May_19_5_10200.txt
p.Q703K,"...a change in the MEFV gene (p.E148Q) and in NLRP3 (p.Q703K), both common polymorphisms with a possibl...",44,1034,Sci_Rep_2015_May_19_5_10200.txt
p.Q703K,"...ctional effect on the protein. In particular, for p.Q703K, functional impairment of NLRP3 has been c...",44,1139,Sci_Rep_2015_May_19_5_10200.txt
p.V200M,Variant V198M (p.V200M) in gene NLRP3 does not cosegregate with P...,85,16,Sci_Rep_2015_May_19_5_10200.txt
p.G786V,IPAF (NLRC4)	149451729	2941	p.G786V	0.004	LRR6,123,29,Sci_Rep_2015_May_19_5_10200.txt
p.A161T,NAIP	61757629	B7	p.A161T	0.02	BIR2,124,18,Sci_Rep_2015_May_19_5_10200.txt
p.V939M,NLRP1	61754791	2942	p.V939M	0.02	LLR5,125,21,Sci_Rep_2015_May_19_5_10200.txt
p.S4L,NLRP2	142463014	2942	p.S4L	0.01	DAPIN,126,22,Sci_Rep_2015_May_19_5_10200.txt
p.G504D, 	novel	B7	p.G504D	0	NACHT,127,12,Sci_Rep_2015_May_19_5_10200.txt
p.L607P, 	182098487	2940	p.L607P	0.005	between NACHT and LRR1,128,18,Sci_Rep_2015_May_19_5_10200.txt
p.V198M,NLRP3	121908147	O5	p.V198M	0.01	between DAPIN and NACHT,129,20,Sci_Rep_2015_May_19_5_10200.txt
p.Q703K," 	35829419	A1,A2	p.Q703K	0.05	between NACHT and LRR1",130,18,Sci_Rep_2015_May_19_5_10200.txt
p.T162M,"NLRP4	117212164	O1,O5	p.T162M	0.004	NACHT",131,23,Sci_Rep_2015_May_19_5_10200.txt
p.N255S,NLRP5	novel	F1	p.N255S	0.001	between DAPIN and NACHT,132,16,Sci_Rep_2015_May_19_5_10200.txt
p.R274Q, 	novel	2940	p.R274Q	0.001	between DAPIN and NACHT,133,14,Sci_Rep_2015_May_19_5_10200.txt
p.I384T,NLRP10	150112481	O1	p.I384T	0.001	NACHT,134,21,Sci_Rep_2015_May_19_5_10200.txt
p.S1025L,NLRP11	11671248	2940	p.S1025L	0.01	C-terminal,135,22,Sci_Rep_2015_May_19_5_10200.txt
p.R211C,"NLRP12	novel	R1,R2	p.R211C	0.001	NACHT",136,20,Sci_Rep_2015_May_19_5_10200.txt
p.C241G,NOD1 (CARD4)	novel	2942	p.C241G	0	NACHT,137,25,Sci_Rep_2015_May_19_5_10200.txt
p.R1005Q,NOD3 (NLRC3)	novel	2940	p.R1005Q	0	LRR15,138,25,Sci_Rep_2015_May_19_5_10200.txt
p.S210L,"NOD4	16965150	2941, F1	p.S210L	0.03	before NACHT domain",139,24,Sci_Rep_2015_May_19_5_10200.txt
p.L193V,NOD5 (NLRX1)	150153921	B7	p.L193V	0.007	NACHT,140,27,Sci_Rep_2015_May_19_5_10200.txt
p.R547W," 	145779362	O1,O5	p.R547W	0.007	between NACHT and LRR1",141,19,Sci_Rep_2015_May_19_5_10200.txt
p.S306L,NWD1	149694092	F1	p.S306L	0.006	between WD and NACHT,142,19,Sci_Rep_2015_May_19_5_10200.txt
p.Val345Met,rs10911390	1q25.3	183616884	C/T	0.08	APOBEC4	p.Val345Met	exon 2	B	D,123,46,Sci_Rep_2015_Oct_13_5_14969.txt
p.Arg18Leu,rs139293	22q13.1	39496336	G/T	0.17	APOBEC3H	p.Arg18Leu	exon 2	D	T,124,45,Sci_Rep_2015_Oct_13_5_14969.txt
p.Lys121Asn,rs139299	22q13.1	39497454	G/C	0.31	APOBEC3H	p.Lys121Asn	exon 3	B	D,125,45,Sci_Rep_2015_Oct_13_5_14969.txt
p.L1491X,BCOR	stopgain SNV	NM_001123384:c.T4472A:p.L1491X	36	0.92	T66,130,41,Sci_Rep_2016_Apr_29_6_25264.txt
p.E1001Q,BCOR	nonsynonymous SNV	NM_001123383:c.G3001C:p.E1001Q	71	0.46	T63,131,46,Sci_Rep_2016_Apr_29_6_25264.txt
p.R976X,BCOR	stopgain SNV	NM_001123383:c.C2926T:p.R976X	56	0.38	T57,133,41,Sci_Rep_2016_Apr_29_6_25264.txt
p.C1436W,CREBBP	nonsynonymous SNV	NM_001079846:c.T4308G:p.C1436W	81	0.17	T62,135,48,Sci_Rep_2016_Apr_29_6_25264.txt
p.A2808T,...ir of compound heterozygous mutations (c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E)) (Table 2) in t...,36,1199,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,...us mutations (c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E)) (Table 2) in the EYS gene (NM_001142800...,36,1224,Sci_Rep_2016_Jan_20_6_19432.txt
p.S624L,...homozygous single-nucleotide mutation (c.1871G>A (p.S624L)) (Table 2) in ARRP-206. To confirm the ac...,36,1358,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,"...he parents were unaffected carriers of c.7868G>A (p.G2623E, father) and c.8422G>A (p.A2808T, mother)...",36,1648,Sci_Rep_2016_Jan_20_6_19432.txt
p.A2808T,"...rs of c.7868G>A (p.G2623E, father) and c.8422G>A (p.A2808T, mother) in family ARRP-49 and c.1871G>A ...",36,1681,Sci_Rep_2016_Jan_20_6_19432.txt
p.S624L,"....A2808T, mother) in family ARRP-49 and c.1871G>A (p.S624L, father) in family ARRP-206. The inheritan...",36,1732,Sci_Rep_2016_Jan_20_6_19432.txt
p.D904Qfs,"...Thus far, the mutations identified in EYS include p.D904Qfs*17, p.S754Afs*6, p.T657Afs*5, p.W2640*, ...",48,89,Sci_Rep_2016_Jan_20_6_19432.txt
p.S754Afs,"...mutations identified in EYS include p.D904Qfs*17, p.S754Afs*6, p.T657Afs*5, p.W2640*, p.E1836* and o...",48,103,Sci_Rep_2016_Jan_20_6_19432.txt
p.T657Afs,"...ntified in EYS include p.D904Qfs*17, p.S754Afs*6, p.T657Afs*5, p.W2640*, p.E1836* and others5918. Mo...",48,116,Sci_Rep_2016_Jan_20_6_19432.txt
p.W2640*,"...S include p.D904Qfs*17, p.S754Afs*6, p.T657Afs*5, p.W2640*, p.E1836* and others5918. Most of these r...",48,129,Sci_Rep_2016_Jan_20_6_19432.txt
p.E1836*,"...p.D904Qfs*17, p.S754Afs*6, p.T657Afs*5, p.W2640*, p.E1836* and others5918. Most of these reported mu...",48,139,Sci_Rep_2016_Jan_20_6_19432.txt
p.A2808T,"...ir of compound heterozygous mutations, c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E), in EYS in fami...",48,396,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,"...us mutations, c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E), in EYS in family ARRP-49. Both mutation...",48,421,Sci_Rep_2016_Jan_20_6_19432.txt
p.A2808T,...fect a conserved amino acid residue. The mutation p.A2808T in exon 43 is a single nucleotide polymor...,48,525,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,...rozygous mutation c.3329C>G18. The novel mutation p.G2623E in exon 40 identified in our study lies i...,48,944,Sci_Rep_2016_Jan_20_6_19432.txt
p.S624L,...ARRP-49. The novel homozygous mutation c.1871G>A (p.S624L) in EYS is likely the causative mutation f...,48,1291,Sci_Rep_2016_Jan_20_6_19432.txt
p.Q1536E,"...10, the compound heterozygous mutations c.C4060G (p.Q1536E) and c.A5038G (p.N1680D) were found, and ...",50,296,Sci_Rep_2016_Jan_20_6_19432.txt
p.N1680D,"...ygous mutations c.C4060G (p.Q1536E) and c.A5038G (p.N1680D) were found, and these mutations are loca...",50,320,Sci_Rep_2016_Jan_20_6_19432.txt
p.G473V,"...18, the compound heterozygous mutations c.G1418T (p.G473V) and c.C2971T (p.L991F) were found, and th...",50,504,Sci_Rep_2016_Jan_20_6_19432.txt
p.L991F,"...zygous mutations c.G1418T (p.G473V) and c.C2971T (p.L991F) were found, and these mutations are locat...",50,527,Sci_Rep_2016_Jan_20_6_19432.txt
p.Y2796X,"... novel homozygous stop-gain mutations, c.8388C>A (p.Y2796X) and c.3024C>A (p.C1008X), respectively, ...",52,105,Sci_Rep_2016_Jan_20_6_19432.txt
p.C1008X,"...in mutations, c.8388C>A (p.Y2796X) and c.3024C>A (p.C1008X), respectively, and these mutations resul...",52,130,Sci_Rep_2016_Jan_20_6_19432.txt
p.A2808T,ARRP-49	43	c.8422G>A	het	p.A2808T	missense	rs111991705	LamG	Tolerated (0.05...,104,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,ARRP-49	40	c.7868G>A	het	p.G2623E	missense	novel	EGF	Damaging (0.009)/Delet...,105,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.S624L,ARRP-206	12	c.1871G>A	hom	p.S624L	missense	novel	Unknown region	Tolerated (0...,106,27,Sci_Rep_2016_Jan_20_6_19432.txt
p.Q1536E,RP:S-10	26	c.4606C>G	het	p.Q1536E	missense	novel	Unknown region	Damaging (0...,108,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.N1680D,RP:S-10	26	c.5038A>G	het	p.N1680D	missense	novel	Unknown region	Damaging (0...,109,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.G473V,RP:S-18	9	c.1418G>T	het	p.G473V	missense	novel	Unknown region	NA/NA,111,25,Sci_Rep_2016_Jan_20_6_19432.txt
p.L991F,RP:S-18	19	c.2971C>T	het	p.L991F	missense	novel	EGF	Tolerated (0.541)/Neutr...,112,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.Y2796X,RP:S-22	43	c.8388C>A	hom	p.Y2796X	stopgain	novel	LamG	NA/NA,113,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.C2396S,RP:S-34	36	c.7187G>C	hom	p.C2396S	missense	novel	EGF	Damaging (0.000)/Delet...,114,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.C1008X,RP:S-48	20	c.3024C>A	hom	p.C1008X	stopgain	novel	EGF-CA	NA/N,116,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.G244S,...with various tumors. A TP53 mutation (c.730G > A; p.G244S) co-segregated with the tumor phenotype wi...,5,1084,Sci_Rep_2016_Jan_28_6_20221.txt
p.G244S,...ple types of tumors. A TP53 mutation (c.730G > A; p.G244S) was identified in the patients. This muta...,13,348,Sci_Rep_2016_Jan_28_6_20221.txt
p.G244S,"...er mother, including a TP53 mutation (c.730G > A; p.G244S) (Fig. 3A)",24,718,Sci_Rep_2016_Jan_28_6_20221.txt
p.G244S,... codons 727–735 of wild-type (WT) and c.730G > A (p.G244S) mutant TP 53 genes. (B) Schematic diagram...,98,75,Sci_Rep_2016_Jan_28_6_20221.txt
p.A191V,"... in the transcript (p.E50_Q93del) and c.572 C >T (p.A191V) in individuals 1 and 2, and c.967T > C (p...",7,1051,Sci_Rep_2016_Jul_20_6_30072.txt
p.S323P,"...(p.A191V) in individuals 1 and 2, and c.967T > C (p.S323P) and c.1243 A > G (p.M415V) in individual ...",7,1100,Sci_Rep_2016_Jul_20_6_30072.txt
p.M415V,"...and 2, and c.967T > C (p.S323P) and c.1243 A > G (p.M415V) in individual 3. Another patient (individ...",7,1127,Sci_Rep_2016_Jul_20_6_30072.txt
p.W318S,... and compound heterozygous mutations [c.953G > C (p.W318S) and c.2242_2244del (p.S748del)] was ident...,7,1268,Sci_Rep_2016_Jul_20_6_30072.txt
p.A191V,"...cing validated the c.279 + 1G > C and c.572C > T (p.A191V) variants in two siblings, which were tran...",19,603,Sci_Rep_2016_Jul_20_6_30072.txt
p.S323P,...pound heterozygous SLC12A5 mutations: c.967T > C (p.S323P) and c.1243A > G (p.M415V) (Fig. 1A),19,975,Sci_Rep_2016_Jul_20_6_30072.txt
p.M415V,... mutations: c.967T > C (p.S323P) and c.1243A > G (p.M415V) (Fig. 1A),19,1001,Sci_Rep_2016_Jul_20_6_30072.txt
p.W318S,"...pound heterozygous SLC12A5 mutations [c.953G > C (p.W318S) and c.2242_2244del (p.S748del)], who was ...",21,474,Sci_Rep_2016_Jul_20_6_30072.txt
p.A191V,"....S748del, respectively)15, transmembrane domains (p.A191V and p.M415V), and the large extracellular ...",23,554,Sci_Rep_2016_Jul_20_6_30072.txt
p.M415V,"...spectively)15, transmembrane domains (p.A191V and p.M415V), and the large extracellular loop (p.W318...",23,566,Sci_Rep_2016_Jul_20_6_30072.txt
p.W318S,"...V and p.M415V), and the large extracellular loop (p.W318S and p.S323P) adjacent to four conserved cy...",23,610,Sci_Rep_2016_Jul_20_6_30072.txt
p.S323P,"...V), and the large extracellular loop (p.W318S and p.S323P) adjacent to four conserved cysteines (C28...",23,622,Sci_Rep_2016_Jul_20_6_30072.txt
p.A191V,...nces in Cl− extrusion function especially between p.A191V and p.S323P mutants and WT KCC2. The surfa...,45,385,Sci_Rep_2016_Jul_20_6_30072.txt
p.S323P,...extrusion function especially between p.A191V and p.S323P mutants and WT KCC2. The surface expressio...,45,397,Sci_Rep_2016_Jul_20_6_30072.txt
p.A191V,"...nal domain (p.E50_Q93del), transmembrane domains (p.A191V and p.M415V) and the large extracellular l...",45,727,Sci_Rep_2016_Jul_20_6_30072.txt
p.M415V,"...p.E50_Q93del), transmembrane domains (p.A191V and p.M415V) and the large extracellular loop (p.S323P...",45,739,Sci_Rep_2016_Jul_20_6_30072.txt
p.S323P,"...1V and p.M415V) and the large extracellular loop (p.S323P), thus might have less effect on trafficki...",45,782,Sci_Rep_2016_Jul_20_6_30072.txt
p.L426P,"...ound heterozygous missense mutations c.1277T > C (p.L426P) and c.1652G > A (p.G551D), and the other ...",49,190,Sci_Rep_2016_Jul_20_6_30072.txt
p.G551D,"... mutations c.1277T > C (p.L426P) and c.1652G > A (p.G551D), and the other two (one deceased) possess...",49,216,Sci_Rep_2016_Jul_20_6_30072.txt
p.L311H,...sessed a homozygous missense mutation c.932T > A (p.L311H). Functional analysis concluded that the C...,49,312,Sci_Rep_2016_Jul_20_6_30072.txt
p.A191V,"...ncluding c.148_279del (p.E50_Q93del), c.572C > T (p.A191V), c.967T > C (p.S323P) and c.1243A > G (p....",64,278,Sci_Rep_2016_Jul_20_6_30072.txt
p.S323P,"...(p.E50_Q93del), c.572C > T (p.A191V), c.967T > C (p.S323P) and c.1243A > G (p.M415V). All variant cD...",64,300,Sci_Rep_2016_Jul_20_6_30072.txt
p.M415V,"... (p.A191V), c.967T > C (p.S323P) and c.1243A > G (p.M415V). All variant cDNAs were verified by seque...",64,326,Sci_Rep_2016_Jul_20_6_30072.txt
p.Ala191Val,"...ons	c.279 + 1G > C, p.Glu50_Gln93del; c.572C > T, p.Ala191Val	c.279 + 1G > C, p.Glu50_Gln93del; c.57...",109,57,Sci_Rep_2016_Jul_20_6_30072.txt
p.Ala191Val,"...Val	c.279 + 1G > C, p.Glu50_Gln93del; c.572C > T, p.Ala191Val	c.967T > C, p.Ser323Pro; c.1243A > G, ...",109,115,Sci_Rep_2016_Jul_20_6_30072.txt
p.Ser323Pro,"...u50_Gln93del; c.572C > T, p.Ala191Val	c.967T > C, p.Ser323Pro; c.1243A > G, p.Met415Val	c.953G > C, ...",109,139,Sci_Rep_2016_Jul_20_6_30072.txt
p.Met415Val,"...p.Ala191Val	c.967T > C, p.Ser323Pro; c.1243A > G, p.Met415Val	c.953G > C, p.Trp318Ser; c.2242_2244de...",109,165,Sci_Rep_2016_Jul_20_6_30072.txt
p.Trp318Ser,"...p.Ser323Pro; c.1243A > G, p.Met415Val	c.953G > C, p.Trp318Ser; c.2242_2244del, p.Ser748del",109,189,Sci_Rep_2016_Jul_20_6_30072.txt
p.His418Leu,Patient 1 Rome (Italy)	c.1253del	#1	12	p.His418Leufs*54	Frameshift	Maternal,109,40,Sci_Rep_2016_Mar_18_6_23213.txt
p.Arg1195A,c.3584G>A	25	p.Arg1195AGln	Missense	Paternal,110,14,Sci_Rep_2016_Mar_18_6_23213.txt
p.Met1908*,c.5720+1G>A (r.5720_5721ins148)	i35	p.Met1908*	Splice-site Frameshift	Paternal,111,37,Sci_Rep_2016_Mar_18_6_23213.txt
p.Arg1858*,Patient 2 Milan (Italy)	c.5572C>T	#2	34	p.Arg1858*	Nonsense	Paternal,112,41,Sci_Rep_2016_Mar_18_6_23213.txt
p.Glu2218*,c.6652G>T	41	p.Glu2218*	Nonsense	Paternal,113,14,Sci_Rep_2016_Mar_18_6_23213.txt
p.Arg2345Trp,c.7033C>T	45	p.Arg2345Trp	Missense	Maternal,114,14,Sci_Rep_2016_Mar_18_6_23213.txt
p.Tyr729*,...and 3B Buenos Aires (Argentina)**	c.2187C>A	#3	16	p.Tyr729*	Nonsense	Maternal and Paternal,115,63,Sci_Rep_2016_Mar_18_6_23213.txt
p.Arg175His,"...n GOF mutations; however, certain mutants such as p.Arg175His, p.Gly245Ser, p.Arg248Trp, p.Arg248Gln...",7,1221,Sci_Rep_2016_May_18_6_26191.txt
p.Gly245Ser,"...ns; however, certain mutants such as p.Arg175His, p.Gly245Ser, p.Arg248Trp, p.Arg248Gln and p.Arg273...",7,1234,Sci_Rep_2016_May_18_6_26191.txt
p.Arg248Trp,"...certain mutants such as p.Arg175His, p.Gly245Ser, p.Arg248Trp, p.Arg248Gln and p.Arg273His have been...",7,1247,Sci_Rep_2016_May_18_6_26191.txt
p.Arg248Gln,"...ts such as p.Arg175His, p.Gly245Ser, p.Arg248Trp, p.Arg248Gln and p.Arg273His have been shown to act...",7,1260,Sci_Rep_2016_May_18_6_26191.txt
p.Arg273His,"...175His, p.Gly245Ser, p.Arg248Trp, p.Arg248Gln and p.Arg273His have been shown to actively promote tu...",7,1276,Sci_Rep_2016_May_18_6_26191.txt
p.Arg175His,"...Furthermore, a number of GOF mutations, including p.Arg175His and p.Arg273His have been linked to th...",7,1404,Sci_Rep_2016_May_18_6_26191.txt
p.Arg273His,"...umber of GOF mutations, including p.Arg175His and p.Arg273His have been linked to the development of...",7,1420,Sci_Rep_2016_May_18_6_26191.txt
p.Leu344Gln,"...e missense mutation occurring outside of the DBD, p.Leu344Gln, was located in exon 10 of TP53. All m...",19,727,Sci_Rep_2016_May_18_6_26191.txt
p.Arg248Gln,"... acid, with approximately 9% (6/68) of mutations (p.Arg248Gln and p.Arg248Trp) occurring at this cod...",21,110,Sci_Rep_2016_May_18_6_26191.txt
p.Arg248Trp,"...oximately 9% (6/68) of mutations (p.Arg248Gln and p.Arg248Trp) occurring at this codon, followed by ...",21,126,Sci_Rep_2016_May_18_6_26191.txt
p.Agr175His,...Arg175 with approximately 6% (4/68) of mutations (p.Agr175His) and Arg342 with approximately 4% (3/6...,21,226,Sci_Rep_2016_May_18_6_26191.txt
p.Arg342*,...Arg342 with approximately 4% (3/68) of mutations (p.Arg342* and p.Arg342Glufs*2) occurring at this a...,21,293,Sci_Rep_2016_May_18_6_26191.txt
p.Arg342Glu,...proximately 4% (3/68) of mutations (p.Arg342* and p.Arg342Glufs*2) occurring at this amino acid (Fig...,21,307,Sci_Rep_2016_May_18_6_26191.txt
p.E298*,"... 5 splice mutations), a single nonsense mutation, p.E298* (exon 8), was classified as ‘Intermediate’...",29,546,Sci_Rep_2016_May_18_6_26191.txt
p.Arg342*,"...ons, all in exon 10 (two independent samples with p.Arg342*, p.Glu343* and p.Glu349*); 2 of 5 splice...",29,831,Sci_Rep_2016_May_18_6_26191.txt
p.Glu343*,"... exon 10 (two independent samples with p.Arg342*, p.Glu343* and p.Glu349*); 2 of 5 splice site mutat...",29,842,Sci_Rep_2016_May_18_6_26191.txt
p.Glu349*,"...independent samples with p.Arg342*, p.Glu343* and p.Glu349*); 2 of 5 splice site mutations (c.376-2A...",29,856,Sci_Rep_2016_May_18_6_26191.txt
p.Ser241Phe,...d to have the TP53 missense mutations c.722C > T (p.Ser241Phe) and c.818G > A (p.Arg273His) respecti...,34,594,Sci_Rep_2016_May_18_6_26191.txt
p.Arg273His,...utations c.722C > T (p.Ser241Phe) and c.818G > A (p.Arg273His) respectively. OV167 had the nonsense ...,34,623,Sci_Rep_2016_May_18_6_26191.txt
p.Glu298*,"...vely. OV167 had the nonsense mutation c.892G > T (p.Glu298*) (Fig. 7d). Further, immunostaining of a...",34,694,Sci_Rep_2016_May_18_6_26191.txt
p.Leu344Gln,...ll occurring in the p53 DBD with the exception of p.Leu344Gln in exon 10. All tumours with missense ...,47,119,Sci_Rep_2016_May_18_6_26191.txt
p.Arg342*,"... exon 10 classified as nonsense (two tumours with p.Arg342*, p.Glu343* and p.Glu349*) and two with f...",47,465,Sci_Rep_2016_May_18_6_26191.txt
p.Glu343*,"...assified as nonsense (two tumours with p.Arg342*, p.Glu343* and p.Glu349*) and two with frameshifts ...",47,476,Sci_Rep_2016_May_18_6_26191.txt
p.Glu349*,"...nsense (two tumours with p.Arg342*, p.Glu343* and p.Glu349*) and two with frameshifts (p.Phe328Hisfs...",47,490,Sci_Rep_2016_May_18_6_26191.txt
p.Phe328His,....Glu343* and p.Glu349*) and two with frameshifts (p.Phe328Hisfs*7 in exon 9 and p.Arg342Glufs*2 in e...,47,527,Sci_Rep_2016_May_18_6_26191.txt
p.Arg342Glu,...o with frameshifts (p.Phe328Hisfs*7 in exon 9 and p.Arg342Glufs*2 in exon 10) also resulted in accum...,47,557,Sci_Rep_2016_May_18_6_26191.txt
p.Glu348*,"...with the exception of a single nonsense mutation, p.Glu348* in exon 8, that demonstrated an ‘Interme...",47,1158,Sci_Rep_2016_May_18_6_26191.txt
p.S267F,... is encoded by the SLC10A1 gene. Variation of the p.S267F (rs2296651) in SLC10A1 gene results in los...,11,172,Sci_Rep_2016_May_23_6_26465.txt
p.Ser267Phe,. The p.Ser267Phe variant in SLC10A1 is associated with ...,201,7,Sci_Rep_2016_May_23_6_26465.txt
p.Y856X,"...two heterozygous nonsense mutations (c.2568C > A, p.Y856X; c.1714C > T, p.R572×16). To the best of o...",31,531,Sci_Rep_2016_Oct_14_6_35414.txt
p.A2064T,"...family 2, a novel missense mutation (c.6190G > A, p.A2064T) and a known splicing mutation (c.6479 + ...",31,705,Sci_Rep_2016_Oct_14_6_35414.txt
p.N965S,"...viously reported missense mutations (c.2894A > G, p.N965S18; c.5929G > A, p.G1977S19) in ABCA4. In f...",31,1039,Sci_Rep_2016_Oct_14_6_35414.txt
p.G1977S,"...e mutations (c.2894A > G, p.N965S18; c.5929G > A, p.G1977S19) in ABCA4. In family 4, in addition to ...",31,1063,Sci_Rep_2016_Oct_14_6_35414.txt
p.L296Cfs,"...20, we discovered a deletion mutation (c.885delC, p.L296CfsX4)17 in the proband F4:II:1, which was p...",31,1200,Sci_Rep_2016_Oct_14_6_35414.txt
p.L296Cfs,"... and c.5196 + 1G > A), introducing a frame shift (p.L296CfsX4) or by the introduction of a premature...",34,190,Sci_Rep_2016_Oct_14_6_35414.txt
p.R572X,...or by the introduction of a premature stop codon (p.R572X and p.Y856X). In silico predictions suppor...,34,253,Sci_Rep_2016_Oct_14_6_35414.txt
p.Y856X,...troduction of a premature stop codon (p.R572X and p.Y856X). In silico predictions supported a pathog...,34,265,Sci_Rep_2016_Oct_14_6_35414.txt
p.A2064T,"...nse mutations found in family 2 and family 3, the p.A2064T mutation had not been reported previously...",39,72,Sci_Rep_2016_Oct_14_6_35414.txt
p.A2064T,"...emplate to predict the likely structure impact of p.A2064T substitution on ABCA4 protein with PyMOL,...",39,486,Sci_Rep_2016_Oct_14_6_35414.txt
p.A2064T,...with the residue ALA-2064 located at chain B. The p.A2064T mutation would induce an additional hydro...,39,1185,Sci_Rep_2016_Oct_14_6_35414.txt
p.N965S,...ional structure. The other two missense mutations p.N965S and p.G1977S were respectively first descr...,39,1524,Sci_Rep_2016_Oct_14_6_35414.txt
p.G1977S,...ure. The other two missense mutations p.N965S and p.G1977S were respectively first described in Dani...,39,1536,Sci_Rep_2016_Oct_14_6_35414.txt
p.N965S,"...anish people. As the Danish founder mutation, the p.N965S mutation was found to account for 16.2% of...",39,1645,Sci_Rep_2016_Oct_14_6_35414.txt
p.R572X,...d as null mutations: two were nonsense mutations (p.R572X and p.Y856X); two were splice-site mutatio...,41,95,Sci_Rep_2016_Oct_14_6_35414.txt
p.Y856X,...tations: two were nonsense mutations (p.R572X and p.Y856X); two were splice-site mutations (c.6479 +...,41,107,Sci_Rep_2016_Oct_14_6_35414.txt
p.L296Cfs,...c.5196 + 1G > A); and one was frameshift variant (p.L296CfsX4). Our data suggested that each of them...,41,219,Sci_Rep_2016_Oct_14_6_35414.txt
p.R572X,F1:III:1	9	0.15/0.15	12	c.1714C > T	p.R572X	Het	Nonsense	—	—	—	Rare	12,73,37,Sci_Rep_2016_Oct_14_6_35414.txt
p.Y856X,16	c.2568C > A	p.Y856X	Het	Nonsense	—	—	—	Novel	This study,74,16,Sci_Rep_2016_Oct_14_6_35414.txt
p.N965S,F3:II:2	49	FC/FC	19	c.2894A > G	p.N965S	Het	Missense	PD(0.999)	DC(0.999)	D(0.012)	...,77,33,Sci_Rep_2016_Oct_14_6_35414.txt
p.G1977S,43	c.5929G > A	p.G1977S	Het	Missense	PD(1.000)	DC(0.999)	D(0.000)...,78,16,Sci_Rep_2016_Oct_14_6_35414.txt
p.L296Cfs,F4:II:1	45	FC/FC	8	c.885delC	p.L296CfsX4	Het	Frameshift	—	—	—	Rare	13,79,30,Sci_Rep_2016_Oct_14_6_35414.txt
p.D38A,Exon 4	rs5035	c.113A > C for eAE1	p.D38A for eAE1	1 incomplete dRTA,152,35,Sci_Rep_2016_Oct_21_6_35841.txt
p.Ile157Thr,... DNA damage3435. The missense variant rs17879961 (p.Ile157Thr) changes Isoleucine to Threonine at po...,28,367,Sci_Rep_2016_Sep_16_6_33542.txt
p.Ile157Thr,...ng of principal substrates. The rs17879961 (CHEK2 p.Ile157Thr) substitution may alter its ability to...,28,593,Sci_Rep_2016_Sep_16_6_33542.txt
p.Lys3326X,"...way for DNA repair394041. The variant rs11571833 (p.Lys3326X) leads to a stop codon, which results i...",28,1024,Sci_Rep_2016_Sep_16_6_33542.txt
p.Lys3326X,...g domain and small protein sequence incorporating p.Lys3326X (amino acids 3265–3330) is capable of b...,28,1330,Sci_Rep_2016_Sep_16_6_33542.txt
p.Ile157Thr,...ing the CHEK2 activity as a result of rs17879961 (p.Ile157Thr)173234,30,1635,Sci_Rep_2016_Sep_16_6_33542.txt
p.Lys3326Ter,...ation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context ...,299,58,Sci_Rep_2016_Sep_16_6_33542.txt
p.Thr400Pro,"...G > A, which resulted in following substitutions: p.Thr400Pro (p.T400P) and p.Arg516His (p.R516H), r...",91,277,Sci_Rep_2016_Sep_20_6_33742.txt
p.T400P,"...resulted in following substitutions: p.Thr400Pro (p.T400P) and p.Arg516His (p.R516H), respectively. ...",91,290,Sci_Rep_2016_Sep_20_6_33742.txt
p.Arg516His,"...ollowing substitutions: p.Thr400Pro (p.T400P) and p.Arg516His (p.R516H), respectively. (B) CCT2 gene...",91,303,Sci_Rep_2016_Sep_20_6_33742.txt
p.R516H,"...titutions: p.Thr400Pro (p.T400P) and p.Arg516His (p.R516H), respectively. (B) CCT2 gene mutations an...",91,316,Sci_Rep_2016_Sep_20_6_33742.txt
p.Q1063K,p.Q1063K	c.3187C > A	NR	1 (1.1)	-	T	C0	-,168,1,Springerplus_2012_Sep_25_1_20.txt
p.Q61K,"...n one FTC. Two NRAS codon 61 mutations (c.181C>A, p.Q61K) were also found, one in FTC and one in PTC...",77,469,Thyroid_2016_Feb_1_26(2)_227-234.txt
p.T158M,"...). In comparison with wild-type MECP2, MECP2 with p.T158M or p.R168X mutation failed to enhance the ...",45,1080,Transl_Psychiatry_2013_Oct_22_3(10)_e316.txt
p.R168X,"...rison with wild-type MECP2, MECP2 with p.T158M or p.R168X mutation failed to enhance the activation ...",45,1091,Transl_Psychiatry_2013_Oct_22_3(10)_e316.txt
p.R270X,...s in the transcription repressor domain of MeCP2 (p.R270X and p.R306C) did not significantly alter M...,45,1425,Transl_Psychiatry_2013_Oct_22_3(10)_e316.txt
p.R306C,...nscription repressor domain of MeCP2 (p.R270X and p.R306C) did not significantly alter MET transcrip...,45,1437,Transl_Psychiatry_2013_Oct_22_3(10)_e316.txt
p.T158M,...is attenuated by RTT-specific mutations in MeCP2 (p.T158M and p.R168X) that impact the methyl-bindin...,45,1677,Transl_Psychiatry_2013_Oct_22_3(10)_e316.txt
p.R168X,"...d by RTT-specific mutations in MeCP2 (p.T158M and p.R168X) that impact the methyl-binding domain, bu...",45,1689,Transl_Psychiatry_2013_Oct_22_3(10)_e316.txt
p.Ala389Asp,"...) paternal allele, g.8280_9560del (ex. 11-12-12), p.Ala389AspfsX151 maternal allele]",15,171,Turk_J_Haematol_2014_Sep_5_31(3)_335-336.txt
p.G13D,...  Frattini M  Piessevaux H    Association of KRAS p.G13D mutation with outcome in patients with chem...,184,146,World_J_Clin_Oncol_2016_Oct_10_7(5)_340-351.txt
p.Phe51Leu,"...sis identified a heterozygous deletion, c.153del (p.Phe51Leufs*144) in exon 1 causing a frameshift m...",4,1854,Yonsei_Med_J_2015_Jan_1_56(1)_300-303.txt
p.Phe51Leu,...rameshift that results in a premature stop codon (p.Phe51Leufs*144). The c.153del mutation is novel ...,12,1807,Yonsei_Med_J_2015_Jan_1_56(1)_300-303.txt
p.Phe51Leu,"...involved a novel heterozygous mutation, c.153del (p.Phe51Leufs*144) in exon 1, which results in a fr...",21,440,Yonsei_Med_J_2015_Jan_1_56(1)_300-303.txt
p.R257X,...x different AIRE gene mutations were detected and p.R257X mutation was present in 63.3 % of patholog...,10,421,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
p.R257X,"...zličnih mutacij gena AIRE, najpogostejša mutacija p.R257X je bila opredeljena pri 63,3 % mutiranih a...",22,461,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
p.R257*,...valent mutation in Slovenian APS-1 population was p.R257* (c.769C>T) present in 63.3 % of pathologic...,54,189,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
p.R257*,...e majority of Slovenian patients share the common p.R257* (c.769C>T) mutation (1). CMC was detected ...,59,390,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
p.R257*,"...th American, British and Norwegian patients (23), p.R257* (c.769C>T) is present in more than 85 % of...",69,236,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
p.R257*,"...stent with other populations in the region, since p.R257* mutation was present in 63,3 % of patholog...",69,479,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
